[
  {
    "objectID": "feb_2025/demographic_clinical.html",
    "href": "feb_2025/demographic_clinical.html",
    "title": "Oncology Cohort Characteristics",
    "section": "",
    "text": "Release Version: Feb 2025 (IRB76049)\nThe oncology OMOP cohort is defined as all patients with an existing record in STARR-OMOP who are either listed in the Stanford Cancer Registry (also known as Neural Frame), or have had a Tumor Board encounter. As of the February 2025 OMOP population, 201,554 patients met the criteria for cancer cohort.\nThese metrics have been generated using the latest Stanford OMOP data and Neural Frame data."
  },
  {
    "objectID": "feb_2025/demographic_clinical.html#demographics",
    "href": "feb_2025/demographic_clinical.html#demographics",
    "title": "Oncology Cohort Characteristics",
    "section": "Demographics",
    "text": "Demographics\n\nAge Distribution\nBelow is the distribution of persons by year of birth.\n\n\n\n\n\n\n\n\nSummary of Patient Population\nThe demographic categories examined include Age, Sex, Race, and Ethnicity.\n\n\n\n\n\n\n\n\nAll Category Metrics - Oncology OMOP\n\n\nCharacteristic\n\nCount (N)\nPercentage (%)\n\n\n\n\nTotal\nTotal number of pts\n201,554\n100\n\n\nAge\n0-17\n2,743\n1\n\n\nAge\n18-44\n20,626\n10\n\n\nAge\n45-64\n60,730\n30\n\n\nAge\n65+\n117,400\n58\n\n\nAge\nNo OMOP Visit\n55\n0\n\n\nSex\nMale\n99,000\n49\n\n\nSex\nFemale\n102,523\n51\n\n\nSex\nOther\n0\n0\n\n\nSex\nUnknown\n31\n0\n\n\nRace\nAmerican Indian-Alaska Native\n720\n0\n\n\nRace\nAsian\n30,374\n15\n\n\nRace\nNative Hawaii\n1,575\n1\n\n\nRace\nBlack\n6,015\n3\n\n\nRace\nWhite\n117,697\n58\n\n\nRace\nOther-Unknown\n45,173\n22\n\n\nEthnicity\nHispanic Latino\n24,229\n12\n\n\nEthnicity\nNOT Hispanic Latino\n159,016\n79\n\n\nEthnicity\nOther-Missing\n18,309\n9"
  },
  {
    "objectID": "feb_2025/demographic_clinical.html#clinical-metrics",
    "href": "feb_2025/demographic_clinical.html#clinical-metrics",
    "title": "Oncology Cohort Characteristics",
    "section": "Clinical Metrics",
    "text": "Clinical Metrics\n\n\n\n\n\n\n\n\n\n\n\nClinical Metric Description\nOncology OMOP N(%)* (Total=201,554)\nTumor Board N(%)* (Total=24,662)\n\n\n\n\nNumber of patients with imaging reports, also a proxy for radiology imaging data\n184,854 (91.7%)\n23,746 (96.3%)\n\n\nNumber of patients with pathology/cytology clinical report\n169,774 (84.2%)\n22,777 (92.4%)\n\n\nNumber of patients given chemo medication\n89,183 (44.2%)\n13,452 (54.5%)\n\n\nNumber of patients with either a Hospital or Stanford Cancer Registry death date\n49,270 (24.4%)\n5,493 (22.3%)\n\n\nNumber of patients with pathology report\n168,052 (83.4%)\n22,910 (92.9%)\n\n\n\n* N(%) represents the counts and the corresponding percentage of the total\n\n\n\n\n\n\n\n\n\nThoracic Cancer Sub-Cohort\nThe following metrics were identified for individuals with thoracic cancer within the oncology OMOP (200k).\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nNumber of patients in Neural Frame and diagnosed with thoracic cancer\n13,379\n\n\nNumber of patients in Neural Frame and diagnosed with thoracic cancer with a death date\n6,212\n\n\nNumber of patients diagnosed with thoracic cancer and have a tumor board encounter\n2,583\n\n\n\n*Death date was defined either within STARR-OMOP or Neural Frame\n\n\n\n\n\n\n\n\n\n\nOMOP Image Occurrence\nAs of the February 2025 oncology OMOP population:\n\n93,333 (46.3%) out of 201,554 patients in the oncology cohort had image occurrence procedures.\n6,736 (50.3%) out of 13,379 thoracic patients had image occurrence procedures.\n2,435 (94.3%) out of 2,583 thoracic patients with tumor board encounter had image occurrence procedures.\n\n\n\nCTSA Metrics\nCTSA metrics are a common set of metrics developed in collaboration with the National Center for Advancing Translational Sciences (NCATS) to compare performance against other institutions within the network, facilitate benchmarking, and measure progress in translating basic science discoveries into clinical applications and patient benefits.\n\n\n\n\n\n\n\n\n\n\n\nCTSA Metrics\nPatient Count\n\n\n\n\nDistinct patients with atleast one address (SDOH)\n201,362\n\n\nDistinct patients with a lab test coded in LOINC\n198,393\n\n\nDistinct patients with an insurance provider (SDOH)\n195,431\n\n\nDistinct patients with a diagnosis coded in SNOMED\n187,552\n\n\nDistinct patients with a diagnosis coded in ICD 9/10\n187,551\n\n\nDistinct patients with a procedure coded in HCPCS or CPT\n184,685\n\n\nDistinct patients with a procedure coded in SNOMED\n182,655\n\n\nDistinct patients with at least one vital sign coded (height, weight, BP, BMI or temp)\n182,037\n\n\nDistinct patients with a medication coded in RxNorm/NDC\n178,101\n\n\nDistinct patients with a procedure coded in ICD 9/10 PCS\n127,946\n\n\nDistinct patients with a smoking status coded at least once\n89,177\n\n\nDistinct patients with opioid use disorder coded\n6,835\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Data\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Outcome Metrics\n\nPatient Count\n\n\n\n\nVital Status\nAlive\n92,689\n\n\nVital Status\nMissing (NA)\n63,893\n\n\nVital Status\nDead\n46,103\n\n\nCancer Status\nEvidence of this tumor\n73,202\n\n\nCancer Status\nMissing (NA)\n70,146\n\n\nCancer Status\nNo evidence of this tumor\n62,400\n\n\nCancer Status\nUnknown, indeterminate whether this tumor is present, not stated in patient record\n5,641\n\n\n\nNumber of Neural Frame Patients: 197,903\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRecurrence Type\nPatient Count\n\n\n\n\nPatient became disease-free after treatment and has not had a recurrence; leukemia in remission.\n109,502\n\n\nSince diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.\n78,504\n\n\nIt is unknown whether the disease has recurred or if the patient was ever disease-free.\n4,809\n\n\nLocal recurrence and there is insufficient information available to code to 13-17. Recurrence is confined to the remnant of the organ of origin; to the organ of origin; to the anastomosis; or to scar tissue where the organ previously existed.\n2,543\n\n\nDisease has recurred, but the type of recurrence is unknown.\n2,284\n\n\nLocal recurrence of an invasive tumor.\n1,835\n\n\nDistant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, and generalized disease.\n945\n\n\nDistant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.\n772\n\n\nDistant recurrence and there is insufficient information available to code to 46-62.\n683\n\n\nDistant recurrence of an invasive tumor in the liver only.\n671\n\n\nDistant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).\n667\n\n\nDistant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.\n657\n\n\nRegional recurrence, and there is insufficient information available to code to 21-27.\n425\n\n\nDistant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.\n415\n\n\nRecurrence of an invasive tumor in regional lymph nodes only.\n390\n\n\nBoth regional recurrence of an invasive tumor in adjacent tissue or organ(s) and/or regional lymph nodes (20-25) and local and/or trocar recurrence (10, 13, 14, or 15).\n295\n\n\nDistant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.\n220\n\n\nRecurrence of an invasive tumor in adjacent tissue or organ(s) only.\n210\n\n\nIn situ recurrence of an in situ tumor.\n100\n\n\nDistant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.\n98\n\n\nDistant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar, and/or regional recurrence (10-15, 20-25, or 30).\n85\n\n\nLocal recurrence of an in situ tumor.\n82\n\n\nIn situ recurrence of an invasive tumor.\n61\n\n\nRecurrence of an invasive tumor in adjacent tissue or organ(s) and in regional lymph nodes (both 21 and 22) at the same time.\n42\n\n\nDistant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.\n32\n\n\nBoth local and trocar recurrence of an invasive tumor (both 13 and 14)\n32\n\n\nDistant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.\n24\n\n\nBoth regional recurrence of an in situ tumor in adjacent tissue or organ(s) and/or regional lymph nodes (26 or 27) and local and/or trocar recurrence (16 or 17).\n16\n\n\nRegional recurrence of an in situ tumor, NOS.\n15\n\n\nBoth local and trocar recurrence of an in situ tumor.\n7\n\n\nDistant recurrence of an in situ tumor.\n7\n\n\nTrocar recurrence of an invasive tumor. Includes recurrence in the trocar path or entrance site following prior surgery.\n5\n\n\nNA\n3\n\n\nRecurrence of an in situ tumor in adjacent tissue or organ(s) and in regional lymph nodes at the same time.\n2\n\n\n\nNumber of Neural Frame Patients: 197,903"
  },
  {
    "objectID": "may_2025/neural_frame.html",
    "href": "may_2025/neural_frame.html",
    "title": "Neural Frame Metrics",
    "section": "",
    "text": "The Stanford Cancer Registry data is integrated with the California Cancer Registry and updated monthly, encompassing approximately 800 variables related to various cancer. As of January 2022, the KACIÂ® application from NeuralFrame was approved for abstracting and transmitting diagnosed cases, with Stanford adopting it in 2023. Neural Frame connects to EPIC to extract relevant data, including pathology notes.\nWithin Neural Frame, Class of Case (CoC) divides cases into two groups: cancer cases are categorized as Analytic (reportable with complete data) or Non-analytic (not reportable by law, with complete data only from 2022 onward).\n\nAnalytic: Analytic cases include patients with initial diagnoses and full or partial treatments at Stanford. Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the programâs primary responsibility in managing the cancer. Analytic cases are grouped according to the location of diagnosis and treatment.\nNon-analytic: Non-analytic cases include recurrences, consults only, and in-transit patients. Non-analytic cases (codes 30-49 and 99) can be abstracted by the facility to fulfill central registry requirements or upon request from the facilityâs cancer program. The grouping of non-analytic cases is based on the reason for their classification, whether they received care at the facility or were abstracted for other reasons."
  },
  {
    "objectID": "may_2025/neural_frame.html#thoracic-cancer-cohort",
    "href": "may_2025/neural_frame.html#thoracic-cancer-cohort",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Cohort",
    "text": "Thoracic Cancer Cohort\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancer. The thoracic cancer cohort includes patients diagnosed with primary malignancies located in the thoracic cavity, as defined by the International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) primary site codes. Specifically, the cohort is defined by the following ICD-O-3 topography codes:\n\nC34.0 â Main bronchus\nC34.1 â Upper lobe, lung\nC34.2 â Middle lobe, lung\nC34.3 â Lower lobe, lung\nC34.8 â Overlapping lesion of lung\nC34.9 â Lung, not otherwise specified (NOS)\nC37.9 â Thymus"
  },
  {
    "objectID": "may_2025/neural_frame.html#multiple-primary",
    "href": "may_2025/neural_frame.html#multiple-primary",
    "title": "Neural Frame Metrics",
    "section": "Multiple Primary",
    "text": "Multiple Primary\nWithin the thoracic cancer cohort, a subset of patients presents with multiple primary thoracic malignancies. This designation refers to the presence of two or more histologically distinct malignant tumors arising independently within the thoracic cavity, rather than as metastases from a single primary site. These neoplasms may occur synchronously, identified concurrently or within a short time interval, or metachronously, developing at distinct time points."
  },
  {
    "objectID": "may_2025/neural_frame.html#thoracic-cancer-metrics",
    "href": "may_2025/neural_frame.html#thoracic-cancer-metrics",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Metrics",
    "text": "Thoracic Cancer Metrics\nThis visualization summarizes the characteristics of thoracic cancer cases by:\n\nCases, Diagnoses, Staging\nTreatment\nSocial History\nFollow up Outcome\n\n\nCases & DiagnosesTreatmentFollow-up OutcomeSocial History\n\n\n\nStanford Cancer Registry Case Status\nThe Stanford Cancer Registry tracks all cancer cases diagnosed or treated at Stanford. Each case is assigned a case status to reflect its reporting stage. The primary categories include:\n\nCompleted: Reportable cases that have been fully abstracted and passed all edit checks. These cases are transmitted to the state registry.\nNot Reportable: Cases that do not meet state reporting requirements or have already been abstracted and submitted.\nIncomplete/Suspense: Reportable cases that have been abstracted but cannot yet be transmitted due to missing treatment information or unresolved edit errors. These may result from version changes, coding updates, or other registry requirements.\n\nThe case status ensures accurate tracking and timely reporting of cancer data to meet regulatory and research standards.\nAs of May 2025, there are 13,598 unique thoracic patients with 78.2 % completed cases.\n\n\n\n\n\n\n\n\n\n\n\nPatient Summary by Diagnosis Year\nThe following distribution summarizes the number of diagnosed thoracic patients over time.\n\n\n\n\n\n\n\n\nHistology Distribution & ICDO3 Codes\nThoracic cancer encompasses a diverse group of histologic subtypes, with Non-Small Cell Lung Cancer (NSCLC) representing the majority of cases and Small Cell Lung Cancer (SCLC).\nThoracic cancer is categorized into detailed histologic groups using ICD-O-3 codes and then further grouped into four overarching categories for simplified analysis. The main histology groups include:\n\nNon-Small Cell Lung Carcinoma (NSCLC): This group encompasses the majority of lung cancer and includes subtypes such as:\n\nAdenocarcinoma (8140â8147)\nSquamous Cell Carcinoma (8070â8080)\nLarge Cell Carcinoma (8010â8015)\nNon-Small Cell Carcinoma NOS (8046)\n\nSmall Cell Lung Carcinoma (SCLC): Represented by ICD-O-3 codes 8041â8045, this group is characterized by more aggressive, rapidly progressing tumors.\nOther Specified Histologies: These include a range of less common thoracic cancer such as:\n\nCarcinoid Tumors (8240â8249)\nSarcoma (8800â8806)\nMesothelioma (9050â9053)\nAcinar Cell Carcinoma (8550â8551)\nBronchiolo-alveolar Carcinoma (8250â8257)\nNeoplasms (8000â8005)\nPapillary Adenocarcinoma (8260â8265)\nPapillary Carcinoma (8050â8052)\n\nOther/Unspecified Histologies: Any histology not falling into the categories above.\n\n\n\nThoracic Cancer Histology Distribution\nFrom 10,634 thoracic patients with completed cases, the majority 7,420 were diagnosed with Non-Small Cell Lung Carcinoma (NSCLC).\n\n\n\n\n\n\n\n\n\n\n\n\nHistology\nN(%) of Patients\n\n\n\n\nNSCLC\n7,420 (69.8%)\n\n\nOther Specified\n1,835 (17.3%)\n\n\nOther Unspecified\n1,118 (10.5%)\n\n\nSCLC\n551 (5.2%)\n\n\n\nNote: Patients could have multiple histologies\n\n\n\n\n\n\n\n\n\n\n\nHistology Type Summary\n\nBar PlotICDO3 Table\n\n\nThe following horizontal bar chart presents the hierarchical distribution of thoracic cancer cases, showing both major categories (NSCLC, SCLC, Other Specified, and Other Unspecified) and their corresponding histological subtypes.\n\nClick legend items to show/hide specific main categories\nHover over bars to see detailed information\nDouble-click legend items to isolate a single category o to restore all categories\n\n\nDistribution of Thoracic Cancer Cases by Histology Types\n\n\n\n\n\n\n\n\nTable Summary of Histology Groups\n\n\n\n\n\n\n\n\n\nAll the ICDO3 code and histology subgrouping are listed in the following table:\n\n\n\n\n\n\n\n\n\n\n\nCancer Staging\nCancer staging is categorized as:\n\nStage 0: Carcinoma in situ (neoplastic cells confined to the epithelium without invasion) with no evidence of invasion beyond the basement membrane.\nOccult: A malignancy is confirmed by cytology or metastatic presentation without a known primary, meaning that the primary tumor is not clinically or radiologically identifiable.\nStage I: A localized tumor confined to the organ of origin, with no regional lymph node involvement or distant metastasis.\nStage II: A tumor of larger size or with limited regional extension that may involve adjacent structures or limited regional lymph nodes.\nStage III: Locally advanced disease characterized by involvement of regional lymph nodes and/or extension to nearby tissues.\nStage IV: Distant metastatic disease where the tumor has spread to distant organs or non-regional lymph nodes.\n\n\n\nSummary of Staging of Thoracic Cancer Patients\nThe following table summarizes the staging status of thoracic patients with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nStaging Status\nPatient Count\nPercentage (%)\n\n\n\n\nStage IV: Distant metastatic disease\n4,351\n41\n\n\nStage I: Localized tumor confined to the organ of origin\n2,785\n26\n\n\nStage III: Locally advanced disease\n1,796\n17\n\n\nUnknown\n1,023\n10\n\n\nStage II: Larger tumor size or limited regional extension\n782\n7\n\n\nOccult: Malignancy confirmed by cytology or metastatic presentation without known primary\n48\n0\n\n\nStage 0: Carcinoma in situ\n37\n0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe following table summarizes the distribution of thoracic cancer treatment types including chemotherapy, radiation therapy, and surgery across the patient cohort with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nTreatment\nPatient Count\nPercentage\n\n\n\n\nChemotherapy\n5,252\n49\n\n\nSurgery\n4,643\n44\n\n\nRadiation Therapy\n4,243\n40\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe following table summarizes the distribution of thoracic cancer recurrence status with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nRecurrence Type Category\nPatient Count\n\n\n\n\nNever been disease-free\n6,126\n\n\nDisease-free after treatment and has not had a recurrence\n4,202\n\n\nDistant recurrence\n427\n\n\nIt is unknown whether the disease has recurred or if the patient was ever disease-free.\n304\n\n\nLocal recurrence\n248\n\n\nDisease has recurred, but the type of recurrence is unknown.\n189\n\n\nRegional recurrence\n97\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFrom 13,598 unique thoracic cancer patients, the majority didnât have any records of smoking status and alcohol use in Neural Frame.\n\nSmoking Status (Neural Frame)\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nNot Available\n13,435\n\n\nNever used\n98\n\n\nPrevious use\n72\n\n\nCigarette smoker, current\n29\n\n\nUnknown\n3\n\n\n\nNote: sum of sungroups exceeds the denominator due to multiple responses by patients\n\n\n\n\n\n\n\n\n\n\nSmoking Status (OMOP)\nThe information regarding the most recent smoking status of patients with thoracic cancer was generated by querying the OMOP database. For patients diagnosed with lung, bronchus, or thymus cancer, relevant patient records were linked to their smoking status in OMOP observation table by filtering out the smoking concept ID (43054909), which included multiple entries over time. By ranking these entries by date, the analysis focused on retrieving only the most recent smoking status for each patient as follow.\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nFormer\n6,087\n\n\nNever\n4,293\n\n\nEvery Day\n674\n\n\nNever Assessed\n317\n\n\nSome Days\n116\n\n\nPassive Smoke Exposure - Never Smoker\n29\n\n\nUnknown\n27\n\n\nLight Smoker\n18\n\n\nHeavy Smoker\n12\n\n\nSmoker, Current Status Unknown\n8\n\n\n\nNote: 2,017 patients didn't have smoking concept ID in the observation table\n\n\n\n\n\n\n\n\n\n\nAlcohol Use (Neural Frame)\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nNot Available\n13,517\n\n\nNo history of alcohol use\n61\n\n\nCurrent use of alcohol\n31\n\n\nPast history of alcohol use, does not currently use\n10\n\n\nAlcohol usage unknown\n3\n\n\n\nNote: sum of sungroups exceeds the denominator due to multiple responses by patients"
  },
  {
    "objectID": "may_2025/neural_frame.html#stanford-cancer-registry-case-status",
    "href": "may_2025/neural_frame.html#stanford-cancer-registry-case-status",
    "title": "Neural Frame Metrics",
    "section": "Stanford Cancer Registry Case Status",
    "text": "Stanford Cancer Registry Case Status\nThe Stanford Cancer Registry tracks all cancer cases diagnosed or treated at Stanford. Each case is assigned a case status to reflect its reporting stage. The primary categories include:\n\nCompleted: Reportable cases that have been fully abstracted and passed all edit checks. These cases are transmitted to the state registry.\nNot Reportable: Cases that do not meet state reporting requirements or have already been abstracted and submitted.\nIncomplete/Suspense: Reportable cases that have been abstracted but cannot yet be transmitted due to missing treatment information or unresolved edit errors. These may result from version changes, coding updates, or other registry requirements.\n\nThe case status ensures accurate tracking and timely reporting of cancer data to meet regulatory and research standards.\nAs of May 2025, there are 13,598 unique thoracic patients with 78.2 % completed cases."
  },
  {
    "objectID": "may_2025/neural_frame.html#patient-summary-by-diagnosis-year",
    "href": "may_2025/neural_frame.html#patient-summary-by-diagnosis-year",
    "title": "Neural Frame Metrics",
    "section": "Patient Summary by Diagnosis Year",
    "text": "Patient Summary by Diagnosis Year\nThe following distribution summarizes the number of diagnosed thoracic patients over time."
  },
  {
    "objectID": "may_2025/neural_frame.html#histology-distribution-icdo3-codes",
    "href": "may_2025/neural_frame.html#histology-distribution-icdo3-codes",
    "title": "Neural Frame Metrics",
    "section": "Histology Distribution & ICDO3 Codes",
    "text": "Histology Distribution & ICDO3 Codes\nThoracic cancer encompasses a diverse group of histologic subtypes, with Non-Small Cell Lung Cancer (NSCLC) representing the majority of cases and Small Cell Lung Cancer (SCLC).\nThoracic cancer is categorized into detailed histologic groups using ICD-O-3 codes and then further grouped into four overarching categories for simplified analysis. The main histology groups include:\n\nNon-Small Cell Lung Carcinoma (NSCLC): This group encompasses the majority of lung cancer and includes subtypes such as:\n\nAdenocarcinoma (8140â8147)\nSquamous Cell Carcinoma (8070â8080)\nLarge Cell Carcinoma (8010â8015)\nNon-Small Cell Carcinoma NOS (8046)\n\nSmall Cell Lung Carcinoma (SCLC): Represented by ICD-O-3 codes 8041â8045, this group is characterized by more aggressive, rapidly progressing tumors.\nOther Specified Histologies: These include a range of less common thoracic cancer such as:\n\nCarcinoid Tumors (8240â8249)\nSarcoma (8800â8806)\nMesothelioma (9050â9053)\nAcinar Cell Carcinoma (8550â8551)\nBronchiolo-alveolar Carcinoma (8250â8257)\nNeoplasms (8000â8005)\nPapillary Adenocarcinoma (8260â8265)\nPapillary Carcinoma (8050â8052)\n\nOther/Unspecified Histologies: Any histology not falling into the categories above."
  },
  {
    "objectID": "may_2025/neural_frame.html#thoracic-cancer-histology-distribution",
    "href": "may_2025/neural_frame.html#thoracic-cancer-histology-distribution",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Histology Distribution",
    "text": "Thoracic Cancer Histology Distribution\nFrom 10,634 thoracic patients with completed cases, the majority 7,420 were diagnosed with Non-Small Cell Lung Carcinoma (NSCLC).\n\n\n\n\n\n\n\n\n\n\n\n\nHistology\nN(%) of Patients\n\n\n\n\nNSCLC\n7,420 (69.8%)\n\n\nOther Specified\n1,835 (17.3%)\n\n\nOther Unspecified\n1,118 (10.5%)\n\n\nSCLC\n551 (5.2%)\n\n\n\nNote: Patients could have multiple histologies"
  },
  {
    "objectID": "may_2025/neural_frame.html#histology-type-summary",
    "href": "may_2025/neural_frame.html#histology-type-summary",
    "title": "Neural Frame Metrics",
    "section": "Histology Type Summary",
    "text": "Histology Type Summary\n\nBar PlotICDO3 Table\n\n\nThe following horizontal bar chart presents the hierarchical distribution of thoracic cancer cases, showing both major categories (NSCLC, SCLC, Other Specified, and Other Unspecified) and their corresponding histological subtypes.\n\nClick legend items to show/hide specific main categories\nHover over bars to see detailed information\nDouble-click legend items to isolate a single category o to restore all categories\n\n\nDistribution of Thoracic Cancer Cases by Histology Types\n\n\n\n\n\n\n\n\nTable Summary of Histology Groups\n\n\n\n\n\n\n\n\n\nAll the ICDO3 code and histology subgrouping are listed in the following table:"
  },
  {
    "objectID": "may_2025/neural_frame.html#distribution-of-thoracic-cancer-cases-by-histology-types",
    "href": "may_2025/neural_frame.html#distribution-of-thoracic-cancer-cases-by-histology-types",
    "title": "Neural Frame Metrics",
    "section": "Distribution of Thoracic Cancer Cases by Histology Types",
    "text": "Distribution of Thoracic Cancer Cases by Histology Types"
  },
  {
    "objectID": "may_2025/neural_frame.html#table-summary-of-histology-groups",
    "href": "may_2025/neural_frame.html#table-summary-of-histology-groups",
    "title": "Neural Frame Metrics",
    "section": "Table Summary of Histology Groups",
    "text": "Table Summary of Histology Groups"
  },
  {
    "objectID": "may_2025/neural_frame.html#cancer-staging",
    "href": "may_2025/neural_frame.html#cancer-staging",
    "title": "Neural Frame Metrics",
    "section": "Cancer Staging",
    "text": "Cancer Staging\nCancer staging is categorized as:\n\nStage 0: Carcinoma in situ (neoplastic cells confined to the epithelium without invasion) with no evidence of invasion beyond the basement membrane.\nOccult: A malignancy is confirmed by cytology or metastatic presentation without a known primary, meaning that the primary tumor is not clinically or radiologically identifiable.\nStage I: A localized tumor confined to the organ of origin, with no regional lymph node involvement or distant metastasis.\nStage II: A tumor of larger size or with limited regional extension that may involve adjacent structures or limited regional lymph nodes.\nStage III: Locally advanced disease characterized by involvement of regional lymph nodes and/or extension to nearby tissues.\nStage IV: Distant metastatic disease where the tumor has spread to distant organs or non-regional lymph nodes."
  },
  {
    "objectID": "may_2025/neural_frame.html#summary-of-staging-of-thoracic-cancer-patients",
    "href": "may_2025/neural_frame.html#summary-of-staging-of-thoracic-cancer-patients",
    "title": "Neural Frame Metrics",
    "section": "Summary of Staging of Thoracic Cancer Patients",
    "text": "Summary of Staging of Thoracic Cancer Patients\nThe following table summarizes the staging status of thoracic patients with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nStaging Status\nPatient Count\nPercentage (%)\n\n\n\n\nStage IV: Distant metastatic disease\n4,351\n41\n\n\nStage I: Localized tumor confined to the organ of origin\n2,785\n26\n\n\nStage III: Locally advanced disease\n1,796\n17\n\n\nUnknown\n1,023\n10\n\n\nStage II: Larger tumor size or limited regional extension\n782\n7\n\n\nOccult: Malignancy confirmed by cytology or metastatic presentation without known primary\n48\n0\n\n\nStage 0: Carcinoma in situ\n37\n0"
  },
  {
    "objectID": "aug_2025/image_occ.html",
    "href": "aug_2025/image_occ.html",
    "title": "OMOP Image Occurrence",
    "section": "",
    "text": "In the OMOP Common Data Model (CDM), the âImage_occurrenceâ table provides a structured way to represent medical imaging events, bridging the gap between imaging and observational research by integrating image-based measurements into the CDM.\nThe OMOP image_occurrence table captures records of medical imaging events at the series level, representing events where one or more related images are acquired as part of a clinical procedure, and it also provides a path to de-identified DICOM images.\nEach record includes metadata such as the modality (e.g., CT, MRI) and the anatomic site of the image. The table maintains foreign key links to the procedure_occurrence and visit_occurrence tables, enabling contextual association with the related clinical procedure and patient encounter.\nAt Stanford, this table has been extended to include a link to the note table, allowing integration of imaging data with relevant clinical documentation. We expect to have larger number of images in the coming months.\nAs of August 2025, this table included images for 182,484 patients with 35,089,368 series. Series are defined as individual imaging acquisitions within a study."
  },
  {
    "objectID": "aug_2025/image_occ.html#image-occurrence-metrics",
    "href": "aug_2025/image_occ.html#image-occurrence-metrics",
    "title": "OMOP Image Occurrence",
    "section": "Image Occurrence Metrics",
    "text": "Image Occurrence Metrics\nThis visualization summarizes distribution of Modality categories and Anatomic sites by series and patient counts for all cancer types and for thoracic patients. Note: We expect the number of patients with imaging data to increase per release.\n\nAll Cancer TypesThoracic Cancer\n\n\n\nModality Types\nTop modality types for series above 5k occurrences are listed as follow.\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report REG: Registration KO: Key Object Selection PR: Presentation State\n\n\n\n\n\n\n\n\nPatient Population\nNote: This visualization shows modality types with more than 1,000 patients.\n\n\n\n\n\n\n\n\nModality Descriptions and Frequency by Series and Patients\nPlease note that the modality descriptions are listed here: Modality Descriptions (DICOM Library).\n\n\n\n\n\n\n\n\nAnatomic Sites\nTop anatomic sites for series above 100k occurrences are listed as follow.\n\n\n\n\n\n\n\n\nPatient Population\nNote: This visualization shows anatomic sites with more than 100k series.\n\n\n\n\n\n\n\n\nAnatomic Site Descriptions and Frequency by Series and Patients\n\n\n\n\n\n\n\n\n\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers.\nAs of August 2025, from 13,880 patients with thoracic cancer, 13,071 had imaging data.\n\nModality Types\nTop modality types for series above 5k occurrences are listed as follow.\n\n\n\n\n\n\n\n\nAnatomic Sites\nTop anatomic sites for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "aug_2025/image_occ.html#modality-types",
    "href": "aug_2025/image_occ.html#modality-types",
    "title": "OMOP Image Occurrence",
    "section": "Modality Types",
    "text": "Modality Types\nTop modality types for series above 5k occurrences are listed as follow.\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report REG: Registration KO: Key Object Selection PR: Presentation State"
  },
  {
    "objectID": "aug_2025/image_occ.html#patient-population",
    "href": "aug_2025/image_occ.html#patient-population",
    "title": "OMOP Image Occurrence",
    "section": "Patient Population",
    "text": "Patient Population\nNote: This visualization shows modality types with more than 1,000 patients."
  },
  {
    "objectID": "aug_2025/image_occ.html#modality-descriptions-and-frequency-by-series-and-patients",
    "href": "aug_2025/image_occ.html#modality-descriptions-and-frequency-by-series-and-patients",
    "title": "OMOP Image Occurrence",
    "section": "Modality Descriptions and Frequency by Series and Patients",
    "text": "Modality Descriptions and Frequency by Series and Patients\nPlease note that the modality descriptions are listed here: Modality Descriptions (DICOM Library)."
  },
  {
    "objectID": "aug_2025/image_occ.html#anatomic-sites",
    "href": "aug_2025/image_occ.html#anatomic-sites",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Sites",
    "text": "Anatomic Sites\nTop anatomic sites for series above 100k occurrences are listed as follow."
  },
  {
    "objectID": "aug_2025/image_occ.html#patient-population-1",
    "href": "aug_2025/image_occ.html#patient-population-1",
    "title": "OMOP Image Occurrence",
    "section": "Patient Population",
    "text": "Patient Population\nNote: This visualization shows anatomic sites with more than 100k series."
  },
  {
    "objectID": "aug_2025/image_occ.html#anatomic-site-descriptions-and-frequency-by-series-and-patients",
    "href": "aug_2025/image_occ.html#anatomic-site-descriptions-and-frequency-by-series-and-patients",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Site Descriptions and Frequency by Series and Patients",
    "text": "Anatomic Site Descriptions and Frequency by Series and Patients"
  },
  {
    "objectID": "aug_2025/image_occ.html#modality-types-1",
    "href": "aug_2025/image_occ.html#modality-types-1",
    "title": "OMOP Image Occurrence",
    "section": "Modality Types",
    "text": "Modality Types\nTop modality types for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "aug_2025/image_occ.html#anatomic-sites-1",
    "href": "aug_2025/image_occ.html#anatomic-sites-1",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Sites",
    "text": "Anatomic Sites\nTop anatomic sites for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "may_2025/image_occ.html",
    "href": "may_2025/image_occ.html",
    "title": "OMOP Image Occurrence",
    "section": "",
    "text": "In the OMOP Common Data Model (CDM), the âImage_occurrenceâ table provides a structured way to represent medical imaging events, bridging the gap between imaging and observational research by integrating image-based measurements into the CDM.\nThe OMOP image_occurrence table captures records of medical imaging events at the series level, representing events where one or more related images are acquired as part of a clinical procedure, and it also provides a path to de-identified DICOM images.\nEach record includes metadata such as the modality (e.g., CT, MRI) and the anatomic site of the image. The table maintains foreign key links to the procedure_occurrence and visit_occurrence tables, enabling contextual association with the related clinical procedure and patient encounter.\nAt Stanford, this table has been extended to include a link to the note table, allowing integration of imaging data with relevant clinical documentation. We expect to have larger number of images in the coming months.\nAs of May 2025, this table included images for 182,155 patients with 34,929,018 series. Series are defined as individual imaging acquisitions within a study."
  },
  {
    "objectID": "may_2025/image_occ.html#image-occurrence-metrics",
    "href": "may_2025/image_occ.html#image-occurrence-metrics",
    "title": "OMOP Image Occurrence",
    "section": "Image Occurrence Metrics",
    "text": "Image Occurrence Metrics\nThis visualization summarizes distribution of Modality categories and Anatomic sites by series and patient counts for all cancer types and for thoracic patients. Note: We expect the number of patients with imaging data to increase per release.\n\nAll Cancer TypesThoracic Cancer\n\n\n\nModality Types\nTop modality types for series above 5k occurrences are listed as follow.\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report REG: Registration KO: Key Object Selection PR: Presentation State\n\n\n\n\n\n\n\n\nPatient Population\nNote: This visualization shows modality types with more than 1,000 patients.\n\n\n\n\n\n\n\n\nModality Descriptions and Frequency by Series and Patients\nPlease note that the modality descriptions are listed here: Modality Descriptions (DICOM Library).\n\n\n\n\n\n\n\n\nAnatomic Sites\nTop anatomic sites for series above 100k occurrences are listed as follow.\n\n\n\n\n\n\n\n\nPatient Population\nNote: This visualization shows anatomic sites with more than 100k series.\n\n\n\n\n\n\n\n\nAnatomic Site Descriptions and Frequency by Series and Patients\n\n\n\n\n\n\n\n\n\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers.\nAs of May 2025, from 13,598 patients with thoracic cancer, 12,975 had imaging data.\n\nModality Types\nTop modality types for series above 5k occurrences are listed as follow.\n\n\n\n\n\n\n\n\nAnatomic Sites\nTop anatomic sites for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "may_2025/image_occ.html#modality-types",
    "href": "may_2025/image_occ.html#modality-types",
    "title": "OMOP Image Occurrence",
    "section": "Modality Types",
    "text": "Modality Types\nTop modality types for series above 5k occurrences are listed as follow.\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report REG: Registration KO: Key Object Selection PR: Presentation State"
  },
  {
    "objectID": "may_2025/image_occ.html#patient-population",
    "href": "may_2025/image_occ.html#patient-population",
    "title": "OMOP Image Occurrence",
    "section": "Patient Population",
    "text": "Patient Population\nNote: This visualization shows modality types with more than 1,000 patients."
  },
  {
    "objectID": "may_2025/image_occ.html#modality-descriptions-and-frequency-by-series-and-patients",
    "href": "may_2025/image_occ.html#modality-descriptions-and-frequency-by-series-and-patients",
    "title": "OMOP Image Occurrence",
    "section": "Modality Descriptions and Frequency by Series and Patients",
    "text": "Modality Descriptions and Frequency by Series and Patients\nPlease note that the modality descriptions are listed here: Modality Descriptions (DICOM Library)."
  },
  {
    "objectID": "may_2025/image_occ.html#anatomic-sites",
    "href": "may_2025/image_occ.html#anatomic-sites",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Sites",
    "text": "Anatomic Sites\nTop anatomic sites for series above 100k occurrences are listed as follow."
  },
  {
    "objectID": "may_2025/image_occ.html#patient-population-1",
    "href": "may_2025/image_occ.html#patient-population-1",
    "title": "OMOP Image Occurrence",
    "section": "Patient Population",
    "text": "Patient Population\nNote: This visualization shows anatomic sites with more than 100k series."
  },
  {
    "objectID": "may_2025/image_occ.html#anatomic-site-descriptions-and-frequency-by-series-and-patients",
    "href": "may_2025/image_occ.html#anatomic-site-descriptions-and-frequency-by-series-and-patients",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Site Descriptions and Frequency by Series and Patients",
    "text": "Anatomic Site Descriptions and Frequency by Series and Patients"
  },
  {
    "objectID": "may_2025/image_occ.html#modality-types-1",
    "href": "may_2025/image_occ.html#modality-types-1",
    "title": "OMOP Image Occurrence",
    "section": "Modality Types",
    "text": "Modality Types\nTop modality types for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "may_2025/image_occ.html#anatomic-sites-1",
    "href": "may_2025/image_occ.html#anatomic-sites-1",
    "title": "OMOP Image Occurrence",
    "section": "Anatomic Sites",
    "text": "Anatomic Sites\nTop anatomic sites for series above 5k occurrences are listed as follow."
  },
  {
    "objectID": "may_2025/tumor_board_updated.html",
    "href": "may_2025/tumor_board_updated.html",
    "title": "Tumor Board",
    "section": "",
    "text": "Please note that the Tumor Board definition has been updated and the previous released metrics are presented here: Old Tumor Board"
  },
  {
    "objectID": "may_2025/tumor_board_updated.html#tumor-board-encounter",
    "href": "may_2025/tumor_board_updated.html#tumor-board-encounter",
    "title": "Tumor Board",
    "section": "Tumor Board Encounter",
    "text": "Tumor Board Encounter"
  },
  {
    "objectID": "may_2025/tumor_board_updated.html#data-sources-across-tumor-board",
    "href": "may_2025/tumor_board_updated.html#data-sources-across-tumor-board",
    "title": "Tumor Board",
    "section": "Data Sources Across Tumor Board",
    "text": "Data Sources Across Tumor Board\n\n\n\n\n\n\n\n\nData Sources Across Tumor Board\n\n\nData Sources\nCount (N)\nPercentage (%)\n\n\n\n\nTumor Board Patients\n23,116\n100\n\n\nTumor Board Patients with Registry Data\n19,900\n86\n\n\nTumor Board Patients with Imaging and Registry Data\n19,740\n85\n\n\nTumor Board Patients with Imaging and Genomic Data\n2,671\n12\n\n\nTumor Board Patients with Thoracic Cancer\n2,489\n11\n\n\n\n\n\n\n\n\n\n\n\n\n\nSummary of Patient Population\nThe demographic categories examined include Age, Sex, Race, and Ethnicity.\n\n\n\n\n\n\n\n\nThoracic Tumor Board\n\n\nCharacteristic\n\nCount (N)\nPercentage (%)\n\n\n\n\nTotal\nTotal number of pts\n2,489\n100\n\n\nAge\n0-17\n2\n0\n\n\nAge\n18-44\n88\n4\n\n\nAge\n45-64\n597\n24\n\n\nAge\n65+\n1,802\n72\n\n\nSex\nMale\n1,133\n46\n\n\nSex\nFemale\n1,355\n54\n\n\nSex\nUnknown\n1\n0\n\n\nRace\nAmerican Indian-Alaska Native\n7\n0\n\n\nRace\nAsian\n787\n32\n\n\nRace\nNative Hawaii\n25\n1\n\n\nRace\nBlack\n65\n3\n\n\nRace\nWhite\n1,322\n53\n\n\nRace\nOther-Unknown\n283\n11\n\n\nEthnicity\nHispanic Latino\n182\n7\n\n\nEthnicity\nNOT Hispanic Latino\n2,248\n90\n\n\nEthnicity\nOther-Missing\n59\n2\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Case Status\nThe Stanford Cancer Registry keeps track of every cancer case at Stanford and uses theÂ case status variableÂ to monitor each caseâs progress. The major categories are:Â Completed, Not Reportable,Â andÂ Incomplete.\n\nNot ReportableÂ cases refer to cases that are not reportable to the state per cancer registry rules, or those that have already been abstracted.\nIncompleteÂ cases are reportable and have been abstracted, but are marked as incomplete due to pending treatment information or unresolved edit errors. These edits can arise for a variety of reasons, such as version changes by the state registry or code updates by standard-setting agencies.\nCompletedÂ cases are reportable, have been fully abstracted, and have passed all edit checks. These cases are transmitted to the state.\n\nPlease note that theÂ IncompleteÂ case status is eventually updated to eitherÂ CompletedÂ orÂ Not Reportable.\nThe distribution of case status for Thoracic Tumor Board encounter patients are listed below:\n\n\n\n\n\n\n\n\n\n\n\nCase Status\nNumber of Patients\n\n\n\n\nComplete\n2,082\n\n\nNot Reportable\n280\n\n\nIncomplete\n127\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nImage Occurrence\nAs of July 2025, 2,486 with thoracic tumor board encounter had image occurrence procedures.\n\nAnatomic SitesModality Types\n\n\n\n\n\n\n\n\n\n\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report, REG: Registration, KO: Key Object Selection, PR: Presentation State"
  },
  {
    "objectID": "may_2025/tumor_board.html",
    "href": "may_2025/tumor_board.html",
    "title": "Tumor Board",
    "section": "",
    "text": "Summary:\nAs of May 2025, Tumor Board encounters are defined using the EPIC patient encounter data tables. Specifically, Thoracic Tumor Board patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers in addition to having a Tumor Board encounter.\nNote: Thoracic Tumor Board definition will be narrowed further due to observations from cross-comparison between encounter data in Epic Hyperspace versus Epic Clarity.\nAs of May 2025, From 13,598 patients with thoracic cancer, 2,662 also had a Tumor Board encounter.\n\n\nSummary of Patient Population\nThe demographic categories examined include Age, Sex, Race, and Ethnicity.\n\n\n\n\n\n\n\n\nThoracic Tumor Board\n\n\nCharacteristic\n\nCount (N)\nPercentage (%)\n\n\n\n\nTotal\nTotal number of pts\n2,662\n100\n\n\nAge\n0-17\n2\n0\n\n\nAge\n18-44\n92\n3\n\n\nAge\n45-64\n627\n24\n\n\nAge\n65+\n1,941\n73\n\n\nSex\nMale\n1,222\n46\n\n\nSex\nFemale\n1,439\n54\n\n\nSex\nUnknown\n1\n0\n\n\nRace\nAmerican Indian-Alaska Native\n8\n0\n\n\nRace\nAsian\n834\n31\n\n\nRace\nNative Hawaii\n26\n1\n\n\nRace\nBlack\n71\n3\n\n\nRace\nWhite\n1,420\n53\n\n\nRace\nOther-Unknown\n303\n11\n\n\nEthnicity\nHispanic Latino\n193\n7\n\n\nEthnicity\nNOT Hispanic Latino\n2,407\n90\n\n\nEthnicity\nOther-Missing\n62\n2\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Case Status\nThe Stanford Cancer Registry keeps track of every cancer case at Stanford and uses theÂ case status variableÂ to monitor each caseâs progress. The major categories are:Â Completed, Not Reportable,Â andÂ Incomplete.\n\nNot ReportableÂ cases refer to cases that are not reportable to the state per cancer registry rules, or those that have already been abstracted.\nIncompleteÂ cases are reportable and have been abstracted, but are marked as incomplete due to pending treatment information or unresolved edit errors. These edits can arise for a variety of reasons, such as version changes by the state registry or code updates by standard-setting agencies.\nCompletedÂ cases are reportable, have been fully abstracted, and have passed all edit checks. These cases are transmitted to the state.\n\nPlease note that theÂ IncompleteÂ case status is eventually updated to eitherÂ CompletedÂ orÂ Not Reportable.\nThe distribution of case status for Thoracic Tumor Board encounter patients are listed below:\n\n\n\n\n\n\n\n\n\n\n\nCase Status\nNumber of Patients\n\n\n\n\nComplete\n2,228\n\n\nIncomplete\n130\n\n\nNot Reportable\n304\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nImage Occurrence\nAs of May 2025, 2,659 with thoracic tumor board encounter had image occurrence procedures.\n\nAnatomic SitesModality Types\n\n\n\n\n\n\n\n\n\n\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report, REG: Registration, KO: Key Object Selection, PR: Presentation State"
  },
  {
    "objectID": "feb_2025/phi_labeling_report.html",
    "href": "feb_2025/phi_labeling_report.html",
    "title": "PHI Labeling Metrics",
    "section": "",
    "text": "In this section, we present an analysis of the population characteristics and note attributes for the labeled sample used in our study. We compare these characteristics with the broader STARR-OMOP population to provide context and highlight any significant differences. The analysis includes age distribution, note length distribution and and note types. For PHI (Protected Health Information) distribution it is only shown on the labeled sample.\n\nAge Distribution\nBelow a histogram of the distribution of ages of the population represented in the labeled notes. For comparison the characteristics of the entire STARR-OMOP population are shown as well. The Age of the patient is calculated as at the moment of the extraction and not at the moment the note was written.\n\nLabeled SampleSTARR-OMOP\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDemographic Groups\nIn this section, we present a detailed analysis of the demographic characteristics of the labeled sample used in our study. We compare these characteristics with the broader STARR-OMOP population to provide context and highlight any significant differences. The analysis includes age distribution, sex, race, and ethnicity. This comparison helps to understand the representativeness of the labeled sample and identify teh characteristics of the biased sample.\n\nAgeSexRaceEthnicity\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAge Group\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\n0-17\n59\n12.55\n24,709,539\n10.82\n\n\n18-44\n112\n23.83\n51,841,502\n22.70\n\n\n45-64\n121\n25.74\n53,873,202\n23.59\n\n\n65+\n178\n37.87\n97,932,528\n42.89\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSex\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nFEMALE\n248\n52.77\n128,810,665\n56.41\n\n\nMALE\n220\n46.81\n99,506,081\n43.57\n\n\nNo matching concept\n2\n0.43\nNA\nNA\n\n\nUnknown\nNA\nNA\n40,025\n0.02\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRace\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nAmerican Indian or Alaska Native\n23\n4.89\n985,689\n0.43\n\n\nAsian\n77\n16.38\n40,808,962\n17.87\n\n\nBlack or African American\n62\n13.19\n11,182,306\n4.90\n\n\nNative Hawaiian or Other Pacific Islander\n35\n7.45\n2,854,092\n1.25\n\n\nUnknown\n161\n34.26\n51,605,777\n22.60\n\n\nWhite\n112\n23.83\n120,919,945\n52.95\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEthnicity\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nHispanic or Latino\n151\n32.13\n39,152,701\n17.15\n\n\nNot Hispanic or Latino\n242\n51.49\n173,951,827\n76.18\n\n\nUnknown\n77\n16.38\n15,252,243\n6.68\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote Length Distribution\nBelow the note length distribution for the clinical notes sampled for the labeling task. For comparison the distribution of the lengths for STARR-OMOP is shown. The note length distribution is shown in characters.\n\nLabeled SampleComparison with STARR-OMOP\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRange\n\nSTARR-OMOP\n\n\nLabeled Sample\n\n\n\nn\n%\nn\n%\n\n\n\n\n0 - 500\n96,583,879\n42.30\n60\n12.77\n\n\n500 - 2500\n71,191,327\n31.18\n407\n86.60\n\n\n2500 - 10000\n49,905,133\n21.85\n3\n0.64\n\n\n10000 - 50000\n10,631,213\n4.66\nNA\nNA\n\n\n50000 - 1e+05\n41,626\n0.02\nNA\nNA\n\n\n1e+05 - 1150000\n3,593\n0.00\nNA\nNA\n\n\n\n\n\n\n\n\n\n\n\n\nPHI Distribution\nIn this section, we present an analysis of the distribution of PHI entities within the labeled sample. The analysis includes the frequency of different PHI entities and their distribution across documents. This helps to understand the prevalence of various PHI types in the dataset and provides insights into the labeling process. The analysis is divided into two parts: the total count of each PHI entity type and the distribution of PHI entities per document. It is important to clarify that DOCTOR and HOSPITAL are not classified as PHI in the Safe-Harbor definition. However, being able to identify and obfuscate such information may be important for potential data sharing use cases.\n\nOverallPer Document\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote Types\nIn this section, we present an analysis of the different types of clinical notes included in the labeled sample used in our study. We compare these note types with the broader STARR-OMOP population to provide context and highlight any significant differences. This comparison helps to understand the representativeness of the labeled sample and identify the differences in the bias sample in the types of notes included. The analysis includes the distribution of note types and their frequencies in both the labeled sample and the STARR-OMOP population. In the distribution below there are several types that contain radiology and pathology reports. Among those are the notes labeled as procedures. Those are a combination of clinical results that are a result of procedures.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDistribution of Note Types in the Dataset\n\n\nNote Type\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn\n%\nn\n%\n\n\n\n\ncare plan note\n17\n3.62\n4,139,518\n1.81\n\n\nletter\n17\n3.62\n6,889,804\n3.02\n\n\nprocedures\n16\n3.40\n2,542,658\n1.11\n\n\ndischarge instructions\n14\n2.98\n1,983,103\n0.87\n\n\nanesthesia postprocedure evaluation\n13\n2.77\n915,373\n0.40\n\n\ncare plan\n13\n2.77\n145,491\n0.06\n\n\nnursing note\n13\n2.77\n1,605,802\n0.70\n\n\nprogress notes\n13\n2.77\n54,086,167\n23.68\n\n\nimaging\n12\n2.55\n27,170,511\n11.90\n\n\npatient instructions\n12\n2.55\n9,786,849\n4.29\n\n\nassessment & plan note\n11\n2.34\n2,240,039\n0.98\n\n\nlab\n11\n2.34\n24,825,380\n10.87\n\n\nanesthesia procedure notes\n10\n2.13\n762,798\n0.33\n\n\nmicrobiology culture\n10\n2.13\n1,097,747\n0.48\n\n\ner notes\n9\n1.91\n43,442\n0.02\n\n\nclinic support note\n8\n1.70\n3,041,493\n1.33\n\n\necg\n8\n1.70\n527,231\n0.23\n\n\nh&p\n8\n1.70\n1,787,536\n0.78\n\n\nlab panel\n8\n1.70\n118,246\n0.05\n\n\npathology and cytology\n8\n1.70\n395,258\n0.17\n\n\nrtf letter\n8\n1.70\n3,549,891\n1.55\n\n\ntelephone encounter\n8\n1.70\n38,675,938\n16.94\n\n\nmicrobiology\n7\n1.49\n812,474\n0.36\n\n\nunmapped external results\n7\n1.49\n900,521\n0.39\n\n\nadvance care planning\n6\n1.28\n97,282\n0.04\n\n\nconsults\n6\n1.28\n3,313,915\n1.45\n\n\ned notes\n6\n1.28\n6,496,913\n2.85\n\n\ned provider notes\n6\n1.28\n1,862,895\n0.82\n\n\npathology\n6\n1.28\n1,812,971\n0.79\n\n\nsign out note\n6\n1.28\n2,080,313\n0.91\n\n\nunmapped external note\n6\n1.28\n277,058\n0.12\n\n\ncode blue/rapid response team note\n5\n1.06\n8,238\n0.00\n\n\ndocumentation clarification\n5\n1.06\n179,822\n0.08\n\n\nh&p interval\n5\n1.06\n244,086\n0.11\n\n\ninterval h&p note\n5\n1.06\n200,704\n0.09\n\n\npft\n5\n1.06\n172,001\n0.08\n\n\nancillary\n4\n0.85\n1,176,069\n0.52\n\n\nanesthesia post-op follow-up note\n4\n0.85\n50,193\n0.02\n\n\nconsult follow-up\n4\n0.85\n1,159,388\n0.51\n\n\nlactation note\n4\n0.85\n274,944\n0.12\n\n\noperative report\n4\n0.85\n969,031\n0.42\n\n\nphysical therapy\n4\n0.85\n184,380\n0.08\n\n\npoint of care testing\n4\n0.85\n368,205\n0.16\n\n\npr charge\n4\n0.85\n617,387\n0.27\n\n\nrehab daily note\n4\n0.85\n516,657\n0.23\n\n\ntransplant summary\n4\n0.85\n1,282,579\n0.56\n\n\nconsult\n3\n0.64\n533,155\n0.23\n\n\ndischarge summary\n3\n0.64\n1,040,761\n0.46\n\n\nhiv lab non-restricted\n3\n0.64\n25,412\n0.01\n\n\nhospice\n3\n0.64\n4,221\n0.00\n\n\nmanual entry echo\n3\n0.64\n11,058\n0.00\n\n\nmiscellaneous\n3\n0.64\n6,922\n0.00\n\n\nprocedure note\n3\n0.64\n241,589\n0.11\n\n\naccountable care division cm note\n2\n0.43\n143,998\n0.06\n\n\nanesthesia post-op\n2\n0.43\n88,070\n0.04\n\n\nanesthesia preprocedure evaluation\n2\n0.43\n1,148,683\n0.50\n\n\nblood bank\n2\n0.43\n21,218\n0.01\n\n\ncardiac angio\n2\n0.43\n6,686\n0.00\n\n\ncommittee review\n2\n0.43\n21,630\n0.01\n\n\ndischarge instr - other orders\n2\n0.43\n37,133\n0.02\n\n\ned triage notes\n2\n0.43\n13,480\n0.01\n\n\ngroup note\n2\n0.43\n66,342\n0.03\n\n\nh&p (view-only)\n2\n0.43\n171,763\n0.08\n\n\nimaging non-reportable\n2\n0.43\n1,584,644\n0.69\n\n\nlab only\n2\n0.43\n1,341\n0.00\n\n\nlab only - beaker\n2\n0.43\n45,177\n0.02\n\n\nneurology\n2\n0.43\n112,384\n0.05\n\n\nnsg picc refer\n2\n0.43\n127,275\n0.06\n\n\noccupational therapy\n2\n0.43\n193,917\n0.08\n\n\noperative note\n2\n0.43\n521,214\n0.23\n\n\noutpatient letter\n2\n0.43\n307,086\n0.13\n\n\nplan of care\n2\n0.43\n646,309\n0.28\n\n\nresult encounter note\n2\n0.43\n37,539\n0.02\n\n\nrn transfer note\n2\n0.43\n238,578\n0.10\n\n\ntransfer of care summary\n2\n0.43\n21,769\n0.01\n\n\naddendum note\n1\n0.21\n2,098,264\n0.92\n\n\nanesthesia followup note\n1\n0.21\n48,523\n0.02\n\n\ncardiac monitors\n1\n0.21\n732\n0.00\n\n\ncardiac services\n1\n0.21\n40,949\n0.02\n\n\ncare conference\n1\n0.21\n29,554\n0.01\n\n\ncase communication\n1\n0.21\n8,315\n0.00\n\n\ncath angio\n1\n0.21\n42,514\n0.02\n\n\ndermatology\n1\n0.21\n5,511\n0.00\n\n\ndischarge instr - activity\n1\n0.21\n15,477\n0.01\n\n\ndischarge instr - radiology\n1\n0.21\n291\n0.00\n\n\necho\n1\n0.21\n642,794\n0.28\n\n\nechocardiography\n1\n0.21\n287,578\n0.13\n\n\nelectrophysiology\n1\n0.21\n26,980\n0.01\n\n\nhiv lab restricted\n1\n0.21\n162,940\n0.07\n\n\nhospital course\n1\n0.21\n18,606\n0.01\n\n\nimmediate post op note\n1\n0.21\n83,068\n0.04\n\n\nip letter\n1\n0.21\n301,987\n0.13\n\n\nir procedure notes\n1\n0.21\n13,264\n0.01\n\n\nmanual entry imaging\n1\n0.21\n7,752\n0.00\n\n\nmanual entry lab\n1\n0.21\n31,434\n0.01\n\n\nmedication review\n1\n0.21\n20,691\n0.01\n\n\nnursing\n1\n0.21\n19,401\n0.01\n\n\nnursing referral\n1\n0.21\n205,098\n0.09\n\n\nob\n1\n0.21\n41,869\n0.02\n\n\nor postop\n1\n0.21\n4,351\n0.00\n\n\nor surgeon\n1\n0.21\n14,425\n0.01\n\n\npatient care conference\n1\n0.21\n25,671\n0.01\n\n\npharmacy medication review\n1\n0.21\n50,057\n0.02\n\n\npre-procedure instructions\n1\n0.21\n1,953\n0.00\n\n\nradiation oncology treatment summary\n1\n0.21\n25,144\n0.01\n\n\nreference labs\n1\n0.21\n503,157\n0.22\n\n\nresearch note\n1\n0.21\n4,243\n0.00\n\n\nrespiratory care\n1\n0.21\n10,302\n0.00\n\n\ntransfer center follow up clinical screen\n1\n0.21\n9,203\n0.00\n\n\ntransfer center initial clinical screen\n1\n0.21\n20,031\n0.01\n\n\nvascular ultrasound\n1\n0.21\n78,447\n0.03\n\n\nwound care\n1\n0.21\n46,420\n0.02",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Report"
    ]
  },
  {
    "objectID": "may_2025/cap_forms_methods.html",
    "href": "may_2025/cap_forms_methods.html",
    "title": "AI for Automatic Synoptic Reporting",
    "section": "",
    "text": "CAP (College of American Pathologists) forms are standardized cancer reporting protocols that have revolutionized pathology practice by replacing inconsistent narrative reports with structured, synoptic formats containing essential diagnostic and prognostic information. Developed over 35 years ago to address significant variability in cancer reporting, these evidence-based protocols ensure complete, uniform documentation of malignant tumors across all healthcare institutions, directly improving patient outcomes and clinical decision-making.\nLung resection CAP forms are particularly critical in thoracic oncology, providing standardized reporting templates for primary lung cancers that include essential elements such as tumor size, histologic type and grade, surgical margins, lymph node status, and staging classifications. These lung-specific protocols have demonstrated measurable clinical impact, with studies showing that synoptic reporting achieves 88.4% completeness compared to only 2.6% for traditional descriptive reports, leading to more accurate staging, better treatment planning, and improved survival rates.\nBy establishing consistent terminology and data capture requirements, CAP lung resection forms enhance communication between pathologists and oncologists, ensure regulatory compliance with Commission on Cancer standards, and provide the structured data foundation necessary for personalized cancer care, targeted therapy selection, and multidisciplinary treatment coordination. The widespread adoption of these standardized protocols, supported by electronic integration into laboratory information systems, has positioned pathologists as key members of the lung cancer care team while enabling seamless data exchange for cancer registries, research, and quality improvement initiatives.\nAt Stanford, CAP forms were implemented within Epic using SmartForms. SmartForms is an Epic product that allows the capture of semi-structured information within the EHR that can later be used to generate free-form reports. In this case, the structured information from the CAP forms is captured on SmartForms, which later generate the synoptic reporting section within the pathology report. As a consequence, for relevant cases, the pathology report will contain this section.\nFor this task, we aim to use AI to populate the CAP forms automatically by using all the other elements from the pathology report. We formulated this as a question-answering problem, where the context for each question is the entire pathology report, the question is the particular CAP form element, and the answer is the value/selection to be populated.\nFor this initial experiment, we collected a dataset with 390 patients and 390 lung resection forms. The forms were reported between November 2022 and April 2025. The table below summarizes the demographics for this dataset.\nAttaching package: 'table1'\n\n\nThe following objects are masked from 'package:base':\n\n    units, units&lt;-\n\n\n\n\n\n\n\n\n\n\n\n\n\nFEMALE\n(N=237)\nMALE\n(N=153)\nOverall\n(N=390)\n\n\n\n\nAge\n\n\n\n\n\n18-44\n6 (2.5%)\n10 (6.5%)\n16 (4.1%)\n\n\n45-59\n47 (19.8%)\n18 (11.8%)\n65 (16.7%)\n\n\n60-69\n72 (30.4%)\n42 (27.5%)\n114 (29.2%)\n\n\n70-79\n87 (36.7%)\n60 (39.2%)\n147 (37.7%)\n\n\n80+\n25 (10.5%)\n23 (15.0%)\n48 (12.3%)\n\n\nRace\n\n\n\n\n\nAmerican Indian or Alaska Native\n2 (0.8%)\n1 (0.7%)\n3 (0.8%)\n\n\nAsian\n74 (31.2%)\n49 (32.0%)\n123 (31.5%)\n\n\nBlack or African American\n4 (1.7%)\n2 (1.3%)\n6 (1.5%)\n\n\nNative Hawaiian or Other Pacific Islander\n2 (0.8%)\n2 (1.3%)\n4 (1.0%)\n\n\nUnknown\n19 (8.0%)\n21 (13.7%)\n40 (10.3%)\n\n\nWhite\n136 (57.4%)\n78 (51.0%)\n214 (54.9%)\n\n\nEthnicity\n\n\n\n\n\nHispanic or Latino\n20 (8.4%)\n10 (6.5%)\n30 (7.7%)\n\n\nNot Hispanic or Latino\n210 (88.6%)\n141 (92.2%)\n351 (90.0%)\n\n\nUnknown\n7 (3.0%)\n2 (1.3%)\n9 (2.3%)",
    "crumbs": [
      "About",
      "Data Labeling",
      "May 2025",
      "AI for Automatic Synoptic Reporting",
      "Methods and Results"
    ]
  },
  {
    "objectID": "may_2025/cap_forms_methods.html#methods-and-results",
    "href": "may_2025/cap_forms_methods.html#methods-and-results",
    "title": "AI for Automatic Synoptic Reporting",
    "section": "Methods and Results",
    "text": "Methods and Results\nFor this experiment, we used several state-of-the-art LLMs to assess their capabilities to extract the information required for lung resection CAP forms. As mentioned before, we formulated the problem as a question-answering problem. Each LLM was tested in a zero-shot setting, where no actual examples were given. Each LLM was asked to answer a single question using the entire pathology report (excluding the synoptic report) and instructions that contained the most recent lung resection CAP forms instructions. We asked the LLMs to provide the answers using JSON to facilitate the parsing of the actual answers.\nTo automatically evaluate the output, we used the traditional BERT score, which evaluates the semantic similarity between the generated answer and the reference answer. The results of this evaluation are shown in the figure below.\n\n\n\n\n\n\nHere, we can see that Claude 3.5 is slightly better than Llama 4. However, the distribution for most LLMs is certainly wide, showing lack of consistency across all questions. To investigate this further, a heatmap was constructed and is shown in the figure below. Here, we can clearly see the variability across different questions and how GPT-4 consistently underperforms for this particular task. The questions itself and the descriptions of each question can be found below the graph.\n\n\n\n\n\n\n\nADDITIONAL FINDINGS - Documents other pathologic findings in the specimen beyond the primary tumor, such as atypical adenomatous hyperplasia, granulomatous inflammation, or emphysema.\n\nCLOSEST MARGIN(S) TO INVASIVE CARCINOMA - Identifies which specific surgical margin (bronchial, vascular, parenchymal, or chest wall) is nearest to the invasive tumor.\n\nDISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN - Measures in centimeters how far the invasive tumor extends from the nearest surgical margin.\n\nHISTOLOGIC GRADE - Assesses the degree of tumor differentiation using grading schemes specific to tumor type (G1-well differentiated to G4-undifferentiated).\n\nLYMPH NODE(S) FROM PRIOR PROCEDURES - Documents whether lymph nodes from previous surgical procedures are included in the current specimen.\n\nLYMPHOVASCULAR INVASION - Reports the presence of tumor cells within lymphatic vessels, arteries, or veins.\n\nMARGIN STATUS FOR INVASIVE CARCINOMA - Determines whether invasive tumor is present at any surgical margin or if all margins are negative.\n\nMARGIN STATUS FOR NON-INVASIVE TUMOR - Assesses whether carcinoma in situ or lepidic components are present at surgical margins.\n\nNODAL SITE(S) EXAMINED - Documents which specific lymph node stations according to the IASLC map were sampled and examined.\n\nNODAL SITE(S) WITH TUMOR - Identifies which specific lymph node stations contain metastatic tumor.\n\nNUMBER OF LYMPH NODES EXAMINED - Provides the total count of lymph nodes examined in the specimen.\n\nNUMBER OF LYMPH NODES WITH TUMOR - Reports the count of lymph nodes containing metastatic tumor.\n\nPROCEDURE - Specifies the type of surgical resection performed (wedge resection, lobectomy, pneumonectomy, etc.).\n\nREGIONAL LYMPH NODE STATUS - Provides overall assessment of whether regional lymph nodes contain tumor or are negative.\n\nSPECIMEN LATERALITY - Indicates whether the lung specimen is from the right or left side.\n\nSPREAD THROUGH AIR SPACES (STAS) - Documents the presence of tumor cells extending beyond the main tumor into surrounding air spaces as micropapillary clusters, solid nests, or single cells.\n\nTNM DESCRIPTORS - Assigns pathologic TNM staging categories (pT, pN, pM) based on tumor size, nodal involvement, and distant metastasis.\n\nTOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR) - Measures the greatest dimension of the entire tumor including both invasive and non-invasive components.\n\nTUMOR FOCALITY - Determines whether there is a single tumor focus, multiple separate nodules, or multifocal disease.\n\nTUMOR SITE - Identifies the specific anatomic location of the tumor within the lung (upper lobe, lower lobe, bronchus, etc.).\n\nVISCERAL PLEURA INVASION - Assesses whether tumor penetrates beyond the elastic layer of the visceral pleura or extends to the pleural surface.\n\nFurther investigation is required to evaluate and characterize the failure modes of each of the LLMs. Additionally, the baseline performance indicates that fine-tuning an open-source model like Llama 4 may yield better results.",
    "crumbs": [
      "About",
      "Data Labeling",
      "May 2025",
      "AI for Automatic Synoptic Reporting",
      "Methods and Results"
    ]
  },
  {
    "objectID": "may_2025/metrics_clinical.html",
    "href": "may_2025/metrics_clinical.html",
    "title": "Oncology Cohort",
    "section": "",
    "text": "Release Version: May 2025 (IRB76049)"
  },
  {
    "objectID": "may_2025/metrics_clinical.html#patient-distribution-across-data-sources",
    "href": "may_2025/metrics_clinical.html#patient-distribution-across-data-sources",
    "title": "Oncology Cohort",
    "section": "Patient Distribution Across Data Sources",
    "text": "Patient Distribution Across Data Sources"
  },
  {
    "objectID": "philips_ispm_data_dict/stamp_addon_data.html",
    "href": "philips_ispm_data_dict/stamp_addon_data.html",
    "title": "STAMP Add-On Data",
    "section": "",
    "text": "The oncology_stamp_add_on_data table includes the panel name and pipeline version from the Stanford Molecular Pathology Lab, as well as the patient identifier and accession number. These fields (patient identifier and accession number) can be used to establish a link to the Philips ISPM onc_philips_mtb_pat_diag_orders table.\nPlease note that multiple records may correspond to the same accession number. The assay_performed_derived and pipeline_version_derived fields can be used to link to the STAMP panel metadata.\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\nColumn Name\nType\nPHI\nPHI-Scrubbing Operation\n\n\n\n\naccession_number\nSTRING\nYes\nHash\n\n\nassay_performed_derived\nSTRING\nNo\nNone\n\n\nassay_performed_source\nSTRING\nNo\nNone\n\n\nperson_id\nINT64\nYes\nStable Between Data Refreshes\n\n\npipeline_version_derived\nSTRING\nNo\nNone\n\n\npipeline_version_source\nSTRING\nNo\nNone\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\n\n\n\nColumns Description\n\naccession_number\nIdentifier for the specimen. This field can be used to link to the pat_diag_orders table. Note that there can be multiple records with the same accession number.\n\n\nassay_performed_derived\nThis value is derived from the assay_performed_source field and is used to link to the assay_performed column in the stamp_pipeline_gene_data table.\n\n\nassay_performed_source\nStanford Molecular Pathology Lab panel name\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\npipeline_version_derived\nThis value is derived from the pipeline_version_source field and is used to link to the pipeline_version column in the stamp_pipeline_gene_data table.\n\n\npipeline_version_source\nStanford Molecular Pathology Lab panel pipeline version\n\n\nstanford_patient_uid\nInternal Stanford tracking ID (this is the patientâs MRN | DOB)",
    "crumbs": [
      "About",
      "Data Dictionary",
      "Philips ISPM",
      "STAMP Add-On Data"
    ]
  },
  {
    "objectID": "philips_ispm_data_dict/pat_diag_orders.html",
    "href": "philips_ispm_data_dict/pat_diag_orders.html",
    "title": "Philips ISPM Orders",
    "section": "",
    "text": "The table onc_philips_mtb_pat_diag_orders contains order-level information from the Philips IntelliSpace Precision Medicine (ISPM) genomics database at Stanford. The fields in this table are related to diagnostic orders, patient demographics, and specimen accession numbers which can be used to link to the other Philips ISPM tables.\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\n\n\n\n\naccession_number\nSTRING\nYes\nHash\n\n\ndate_of_test\nDATE\nYes\nJitter\n\n\ndiagnosis_code\nSTRING\n\n\n\n\ndiagnosis_display\nSTRING\n\n\n\n\ndiagnosis_for_interpretation_code\nSTRING\n\n\n\n\ndiagnosis_for_interpretation_display\nSTRING\n\n\n\n\ndiagnosis_system\nSTRING\n\n\n\n\ndiagnostic_order_uuid\nSTRING\nYes\nStable Between Data Refreshes\n\n\nmtb_date\nDATE\nYes\nJitter\n\n\norderer_name\nSTRING\n\nNullified\n\n\norderer_npi\nSTRING\n\nNullified\n\n\npatient_data_birthdate\nDATE\nYes\nJitter\n\n\npatient_data_ethnicity\nSTRING\nYes\nNullified\n\n\npatient_data_first_name\nSTRING\nYes\nNullified\n\n\npatient_data_gender\nSTRING\nYes\nNullified\n\n\npatient_data_last_name\nSTRING\nYes\nNullified\n\n\npatient_data_mrn\nSTRING\nYes\nNullified\n\n\npatient_data_race\nSTRING\nYes\nNullified\n\n\nperson_id\n\nYes\nStable Between Data Refreshes\n\n\nreferring_practitioner_name\nSTRING\n\nNullified\n\n\nreferring_practitioner_npi\nSTRING\n\nNullified\n\n\nsite_code\nSTRING\n\n\n\n\nsite_display\nSTRING\n\n\n\n\nspecimen_identifier\nSTRING\nYes\nNullified\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\ntest_type\nSTRING\n\n\n\n\nworkflow_request_uuid\nSTRING\nYes\nNullified\n\n\n\n\n\n\nColumns Description\n\naccession_number\nIdentifier for the specimen. This field can be used to link to the pat_diag_orders table. Note that there can be multiple records with the same accession number.\n\n\ndate_of_test\nDate the STAMP or Foundation One test was performed\n\n\ndiagnosis_code\nNo description available. This field is not well-populated.\n\n\ndiagnosis_display\nNo description available. Entirely null field\n\n\ndiagnosis_for_interpretation_code\nNo description available. This field is not well-populated.\n\n\ndiagnosis_for_interpretation_display\nNo description available. This field is not well-populated.\n\n\ndiagnosis_system\nNo description available. This field is not well-populated.\n\n\ndiagnostic_order_uuid\nPrimary Key for pat_diag_orders table\n\n\nmtb_date\nThe date of the molecular tumor board (MTB) if it exists in the source data. This field is not well-populated.\n\n\norderer_name\nName of Provider who ordered the test\n\n\norderer_npi\nNPI of Provider who ordered the test\n\n\npatient_data_birthdate\nPatient BirthDate\n\n\npatient_data_ethnicity\nPatient Ethnicity\n\n\npatient_data_first_name\nPatient First Name\n\n\npatient_data_gender\nPatient Gender\n\n\npatient_data_last_name\nPatient Last Name\n\n\npatient_data_mrn\nPatient MRN\n\n\npatient_data_race\nPatient Race\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\nreferring_practitioner_name\nName of Provider who referred patient\n\n\nreferring_practitioner_npi\nNPI of Provider who referred patient\n\n\nsite_code\nNo description available.\n\n\nsite_display\nNo description available.\n\n\nspecimen_identifier\nString containing either both the patient MRN and accession number (if STAMP test), or the order proc id which starts with ORD (if FoundationOne test)\n\n\nstanford_patient_uid\nInternal Stanford tracking ID (this is the patientâs MRN | DOB)\n\n\ntest_type\nType of Test (STAMP or FoundationOne)\n\n\nworkflow_request_uuid\nAnother unique key which is being nullified. Unsure of definition but it is also a unique identifier.",
    "crumbs": [
      "About",
      "Data Dictionary",
      "Philips ISPM",
      "Philips ISPM Orders"
    ]
  },
  {
    "objectID": "neuralframe_data_dict/case_treatments.html",
    "href": "neuralframe_data_dict/case_treatments.html",
    "title": "NeuralFrame Case Treatments",
    "section": "",
    "text": "The table onc_neuralframe_case_treatments outlines the various treatments administered to patients, including surgical interventions, chemotherapy, radiation therapy, and other therapeutic approaches.\n\nTable Columns\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\nnaaccr number\n\n\n\n\ndate1stcrsrxcoc\nSTRING\nYes\nJitter\n1270\n\n\ndateinitialrxseer\nSTRING\nYes\nJitter\n1260\n\n\ndatesurgproc1\nSTRING\nYes\nJitter\n70002\n\n\ndatesurgproc1flag\nSTRING\n\n\n70003\n\n\ndatesurgproc1flagdescription\nSTRING\n\n\n\n\n\ndatesurgproc2\nSTRING\nYes\nJitter\n70004\n\n\ndatesurgproc2flag\nSTRING\n\n\n70005\n\n\ndatesurgproc2flagdescription\nSTRING\n\n\n\n\n\ndatesurgproc3\nSTRING\nYes\nJitter\n70006\n\n\ndatesurgproc3flag\nSTRING\n\n\n70007\n\n\ndatesurgproc3flagdescription\nSTRING\n\n\n\n\n\nintentoftreatment\nSTRING\n\n\n1560\n\n\nintentoftreatmentdescription\nSTRING\n\n\n\n\n\nnameofradiationdrug\nSTRING\n\n\n10008\n\n\nnameofradiationdrugdescription\nSTRING\n\n\n\n\n\nneoadjuvanttherapy\nSTRING\n\n\n1632\n\n\nneoadjuvanttherapydescription\nSTRING\n\n\n\n\n\nneoadjuvtherapyclinicalresponse\nSTRING\n\n\n1633\n\n\nneoadjuvtherapyclinicalresponsedescription\nSTRING\n\n\n\n\n\nneoadjuvtherapytreatmenteffect\nSTRING\n\n\n1634\n\n\nneoadjuvtherapytreatmenteffectdescription\nSTRING\n\n\n\n\n\nnfcaseentityid\nSTRING\nYes\nStable Between Data Refreshes\n\n\n\nnfcasestatus\nSTRING\n\n\n\n\n\nnmtexthemtransplantendocrine\nSTRING\nYes\nTiDE\n10030\n\n\nnumberphasesofradtxtovolume\nSTRING\n\n\n1532\n\n\nnumberphasesofradtxtovolumedescription\nSTRING\n\n\n\n\n\nperson_id\nINTEGER\nYes\nStable Between Data Refreshes\n\n\n\nphase1doseperfraction\nSTRING\n\n\n1501\n\n\nphase1doseperfractiondescription\nSTRING\n\n\n\n\n\nphase1numberoffractions\nSTRING\n\n\n1503\n\n\nphase1numberoffractionsdescription\nSTRING\n\n\n\n\n\nphase1radiationexternalbeamtech\nSTRING\n\n\n1502\n\n\nphase1radiationexternalbeamtechdescription\nSTRING\n\n\n\n\n\nphase1radiationprimarytxvolume\nSTRING\n\n\n1504\n\n\nphase1radiationprimarytxvolumedescription\nSTRING\n\n\n\n\n\nphase1radiationtodrainingln\nSTRING\n\n\n1505\n\n\nphase1radiationtodraininglndescription\nSTRING\n\n\n\n\n\nphase1radiationtreatmentmodality\nSTRING\n\n\n1506\n\n\nphase1radiationtreatmentmodalitydescription\nSTRING\n\n\n\n\n\nphase1totaldose\nSTRING\n\n\n1507\n\n\nphase1totaldosedescription\nSTRING\n\n\n\n\n\nphase2doseperfraction\nSTRING\n\n\n1511\n\n\nphase2doseperfractiondescription\nSTRING\n\n\n\n\n\nphase2numberoffractions\nSTRING\n\n\n1513\n\n\nphase2numberoffractionsdescription\nSTRING\n\n\n\n\n\nphase2radiationexternalbeamtech\nSTRING\n\n\n1512\n\n\nphase2radiationexternalbeamtechdescription\nSTRING\n\n\n\n\n\nphase2radiationprimarytxvolume\nSTRING\n\n\n1514\n\n\nphase2radiationprimarytxvolumedescription\nSTRING\n\n\n\n\n\nphase2radiationtodrainingln\nSTRING\n\n\n1515\n\n\nphase2radiationtodraininglndescription\nSTRING\n\n\n\n\n\nphase2radiationtreatmentmodality\nSTRING\n\n\n1516\n\n\nphase2radiationtreatmentmodalitydescription\nSTRING\n\n\n\n\n\nphase2totaldose\nSTRING\n\n\n1517\n\n\nphase2totaldosedescription\nSTRING\n\n\n\n\n\nphase3doseperfraction\nSTRING\n\n\n1521\n\n\nphase3doseperfractiondescription\nSTRING\n\n\n\n\n\nphase3numberoffractions\nSTRING\n\n\n1523\n\n\nphase3numberoffractionsdescription\nSTRING\n\n\n\n\n\nphase3radiationexternalbeamtech\nSTRING\n\n\n1522\n\n\nphase3radiationexternalbeamtechdescription\nSTRING\n\n\n\n\n\nphase3radiationprimarytxvolume\nSTRING\n\n\n1524\n\n\nphase3radiationprimarytxvolumedescription\nSTRING\n\n\n\n\n\nphase3radiationtodrainingln\nSTRING\n\n\n1525\n\n\nphase3radiationtodraininglndescription\nSTRING\n\n\n\n\n\nphase3radiationtreatmentmodality\nSTRING\n\n\n1526\n\n\nphase3radiationtreatmentmodalitydescription\nSTRING\n\n\n\n\n\nphase3totaldose\nSTRING\n\n\n1527\n\n\nphase3totaldosedescription\nSTRING\n\n\n\n\n\nradboostdosecgy\nSTRING\n\n\n3210\n\n\nradboostdosecgydescription\nSTRING\n\n\n\n\n\nradboostrxmodality\nSTRING\n\n\n3200\n\n\nradboostrxmodalitydescription\nSTRING\n\n\n\n\n\nradiationcompletionstatus\nSTRING\n\n\n10071\n\n\nradiationlocalcontrolstatus\nSTRING\n\n\n1590\n\n\nradiationlocalcontrolstatusdescription\nSTRING\n\n\n\n\n\nradiationtxdiscontinuedearly\nSTRING\n\n\n1531\n\n\nradiationtxdiscontinuedearlydescription\nSTRING\n\n\n\n\n\nradlocationofrx\nSTRING\n\n\n1550\n\n\nradlocationofrxdescription\nSTRING\n\n\n\n\n\nradnooftreatmentvol\nSTRING\n\n\n1520\n\n\nradnooftreatmentvoldescription\nSTRING\n\n\n\n\n\nradregionaldosecgy\nSTRING\n\n\n1510\n\n\nradregionaldosecgydescription\nSTRING\n\n\n\n\n\nradregionalrxmodality\nSTRING\n\n\n1570\n\n\nradregionalrxmodalitydescription\nSTRING\n\n\n\n\n\nradtreatmentvolume\nSTRING\n\n\n1540\n\n\nradtreatmentvolumedescription\nSTRING\n\n\n\n\n\nreadmsamehosp30days\nSTRING\n\n\n3190\n\n\nreadmsamehosp30daysdescription\nSTRING\n\n\n\n\n\nreasonfornoradiation\nSTRING\n\n\n1430\n\n\nreasonfornoradiationdescription\nSTRING\n\n\n\n\n\nreasonfornosurgery\nSTRING\n\n\n1340\n\n\nreasonfornosurgerydescription\nSTRING\n\n\n\n\n\nrxcodingsystemcurrent\nSTRING\n\n\n1460\n\n\nrxcodingsystemcurrentdescription\nSTRING\n\n\n\n\n\nrxdatebrm\nSTRING\nYes\nJitter\n1240\n\n\nrxdatebrmflag\nSTRING\n\n\n1241\n\n\nrxdatebrmflagdescription\nSTRING\n\n\n\n\n\nrxdatechemo\nSTRING\nYes\nJitter\n1220\n\n\nrxdatechemoflag\nSTRING\n\n\n1221\n\n\nrxdatechemoflagdescription\nSTRING\n\n\n\n\n\nrxdatedxstgproc\nSTRING\n\n\n1280\n\n\nrxdatedxstgprocflag\nSTRING\nYes\nJitter\n1281\n\n\nrxdatedxstgprocflagdescription\nSTRING\n\n\n\n\n\nrxdatehormone\nSTRING\nYes\nJitter\n1230\n\n\nrxdatehormoneflag\nSTRING\n\n\n1231\n\n\nrxdatehormoneflagdescription\nSTRING\n\n\n\n\n\nrxdatemostdefinsurg\nSTRING\nYes\nJitter\n3170\n\n\nrxdatemostdefinsurgflag\nSTRING\n\n\n3171\n\n\nrxdatemostdefinsurgflagdescription\nSTRING\n\n\n\n\n\nrxdateother\nSTRING\nYes\nJitter\n1250\n\n\nrxdateotherflag\nSTRING\n\n\n1251\n\n\nrxdateotherflagdescription\nSTRING\n\n\n\n\n\nrxdateradiation\nSTRING\nYes\nJitter\n1210\n\n\nrxdateradiationended\nSTRING\nYes\nJitter\n3220\n\n\nrxdateradiationendedflag\nSTRING\n\n\n3221\n\n\nrxdateradiationendedflagdescription\nSTRING\n\n\n\n\n\nrxdateradiationflag\nSTRING\n\n\n1211\n\n\nrxdateradiationflagdescription\nSTRING\n\n\n\n\n\nrxdatesurgery\nSTRING\nYes\nJitter\n1200\n\n\nrxdatesurgeryflag\nSTRING\n\n\n1201\n\n\nrxdatesurgeryflagdescription\nSTRING\n\n\n\n\n\nrxdatesurgicaldisch\nSTRING\nYes\nJitter\n3180\n\n\nrxdatesurgicaldischflag\nSTRING\n\n\n3181\n\n\nrxdatesurgicaldischflagdescription\nSTRING\n\n\n\n\n\nrxdatesystemic\nSTRING\nYes\nJitter\n3230\n\n\nrxdatesystemicflag\nSTRING\n\n\n3231\n\n\nrxdatesystemicflagdescription\nSTRING\n\n\n\n\n\nrxdatetranspendo\nSTRING\nYes\nJitter\n70043\n\n\nrxdatetranspendoflag\nSTRING\n\n\n70044\n\n\nrxdatetranspendoflagdescription\nSTRING\n\n\n\n\n\nrxhospbrm\nSTRING\n\n\n720\n\n\nrxhospbrmdescription\nSTRING\n\n\n\n\n\nrxhospchemo\nSTRING\n\n\n700\n\n\nrxhospchemodescription\nSTRING\n\n\n\n\n\nrxhosphormone\nSTRING\n\n\n710\n\n\nrxhosphormonedescription\nSTRING\n\n\n\n\n\nrxhospother\nSTRING\n\n\n730\n\n\nrxhospotherdescription\nSTRING\n\n\n\n\n\nrxhosppalliativeproc\nSTRING\n\n\n3280\n\n\nrxhosppalliativeprocdescription\nSTRING\n\n\n\n\n\nrxhospradiation\nSTRING\n\n\n\n\n\nrxhospreconbreast\nSTRING\n\n\n10106\n\n\nrxhospreconbreastdescription\nSTRING\n\n\n\n\n\nrxhospreglnremoved\nSTRING\n\n\n\n\n\nrxhospscopereg9802\nSTRING\n\n\n747\n\n\nrxhospscopereg9802description\nSTRING\n\n\n\n\n\nrxhospscopereglnsur\nSTRING\n\n\n672\n\n\nrxhospscopereglnsurdescription\nSTRING\n\n\n\n\n\nrxhospsurgapp2010\nSTRING\n\n\n668\n\n\nrxhospsurgapp2010description\nSTRING\n\n\n\n\n\nrxhospsurgbreast\nSTRING\n\n\n10104\n\n\nrxhospsurgbreastdescription\nSTRING\n\n\n\n\n\nrxhospsurgoth9802\nSTRING\n\n\n748\n\n\nrxhospsurgoth9802description\nSTRING\n\n\n\n\n\nrxhospsurgothregdis\nSTRING\n\n\n674\n\n\nrxhospsurgothregdisdescription\nSTRING\n\n\n\n\n\nrxhospsurgprimsite\nSTRING\n\n\n670\n\n\nrxhospsurgprimsite2023\nSTRING\n\n\n671\n\n\nrxhospsurgprimsite2023description\nSTRING\n\n\n\n\n\nrxhospsurgprimsitedescription\nSTRING\n\n\n\n\n\nrxhospsurgsite9802\nSTRING\n\n\n746\n\n\nrxhospsurgsite9802description\nSTRING\n\n\n\n\n\nrxsummbrm\nSTRING\n\n\n1410\n\n\nrxsummbrmdescription\nSTRING\n\n\n\n\n\nrxsummchemo\nSTRING\n\n\n1390\n\n\nrxsummchemodescription\nSTRING\n\n\n\n\n\nrxsummdxstgproc\nSTRING\n\n\n1350\n\n\nrxsummdxstgprocdescription\nSTRING\n\n\n\n\n\nrxsummhormone\nSTRING\n\n\n1400\n\n\nrxsummhormonedescription\nSTRING\n\n\n\n\n\nrxsummother\nSTRING\n\n\n1420\n\n\nrxsummotherdescription\nSTRING\n\n\n\n\n\nrxsummpalliativeproc\nSTRING\n\n\n3270\n\n\nrxsummpalliativeprocdescription\nSTRING\n\n\n\n\n\nrxsummradiation\nSTRING\n\n\n1360\n\n\nrxsummradiationdescription\nSTRING\n\n\n\n\n\nrxsummradtocns\nSTRING\n\n\n\n\n\nrxsummreconbreast\nSTRING\n\n\n10107\n\n\nrxsummreconbreastdescription\nSTRING\n\n\n\n\n\nrxsummreconstruct1st\nSTRING\n\n\n1330\n\n\nrxsummreconstruct1stdescription\nSTRING\n\n\n\n\n\nrxsummreglnexamined\nSTRING\n\n\n1296\n\n\nrxsummreglnexamineddescription\nSTRING\n\n\n\n\n\nrxsummscopereg9802\nSTRING\n\n\n1647\n\n\nrxsummscopereg9802description\nSTRING\n\n\n\n\n\nrxsummscopereglnsur\nSTRING\n\n\n1292\n\n\nrxsummscopereglnsurdescription\nSTRING\n\n\n\n\n\nrxsummsurgbreast\nSTRING\n\n\n10105\n\n\nrxsummsurgbreastdescription\nSTRING\n\n\n\n\n\nrxsummsurgerytype\nSTRING\n\n\n\n\n\nrxsummsurgicalapproch\nSTRING\n\n\n1310\n\n\nrxsummsurgicalapprochdescription\nSTRING\n\n\n\n\n\nrxsummsurgicalmargins\nSTRING\n\n\n1320\n\n\nrxsummsurgicalmarginsdescription\nSTRING\n\n\n\n\n\nrxsummsurgoth9802\nSTRING\n\n\n1648\n\n\nrxsummsurgoth9802description\nSTRING\n\n\n\n\n\nrxsummsurgothregdis\nSTRING\n\n\n1294\n\n\nrxsummsurgothregdisdescription\nSTRING\n\n\n\n\n\nrxsummsurgprimsite\nSTRING\n\n\n1290\n\n\nrxsummsurgprimsite2023\nSTRING\n\n\n1291\n\n\nrxsummsurgprimsite2023description\nSTRING\n\n\n\n\n\nrxsummsurgprimsitedescription\nSTRING\n\n\n\n\n\nrxsummsurgradseq\nSTRING\n\n\n1380\n\n\nrxsummsurgradseqdescription\nSTRING\n\n\n\n\n\nrxsummsurgsite9802\nSTRING\n\n\n1646\n\n\nrxsummsurgsite9802description\nSTRING\n\n\n\n\n\nrxsummsystemicsurseq\nSTRING\n\n\n1639\n\n\nrxsummsystemicsurseqdescription\nSTRING\n\n\n\n\n\nrxsummtransplntendocr\nSTRING\n\n\n3250\n\n\nrxsummtransplntendocrdescription\nSTRING\n\n\n\n\n\nrxsummtreatmentstatus\nSTRING\n\n\n1285\n\n\nrxsummtreatmentstatusdescription\nSTRING\n\n\n\n\n\nrxtextbrm\nSTRING\nYes\nTiDE\n2660\n\n\nrxtextchemo\nSTRING\nYes\nTiDE\n2640\n\n\nrxtexthormone\nSTRING\nYes\nTiDE\n2650\n\n\nrxtextother\nSTRING\nYes\nTiDE\n2670\n\n\nrxtextpalliative\nSTRING\nYes\nTiDE\n100039\n\n\nrxtextradiation\nSTRING\nYes\nTiDE\n2620\n\n\nrxtextradiationother\nSTRING\nYes\nTiDE\n2630\n\n\nrxtextsurgery\nSTRING\nYes\nTiDE\n2610\n\n\nrxtextsurgery1\nSTRING\nYes\nTiDE\n70066\n\n\nrxtextsurgery2\nSTRING\nYes\nTiDE\n70067\n\n\nrxtextsurgery3\nSTRING\nYes\nTiDE\n70068\n\n\nstanford1stcoursechemofacility\nSTRING\n\n\n23008\n\n\nstanford1stcoursechemofacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcoursehormonefacility\nSTRING\n\n\n23011\n\n\nstanford1stcoursehormonefacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcourseimmunofacility\nSTRING\n\n\n23010\n\n\nstanford1stcourseimmunofacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcourseotherrxfacility\nSTRING\n\n\n23013\n\n\nstanford1stcourseotherrxfacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcoursepalliativefacility\nSTRING\n\n\n23012\n\n\nstanford1stcoursepalliativefacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcourseradiationfacility\nSTRING\n\n\n23009\n\n\nstanford1stcourseradiationfacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcoursesurgeryfacility\nSTRING\n\n\n23007\n\n\nstanford1stcoursesurgeryfacilitydescription\nSTRING\n\n\n\n\n\nstanford1stcoursetransplantendocrinefacility\nSTRING\n\n\n33043\n\n\nstanford1stcoursetransplantendocrinefacilitydescription\nSTRING\n\n\n\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\nstanfordadditionaltext\nSTRING\nYes\nTiDE\n10032\n\n\nstanfordradiationgivenateden\nSTRING\n\n\n23038\n\n\nstanfordradiationgivenatedendescription\nSTRING\n\n\n\n\n\nstanfordradiationgivenatseroc\nSTRING\n\n\n10011\n\n\nstanfordradiationgivenatserocdescription\nSTRING\n\n\n\n\n\nstanfordrouteofadministrationhormone\nSTRING\n\n\n33046\n\n\nstanfordrouteofadministrationhormonedescription\nSTRING\n\n\n\n\n\nstanfordrouteofadministrationimmuno\nSTRING\n\n\n33047\n\n\nstanfordrouteofadministrationimmunodescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1chemofacility\nSTRING\n\n\n23016\n\n\nstanfordsubsequent1chemofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1hormonefacility\nSTRING\n\n\n23019\n\n\nstanfordsubsequent1hormonefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1immunofacility\nSTRING\n\n\n23018\n\n\nstanfordsubsequent1immunofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1otherrxfacility\nSTRING\n\n\n23021\n\n\nstanfordsubsequent1otherrxfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1palliativefacility\nSTRING\n\n\n23020\n\n\nstanfordsubsequent1palliativefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1radiationfacility\nSTRING\n\n\n23017\n\n\nstanfordsubsequent1radiationfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1surgeryfacility\nSTRING\n\n\n23014\n\n\nstanfordsubsequent1surgeryfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent1transplantendocrinefacility\nSTRING\n\n\n10012\n\n\nstanfordsubsequent1transplantendocrinefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2chemofacility\nSTRING\n\n\n23024\n\n\nstanfordsubsequent2chemofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2hormonefacility\nSTRING\n\n\n23027\n\n\nstanfordsubsequent2hormonefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2immunofacility\nSTRING\n\n\n23026\n\n\nstanfordsubsequent2immunofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2otherrxfacility\nSTRING\n\n\n23029\n\n\nstanfordsubsequent2otherrxfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2palliativefacility\nSTRING\n\n\n23028\n\n\nstanfordsubsequent2palliativefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2radiationfacility\nSTRING\n\n\n23025\n\n\nstanfordsubsequent2radiationfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2surgeryfacility\nSTRING\n\n\n23022\n\n\nstanfordsubsequent2surgeryfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2transplantendocrinefacility\nSTRING\n\n\n33041\n\n\nstanfordsubsequent2transplantendocrinefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3chemofacility\nSTRING\n\n\n23032\n\n\nstanfordsubsequent3chemofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3hormonefacility\nSTRING\n\n\n23035\n\n\nstanfordsubsequent3hormonefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3immunofacility\nSTRING\n\n\n23034\n\n\nstanfordsubsequent3immunofacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3otherrxfacility\nSTRING\n\n\n23037\n\n\nstanfordsubsequent3otherrxfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3palliativefacility\nSTRING\n\n\n23036\n\n\nstanfordsubsequent3palliativefacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3radiationfacility\nSTRING\n\n\n23033\n\n\nstanfordsubsequent3radiationfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3surgeryfacility\nSTRING\n\n\n23030\n\n\nstanfordsubsequent3surgeryfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3transplantendocrinefacility\nSTRING\n\n\n33042\n\n\nstanfordsubsequent3transplantendocrinefacilitydescription\nSTRING\n\n\n\n\n\nstanfordtextprotocol\nSTRING\nYes\nTiDE\n33044\n\n\nsubsequenttreatmentneeded\nSTRING\n\n\n\n\n\nsubsequenttreatmentneededdescription\nSTRING\n\n\n\n\n\nsubsequenttreatmenttext\nSTRING\nYes\nTiDE\n\n\n\nsubsqrx2ndcoursechemo\nSTRING\n\n\n\n\n\nsubsqrx2ndcoursedate\nSTRING\nYes\nJitter\n\n\n\nsubsqrx2ndcourseoth\nSTRING\n\n\n\n\n\nsubsqrx2ndcourserad\nSTRING\n\n\n\n\n\nsubsqrx2ndcoursesurg\nSTRING\n\n\n\n\n\nsubsqrx2ndreglnrem\nSTRING\n\n\n\n\n\nsubsqrx2ndscopelnsu\nSTRING\n\n\n\n\n\nsubsqrx2ndsurgoth\nSTRING\n\n\n\n\n\nsubsqrx3rdcoursedate\nSTRING\nYes\nJitter\n\n\n\nsubsqrx3rdcourserad\nSTRING\n\n\n\n\n\nsubsqrx3rdcoursesurg\nSTRING\n\n\n\n\n\nsubsqrx3rdreglnrem\nSTRING\n\n\n\n\n\nsubsqrx3rdscopelnsu\nSTRING\n\n\n\n\n\nsubsqrx3rdsurgoth\nSTRING\n\n\n\n\n\nsubsqrx4thcoursedate\nSTRING\nYes\nJitter\n\n\n\nsubsqrx4thcourserad\nSTRING\n\n\n\n\n\nsubsqrx4thcoursesurg\nSTRING\n\n\n\n\n\nsubsqrx4thscopelnsu\nSTRING\n\n\n\n\n\nsubsqrx4thsurgoth\nSTRING\n\n\n\n\n\nsubsqrxreconstructdel\nSTRING\n\n\n\n\n\nsurgotherproc1\nSTRING\n\n\n70050\n\n\nsurgotherproc1description\nSTRING\n\n\n\n\n\nsurgotherproc2\nSTRING\n\n\n70051\n\n\nsurgotherproc2description\nSTRING\n\n\n\n\n\nsurgotherproc3\nSTRING\n\n\n70052\n\n\nsurgotherproc3description\nSTRING\n\n\n\n\n\nsurgprimproc1\nSTRING\n\n\n70053\n\n\nsurgprimproc1description\nSTRING\n\n\n\n\n\nsurgprimproc2\nSTRING\n\n\n70054\n\n\nsurgprimproc20231\nSTRING\n\n\n70069\n\n\nsurgprimproc20231description\nSTRING\n\n\n\n\n\nsurgprimproc20232\nSTRING\n\n\n70070\n\n\nsurgprimproc20232description\nSTRING\n\n\n\n\n\nsurgprimproc20233\nSTRING\n\n\n70071\n\n\nsurgprimproc20233description\nSTRING\n\n\n\n\n\nsurgprimproc2description\nSTRING\n\n\n\n\n\nsurgprimproc3\nSTRING\n\n\n70055\n\n\nsurgprimproc3description\nSTRING\n\n\n\n\n\ntotaldose\nSTRING\n\n\n1533\n\n\ntotaldosedescription\nSTRING\n\n\n\n\n\ntranspendohosp\nSTRING\n\n\n70058\n\n\ntranspendohospdescription\nSTRING\n\n\n\n\n\ntreatmenthospitalnumberproc1\nSTRING\n\n\n70059\n\n\ntreatmenthospitalnumberproc1description\nSTRING\n\n\n\n\n\ntreatmenthospitalnumberproc2\nSTRING\n\n\n70060\n\n\ntreatmenthospitalnumberproc2description\nSTRING\n\n\n\n\n\ntreatmenthospitalnumberproc3\nSTRING\n\n\n70061\n\n\ntreatmenthospitalnumberproc3description\nSTRING\n\n\n\n\n\n\n\n\n\nColumns Description\n\ndate1stcrsrxcoc\nDate 1st Crs RX CoC\n\n\ndateinitialrxseer\nDate Initial RX SEER\n\n\ndatesurgproc1\nDate Surg Proc 1\n\n\ndatesurgproc1flag\nDate Surg Proc 1 Flag\n\n\ndatesurgproc1flagdescription\nnan\n\n\ndatesurgproc2\nDate Surg Proc 2\n\n\ndatesurgproc2flag\nDate Surg Proc 2 Flag\n\n\ndatesurgproc2flagdescription\nnan\n\n\ndatesurgproc3\nDate Surg Proc 3\n\n\ndatesurgproc3flag\nDate Surg Proc 3 Flag\n\n\ndatesurgproc3flagdescription\nnan\n\n\nintentoftreatment\nIntent of Treatment - Radiation\n\n\nintentoftreatmentdescription\nnan\n\n\nnameofradiationdrug\nName of Radiation Drug\n\n\nnameofradiationdrugdescription\nnan\n\n\nneoadjuvanttherapy\nNeoadjuvant Therapy\n\n\nneoadjuvanttherapydescription\nnan\n\n\nneoadjuvtherapyclinicalresponse\nNeoadjuvant Therapy-Clinical Response\n\n\nneoadjuvtherapyclinicalresponsedescription\nnan\n\n\nneoadjuvtherapytreatmenteffect\nNeoadjuvant Therapy-Treatment Effect\n\n\nneoadjuvtherapytreatmenteffectdescription\nnan\n\n\nnfcaseentityid\nUnique number corresponding to every new neural frame âcaseâ or event\n\n\nnfcasestatus\nnan\n\n\nnmtexthemtransplantendocrine\nText-Hem Transplant Endocrine\n\n\nnumberphasesofradtxtovolume\nNumber of Phases of Rad Treatment to this Volume\n\n\nnumberphasesofradtxtovolumedescription\nnan\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\nphase1doseperfraction\nPhase I Dose per Fraction\n\n\nphase1doseperfractiondescription\nnan\n\n\nphase1numberoffractions\nPhase I Number of Fractions\n\n\nphase1numberoffractionsdescription\nnan\n\n\nphase1radiationexternalbeamtech\nPhase I Radiation External Beam Planning Tech\n\n\nphase1radiationexternalbeamtechdescription\nnan\n\n\nphase1radiationprimarytxvolume\nPhase I Radiation Primary Treatment Volume\n\n\nphase1radiationprimarytxvolumedescription\nnan\n\n\nphase1radiationtodrainingln\nPhase I Radiation to Draining Lymph Nodes\n\n\nphase1radiationtodraininglndescription\nnan\n\n\nphase1radiationtreatmentmodality\nPhase I Radiation Treatment Modality\n\n\nphase1radiationtreatmentmodalitydescription\nnan\n\n\nphase1totaldose\nPhase I Total Dose\n\n\nphase1totaldosedescription\nnan\n\n\nphase2doseperfraction\nPhase II Dose per Fraction\n\n\nphase2doseperfractiondescription\nnan\n\n\nphase2numberoffractions\nPhase II Number of Fractions\n\n\nphase2numberoffractionsdescription\nnan\n\n\nphase2radiationexternalbeamtech\nPhase II Radiation External Beam Planning Tech\n\n\nphase2radiationexternalbeamtechdescription\nnan\n\n\nphase2radiationprimarytxvolume\nPhase II Radiation Primary Treatment Volume\n\n\nphase2radiationprimarytxvolumedescription\nnan\n\n\nphase2radiationtodrainingln\nPhase II Radiation to Draining Lymph Nodes\n\n\nphase2radiationtodraininglndescription\nnan\n\n\nphase2radiationtreatmentmodality\nPhase II Radiation Treatment Modality\n\n\nphase2radiationtreatmentmodalitydescription\nnan\n\n\nphase2totaldose\nPhase II Total Dose\n\n\nphase2totaldosedescription\nnan\n\n\nphase3doseperfraction\nPhase III Dose per Fraction\n\n\nphase3doseperfractiondescription\nnan\n\n\nphase3numberoffractions\nPhase III Number of Fractions\n\n\nphase3numberoffractionsdescription\nnan\n\n\nphase3radiationexternalbeamtech\nPhase III Radiation External Beam Planning Tech\n\n\nphase3radiationexternalbeamtechdescription\nnan\n\n\nphase3radiationprimarytxvolume\nPhase III Radiation Primary Treatment Volume\n\n\nphase3radiationprimarytxvolumedescription\nnan\n\n\nphase3radiationtodrainingln\nPhase III Radiation to Draining Lymph Nodes\n\n\nphase3radiationtodraininglndescription\nnan\n\n\nphase3radiationtreatmentmodality\nPhase III Radiation Treatment Modality\n\n\nphase3radiationtreatmentmodalitydescription\nnan\n\n\nphase3totaldose\nPhase III Total Dose\n\n\nphase3totaldosedescription\nnan\n\n\nradboostdosecgy\nRadâBoost Dose cGy\n\n\nradboostdosecgydescription\nnan\n\n\nradboostrxmodality\nRadâBoost RX Modality\n\n\nradboostrxmodalitydescription\nnan\n\n\nradiationcompletionstatus\nRadiation Completion Status\n\n\nradiationlocalcontrolstatus\nRadiation Local Control Status\n\n\nradiationlocalcontrolstatusdescription\nnan\n\n\nradiationtxdiscontinuedearly\nRadiation Treatment Discontinued Early\n\n\nradiationtxdiscontinuedearlydescription\nnan\n\n\nradlocationofrx\nRadâLocation of RX\n\n\nradlocationofrxdescription\nnan\n\n\nradnooftreatmentvol\nRadâNo of Treatment Vol\n\n\nradnooftreatmentvoldescription\nnan\n\n\nradregionaldosecgy\nRadâRegional Dose: cGy\n\n\nradregionaldosecgydescription\nnan\n\n\nradregionalrxmodality\nRadâRegional RX Modality\n\n\nradregionalrxmodalitydescription\nnan\n\n\nradtreatmentvolume\nRadâTreatment Volume\n\n\nradtreatmentvolumedescription\nnan\n\n\nreadmsamehosp30days\nReadm Same Hosp 30 Days\n\n\nreadmsamehosp30daysdescription\nnan\n\n\nreasonfornoradiation\nReason for No Radiation\n\n\nreasonfornoradiationdescription\nnan\n\n\nreasonfornosurgery\nReason for No Surgery\n\n\nreasonfornosurgerydescription\nnan\n\n\nrxcodingsystemcurrent\nRX Coding SystemâCurrent\n\n\nrxcodingsystemcurrentdescription\nnan\n\n\nrxdatebrm\nRX Date BRM\n\n\nrxdatebrmflag\nRx Date Brm Flag\n\n\nrxdatebrmflagdescription\nnan\n\n\nrxdatechemo\nRX Date Chemo\n\n\nrxdatechemoflag\nRx Date Chemo Flag\n\n\nrxdatechemoflagdescription\nnan\n\n\nrxdatedxstgproc\nRX Date DX/Stg Proc\n\n\nrxdatedxstgprocflag\nRx Date Dx/Stg Proc Flag\n\n\nrxdatedxstgprocflagdescription\nnan\n\n\nrxdatehormone\nRX Date Hormone\n\n\nrxdatehormoneflag\nRx Date Hormone Flag\n\n\nrxdatehormoneflagdescription\nnan\n\n\nrxdatemostdefinsurg\nRX Date Mst Defn Srg\n\n\nrxdatemostdefinsurgflag\nRx Date Mst Defn Srg Flag\n\n\nrxdatemostdefinsurgflagdescription\nnan\n\n\nrxdateother\nRX Date Other\n\n\nrxdateotherflag\nRx Date Other Flag\n\n\nrxdateotherflagdescription\nnan\n\n\nrxdateradiation\nRX Date Radiation\n\n\nrxdateradiationended\nRX Date Rad Ended\n\n\nrxdateradiationendedflag\nRx Date Rad Ended Flag\n\n\nrxdateradiationendedflagdescription\nnan\n\n\nrxdateradiationflag\nRx Date Radiation Flag\n\n\nrxdateradiationflagdescription\nnan\n\n\nrxdatesurgery\nRX Date Surgery\n\n\nrxdatesurgeryflag\nRx Date Surgery Flag\n\n\nrxdatesurgeryflagdescription\nnan\n\n\nrxdatesurgicaldisch\nRX Date Surg Disch\n\n\nrxdatesurgicaldischflag\nRx Date Surg Disch Flag\n\n\nrxdatesurgicaldischflagdescription\nnan\n\n\nrxdatesystemic\nRX Date Systemic\n\n\nrxdatesystemicflag\nRx Date Systemic Flag\n\n\nrxdatesystemicflagdescription\nnan\n\n\nrxdatetranspendo\nRX Date Transp Endo\n\n\nrxdatetranspendoflag\nRX Date Transp Endo Flag\n\n\nrxdatetranspendoflagdescription\nnan\n\n\nrxhospbrm\nRX HospâBRM\n\n\nrxhospbrmdescription\nnan\n\n\nrxhospchemo\nRX HospâChemo\n\n\nrxhospchemodescription\nnan\n\n\nrxhosphormone\nRX HospâHormone\n\n\nrxhosphormonedescription\nnan\n\n\nrxhospother\nRX HospâOther\n\n\nrxhospotherdescription\nnan\n\n\nrxhosppalliativeproc\nRX HospâPalliative Proc\n\n\nrxhosppalliativeprocdescription\nnan\n\n\nrxhospradiation\nnan\n\n\nrxhospreconbreast\nRX HospâRecon Breast\n\n\nrxhospreconbreastdescription\nnan\n\n\nrxhospreglnremoved\nnan\n\n\nrxhospscopereg9802\nRX HospâScope Reg 98-02\n\n\nrxhospscopereg9802description\nnan\n\n\nrxhospscopereglnsur\nRX HospâScope Reg LN Sur\n\n\nrxhospscopereglnsurdescription\nnan\n\n\nrxhospsurgapp2010\nRX HospâSurg App 2010\n\n\nrxhospsurgapp2010description\nnan\n\n\nrxhospsurgbreast\nRX HospâSurg Breast\n\n\nrxhospsurgbreastdescription\nnan\n\n\nrxhospsurgoth9802\nRX HospâSurg Oth 98-02\n\n\nrxhospsurgoth9802description\nnan\n\n\nrxhospsurgothregdis\nRX HospâSurg Oth Reg/Dis\n\n\nrxhospsurgothregdisdescription\nnan\n\n\nrxhospsurgprimsite\nRX HospâSurg Prim Site 03-2022\n\n\nrxhospsurgprimsite2023\nRX HospâSurg Prim Site 2023\n\n\nrxhospsurgprimsite2023description\nnan\n\n\nrxhospsurgprimsitedescription\nnan\n\n\nrxhospsurgsite9802\nRX HospâSurg Site 98-02\n\n\nrxhospsurgsite9802description\nnan\n\n\nrxsummbrm\nRX SummâBRM\n\n\nrxsummbrmdescription\nnan\n\n\nrxsummchemo\nRX SummâChemo\n\n\nrxsummchemodescription\nnan\n\n\nrxsummdxstgproc\nRX SummâDX/Stg Proc\n\n\nrxsummdxstgprocdescription\nnan\n\n\nrxsummhormone\nRX SummâHormone\n\n\nrxsummhormonedescription\nnan\n\n\nrxsummother\nRX SummâOther\n\n\nrxsummotherdescription\nnan\n\n\nrxsummpalliativeproc\nRX SummâPalliative Proc\n\n\nrxsummpalliativeprocdescription\nnan\n\n\nrxsummradiation\nRX SummâRadiation\n\n\nrxsummradiationdescription\nnan\n\n\nrxsummradtocns\nnan\n\n\nrxsummreconbreast\nRX SummâRecon Breast\n\n\nrxsummreconbreastdescription\nnan\n\n\nrxsummreconstruct1st\nRX SummâReconstruct 1st\n\n\nrxsummreconstruct1stdescription\nnan\n\n\nrxsummreglnexamined\nRX SummâReg LN Examined\n\n\nrxsummreglnexamineddescription\nnan\n\n\nrxsummscopereg9802\nRX SummâScope Reg 98-02\n\n\nrxsummscopereg9802description\nnan\n\n\nrxsummscopereglnsur\nRX SummâScope Reg LN Sur\n\n\nrxsummscopereglnsurdescription\nnan\n\n\nrxsummsurgbreast\nRX SummâSurg Breast\n\n\nrxsummsurgbreastdescription\nnan\n\n\nrxsummsurgerytype\nnan\n\n\nrxsummsurgicalapproch\nRX SummâSurgical Approch\n\n\nrxsummsurgicalapprochdescription\nnan\n\n\nrxsummsurgicalmargins\nRX SummâSurgical Margins\n\n\nrxsummsurgicalmarginsdescription\nnan\n\n\nrxsummsurgoth9802\nRX SummâSurg Oth 98-02\n\n\nrxsummsurgoth9802description\nnan\n\n\nrxsummsurgothregdis\nRX SummâSurg Oth Reg/Dis\n\n\nrxsummsurgothregdisdescription\nnan\n\n\nrxsummsurgprimsite\nRX SummâSurg Prim Site 03-2022\n\n\nrxsummsurgprimsite2023\nRX SummâSurg Prim Site 2023\n\n\nrxsummsurgprimsite2023description\nnan\n\n\nrxsummsurgprimsitedescription\nnan\n\n\nrxsummsurgradseq\nRX SummâSurg/Rad Seq\n\n\nrxsummsurgradseqdescription\nnan\n\n\nrxsummsurgsite9802\nRX SummâSurg Site 98-02\n\n\nrxsummsurgsite9802description\nnan\n\n\nrxsummsystemicsurseq\nRX SummâSystemic/Sur Seq\n\n\nrxsummsystemicsurseqdescription\nnan\n\n\nrxsummtransplntendocr\nRX SummâTransplnt/Endocr\n\n\nrxsummtransplntendocrdescription\nnan\n\n\nrxsummtreatmentstatus\nRX SummâTreatment Status\n\n\nrxsummtreatmentstatusdescription\nnan\n\n\nrxtextbrm\nRX TextâBRM\n\n\nrxtextchemo\nRX TextâChemo\n\n\nrxtexthormone\nRX TextâHormone\n\n\nrxtextother\nRX TextâOther\n\n\nrxtextpalliative\nText-Palliative Services\n\n\nrxtextradiation\nRX TextâRadiation (Beam)\n\n\nrxtextradiationother\nRX TextâRadiation Other\n\n\nrxtextsurgery\nRX TextâSurgery\n\n\nrxtextsurgery1\nRX Text Surgery 1\n\n\nrxtextsurgery2\nRX Text Surgery 2\n\n\nrxtextsurgery3\nRX Text Surgery 3\n\n\nstanford_patient_uid\nInternal Stanford tracking ID for Neural frame (this is the patientâs MRN | DOB)\n\n\nstanford1stcoursechemofacility\nStanford 1st Course Chemo Facility\n\n\nstanford1stcoursechemofacilitydescription\nnan\n\n\nstanford1stcoursehormonefacility\nStanford 1st Course Hormone Facility\n\n\nstanford1stcoursehormonefacilitydescription\nnan\n\n\nstanford1stcourseimmunofacility\nStanford 1st Course Immuno Facility\n\n\nstanford1stcourseimmunofacilitydescription\nnan\n\n\nstanford1stcourseotherrxfacility\nStanford 1st Course Other Rx Facility\n\n\nstanford1stcourseotherrxfacilitydescription\nnan\n\n\nstanford1stcoursepalliativefacility\nStanford 1st Course Palliative Facility\n\n\nstanford1stcoursepalliativefacilitydescription\nnan\n\n\nstanford1stcourseradiationfacility\nStanford 1st Course Radiation Facility\n\n\nstanford1stcourseradiationfacilitydescription\nnan\n\n\nstanford1stcoursesurgeryfacility\nStanford 1st Course Surgery Facility\n\n\nstanford1stcoursesurgeryfacilitydescription\nnan\n\n\nstanford1stcoursetransplantendocrinefacility\nStanford 1st Course Transplant Endocrine Facility\n\n\nstanford1stcoursetransplantendocrinefacilitydescription\nnan\n\n\nstanfordadditionaltext\nText - Followup/Outcomes\n\n\nstanfordradiationgivenateden\nStanford Radiation Given At EDEN\n\n\nstanfordradiationgivenatedendescription\nnan\n\n\nstanfordradiationgivenatseroc\nStanford Radiation Given At SEROC\n\n\nstanfordradiationgivenatserocdescription\nnan\n\n\nstanfordrouteofadministrationhormone\nStanford Route Of Administration Hormone\n\n\nstanfordrouteofadministrationhormonedescription\nnan\n\n\nstanfordrouteofadministrationimmuno\nStanford Route Of Administration Immuno\n\n\nstanfordrouteofadministrationimmunodescription\nnan\n\n\nstanfordsubsequent1chemofacility\nStanford Subsequent 1 Chemo Facility\n\n\nstanfordsubsequent1chemofacilitydescription\nnan\n\n\nstanfordsubsequent1hormonefacility\nStanford Subsequent 1 Hormone Facility\n\n\nstanfordsubsequent1hormonefacilitydescription\nnan\n\n\nstanfordsubsequent1immunofacility\nStanford Subsequent 1 Immuno Facility\n\n\nstanfordsubsequent1immunofacilitydescription\nnan\n\n\nstanfordsubsequent1otherrxfacility\nStanford Subsequent 1 Other Rx Facility\n\n\nstanfordsubsequent1otherrxfacilitydescription\nnan\n\n\nstanfordsubsequent1palliativefacility\nStanford Subsequent 1 Palliative Facility\n\n\nstanfordsubsequent1palliativefacilitydescription\nnan\n\n\nstanfordsubsequent1radiationfacility\nStanford Subsequent 1 Radiation Facility\n\n\nstanfordsubsequent1radiationfacilitydescription\nnan\n\n\nstanfordsubsequent1surgeryfacility\nStanford Subsequent 1 Surgery Facility\n\n\nstanfordsubsequent1surgeryfacilitydescription\nnan\n\n\nstanfordsubsequent1transplantendocrinefacility\nStanford Subsequent 1 Transplant Endocrine Facility\n\n\nstanfordsubsequent1transplantendocrinefacilitydescription\nnan\n\n\nstanfordsubsequent2chemofacility\nStanford Subsequent 2 Chemo Facility\n\n\nstanfordsubsequent2chemofacilitydescription\nnan\n\n\nstanfordsubsequent2hormonefacility\nStanford Subsequent 2 Hormone Facility\n\n\nstanfordsubsequent2hormonefacilitydescription\nnan\n\n\nstanfordsubsequent2immunofacility\nStanford Subsequent 2 Immuno Facility\n\n\nstanfordsubsequent2immunofacilitydescription\nnan\n\n\nstanfordsubsequent2otherrxfacility\nStanford Subsequent 2 Other Rx Facility\n\n\nstanfordsubsequent2otherrxfacilitydescription\nnan\n\n\nstanfordsubsequent2palliativefacility\nStanford Subsequent 2 Palliative Facility\n\n\nstanfordsubsequent2palliativefacilitydescription\nnan\n\n\nstanfordsubsequent2radiationfacility\nStanford Subsequent 2 Radiation Facility\n\n\nstanfordsubsequent2radiationfacilitydescription\nnan\n\n\nstanfordsubsequent2surgeryfacility\nStanford Subsequent 2 Surgery Facility\n\n\nstanfordsubsequent2surgeryfacilitydescription\nnan\n\n\nstanfordsubsequent2transplantendocrinefacility\nStanford Subsequent 2 Transplant Endocrine Facility\n\n\nstanfordsubsequent2transplantendocrinefacilitydescription\nnan\n\n\nstanfordsubsequent3chemofacility\nStanford Subsequent 3 Chemo Facility\n\n\nstanfordsubsequent3chemofacilitydescription\nnan\n\n\nstanfordsubsequent3hormonefacility\nStanford Subsequent 3 Hormone Facility\n\n\nstanfordsubsequent3hormonefacilitydescription\nnan\n\n\nstanfordsubsequent3immunofacility\nStanford Subsequent 3 Immuno Facility\n\n\nstanfordsubsequent3immunofacilitydescription\nnan\n\n\nstanfordsubsequent3otherrxfacility\nStanford Subsequent 3 Other Rx Facility\n\n\nstanfordsubsequent3otherrxfacilitydescription\nnan\n\n\nstanfordsubsequent3palliativefacility\nStanford Subsequent 3 Palliative Facility\n\n\nstanfordsubsequent3palliativefacilitydescription\nnan\n\n\nstanfordsubsequent3radiationfacility\nStanford Subsequent 3 Radiation Facility\n\n\nstanfordsubsequent3radiationfacilitydescription\nnan\n\n\nstanfordsubsequent3surgeryfacility\nStanford Subsequent 3 Surgery Facility\n\n\nstanfordsubsequent3surgeryfacilitydescription\nnan\n\n\nstanfordsubsequent3transplantendocrinefacility\nStanford Subsequent 3 Transplant Endocrine Facility\n\n\nstanfordsubsequent3transplantendocrinefacilitydescription\nnan\n\n\nstanfordtextprotocol\nText-Protocol\n\n\nsubsequenttreatmentneeded\nnan\n\n\nsubsequenttreatmentneededdescription\nnan\n\n\nsubsequenttreatmenttext\nTreatment Protocol\n\n\nsubsqrx2ndcoursechemo\nnan\n\n\nsubsqrx2ndcoursedate\nnan\n\n\nsubsqrx2ndcourseoth\nnan\n\n\nsubsqrx2ndcourserad\nnan\n\n\nsubsqrx2ndcoursesurg\nnan\n\n\nsubsqrx2ndreglnrem\nnan\n\n\nsubsqrx2ndscopelnsu\nnan\n\n\nsubsqrx2ndsurgoth\nnan\n\n\nsubsqrx3rdcoursedate\nnan\n\n\nsubsqrx3rdcourserad\nnan\n\n\nsubsqrx3rdcoursesurg\nnan\n\n\nsubsqrx3rdreglnrem\nnan\n\n\nsubsqrx3rdscopelnsu\nnan\n\n\nsubsqrx3rdsurgoth\nnan\n\n\nsubsqrx4thcoursedate\nnan\n\n\nsubsqrx4thcourserad\nnan\n\n\nsubsqrx4thcoursesurg\nnan\n\n\nsubsqrx4thscopelnsu\nnan\n\n\nsubsqrx4thsurgoth\nnan\n\n\nsubsqrxreconstructdel\nnan\n\n\nsurgotherproc1\nSurg Other Proc 1\n\n\nsurgotherproc1description\nnan\n\n\nsurgotherproc2\nSurg Other Proc 2\n\n\nsurgotherproc2description\nnan\n\n\nsurgotherproc3\nSurg Other Proc 3\n\n\nsurgotherproc3description\nnan\n\n\nsurgprimproc1\nSurg Prim Proc 1\n\n\nsurgprimproc1description\nnan\n\n\nsurgprimproc2\nSurg Prim Proc 2\n\n\nsurgprimproc20231\nSurg Prim Proc 2023 1\n\n\nsurgprimproc20231description\nnan\n\n\nsurgprimproc20232\nSurg Prim Proc 2023 2\n\n\nsurgprimproc20232description\nnan\n\n\nsurgprimproc20233\nSurg Prim Proc 2023 3\n\n\nsurgprimproc20233description\nnan\n\n\nsurgprimproc2description\nnan\n\n\nsurgprimproc3\nSurg Prim Proc 3\n\n\nsurgprimproc3description\nnan\n\n\ntotaldose\nTotal Dose\n\n\ntotaldosedescription\nnan\n\n\ntranspendohosp\nTransp Endo Hosp\n\n\ntranspendohospdescription\nnan\n\n\ntreatmenthospitalnumberproc1\nTreatment Hospital Number Procedure 1\n\n\ntreatmenthospitalnumberproc1description\nnan\n\n\ntreatmenthospitalnumberproc2\nTreatment Hospital Number Procedure 2\n\n\ntreatmenthospitalnumberproc2description\nnan\n\n\ntreatmenthospitalnumberproc3\nTreatment Hospital Number Procedure 3\n\n\ntreatmenthospitalnumberproc3description\nnan",
    "crumbs": [
      "About",
      "Data Dictionary",
      "NeuralFrame",
      "NeuralFrame Case Treatments"
    ]
  },
  {
    "objectID": "neuralframe_data_dict/case_misc_details.html",
    "href": "neuralframe_data_dict/case_misc_details.html",
    "title": "NeuralFrame Case Miscellaneous Details",
    "section": "",
    "text": "The table onc_neuralframe_case_misc_details includes additional data that may not fit into the other categories, such as demographic information, patient-reported outcomes, and other relevant clinical data.\n\nTable Columns\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\nnaaccr number\n\n\n\n\nabstractedby\nSTRING\nYes\nDel\n570\n\n\nabstractedbydescription\nSTRING\nYes\nDel\n\n\n\naddratdxcity\nSTRING\nYes\nDel\n\n\n\naddratdxcitydescription\nSTRING\nYes\nDel\n\n\n\naddratdxcountry\nSTRING\n\n\n102\n\n\naddratdxcountrydescription\nSTRING\n\n\n\n\n\naddratdxnostreet\nSTRING\nYes\nDel\n2330\n\n\naddratdxnostreetdescription\nSTRING\nYes\nDel\n\n\n\naddratdxpostalcode\nSTRING\nYes\nRedZip\n100\n\n\naddratdxpostalcodedescription\nSTRING\n\n\n\n\n\naddratdxstate\nSTRING\n\n\n80\n\n\naddratdxstatedescription\nSTRING\n\n\n\n\n\naddratdxsupplementl\nSTRING\nYes\nDel\n2335\n\n\naddrcurrentcity\nSTRING\nYes\nDel\n1810\n\n\naddrcurrentcountry\nSTRING\n\n\n1832\n\n\naddrcurrentcountrydescription\nSTRING\n\n\n\n\n\naddrcurrentcounty\nSTRING\n\n\n\n\n\naddrcurrentnostreet\nSTRING\nYes\nDel\n2350\n\n\naddrcurrentpostalcode\nSTRING\nYes\nRedZip\n1830\n\n\naddrcurrentpostalcodedescription\nSTRING\n\n\n\n\n\naddrcurrentstate\nSTRING\n\n\n1820\n\n\naddrcurrentstatedescription\nSTRING\n\n\n\n\n\naddrcurrentsupplementl\nSTRING\nYes\nDel\n2355\n\n\nageatdiagnosis\nSTRING\nYes\nJitter\n230\n\n\nageatdiagnosisdescription\nSTRING\n\n\n\n\n\nagedecadediagnosis\nSTRING\nYes\nJitter\n\n\n\narchivefin\nSTRING\n\n\n3100\n\n\narchivefindescription\nSTRING\n\n\n\n\n\nbirthplacecountry\nSTRING\n\n\n254\n\n\nbirthplacecountrydescription\nSTRING\n\n\n\n\n\nbirthplacestate\nSTRING\n\n\n252\n\n\nbirthplacestatedescription\nSTRING\n\n\n\n\n\ncaliforniacountyatdx\nSTRING\n\n\n23002\n\n\ncaliforniacountyatdxdescription\nSTRING\n\n\n\n\n\ncaliforniareportingfacility\nSTRING\n\n\n23001\n\n\ncaliforniareportingfacilitydescription\nSTRING\n\n\n\n\n\ncaseassignedto\nSTRING\nYes\nDel\n50070\n\n\ncaseassignedtodescription\nSTRING\nYes\nDel\n\n\n\ncasefindingreviewstatus\nSTRING\n\n\n50010\n\n\ncasefindingreviewstatusdescription\nSTRING\n\n\n\n\n\ncauseofdeath\nSTRING\n\n\n1910\n\n\ncauseofdeathdescription\nSTRING\n\n\n\n\n\ncensusindcode19702000\nSTRING\n\n\n\n\n\ncensusocccode19702000\nSTRING\n\n\n\n\n\ncontactname\nSTRING\nYes\nDel\n70001\n\n\ncountyatdx\nSTRING\n\n\n90\n\n\ncountyatdxdescription\nSTRING\n\n\n\n\n\ndateofbirth\nSTRING\nYes\nJitter\n\n\n\ndcstatefilenumber\nSTRING\nYes\nDel\n2380\n\n\nfollowupcontactcity\nSTRING\n\n\n\n\n\nfollowupcontactcountry\nSTRING\n\n\n\n\n\nfollowupcontactnost\nSTRING\nYes\nDel\n\n\n\nfollowupcontactpostal\nSTRING\nYes\nRedZip\n\n\n\nfollowupcontactstate\nSTRING\n\n\n\n\n\nfollowupcontactsuppl\nSTRING\n\n\n\n\n\nfollowuplasttypepatient\nSTRING\n\n\n70010\n\n\nfollowuplasttypepatientdescription\nSTRING\n\n\n\n\n\nfollowupnexttype\nSTRING\n\n\n70012\n\n\nfollowupnexttypedescription\nSTRING\n\n\n\n\n\nheight\nSTRING\n\n\n9960\n\n\nheightdescription\nSTRING\n\n\n\n\n\nhosppatno\nSTRING\nYes\nDel\n70013\n\n\nmaritalstatusatdx\nSTRING\n\n\n150\n\n\nmaritalstatusatdxdescription\nSTRING\n\n\n\n\n\nmedicarebeneficiaryidentifier\nSTRING\nYes\nDel\n2315\n\n\nnaaccralcohol\nSTRING\n\n\n350\n\n\nnaaccralcoholdescription\nSTRING\n\n\n\n\n\nnaaccrrecordversion\nSTRING\n\n\n50\n\n\nnaaccrrecordversiondescription\nSTRING\n\n\n\n\n\nnaaccrtobacco\nSTRING\n\n\n340\n\n\nnaaccrtobaccodescription\nSTRING\n\n\n\n\n\nnamealias\nSTRING\nYes\nDel\n2280\n\n\nnamealiasfirst\nSTRING\nYes\nDel\n70016\n\n\nnamebirthsurname\nSTRING\nYes\nDel\n2232\n\n\nnamefirst\nSTRING\nYes\nDel\n2240\n\n\nnamelast\nSTRING\nYes\nDel\n2230\n\n\nnamemaiden\nSTRING\nYes\nDel\n\n\n\nnamemiddle\nSTRING\nYes\nDel\n2250\n\n\nnameprefix\nSTRING\nYes\nDel\n\n\n\nnamespouseparent\nSTRING\nYes\nDel\n\n\n\nnamesuffix\nSTRING\nYes\nDel\n\n\n\nnfcaseentityid\nSTRING\nYes\nStable between Data Refreshes\n\n\n\nnfcasestatus\nSTRING\n\n\n\n\n\nnfcreatedat\nSTRING\nYes\nJitter\n\n\n\nnfupdatedat\nSTRING\nYes\nJitter\n\n\n\noverridespanishbpl\nSTRING\n\n\n70023\n\n\noverridespanishbpldescription\nSTRING\n\n\n\n\n\npatientsystemidhosp\nSTRING\n\n\n21\n\n\npatnocontact\nSTRING\n\n\n70024\n\n\npatnocontactdescription\nSTRING\n\n\n\n\n\npaymentsourcetext\nSTRING\n\n\n70026\n\n\npaysource2\nSTRING\n\n\n70025\n\n\npaysource2description\nSTRING\n\n\n\n\n\nperson_id\nINTEGER\nYes\nStable between Data Refreshes\n\n\n\nplaceofdeath\nSTRING\n\n\n\n\n\nplaceofdeathcountry\nSTRING\n\n\n1944\n\n\nplaceofdeathcountrydescription\nSTRING\n\n\n\n\n\nplaceofdeathstate\nSTRING\n\n\n1942\n\n\nplaceofdeathstatedescription\nSTRING\n\n\n\n\n\nprimarypayeratdx\nSTRING\n\n\n630\n\n\nprimarypayeratdxdescription\nSTRING\n\n\n\n\n\nrace1\nSTRING\n\n\n160\n\n\nrace1description\nSTRING\n\n\n\n\n\nrace2\nSTRING\n\n\n161\n\n\nrace2description\nSTRING\n\n\n\n\n\nrace3\nSTRING\n\n\n162\n\n\nrace3description\nSTRING\n\n\n\n\n\nrace4\nSTRING\n\n\n163\n\n\nrace4description\nSTRING\n\n\n\n\n\nrace5\nSTRING\n\n\n164\n\n\nrace5description\nSTRING\n\n\n\n\n\nracecodingsyscurrent\nSTRING\n\n\n170\n\n\nracecodingsyscurrentdescription\nSTRING\n\n\n\n\n\nracecodingsysoriginal\nSTRING\n\n\n180\n\n\nracecodingsysoriginaldescription\nSTRING\n\n\n\n\n\nreasoncasenotsubmittedstate\nSTRING\n\n\n50014\n\n\nreasoncasenr\nSTRING\n\n\n\n\n\nreasoncasenrdescription\nSTRING\n\n\n\n\n\nrecordtype\nSTRING\n\n\n10\n\n\nrecordtypedescription\nSTRING\n\n\n\n\n\nregistryid\nSTRING\n\n\n40\n\n\nregistryiddescription\nSTRING\n\n\n\n\n\nregistrytype\nSTRING\n\n\n30\n\n\nregistrytypedescription\nSTRING\n\n\n\n\n\nreligion\nSTRING\n\n\n260\n\n\nreligiondescription\nSTRING\n\n\n\n\n\nreportingfacility\nSTRING\n\n\n540\n\n\nreportingfacilitydescription\nSTRING\n\n\n\n\n\nresearchthisfacility\nSTRING\n\n\n100048\n\n\nresearchthisfacilitydescription\nSTRING\n\n\n\n\n\nsex\nSTRING\n\n\n220\n\n\nsexdescription\nSTRING\n\n\n\n\n\nsocialsecuritynumber\nSTRING\nYes\nDel\n2320\n\n\nsocialsecuritynumberdescription\nSTRING\nYes\nDel\n\n\n\nspanishhispanicorigin\nSTRING\n\n\n190\n\n\nspanishhispanicorigindescription\nSTRING\n\n\n\n\n\nssnsuffix\nSTRING\nYes\nDel\n70048\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\nstateexportflag\nSTRING\n\n\n50080\n\n\nstateexportflagdescription\nSTRING\n\n\n\n\n\ntelephone\nSTRING\nYes\nDel\n2360\n\n\ntelephonedescription\nSTRING\nYes\nDel\n\n\n\ntextusualindustry\nSTRING\nYes\nTiDE\n320\n\n\ntextusualoccupation\nSTRING\nYes\nDel\n310\n\n\ntobaccousecigarettes\nSTRING\n\n\n9965\n\n\ntobaccousecigarettesdescription\nSTRING\n\n\n\n\n\ntobaccousenos\nSTRING\n\n\n9968\n\n\ntobaccousenosdescription\nSTRING\n\n\n\n\n\ntobaccouseothersmoke\nSTRING\n\n\n9966\n\n\ntobaccouseothersmokedescription\nSTRING\n\n\n\n\n\ntobaccousesmokeless\nSTRING\n\n\n9967\n\n\ntobaccousesmokelessdescription\nSTRING\n\n\n\n\n\ntobaccousesmokingstatus\nSTRING\n\n\n344\n\n\ntobaccousesmokingstatusdescription\nSTRING\n\n\n\n\n\nweight\nSTRING\n\n\n9961\n\n\nweightdescription\nSTRING\n\n\n\n\n\n\n\n\n\nColumns Description\n\nabstractedby\nAbstracted By\n\n\nabstractedbydescription\nnan\n\n\naddratdxcity\nnan\n\n\naddratdxcitydescription\nnan\n\n\naddratdxcountry\nAddr at DXâCountry\n\n\naddratdxcountrydescription\nnan\n\n\naddratdxnostreet\nAddr at DXâNo & Street\n\n\naddratdxnostreetdescription\nnan\n\n\naddratdxpostalcode\nAddr at DXâPostal Code\n\n\naddratdxpostalcodedescription\nnan\n\n\naddratdxstate\nAddr at DXâState\n\n\naddratdxstatedescription\nnan\n\n\naddratdxsupplementl\nAddr at DXâSupplementl\n\n\naddrcurrentcity\nAddr CurrentâCity\n\n\naddrcurrentcountry\nAddr CurrentâCountry\n\n\naddrcurrentcountrydescription\nnan\n\n\naddrcurrentcounty\nnan\n\n\naddrcurrentnostreet\nAddr CurrentâNo & Street\n\n\naddrcurrentpostalcode\nAddr CurrentâPostal Code\n\n\naddrcurrentpostalcodedescription\nnan\n\n\naddrcurrentstate\nAddr CurrentâState\n\n\naddrcurrentstatedescription\nnan\n\n\naddrcurrentsupplementl\nAddr CurrentâSupplementl\n\n\nageatdiagnosis\nAge at Diagnosis\n\n\nageatdiagnosisdescription\nnan\n\n\nagedecadediagnosis\nDecade of Diagnosis\n\n\narchivefin\nArchive FIN\n\n\narchivefindescription\nnan\n\n\nbirthplacecountry\nBirthplaceâCountry\n\n\nbirthplacecountrydescription\nnan\n\n\nbirthplacestate\nBirthplaceâState\n\n\nbirthplacestatedescription\nnan\n\n\ncaliforniacountyatdx\nCalifornia County At Dx\n\n\ncaliforniacountyatdxdescription\nnan\n\n\ncaliforniareportingfacility\nCalifornia Reporting Facility\n\n\ncaliforniareportingfacilitydescription\nnan\n\n\ncaseassignedto\nCase Assigned To\n\n\ncaseassignedtodescription\nnan\n\n\ncasefindingreviewstatus\nCase Finding Review Status\n\n\ncasefindingreviewstatusdescription\nnan\n\n\ncauseofdeath\nCause of Death\n\n\ncauseofdeathdescription\nnan\n\n\ncensusindcode19702000\nnan\n\n\ncensusocccode19702000\nnan\n\n\ncontactname\nContact Name\n\n\ncountyatdx\nCounty at DX Reported\n\n\ncountyatdxdescription\nnan\n\n\ndcstatefilenumber\nDC State File Number\n\n\ndateofbirth\nDate of Birth\n\n\nfollowupcontactcity\nnan\n\n\nfollowupcontactcountry\nnan\n\n\nfollowupcontactnost\nnan\n\n\nfollowupcontactpostal\nnan\n\n\nfollowupcontactstate\nnan\n\n\nfollowupcontactsuppl\nnan\n\n\nfollowuplasttypepatient\nFollow-Up Last Type Patient\n\n\nfollowuplasttypepatientdescription\nnan\n\n\nfollowupnexttype\nFollow-Up Next Type\n\n\nfollowupnexttypedescription\nnan\n\n\nheight\nHeight\n\n\nheightdescription\nnan\n\n\nhosppatno\nHosp Pat No\n\n\nmaritalstatusatdx\nMarital Status at DX\n\n\nmaritalstatusatdxdescription\nnan\n\n\nmedicarebeneficiaryidentifier\nMedicare Beneficiary Identifier\n\n\nnaaccralcohol\nAlcohol History\n\n\nnaaccralcoholdescription\nnan\n\n\nnaaccrrecordversion\nNAACCR Record Version\n\n\nnaaccrrecordversiondescription\nnan\n\n\nnaaccrtobacco\nTobacco History\n\n\nnaaccrtobaccodescription\nnan\n\n\nnamealias\nNameâAlias\n\n\nnamealiasfirst\nNameâAlias First\n\n\nnamebirthsurname\nNameâBirth Surname\n\n\nnamefirst\nNameâFirst\n\n\nnamelast\nNameâLast\n\n\nnamemaiden\nnan\n\n\nnamemiddle\nNameâMiddle\n\n\nnameprefix\nnan\n\n\nnamespouseparent\nnan\n\n\nnamesuffix\nnan\n\n\nnfcaseentityid\nUnique number corresponding to every new neural frame âcaseâ or event\n\n\nnfcasestatus\nnan\n\n\nnfcreatedat\ndate created\n\n\nnfupdatedat\ndate created\n\n\noverridespanishbpl\nOver-ride Spanish BPL\n\n\noverridespanishbpldescription\nnan\n\n\npatientsystemidhosp\nPatient System ID-Hosp\n\n\npatnocontact\nPat No Contact\n\n\npatnocontactdescription\nnan\n\n\npaymentsourcetext\nPayment Source Text\n\n\npaysource2\nPay Source 2\n\n\npaysource2description\nnan\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\nplaceofdeath\nPlace of Death\n\n\nplaceofdeathcountry\nPlace of DeathâCountry\n\n\nplaceofdeathcountrydescription\nnan\n\n\nplaceofdeathstate\nPlace of DeathâState\n\n\nplaceofdeathstatedescription\nnan\n\n\nprimarypayeratdx\nPrimary Payer at DX\n\n\nprimarypayeratdxdescription\nnan\n\n\nrace1\nRace 1\n\n\nrace1description\nnan\n\n\nrace2\nRace 2\n\n\nrace2description\nnan\n\n\nrace3\nRace 3\n\n\nrace3description\nnan\n\n\nrace4\nRace 4\n\n\nrace4description\nnan\n\n\nrace5\nRace 5\n\n\nrace5description\nnan\n\n\nracecodingsyscurrent\nRace Coding SysâCurrent\n\n\nracecodingsyscurrentdescription\nnan\n\n\nracecodingsysoriginal\nRace Coding SysâOriginal\n\n\nracecodingsysoriginaldescription\nnan\n\n\nreasoncasenotsubmittedstate\nReason Case Not Submitted to State\n\n\nreasoncasenr\nnan\n\n\nreasoncasenrdescription\nnan\n\n\nrecordtype\nRecord Type\n\n\nrecordtypedescription\nnan\n\n\nregistryid\nRegistry ID\n\n\nregistryiddescription\nnan\n\n\nregistrytype\nRegistry Type\n\n\nregistrytypedescription\nnan\n\n\nreligion\nReligion\n\n\nreligiondescription\nnan\n\n\nreportingfacility\nReporting Facility\n\n\nreportingfacilitydescription\nnan\n\n\nresearchthisfacility\nResearch This Facility\n\n\nresearchthisfacilitydescription\nnan\n\n\nsex\nSex\n\n\nsexdescription\nnan\n\n\nsocialsecuritynumber\nSocial Security Number\n\n\nsocialsecuritynumberdescription\nnan\n\n\nspanishhispanicorigin\nSpanish/Hispanic Origin\n\n\nspanishhispanicorigindescription\nnan\n\n\nssnsuffix\nSSN Suffix\n\n\nstanford_patient_uid\nInternal Stanford tracking ID for Neural frame\n\n\nstateexportflag\nState Export Flag\n\n\nstateexportflagdescription\nnan\n\n\ntelephone\nTelephone\n\n\ntelephonedescription\nnan\n\n\ntextusualindustry\nTextâUsual Industry\n\n\ntextusualoccupation\nnan\n\n\ntextusualoccupation\nTextâUsual Occupation\n\n\ntobaccousecigarettes\nTobacco Use Cigarettes\n\n\ntobaccousecigarettesdescription\nnan\n\n\ntobaccousenos\nTobacco Use NOS\n\n\ntobaccousenosdescription\nnan\n\n\ntobaccouseothersmoke\nTobacco Use Other Smoke\n\n\ntobaccouseothersmokedescription\nnan\n\n\ntobaccousesmokeless\nTobacco Use Smokeless\n\n\ntobaccousesmokelessdescription\nnan\n\n\ntobaccousesmokingstatus\nTobacco Use Smoking Status\n\n\ntobaccousesmokingstatusdescription\nnan\n\n\nweight\nWeight\n\n\nweightdescription\nnan",
    "crumbs": [
      "About",
      "Data Dictionary",
      "NeuralFrame",
      "NeuralFrame Case Miscellaneous Details"
    ]
  },
  {
    "objectID": "aug_2025/released_datasets.html",
    "href": "aug_2025/released_datasets.html",
    "title": "Released Datasets",
    "section": "",
    "text": "This document provides a list of datasets as part of the August 2025 released. Each dataset is described briefly, including whether it contains Protected Health Information (PHI) or if the PHI has been scrubbed.\n\nOMOP Datasets\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_omop_phi_irb76049_aug2025\nOncology OMOP-CDM v5.3.1 dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_omop_confidential_irb76049_aug2025\nOncology OMOP-CDM v5.3.1 dataset with PHI Scrubbed\n\n\n\n\n\nNeuralFrame Datasets\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_phi_irb76049_aug2025\nNeuralFrame dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_confidential_irb76049_aug2025\nNeuralFrame dataset with PHI Scrubbed\n\n\n\n\n\nPhilips ISPM Datasets\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_philips_phi_irb76049_aug2025\nPhilips ISPM dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_philips_confidential_irb76049_aug2025\nPhilips ISPM dataset with PHI Scrubbed\n\n\n\n\n\nSTAMP Add-On Data\n\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_stamp_add_on_data_irb76049_aug2025.oncology_stamp_add_on_data_phi\nSTAMP add on dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_stamp_add_on_data_irb76049_aug2025.stamp_add_on_data_confidential\nSTAMP add on dataset Scrubbed",
    "crumbs": [
      "About",
      "August 2025",
      "Released Datasets"
    ]
  },
  {
    "objectID": "feb_2025/released_datasets.html",
    "href": "feb_2025/released_datasets.html",
    "title": "Released Datasets",
    "section": "",
    "text": "This document provides a list of datasets as part of the February 2025 released. Each dataset is described briefly, including whether it contains Protected Health Information (PHI) or if the PHI has been scrubbed.\n\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_omop_phi_irb76049_feb2025\nOncology OMOP-CDM v5.3.1 dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_omop_confidential_irb76049_feb2025\nOncology OMOP-CDM v5.3.1 dataset with PHI Scrubbed\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_phi_irb76049_feb2025\nNeuralFrame dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_confidential_irb76049_feb2025\nNeuralFrame dataset with PHI Scrubbed\n\n\noncology_omop_phi_flags_irb76049_feb2025\nTable with flags used to compute several metrics",
    "crumbs": [
      "About",
      "February 2025",
      "Released Datasets"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_guidelines.html",
    "href": "feb_2025/phi_labeling_guidelines.html",
    "title": "PHI Labeling Guidelines",
    "section": "",
    "text": "This task consists of labeling instances of Protected Health Information (PHI) that occur within the context of clinical notes. PHI is defined as information that can be used by itself or in combination with other readily available information to identify an individual within the database. A more formal definition can be found on this HHS website.\nSpecifically, in this task, we will highlight spans of text that can be identified as PHI either by itself or in combination with other information within the note. The different categories to annotate are:",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Guidelines"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_guidelines.html#how-to-annotate",
    "href": "feb_2025/phi_labeling_guidelines.html#how-to-annotate",
    "title": "PHI Labeling Guidelines",
    "section": "How to Annotate",
    "text": "How to Annotate\nThe software we will use for this annotation task is Argilla. Hugging Face recently acquired this startup, so we can expect continued support moving forward, given the extensive Hugging Face community. The software has been deployed in our internal cloud infrastructure. Once you connect, you should see the following screen. The software is only available internally.\n\n\nAccepting/adding annotations\nThe software will automatically assign clinical notes to you. Most PHI should already be labeled by the LLM. Your job is\n\nVerify that the output is correct.\n\nIf the label is incorrect delete it and assign a new label\n\nIf the span is not PHI according to the guidelines delete it\n\n\nAdd PHI missed by the algorithm: Even the LLMs miss.\nClick Submit",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Guidelines"
    ]
  },
  {
    "objectID": "omop_data_dict/vocabulary.html",
    "href": "omop_data_dict/vocabulary.html",
    "title": "vocabulary",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nvocabulary_id\nSTRING\nYes\nNo\n\n\n\nvocabulary_name\nSTRING\nYes\nNo\n\n\n\nvocabulary_reference\nSTRING\nYes\nNo\n\n\n\nvocabulary_version\nSTRING\nNo\nNo\n\n\n\nvocabulary_concept_id\nINTEGER\nYes\nNo\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\n\n\n\n\nColumns Description\n\nvocabulary_id\nA unique identifier for each Vocabulary, such as ICD9CM, SNOMED, Visit.\n\n\nvocabulary_name\nThe name describing the vocabulary, for example âInternational Classification of Diseases, Ninth Revision, Clinical Modification, Volume 1 and 2 (NCHS)â etc.\n\n\nvocabulary_reference\nExternal reference to documentation or available download of the about the vocabulary.\n\n\nvocabulary_version\nVersion of the Vocabulary as indicated in the source.\n\n\nvocabulary_concept_id\nA foreign key that refers to a standard concept identifier in the CONCEPT table for the Vocabulary the VOCABULARY record belongs to\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "vocabulary"
    ]
  },
  {
    "objectID": "omop_data_dict/visit_detail.html",
    "href": "omop_data_dict/visit_detail.html",
    "title": "visit_detail",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nvisit_detail_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nvisit_detail_concept_id\nINTEGER\nYes\n\n\n\n\nvisit_detail_start_date\nDATE\nNo\nYes\nJitter\n\n\nvisit_detail_start_datetime\nDATETIME\nYes\nYes\nJitter\n\n\nvisit_detail_end_date\nDATE\nNo\nYes\nJitter\n\n\nvisit_detail_end_datetime\nDATETIME\nYes\nYes\nJitter\n\n\nvisit_detail_type_concept_id\nINTEGER\nYes\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\ncare_site_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_source_value\nSTRING\nNo\nYes\n\n\n\nvisit_detail_source_concept_id\nINTEGER\nYes\n\n\n\n\nadmitted_from_source_value\nSTRING\nNo\nYes\n\n\n\nadmitted_from_concept_id\nINTEGER\nYes\n\n\n\n\ndischarge_to_source_value\nSTRING\nNo\nYes\n\n\n\ndischarge_to_concept_id\nINTEGER\nYes\n\n\n\n\npreceding_visit_detail_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_parent_id\nINTEGER\nNo\n\n\n\n\nvisit_occurrence_id\nINTEGER\nYes\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nvisit_detail_id\nA unique identifier for each Personâs visit or encounter at a healthcare provider.\n\n\nperson_id\nA foreign key identifier to the Person for whom the visit is recorded. The demographic details of that Person are stored in the PERSON table.\n\n\nvisit_detail_concept_id\nThis field contains a concept id representing the kind of visit detail, like inpatient or outpatient. All concepts in this field should be standard and belong to the Visit domain.\n\n\nvisit_detail_start_date\nThe start date of the visit.\n\n\nvisit_detail_start_datetime\nThe date and time when the visit started. This defaults to 00:00:00 (midnight) if no time information is available.\n\n\nvisit_detail_end_date\nThe end date of the visit. If this is a one-day visit the end date should match the start date.\n\n\nvisit_detail_end_datetime\nThe date and time when the visit ended.This defaults to 00:00:00 (midnight) if no time information is available.\n\n\nvisit_detail_type_concept_id\nUse this field to understand the provenance of the visit detail record, or where the record comes from.\n\n\nprovider_id\nA foreign key to the provider in the provider table who was associated with the visit.\n\n\ncare_site_id\nA foreign key to the care site in the care site table that was visited.\n\n\nvisit_detail_source_value\nThe source ID for the visit as it appears in the source data; this corresponds to the Epic Clarity pat_enc_csn_id for STARR-OMOP.\n\n\nvisit_detail_source_concept_id\nA foreign key to a Concept that repersents a distinct combination of the following three variables: ADT patient class, hospital admission type, and encounter type. One or more of these variables may be null for any given visit.\n\n\nadmitted_from_source_value\nThe source code for the admitting source as it appears in the source data.\n\n\nadmitted_from_concept_id\nA foreign key to the predefined concept in the âPlace of Serviceâ Vocabulary reflecting the admitting source for a visit.\n\n\ndischarge_to_source_value\nThe source code for the discharge disposition as it appears in the source data.\n\n\ndischarge_to_concept_id\nA foreign key to the predefined concept in the âPlace of Serviceâ Vocabulary reflecting the discharge disposition for a visit.\n\n\npreceding_visit_detail_id\nA foreign key to the VISIT_DETAIL table of the visit immediately preceding this visit\n\n\nvisit_detail_parent_id\nA foreign key to the VISIT_DETAIL table record to represent the parent Visit Detail this Visit Detail belongs to, to allow for multiple levels of nested visits.\n\n\nvisit_occurrence_id\nA foreign key that refers to the record in the VISIT_OCCURRENCE table. This is a required field, because every visit_detail is associated with a visit_occurrence and cannot exist without a corresponding record in visit_occurrence\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "visit_detail"
    ]
  },
  {
    "objectID": "omop_data_dict/provider.html",
    "href": "omop_data_dict/provider.html",
    "title": "provider",
    "section": "",
    "text": "Standarized Health System Data Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nprovider_id\nINTEGER\nYes\nNo\nOffset\n\n\nprovider_name\nSTRING\nNo\nNo\n\n\n\nnpi\nSTRING\nNo\nNo\n\n\n\ndea\nSTRING\nNo\nNo\nDel\n\n\nspecialty_concept_id\nSTRING\nYes\nNo\n\n\n\ncare_site_id\nINTEGER\nNo\nNo\nOffset\n\n\nyear_of_birth\nINTEGER\nNo\nNo\n\n\n\ngender_concept_id\nINTEGER\nYes\nNo\n\n\n\nprovider_source_value\nSTRING\nNo\nYes\n\n\n\nspecialty_source_value\nSTRING\nNo\nNo\n\n\n\nspecialty_source_concept_id\nINTEGER\nYes\nNo\n\n\n\ngender_source_value\nSTRING\nNo\nNo\n\n\n\ngender_source_concept_id\nINTEGER\nYes\nNo\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nNo\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\n\n\n\n\nColumns Description\n\nprovider_id\nA unique identifier for each Provider.\n\n\nprovider_name\nA description of the Healthcare Provider.\n\n\nnpi\nThe National Provider Identifier (NPI) of the providers in the US by the Centers for Medicare and Medicaid Services (CMS).\n\n\ndea\nThis is the identifier issued by the DEA, a US federal agency, that allows a provider to write prescriptions for controlled substances.\n\n\nspecialty_concept_id\nThis is the CARE_SITE_ID for the location that the provider primarily practices in.\n\n\ncare_site_id\nThis field either represents the most common specialty that occurs in the data or the most specific concept that represents all specialties listed, should the provider have more than one.\n\n\nyear_of_birth\nThe year of birth of the Provider.\n\n\ngender_concept_id\nThe gender of the Provider.\n\n\nprovider_source_value\nThe identifier used for the Provider in the source data, stored here for reference.\n\n\nspecialty_source_value\nThe source code for the Provider specialty as it appears in the source data, stored here for reference.\n\n\nspecialty_source_concept_id\nA foreign key to a Concept that refers to the code used in the source.\n\n\ngender_source_value\nThe gender code for the Provider as it appears in the source data, stored here for reference.\n\n\ngender_source_concept_id\nA foreign key to a Concept that refers to the code used in the source for storing the providers gender\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "provider"
    ]
  },
  {
    "objectID": "omop_data_dict/person.html",
    "href": "omop_data_dict/person.html",
    "title": "person",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\ngender_concept_id\nINTEGER\nYes\n\n\n\n\nyear_of_birth\nINTEGER\nYes\n\n\n\n\nmonth_of_birth\nINTEGER\nNo\nYes\nJitt\n\n\nday_of_birth\nINTEGER\nNo\nYes\nJitt\n\n\nbirth_datetime\nDATETIME\nNo\nYes\nJitt\n\n\nrace_concept_id\nINTEGER\nYes\n\n\n\n\nethnicity_concept_id\nINTEGER\nYes\n\n\n\n\nlocation_id\nINTEGER\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\ncare_site_id\nINTEGER\nNo\n\n\n\n\nperson_source_value\nSTRING\nNo\nYes\nSub\n\n\ngender_source_value\nSTRING\nNo\n\n\n\n\ngender_source_concept_id\nINTEGER\nYes\n\n\n\n\nrace_source_value\nSTRING\nNo\n\n\n\n\nrace_source_concept_id\nINTEGER\nYes\n\n\n\n\nethnicity_source_value\nSTRING\nNo\n\n\n\n\nethnicity_source_concept_id\nINTEGER\nYes\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nperson_id\nA unique identifier for each person.\n\n\ngender_concept_id\nThis field is meant to capture the biological sex at birth of the Person. This field should not be used to study gender identity issues.\n\n\nyear_of_birth\nThe year of birth of the person. For data sources with date of birth, the year is extracted. For data sources where the year of birth is not available, the approximate year of birth is derived based on any age group categorization available.\n\n\nmonth_of_birth\nThe month of birth of the person. For data sources that provide the precise date of birth, the month is extracted and stored in this field.\n\n\nday_of_birth\nThe day of the month of birth of the person. For data sources that provide the precise date of birth, the day is extracted and stored in this field.\n\n\nbirth_datetime\nThe date and time of birth of the person.\n\n\nrace_concept_id\nThis field captures race or ethnic background of the person.\n\n\nethnicity_concept_id\nThis field captures ethnicity as defined by the Office of Management and Budget (OMB) of the US Government: it distinguishes only between âHispanicâ and âNot Hispanicâ. Races and ethnic backgrounds are not stored here.\n\n\nlocation_id\nA foreign key to the place of residency for the person in the location table, where the detailed address information is stored. This field should capture the last known location of the person.\n\n\nprovider_id\nA foreign key to the primary care provider the person is seeing in the provider table.\n\n\ncare_site_id\nA foreign key to the site of primary care in the care_site table, where the details of the care site are stored.\n\n\nperson_source_value\nAn (encrypted) key derived from the person identifier in the source data. This is necessary when a use case requires a link back to the person data at the source dataset. In STARR-OMOP person_source_value is: MRN | D.O.B.\n\n\ngender_source_value\nThe source code for the gender of the person as it appears in the source data. The personâs gender is mapped to a standard gender concept in the Standardized Vocabularies; the original value is stored here for reference.\n\n\ngender_source_concept_id\nA foreign key to the gender concept that refers to the code used in the source.\n\n\nrace_source_value\nThe source code for the race of the person as it appears in the source data. The person race is mapped to a standard race concept in the Standardized Vocabularies and the original value is stored here for reference.\n\n\nrace_source_concept_id\nA foreign key to the race concept that refers to the code used in the source.\n\n\nethnicity_source_value\nThe source code for the ethnicity of the person as it appears in the source data. The person ethnicity is mapped to a standard ethnicity concept in the Standardized Vocabularies and the original code is, stored here for reference.\n\n\nethnicity_source_concept_id\nA foreign key to the ethnicity concept that refers to the code used in the source.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference to the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "person"
    ]
  },
  {
    "objectID": "omop_data_dict/observation_period.html",
    "href": "omop_data_dict/observation_period.html",
    "title": "observation_period",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nobservation_period_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nobservation_period_start_date\nDATE\nYes\nYes\nJitt\n\n\nobservation_period_end_date\nDATE\nYes\nYes\nJitt\n\n\nperiod_type_concept_id\nINTEGER\nYes\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\n\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nobservation_period_id\nA unique identifier for each observation period. A Person can have multiple discrete Observation Periods which are identified by the Observation_Period_Id.\n\n\nperson_id\nA foreign key identifier to the person for whom the observation period is defined. The demographic details of that person are stored in the person table.\n\n\nobservation_period_start_date\nThe start date of the observation period for which data are available from the data source.\n\n\nobservation_period_end_date\nThe end date of the observation period for which data are available from the data source.\n\n\nperiod_type_concept_id\nThis field. stores the provenance of the Observation Period as in whether the period was determined from an insurance enrollment file, EHR healthcare encounters, or other sources.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "observation_period"
    ]
  },
  {
    "objectID": "omop_data_dict/note.html",
    "href": "omop_data_dict/note.html",
    "title": "note",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nnote_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nnote_date\nDATE\nNo\nYes\nJitt\n\n\nnote_datetime\nDATETIME\nYes\nYes\nJitt\n\n\nnote_type_concept_id\nINTEGER\nYes\n\n\n\n\nnote_class_concept_id\nINTEGER\nYes\n\n\n\n\nnote_title\nSTRING\nNo\nYes\n\n\n\nnote_text\nSTRING\nYes\nYes\nTiDE\n\n\nencoding_concept_id\nINTEGER\nYes\n\n\n\n\nlanguage_concept_id\nINTEGER\nYes\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\nnote_source_value\nSTRING\nNo\n\nOffset\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nnote_id\nA unique identifier for each note.\n\n\nperson_id\nA foreign key identifier to the Person about whom the Note was recorded. The demographic details of that Person are stored in the PERSON table.\n\n\nnote_date\nThe date the note was recorded.\n\n\nnote_datetime\nThe date and time the note was recorded.\n\n\nnote_type_concept_id\nConcept id that describes the provenance of the note.\n\n\nnote_class_concept_id\nA foreign key to the predefined Concept in the Standardized Vocabularies reflecting the HL7 LOINC Document Type Vocabulary classification of the note.\n\n\nnote_title\nIn our OMOP this column ususally refers the note type. (Procedure note type, h&p etc)\n\n\nnote_text\nThe content of the Note.\n\n\nencoding_concept_id\nA foreign key to the predefined Concept in the Standardized Vocabularies reflecting the note character encoding type\n\n\nlanguage_concept_id\nA foreign key to the predefined Concept in the Standardized Vocabularies reflecting the language of the note\n\n\nprovider_id\nA foreign key to the Provider in the PROVIDER table who took the Note.\n\n\nvisit_occurrence_id\nA foreign key to the Visit in the VISIT_OCCURRENCE table when the Note was taken.\n\n\nvisit_detail_id\nA foreign key to the Visit in the VISIT_DETAIL table when the Note was taken.\n\n\nnote_source_value\nThe source value associated with the origin of the Note - In this case it often the clarity note_id (from hno_note)\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "note"
    ]
  },
  {
    "objectID": "omop_data_dict/measurement.html",
    "href": "omop_data_dict/measurement.html",
    "title": "measurement",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nmeasurement_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nmeasurement_concept_id\nINTEGER\nYes\n\n\n\n\nmeasurement_date\nDATE\nNo\nYes\nJitter\n\n\nmeasurement_datetime\nDATETIME\nYes\nYes\nJitter\n\n\nmeasurement_time\nSTRING\nNo\n\nNull\n\n\nmeasurement_type_concept_id\nINTEGER\nYes\n\n\n\n\noperator_concept_id\nINTEGER\nNo\n\n\n\n\nvalue_as_number\nFLOAT\nNo\n\n\n\n\nvalue_as_concept_id\nINTEGER\nNo\n\n\n\n\nunit_concept_id\nINTEGER\nNo\n\n\n\n\nrange_low\nFLOAT\nNo\n\n\n\n\nrange_high\nFLOAT\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\nmeasurement_source_value\nSTRING\nNo\nYes\nTiDE?\n\n\nmeasurement_source_concept_id\nINTEGER\nYes\n\n\n\n\nunit_source_value\nSTRING\nNo\n\n\n\n\nvalue_source_value\nSTRING\nNo\nYes\nTiDE\n\n\nmodifier_of_event_id\n\nNo\n\nOffset\n\n\nmodifier_of_field_concept_id\n\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nmeasurement_id\nA unique identifier for each Measurement.\n\n\nperson_id\nA foreign key identifier to the Person about whom the measurement was recorded. The demographic details of that Person are stored in the PERSON table.\n\n\nmeasurement_concept_id\nThe standard concept_id that the measurement_source_value maps to\n\n\nmeasurement_date\nThe date of the Measurement. If there are multiple dates in the source data associated with a record such as order_date, draw_date, and result_date, we choose the one that is closest to the date the sample was drawn from the patient.\n\n\nmeasurement_datetime\nThe date and time of the Measurement.\n\n\nmeasurement_time\nThe time of the Measurement. This is present for backwards compatibility and will be deprecated in an upcoming version\n\n\nmeasurement_type_concept_id\nThe measurement_type_concept_id that best represents the provenance of the record, for example whether it came from an EHR record or billing claim.\n\n\noperator_concept_id\nA foreign key identifier to the predefined Concept in the Standardized Vocabularies reflecting the mathematical operator that is applied to the value_as_number. Operators are &lt;, &lt;=, =, &gt;=, &gt; and these concepts belong to the âMeas Value Operatorâ domain.\n\n\nvalue_as_number\nThis is the numerical value of the Result of the Measurement, if available. Note that measurements such as blood pressures will be split into their component parts i.e.Â one record for systolic, one record for diastolic.\n\n\nvalue_as_concept_id\nIf the raw data gives a categorial result for measurements those values are captured and mapped to standard concepts in the âMeas Valueâ domain.\n\n\nunit_concept_id\nA foreign key to a Standard Concept ID of Measurement Units in the Standardized Vocabularies that belong to the âUnitâ domain.\n\n\nrange_low\nThe lower limit of the normal range of the Measurement result. The lower range is assumed to be of the same unit of measure as the Measurement value.\n\n\nrange_high\nThe upper limit of the normal range of the Measurement. The upper range is assumed to be of the same unit of measure as the Measurement value.\n\n\nprovider_id\nA foreign key to the provider in the PROVIDER table who was responsible for initiating or obtaining the measurement.\n\n\nvisit_occurrence_id\nA foreign key to the Visit in the VISIT_OCCURRENCE table during which the Measurement was recorded.\n\n\nvisit_detail_id\nA foreign key to the Visit Detail in the VISIT_DETAIL table during which the Measurement was recorded.\n\n\nmeasurement_source_value\nThe Measurement name as it appears in the source data. This code is mapped to a Standard Concept in the Standardized Vocabularies and the original code is stored here for reference.\n\n\nmeasurement_source_concept_id\nA foreign key to a Concept in the Standard Vocabularies that refers to the code used in the source.\n\n\nunit_source_value\nThe source code for the unit as it appears in the source data. This code is mapped to a standard unit concept in the Standardized Vocabularies and the original code is stored here for reference.\n\n\nvalue_source_value\nThe source value associated with the content of the value_as_number or value_as_concept_id as stored in the source data.\n\n\nmodifier_of_event_id\nnan\n\n\nmodifier_of_field_concept_id\nnan\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "measurement"
    ]
  },
  {
    "objectID": "omop_data_dict/image_occurrence.html",
    "href": "omop_data_dict/image_occurrence.html",
    "title": "image_occurrence",
    "section": "",
    "text": "Clinical Data Table (not yet a Standard)\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nimage_occurrence_id (PK)\nINTEGER\nYes\n\nOffset\n\n\nperson_id (FK)\nINTEGER\nYes\n\nSub\n\n\nprocedure_occurrence_id\nINTEGER\nYes\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nanatomic_site_source_value\nSTRING\nNo\n\nWhitelist\n\n\nwadors_uri\nSTRING\nNo\n\nDel\n\n\nlocal_path\nSTRING\nNo\n\nDel\n\n\nimage_occurrence_date\nDATE\nYes\n\nJitt\n\n\nimage_occurrence_datetime\nDATETIME\nYes\n\nJitt\n\n\nimage_study_uid\nSTRING\nYes\n\nHash\n\n\nimage_series_uid\nSTRING\nYes\n\nHash\n\n\nmodality_source_value\nSTRING\nYes\n\nWhitelist\n\n\n_accession_number\nSTRING\nNo\n\nHash\n\n\n_note_id\nINTEGER\nNo\n\nOffset\n\n\n_study_description\nSTRING\nNo\n\nTide-lite\n\n\n_series_description\nSTRING\nNo\n\nTide-lite\n\n\nsource_flag (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\n\nDel\n\n\n\n\n\n\nColumns Description\n\nimage_occurrence_id (pk)\nA system-generated unique identifier for each Image Occurrence event\n\n\nperson_id (fk)\nA foreign key identifier to the Person who is subjected to the Drug. The demographic details of that Person are stored in the PERSON table\n\n\nprocedure_occurrence_id\nThe unique key is given to a procedure record for a person. Links to the Procedure_occurrence table\n\n\nvisit_occurrence_id\nThe unique key is given to the visit record for a person. Links to the Visit_occurrence table\n\n\nanatomic_site_source_value\nAnatomical location of the imaging procedure by the medical acquisition device (gross anatomy). It maps the ANATOMIC_SITE_SOURCE_VALUE to a Standard Concept in the Spec Anatomic Site domain. This should be coded at the lowest level of granularit\n\n\nwadors_uri\nWeb Access to DICOM Objects via Restful Web Services Uniform Resource Identifier on study level\n\n\nlocal_path\nLocal path to the folder containing the image object file (access via a storage block access protocol)\n\n\nimage_occurrence_date\nThe date the imaging procedure occurred\n\n\nimage_study_uid\nDICOM Study UID(unique identifier). One study can include several series\n\n\nimage_series_uid\nDICOM Series UID (unique identifier)\n\n\nmodality_source_value\nA label that defines the imaging procedures and usually refers to the type of imaging device used. It is of the attributes of the DICOM file (e.g., US, CT, MR, PT, DR, CR, NM)\n\n\n_accession_number\nA unique identifier assigned to a patientâs specimen or procedure order when it is entered into the system. Note that accession numbers may not be unique across departments, but are usually unique across modalities\n\n\n_study_description\nStudy description as is appears in the DICOM metadata\n\n\n_series_description\nSeries description as is appears in the DICOM metadata\n\n\nsource_flag (stanford construct for traceability)\nThe primary hospital system the data is sourced from\n\n\nload_table_id (stanford construct for traceability)\nThe primary starr-common table the data is sourced from\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "image_occurrence"
    ]
  },
  {
    "objectID": "omop_data_dict/drug_strength.html",
    "href": "omop_data_dict/drug_strength.html",
    "title": "drug_strength",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndrug_concept_id\nINTEGER\nYes\n\n\n\n\ningredient_concept_id\nINTEGER\nYes\n\n\n\n\namount_value\nFLOAT\nNo\n\n\n\n\namount_unit_concept_id\nINTEGER\nNo\n\n\n\n\nnumerator_value\nFLOAT\nNo\n\n\n\n\nnumerator_unit_concept_id\nINTEGER\nNo\n\n\n\n\ndenominator_value\nFLOAT\nNo\n\n\n\n\ndenominator_unit_concept_id\nINTEGER\nNo\n\n\n\n\nbox_size\nINTEGER\nNo\n\n\n\n\nvalid_start_date\nDATE\nYes\n\n\n\n\nvalid_end_date\nDATE\nYes\n\n\n\n\ninvalid_reason\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row _id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndrug_concept_id\nA foreign key to the Concept in the CONCEPT table representing the identifier for Branded Drug or Clinical Drug Concept.\n\n\ningredient_concept_id\nA foreign key to the Concept in the CONCEPT table, representing the identifier for drug Ingredient Concept contained within the drug product.\n\n\namount_value\nThe numeric value associated with the amount of active ingredient contained within the product.\n\n\namount_unit_concept_id\nA foreign key to the Concept in the CONCEPT table representing the identifier for the Unit for the absolute amount of active ingredient.\n\n\nnumerator_value\nThe numeric value associated with the concentration of the active ingredient contained in the product\n\n\nnumerator_unit_concept_id\nA foreign key to the Concept in the CONCEPT table representing the identifier for the numerator Unit for the concentration of active ingredient.\n\n\ndenominator_value\nThe amount of total liquid (or other divisible product, such as ointment, gel, spray, etc.).\n\n\ndenominator_unit_concept_id\nA foreign key to the Concept in the CONCEPT table representing the identifier for the denominator Unit for the concentration of active ingredient.\n\n\nbox_size\nThe number of units of Clinical of Branded Drug, or Quantified Clinical or Branded Drug contained in a box as dispensed to the patient\n\n\nvalid_start_date\nThe date when the Concept was first recorded. The default value is 1-Jan-1970.\n\n\nvalid_end_date\nThe date when the concept became invalid because it was deleted or superseded (updated) by a new Concept. The default value is 31-Dec-2099.\n\n\ninvalid_reason\nReason the concept was invalidated. Possible values are âDâ (deleted), âUâ (replaced with an update) or NULL when valid_end_date has the default value.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row _id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "drug_strength"
    ]
  },
  {
    "objectID": "omop_data_dict/drug_era.html",
    "href": "omop_data_dict/drug_era.html",
    "title": "drug_era",
    "section": "",
    "text": "Standardized Derived Elements\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndrug_era_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\ndrug_concept_id\nINTEGER\nYes\n\n\n\n\ndrug_era_start_date\nDATETIME\nYes\nYes\nJitter\n\n\ndrug_era_end_date\nDATETIME\nYes\nYes\nJitter\n\n\ndrug_exposure_count\nINTEGER\nNo\n\n\n\n\ngap_days\nINTEGER\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndrug_era_id\nA unique identifier for each Drug Era.\n\n\nperson_id\nA foreign key identifier to the Person who is subjected to the drug during the Drug Era. The demographic details of that Person are stored in the PERSON table.\n\n\ndrug_concept_id\nA foreign key that refers to a Standard Concept identifier in the Standardized Vocabularies for the Ingredient Concept.\n\n\ndrug_era_start_date\nThe start date for the Drug Era constructed from the individual instances of Drug Exposures. It is the start date of the very first chronologically recorded instance of conutilization of a Drug.\n\n\ndrug_era_end_date\nThe end date for the drug era constructed from the individual instance of drug exposures. It is the end date of the final continuously recorded instance of utilization of a drug.\n\n\ndrug_exposure_count\nThe number of individual Drug Exposure occurrences used to construct the Drug Era.\n\n\ngap_days\nThe number of days that are not covered by drug_exposure records that were used to make up the era record.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "drug_era"
    ]
  },
  {
    "objectID": "omop_data_dict/device_exposure.html",
    "href": "omop_data_dict/device_exposure.html",
    "title": "device_exposure",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndevice_exposure_id\nINTEGER\nYes\nYes\nOffset\n\n\nperson_id\nINTEGER\nYes\nYes\nSub\n\n\ndevice_concept_id\nINTEGER\nYes\n\n\n\n\ndevice_exposure_start_date\nDATE\nNo\nYes\nJitter\n\n\ndevice_exposure_start_datetime\nDATETIME\nYes\nYes\nJitter\n\n\ndevice_exposure_end_date\nDATE\nNo\nYes\nJitter\n\n\ndevice_exposure_end_datetime\nDATETIME\nNo\nYes\nJitter\n\n\ndevice_type_concept_id\nINTEGER\nYes\n\n\n\n\nunique_device_id\nSTRING\nNo\n\n\n\n\nquantity\nINTEGER\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\nYes\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\ndevice_source_value\nSTRING\nNo\n\n\n\n\ndevice_source_concept_id\nINTEGER\nYes\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndevice_exposure_id\nA system-generated unique identifier for each Device Exposure.\n\n\nperson_id\nA foreign key identifier to the Person who is subjected to the Device. The demographic details of that Person are stored in the PERSON table.\n\n\ndevice_concept_id\nA foreign key that refers to a Standard Concept identifier in the Standardized Vocabularies belonging to the âDeviceâ domain.\n\n\ndevice_exposure_start_date\nThe date the Device or supply was applied or used.\n\n\ndevice_exposure_start_datetime\nThe date and time the Device or supply was applied or used.\n\n\ndevice_exposure_end_date\nThe date use of the Device or supply was ceased.\n\n\ndevice_exposure_end_datetime\nThe date and time use of the Device or supply was ceased.\n\n\ndevice_type_concept_id\nThis field can be used to determine the provenance of the record, as in whether the condition was from an EHR system, insurance claim, registry, or other sources.\n\n\nunique_device_id\nA UDI or equivalent identifying the instance of the Device used in the Person.\n\n\nquantity\nThe number of individual Devices used in the exposure.\n\n\nprovider_id\nA foreign key to the provider in the PROVIDER table who initiated or administered the Device.\n\n\nvisit_occurrence_id\nA foreign key to the visit in the VISIT_OCCURRENCE table during which the Device was used.\n\n\nvisit_detail_id\nA foreign key to the visit detail record in the VISIT_DETAIL table during which the Device was used.\n\n\ndevice_source_value\nThe source code for the Device as it appears in the source data. This code is mapped to a Standard Device Concept in the Standardized Vocabularies and the original code is stored here for reference.\n\n\ndevice_source_concept_id\nA foreign key to a Device Concept that refers to the code used in the source.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference to the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "device_exposure"
    ]
  },
  {
    "objectID": "omop_data_dict/condition_occurrence.html",
    "href": "omop_data_dict/condition_occurrence.html",
    "title": "condition_occurrence",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ncondition_occurrence_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\ncondition_concept_id\nINTEGER\nYes\n\n\n\n\ncondition_start_date\nDATE\nNo\nYes\nJitter\n\n\ncondition_start_datetime\nDATETIME\nYes\nYes\nJitter\n\n\ncondition_end_date\nDATE\nNo\nYes\nJitter\n\n\ncondition_end_datetime\nDATETIME\nNo\nYes\nJitter\n\n\ncondition_type_concept_id\nINTEGER\nYes\n\n\n\n\ncondition_status_concept_id\nINTEGER\nYes\n\n\n\n\nstop_reason\nSTRING\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\ncondition_source_value\nSTRING\nNo\n\n\n\n\ncondition_source_concept_id\nINTEGER\nYes\n\n\n\n\ncondition_status_source_value\nSTRING\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ncondition_occurrence_id\nA unique identifier for each Condition Occurrence event.\n\n\nperson_id\nA foreign key identifier to the Person who is experiencing the condition. The demographic details of that Person are stored in the PERSON table.\n\n\ncondition_concept_id\nA foreign key that refers to a Standard Concept identifier in the Standardized Vocabularies belonging to the âConditionâ domain.\n\n\ncondition_start_date\nThe date when the instance of the Condition is recorded.\n\n\ncondition_start_datetime\nThe date and time when the instance of the Condition is recorded.\n\n\ncondition_end_date\nThe date when the instance of the Condition is considered to have ended.\n\n\ncondition_end_datetime\nThe date when the instance of the Condition is considered to have ended.\n\n\ncondition_type_concept_id\nThis field is used to determine the provenance of the Condition record, as in whether the condition was from an EHR system, insurance claim, registry, or other sources.\n\n\ncondition_status_concept_id\nA foreign key that refers to a Standard Concept identifier in the Standardized Vocabularies reflecting the point of care at which the Condition was diagnosed.\n\n\nstop_reason\nThe reason that the Condition was no longer present, as indicated in the source data.\n\n\nprovider_id\nA foreign key to the Provider in the PROVIDER table who was responsible for capturing (diagnosing) the Condition.\n\n\nvisit_occurrence_id\nA foreign key to the visit in the VISIT_OCCURRENCE table during which the Condition was determined (diagnosed).\n\n\nvisit_detail_id\nA foreign key to the visit in the VISIT_DETAIL table during which the Condition was determined (diagnosed).\n\n\ncondition_source_value\nThe source code for the Condition as it appears in the source data. It is typically ICD9 or ICD10; or the dx_id if we dont have the ICD codes.\n\n\ncondition_source_concept_id\nA foreign key to a Condition Concept that refers to the code used in the source.\n\n\ncondition_status_source_value\nThe source code for the condition status as it appears in the source data. This code is mapped to a Standard Concept in the Standardized Vocabularies and the original code is stored here for reference.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "condition_occurrence"
    ]
  },
  {
    "objectID": "omop_data_dict/concept_synonym.html",
    "href": "omop_data_dict/concept_synonym.html",
    "title": "concept_synonym",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nconcept_id\nINTEGER\nYes\n\n\n\n\nconcept_synonym_name\nSTRING\nYes\n\n\n\n\nlanguage_concept_id\nINTEGER\nYes\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nconcept_id\nA foreign key to the Concept in the CONCEPT table.\n\n\nconcept_synonym_name\nThe alternative name for the Concept.\n\n\nlanguage_concept_id\nA foreign key to a Concept representing the language.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "concept_synonym"
    ]
  },
  {
    "objectID": "omop_data_dict/concept_class.html",
    "href": "omop_data_dict/concept_class.html",
    "title": "concept_class",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nconcept_class_id\nSTRING\nYes\n\n\n\n\nconcept_class_name\nSTRING\nYes\n\n\n\n\nconcept_class_concept_id\nINTEGER\nYes\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nconcept_class_id\nA unique key for each class.\n\n\nconcept_class_name\nThe name describing the Concept Class, e.g.Â âClinical Findingâ, âIngredientâ, etc.\n\n\nconcept_class_concept_id\nA foreign key that refers to an identifier in the CONCEPT table for the unique Concept Class the record belongs to.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "concept_class"
    ]
  },
  {
    "objectID": "omop_data_dict/concept.html",
    "href": "omop_data_dict/concept.html",
    "title": "concept",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nconcept_id\nINTEGER\nYes\n\n\n\n\nconcept_name\nSTRING\nYes\n\n\n\n\ndomain_id\nSTRING\nYes\n\n\n\n\nvocabulary_id\nSTRING\nYes\n\n\n\n\nconcept_class_id\nSTRING\nYes\n\n\n\n\nstandard_concept\nSTRING\nNo\n\n\n\n\nconcept_code\nSTRING\nYes\n\n\n\n\nvalid_start_date\nDATE\nYes\n\n\n\n\nvalid_end_date\nDATE\nYes\n\n\n\n\ninvalid_reason\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nconcept_id\nA unique identifier for each Concept across all domains.\n\n\nconcept_name\nAn unambiguous, meaningful and descriptive name for the Concept.\n\n\ndomain_id\nA foreign key to the DOMAIN table the Concept belongs to.\n\n\nvocabulary_id\nA foreign key to the VOCABULARY table indicating from which source the Concept has been adapted.\n\n\nconcept_class_id\nThe attribute or concept class of the Concept. Examples are âClinical Drugâ, âIngredientâ, âClinical Findingâ etc.\n\n\nstandard_concept\nThis flag determines where a Concept is a Standard Concept, i.e.Â is used in the data, a Classification Concept, or a non-standard Source Concept. The allowables values are âSâ (Standard Concept) and âCâ (Classification Concept), otherwise the content is NULL.\n\n\nconcept_code\nThe concept code represents the identifier of the Concept in the source vocabulary, such as SNOMED-CT concept IDs, RxNorm RXCUIs etc. Note that concept codes are not unique across vocabularies.\n\n\nvalid_start_date\nThe date when the Concept was first recorded. The default value is 1-Jan-1970, meaning, the Concept has no (known) date of inception.\n\n\nvalid_end_date\nThe date when the Concept became invalid because it was deleted or superseded (updated) by a new concept. The default value is 31-Dec-2099, meaning, the Concept is valid until it becomes deprecated.\n\n\ninvalid_reason\nReason the Concept was invalidated. Possible values are D (deleted), U (replaced with an update) or NULL when valid_end_date has the default value.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "concept"
    ]
  },
  {
    "objectID": "omop_data_dict/care_site.html",
    "href": "omop_data_dict/care_site.html",
    "title": "care_site",
    "section": "",
    "text": "Standarized Health System Data Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ncare_site_id\nINTEGER\nYes\n\nOffset\n\n\ncare_site_name\nSTRING\nNo\n\nNone\n\n\nplace_of_service_concept_id\nINTEGER\nYes\n\nNone\n\n\nlocation_id\nINTEGER\nNo\n\nOffset\n\n\ncare_site_source_value\nSTRING\nNo\n\nNone\n\n\nplace_of_service_source_value\nSTRING\nNo\n\nNone\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\n\ndelete\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\nNone\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\nNone\n\n\n\n\n\n\nColumns Description\n\ncare_site_id\nA unique identifier for each Care Site.\n\n\ncare_site_name\nThe verbatim description or name of the Care Site as in data source\n\n\nplace_of_service_concept_id\nA foreign key that refers to a Place of Service Concept ID in the Standardized Vocabularies.\n\n\nlocation_id\nA foreign key to the geographic Location in the LOCATION table, where the detailed address information is stored.\n\n\ncare_site_source_value\nThe identifier for the Care Site in the source data, stored here for reference.\n\n\nplace_of_service_source_value\nThe source code for the Place of Service as it appears in the source data, stored here for reference.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced.\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced.Is a Stanford specific column.",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "care_site"
    ]
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About",
    "section": "",
    "text": "Welcome to the VISTA Oncology Data Lake project. This website provides documentation for the datasets released as part of the project.",
    "crumbs": [
      "About"
    ]
  },
  {
    "objectID": "about.html#data-privacy-and-security",
    "href": "about.html#data-privacy-and-security",
    "title": "About",
    "section": "Data Privacy and Security",
    "text": "Data Privacy and Security\nWe prioritize patient privacy and data security. Our datasets undergo rigorous phi scrubbing processes. Most vocabulary tables contain standard terminology, do not vary between institutions, and do not contain any PHI. We have included all populated tables in the CDM, along with descriptions of the fields, on this website.",
    "crumbs": [
      "About"
    ]
  },
  {
    "objectID": "about.html#project-resources",
    "href": "about.html#project-resources",
    "title": "About",
    "section": "Project Resources",
    "text": "Project Resources\nFor more information regarding our source data and methods, please refer to the following resources:\n\nSource Data\n\nImaging\nDeath Data\n\nMethods\n\nText De-identification\nImaging De-identification\n\nPublications",
    "crumbs": [
      "About"
    ]
  },
  {
    "objectID": "about.html#acknowledgments",
    "href": "about.html#acknowledgments",
    "title": "About",
    "section": "Acknowledgments",
    "text": "Acknowledgments\nThis research was funded, in part, by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.",
    "crumbs": [
      "About"
    ]
  },
  {
    "objectID": "data_dictionary.html",
    "href": "data_dictionary.html",
    "title": "Data Dictionary",
    "section": "",
    "text": "OMOP-CDM\nThis document provides a comprehensive overview of the OMOP Common Data Model (CDM) tables available in the initial release of the dataset. The OMOP-CDM is a standardized data model designed to facilitate the analysis and sharing of healthcare data across different institutions and studies. By using a common structure and terminology, the OMOP-CDM enables researchers to perform large-scale observational research and generate real-world evidence.\nIn this data dictionary, you will find detailed descriptions of each table and its columns, including data types, requirements, and any specific operations applied to the data. This information is crucial for understanding the structure and content of the dataset, ensuring accurate and meaningful analysis.\n\nList of OMOP-CDM tables available\nThe following OMOP-CDM tables are available in the initial release of dataset:\n\n\n\n\nCategory\nTable Name\n\n\n\n\nClinical Data\ncondition_occurrence, drug_exposure, device_exposure, measurement, observation, procedure_occurrence, visit_occurrence, visit_detail, note, death\n\n\nVocabularies\nconcept, concept_ancestor, concept_class, concept_relationship, concept_synonym, domain, relationship, vocabulary\n\n\nHealth System Data\ncare_site, location, provider\n\n\nDerived Elements\ncondition_era, drug_era\n\n\nHealth Economics\npayer_plan_period\n\n\nMetadata\ncdm_source, metadata\n\n\n\n\n\n\n\nNeuralFrame\nThe following NeuralFrame tables are available in the release of the dataset:\n\nCase Diagnoses\nMisc Details\nCase Outcomes\nCase Treatments\n\n\n\nPhillips ISPM\nThe following tables are available in the initial release of the dataset:\n\nPhilips ISPM Aberration\nPhilips ISPM Orders\nPhilips ISPM Specimen\n\n\n\nSTAMP\n\nSTAMP Add On Data\n\n\n\nPHI Scrubbing Operations Definitions\nIn order to protect patient information, various PHI (Protected Health Information) scrubbing operations are applied to the dataset. These operations are designed to scrub sensitive data elements. Below are the definitions of the PHI scrubbing operations used in this dataset:\n\n\n\n\nPHi-Scrubbing Operation Name\nDescription\n\n\n\n\nOffset\nOffset specific to the project and dataset column\n\n\nJitter\nJitter specific to the project and dataset column\n\n\nDel\nDelete the values in this Column\n\n\nSub\nSubstitute with a value specific to the project and dataset column\n\n\nWhitelist\nOnly allow the values in the âallowed listâ table to pass through; otherwise replace with NULL\n\n\nHash\nReplace with a hash value based on a hashing function specific to the project and dataset column\n\n\nTiDE\nPass through TiDE, Stanfordâs text PHI scrubbing algorithm\n\n\nRedZip\nReduce the Zipcode precision based on Stanfordâs University Privacy Office guidelines as outlined here, Sec 1.4\n\n\nDrop\nDrop this column in the PHI scrubbed dataset\n\n\nStable Between Data Refreshes\nSubstitute with a stable identifier specific to the project and dataset column that will persist between data refreshes. This may be an integer or alphanumeric based on other requirements of the table\n\n\nNot Stable between Data Refreshes\nSubstitute with an identifier that is only specific and self consistent for that data refresh -could be an integer or alphanumeric based on requirements of the table\n\n\nNone\npass as is- no PHI scrubbing operation\n\n\n\n\n\nDICOM PHI Scrubbing\nFor DICOM data the PHI scrubbing module protects PII and sensitive information through a two-stage process. First, it uses regex patterns to identify and mask specific data types including dates, times, email addresses, URLs, numeric identifiers, and hexadecimal sequences. Second, it tokenizes the text using configurable delimiters and numeric-to-alpha and alpha-to-numeric transitions, then replaces any tokens not found in a predefined allowlist with âXâ characters of equivalent length. The system preserves the original text structure by maintaining spacing and delimiters while systematically redacting content. It includes specialized date handling through regex patterns that match various date formats, ensuring that only approved vocabulary passes through unredacted while obscuring all other potentially sensitive information.\nThis redaction only applies to series_description, study_description, and protocol_name attributes (tags).",
    "crumbs": [
      "About",
      "Data Dictionary"
    ]
  },
  {
    "objectID": "omop_data_dict/cdm_source.html",
    "href": "omop_data_dict/cdm_source.html",
    "title": "cdm_source",
    "section": "",
    "text": "Standardized Metadata Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ncdm_source_name\nSTRING\nYes\n\n\n\n\ncdm_source_abbreviation\nSTRING\nNo\n\n\n\n\ncdm_holder\nSTRING\nNo\n\n\n\n\nsource_description\nSTRING\nNo\n\n\n\n\nsource_documentation_reference\nSTRING\nNo\n\n\n\n\ncdm_etl_reference\nSTRING\nNo\n\n\n\n\nsource_release_date\nDATE\nNo\n\n\n\n\ncdm_release_date\nDATE\nNo\n\n\n\n\ncdm_version\nSTRING\nNo\n\n\n\n\nvocabulary_version\nSTRING\nNo\n\n\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ncdm_source_name\nThe full name of the various raw datasources,\n\n\ncdm_source_abbreviation\nAn abbreviation of the CDM source.\n\n\ncdm_holder\nThe name of the organization responsible for the development of the CDM instance\n\n\nsource_description\nPrimary IRB\n\n\nsource_documentation_reference\nURL or other external reference to location of source documentation\n\n\ncdm_etl_reference\nURL or other external reference to location of ETL specification documentation and ETL source code\n\n\nsource_release_date\nThe date for which the source data are most current, such as the last day of data capture\n\n\ncdm_release_date\nThe date when the CDM was instantiated\n\n\ncdm_version\nThe version of CDM used\n\n\nvocabulary_version\nThe version of the vocabulary used\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "cdm_source"
    ]
  },
  {
    "objectID": "omop_data_dict/concept_ancestor.html",
    "href": "omop_data_dict/concept_ancestor.html",
    "title": "concept_ancestor",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nancestor_concept_id\nINTEGER\nYes\n\n\n\n\ndescendant_concept_id\nINTEGER\nYes\n\n\n\n\nmin_levels_of_separation\nINTEGER\nYes\n\n\n\n\nmax_levels_of_separation\nINTEGER\nYes\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nancestor_concept_id\nA foreign key to the concept in the concept table for the higher-level concept that forms the ancestor in the relationship.\n\n\ndescendant_concept_id\nA foreign key to the concept in the concept table for the lower-level concept that forms the descendant in the relationship.\n\n\nmin_levels_of_separation\nThe minimum separation in number of levels of hierarchy between ancestor and descendant concepts. This is an attribute that is used to simplify hierarchic analysis.\n\n\nmax_levels_of_separation\nThe maximum separation in number of levels of hierarchy between ancestor and descendant concepts. This is an attribute that is used to simplify hierarchic analysis.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "concept_ancestor"
    ]
  },
  {
    "objectID": "omop_data_dict/concept_relationship.html",
    "href": "omop_data_dict/concept_relationship.html",
    "title": "concept_relationship",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nconcept_id_1\nINTEGER\nYes\n\n\n\n\nconcept_id_2\nINTEGER\nYes\n\n\n\n\nrelationship_id\nSTRING\nYes\n\n\n\n\nvalid_start_date\nDATE\nYes\n\n\n\n\nvalid_end_date\nDATE\nYes\n\n\n\n\ninvalid_reason\nSTRING\nNo\n\n\n\n\nload_table_id\nSTRING\nNo\n\n\n\n\nload_row_id\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nconcept_id_1\nA foreign key to a Concept in the CONCEPT table associated with the relationship. Relationships are directional, and this field represents the source concept designation.\n\n\nconcept_id_2\nA foreign key to a Concept in the CONCEPT table associated with the relationship. Relationships are directional, and this field represents the destination concept designation.\n\n\nrelationship_id\nA unique identifier to the type or nature of the Relationship as defined in the RELATIONSHIP table.\n\n\nvalid_start_date\nThe date when the instance of the Concept Relationship is first recorded.\n\n\nvalid_end_date\nThe date when the Concept Relationship became invalid because it was deleted or superseded (updated) by a new relationship. Default value is 31-Dec-2099.\n\n\ninvalid_reason\nReason the relationship was invalidated. Possible values are âDâ (deleted), âUâ (replaced with an update) or NULL when valid_end_date has the default value.\n\n\nload_table_id\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "concept_relationship"
    ]
  },
  {
    "objectID": "omop_data_dict/condition_era.html",
    "href": "omop_data_dict/condition_era.html",
    "title": "condition_era",
    "section": "",
    "text": "Standardized Derived Elements\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ncondition_era_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\ncondition_concept_id\nINTEGER\nYes\n\n\n\n\ncondition_era_start_date\nDATETIME\nYes\nYes\nJitter\n\n\ncondition_era_end_date\nDATETIME\nYes\nYes\nJitter\n\n\ncondition_occurrence_count\nINTEGER\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\n\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ncondition_era_id\nA unique identifier for each Condition Era.\n\n\nperson_id\nA foreign key identifier to the Person who is experiencing the Condition during the Condition Era. The demographic details of that Person are stored in the PERSON table.\n\n\ncondition_concept_id\nA foreign key that refers to a standard Condition Concept identifier in the Standardized Vocabularies.\n\n\ncondition_era_start_date\nThe start date for the Condition Era constructed from the individual instances of Condition Occurrences. It is the start date of the very first chronologically recorded instance of the condition.\n\n\ncondition_era_end_date\nThe end date for the Condition Era constructed from the individual instances of Condition Occurrences. It is the end date of the final continuously recorded instance of the Condition.\n\n\ncondition_occurrence_count\nThe number of individual Condition Occurrences used to construct the condition era.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "condition_era"
    ]
  },
  {
    "objectID": "omop_data_dict/death.html",
    "href": "omop_data_dict/death.html",
    "title": "death",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nperson_id\n\nYes\n\nSub\n\n\ndeath_date\n\nYes\nYes\nJitter\n\n\ndeath_datetime\n\nNo\nYes\nJitter\n\n\ndeath_type_concept_id\n\nNo\n\n\n\n\ncause_concept_id\n\nNo\n\n\n\n\ncause_source_value\n\nNo\n\n\n\n\ncause_source_concept_id\n\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\n\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\n\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\n\nNo\n\n\n\n\n_death_date_external (Stanford construct for traceability)\n\nNo\nYes\nDel\n\n\n\n\n\n\nColumns Description\n\nperson_id\nA foreign key identifier to the deceased person. The demographic details of that person are stored in the person table.\n\n\ndeath_date\nThe date the person was deceased as reported in the EHR. If the precise date including day or month is not known or not allowed, December is used as the default month, and the last day of the month the default day.\n\n\ndeath_datetime\nThe date and time the person was deceased as reported in the EHR. If the precise date including day or month is not known or not allowed, December is used as the default month, and the last day of the month the default day. (currently empty)\n\n\ndeath_type_concept_id\nThis field can be used to determine the provenance of the Death record, as in whether the death information was from an EHR system, insurance claim, registry, or other sources.\n\n\ncause_concept_id\nA foreign key referring to a standard concept identifier in the Standardized Vocabularies for conditions.\n\n\ncause_source_value\nThe source code for the cause of death as it appears in the source data. This code is mapped to a standard concept in the Standardized Vocabularies and the original code is, stored here for reference.\n\n\ncause_source_concept_id\nA foreign key to the concept that refers to the code used in the source. Note, this variable name is abbreviated to ensure it will be allowable across database platforms.\n\n\ntrace_id (stanford construct for traceability)\nThe trace_id column contains a JSON string that provides information about the source of the data for a given row in the table. For instance, the JSON string consists of a key-value pair where the key is âpat_idâ and the value is âZ756XXXâ. This indicates that the primary key of the table in Clarity, from which most of the information for a given row is sourced, is associated with the patient ID âZ756XXXâ. Example: {âpat_idâ:âZ756XXXâ}.\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data (currently empty)\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced. Options are shc_patient or lpch_patient\n\n\n_death_date_external (stanford construct for traceability)\nThis field stores a string that combines the âdeath_type_concept_idâ with the actual death date, separated by a pipe â|â. The âdeath_type_concept_idâ indicates the source of the death information, such as â32885â for the Social Security Death Master File. Following the pipe, the death date is provided in âYYYY-MM-DDâ format. This format allows for the association of a specific death date with its corresponding data source. Example format: â32885|2019-09-24â, where â32885â represents the Social Security Death Master File and â2019-09-24â is the date of death from that source. This field is essential for tracking and verifying death information from various external sources.",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "death"
    ]
  },
  {
    "objectID": "omop_data_dict/domain.html",
    "href": "omop_data_dict/domain.html",
    "title": "domain",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndomain_id\nSTRING\nYes\n\n\n\n\ndomain_name\nSTRING\nYes\n\n\n\n\ndomain_concept_id\nINTEGER\nYes\n\n\n\n\nload_table_id\nSTRING\nNo\n\n\n\n\nload_row_id\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndomain_id\nA unique key for each domain.\n\n\ndomain_name\nThe name describing the Domain, e.g.Â âConditionâ, âProcedureâ, âMeasurementâ etc.\n\n\ndomain_concept_id\nA Concept representing the Domain Concept the DOMAIN record belongs to.\n\n\nload_table_id\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "domain"
    ]
  },
  {
    "objectID": "omop_data_dict/drug_exposure.html",
    "href": "omop_data_dict/drug_exposure.html",
    "title": "drug_exposure",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndrug_exposure_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\ndrug_concept_id\nINTEGER\nYes\n\n\n\n\ndrug_exposure_start_date\nDATE\nNo\nYes\nJitter\n\n\ndrug_exposure_start_datetime\nDATETIME\nYes\nYes\nJitter\n\n\ndrug_exposure_end_date\nDATE\nNo\nYes\nJitter\n\n\ndrug_exposure_end_datetime\nDATETIME\nYes\nYes\nJitter\n\n\nverbatim_end_date\nDATE\nNo\nYes\nJitter\n\n\ndrug_type_concept_id\nINTEGER\nYes\n\n\n\n\nstop_reason\nSTRING\nNo\n\n\n\n\nrefills\nINTEGER\nNo\n\n\n\n\nquantity\nFLOAT\nNo\n\n\n\n\ndays_supply\nINTEGER\nNo\n\n\n\n\nsig\nSTRING\nNo\nYes\nTiDE or Del\n\n\nroute_concept_id\nINTEGER\nYes\n\n\n\n\nlot_number\nSTRING\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\ndrug_source_value\nSTRING\nNo\n\n\n\n\ndrug_source_concept_id\nINTEGER\nYes\n\n\n\n\nroute_source_value\nSTRING\nNo\n\n\n\n\ndose_unit_source_value\nSTRING\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndrug_exposure_id\nA system-generated unique identifier for each Drug utilization event.\n\n\nperson_id\nA foreign key identifier to the Person who is subjected to the Drug. The demographic details of that Person are stored in the PERSON table.\n\n\ndrug_concept_id\nThe standard concept_id belonging to the âDrugâ domain.that the drug_source_value maps to.\n\n\ndrug_exposure_start_date\nThe start date for the current instance of Drug utilization. Valid entries include a start date of a prescription, the date a prescription was filled, or the date on which a Drug administration procedure was recorded.\n\n\ndrug_exposure_start_datetime\nThe start date and time for the current instance of Drug utilization. Valid entries include a start datetime of a prescription, the date and time a prescription was filled, or the date and time on which a Drug administration procedure was recorded.\n\n\ndrug_exposure_end_date\nThe end date for the current instance of Drug utilization. Depending on different sources, it could be a known or an inferred date and denotes the last day at which the patient was still exposed to Drug.\n\n\ndrug_exposure_end_datetime\nThe end date and time for the current instance of Drug utilization. Depending on different sources, it could be a known or an inferred date and time and denotes the last day at which the patient was still exposed to Drug.\n\n\nverbatim_end_date\nThe known end date of a drug_exposure as provided by the source.\n\n\ndrug_type_concept_id\nThe type_concept_id can be used to delineate between prescriptions written vs.Â prescriptions dispensed vs.Â medication history vs.Â patient-reported exposure, etc.\n\n\nstop_reason\nThe reason the Drug was stopped. Reasons include regimen completed, changed, removed, etc.\n\n\nrefills\nThis is only filled in when the record is coming from a prescription written. This field is meant to represent intended refills at time of the prescription.\n\n\nquantity\nThe quantity of drug as recorded in the original prescription or dispensing record.\n\n\ndays_supply\nThe number of days of supply of the medication as prescribed. This reflects the intention of the provider for the length of exposure.\n\n\nsig\nThis is the verbatim instruction for the drug as written by the provider.\n\n\nroute_concept_id\nA foreign key that refers to a Standard Concept identifier in the Standardized Vocabularies reflecting the route of administration and belonging to the âRouteâ domain.\n\n\nlot_number\nAn identifier assigned to a particular quantity or lot of Drug product from the manufacturer.\n\n\nprovider_id\nThe Provider associated with drug record, e.g.Â the provider who wrote the prescription or the provider who administered the drug.\n\n\nvisit_occurrence_id\nThe Visit during which the drug was prescribed, administered or dispensed.\n\n\nvisit_detail_id\nA foreign key to the Visit Detail in the VISIT_DETAIL table during which the Drug Exposure was initiated.\n\n\ndrug_source_value\nThe source code for the Drug as it appears in the source data. This code is mapped to a Standard Drug concept in the Standardized Vocabularies and the original code is, stored here for reference.\n\n\ndrug_source_concept_id\nA foreign key to a Drug Concept that refers to the code used in the source.\n\n\nroute_source_value\nThe information about the route of administration as detailed in the source.\n\n\ndose_unit_source_value\nThe information about the dose unit as detailed in the source.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "drug_exposure"
    ]
  },
  {
    "objectID": "omop_data_dict/fact_relationship.html",
    "href": "omop_data_dict/fact_relationship.html",
    "title": "fact_relationship",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\ndomain_concept_id_1\nINTEGER\nYes\n\n\n\n\nfact_id_1\nINTEGER\nYes\n\n\n\n\ndomain_concept_id_2\nINTEGER\nYes\n\n\n\n\nfact_id_2\nINTEGER\nYes\n\n\n\n\nrelationship_concept_id\nINTEGER\nYes\n\n\n\n\ntrace_id\nSTRING\nNo\n\nDel\n\n\nunit_id\nSTRING\nNo\n\n\n\n\nload_table_id\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\ndomain_concept_id_1\nThe concept representing the domain of fact one, from which the corresponding table can be inferred.\n\n\nfact_id_1\nThe unique identifier in the table corresponding to the domain of fact one.\n\n\ndomain_concept_id_2\nThe concept representing the domain of fact two, from which the corresponding table can be inferred.\n\n\nfact_id_2\nThe unique identifier in the table corresponding to the domain of fact two.\n\n\nrelationship_concept_id\nA foreign key to a Standard Concept ID of relationship in the Standardized Vocabularies.\n\n\ntrace_id\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "fact_relationship"
    ]
  },
  {
    "objectID": "omop_data_dict/location.html",
    "href": "omop_data_dict/location.html",
    "title": "location",
    "section": "",
    "text": "Standarized Health System Data Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nlocation_id\nINTEGER\nYes\nNo\nOffset\n\n\naddress_1\nSTRING\nNo\nYes\nDel\n\n\naddress_2\nSTRING\nNo\nYes\nDel\n\n\ncity\nSTRING\nNo\nYes\nDel\n\n\nstate\nSTRING\nNo\nYes\n\n\n\nzip\nSTRING\nNo\nYes\nRedZip\n\n\ncounty\nSTRING\nNo\nNo\nDel\n\n\nlocation_source_value\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\nNo\n\n\n\n_census_block_group (available only at Stanford)\nSTRING\nNo\nYes\nDrop\n\n\nlatitude (available only at Stanford)\nFLOAT\nNo\nYes\nDrop\n\n\nlongitude (available only at Stanford)\nFLOAT\nNo\nYes\nDrop\n\n\n\n\n\n\nColumns Description\n\nlocation_id\nA unique identifier for each geographic location.\n\n\naddress_1\nThe address field 1, typically used for the street address, as it appears in the source data.\n\n\naddress_2\nThe address field 2, typically used for additional detail such as buildings, suites, floors, as it appears in the source data.\n\n\ncity\nThe city field as it appears in the source data.\n\n\nstate\nThe state field as it appears in the source data.\n\n\nzip\nThe 5 digit zip or postal code of the locatin address\n\n\ncounty\nThe name of the county.\n\n\nlocation_source_value\nThe MRN|DOB of the person this location corresponds to\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\n_census_block_group (available only at stanford)\nThe census block group as indicated by United States Census Bureau API for this address location\n\n\nlatitude (available only at stanford)\nlatitude of the address if available\n\n\nlongitude (available only at stanford)\nlongitude of the address if available",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "location"
    ]
  },
  {
    "objectID": "omop_data_dict/metadata.html",
    "href": "omop_data_dict/metadata.html",
    "title": "metadata",
    "section": "",
    "text": "Standardized Metadata Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nmetadata_concept_id\nINTEGER\nYes\n\n\n\n\nmetadata_type_concept_id\nINTEGER\nYes\n\n\n\n\nname\nSTRING\nYes\n\n\n\n\nvalue_as_string\nSTRING\nNo\n\n\n\n\nvalue_as_concept_id\nINTEGER\nNo\n\n\n\n\nmetadata_date\nDATE\nNo\n\n\n\n\nmetadata_datetime\nDATETIME\nNo\n\n\n\n\nunit_id\nSTRING\nNo\n\n\n\n\nload_table\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nmetadata_concept_id\nStandard concept corresponding to the OMOP version.\n\n\nmetadata_type_concept_id\nconcept_id describing the provenance of the data.\n\n\nname\nOMOP Version name\n\n\nvalue_as_string\nnan\n\n\nvalue_as_concept_id\nnan\n\n\nmetadata_date\nRaw clarity source date.\n\n\nmetadata_datetime\nRaw clarity source datetime.\n\n\nunit_id\nIs a reference for the position in the ETL code responsible for bringing in this row level data\n\n\nload_table\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "metadata"
    ]
  },
  {
    "objectID": "omop_data_dict/observation.html",
    "href": "omop_data_dict/observation.html",
    "title": "observation",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nobservation_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nobservation_concept_id\nINTEGER\nYes\n\n\n\n\nobservation_date\nDATE\nNo\nYes\nJitt\n\n\nobservation_datetime\nDATETIME\nYes\nYes\nJitt\n\n\nobservation_type_concept_id\nINTEGER\nYes\n\n\n\n\nvalue_as_number\nFLOAT\nNo\n\n\n\n\nvalue_as_string\nSTRING\nNo\nYes\nTiDE\n\n\nvalue_as_concept_id\nINTEGER\nNo\n\nTiDE\n\n\nqualifier_concept_id\nINTEGER\nNo\n\n\n\n\nunit_concept_id\nINTEGER\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\n\n\n\nvisit_detail_id\nINTEGER\nNo\n\n\n\n\nobservation_source_value\nSTRING\nNo\nYes\n\n\n\nobservation_source_concept_id\nINTEGER\nYes\n\n\n\n\nunit_source_value\nSTRING\nNo\nYes\n\n\n\nqualifier_source_value\nSTRING\nNo\n\nDel\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\n\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nobservation_id\nA unique identifier for each observation.\n\n\nperson_id\nA foreign key identifier to the Person about whom the observation was recorded. The demographic details of that Person are stored in the PERSON table.\n\n\nobservation_concept_id\nA foreign key to the standard observation concept identifier in the Standardized Vocabularies.\n\n\nobservation_date\nThe date the observation was obtained\n\n\nobservation_datetime\nThe date and time the observation was obtained.\n\n\nobservation_type_concept_id\nThis field is used to determine the provenance of the Observation record, as in whether the measurement was from an EHR system, insurance claim, registry, or other sources.\n\n\nvalue_as_number\nThis is the numerical value of the Result of the Observation, if applicable and available.\n\n\nvalue_as_string\nThis is the categorical value of the Result of the Observation, if applicable and available\n\n\nvalue_as_concept_id\nThe standard concept corresponding to the value of a clinical Observation\n\n\nqualifier_concept_id\nThis field contains all attributes specifying the clinical fact further, such as as degrees, severities, drug-drug interaction alerts etc.\n\n\nunit_concept_id\nThe standard Concept in the Unit domain corresponding to the unit source value.\n\n\nprovider_id\nA foreign key to the provider in the PROVIDER table who was responsible for making the observation.\n\n\nvisit_occurrence_id\nA foreign key to the visit in the VISIT_OCCURRENCE table during which the observation was recorded.\n\n\nvisit_detail_id\nA foreign key to the visit in the VISIT_DETAIL table during which the observation was recorded.\n\n\nobservation_source_value\nThe observation code as it appears in the source data. This code is mapped to a Standard Concept in the Standardized Vocabularies and the original code is, stored here for reference.\n\n\nobservation_source_concept_id\nA foreign key to a Concept that refers to the code used in the source.\n\n\nunit_source_value\nThe source code for the unit as it appears in the source data. This code is mapped to a standard unit concept in the Standardized Vocabularies and the original code is, stored here for reference.\n\n\nqualifier_source_value\nThe verbatim value from the source data representing the qualifier of the Observation that occurred.\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "observation"
    ]
  },
  {
    "objectID": "omop_data_dict/payer_plan_period.html",
    "href": "omop_data_dict/payer_plan_period.html",
    "title": "payer_plan_period",
    "section": "",
    "text": "Standardized Health Economics data Table, currently empty\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\npayer_plan_period_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\npayer_plan_period_start_date\nDATE\nYes\nYes\nJitt\n\n\npayer_plan_period_end_date\nDATE\nYes\nYes\nJitt\n\n\npayer_concept_id\nINTEGER\nYes\n\n\n\n\npayer_source_value\nSTRING\nNo\nYes\n\n\n\npayer_source_concept_id\nINTEGER\nYes\n\n\n\n\nplan_concept_id\nINTEGER\nYes\n\n\n\n\nplan_source_value\nSTRING\nNo\nYes\nDel\n\n\nplan_source_concept_id\nINTEGER\nYes\n\n\n\n\nsponsor_concept_id\nINTEGER\nYes\n\n\n\n\nsponsor_source_value\nSTRING\nNo\n\n\n\n\nsponsor_source_concept_id\nINTEGER\nYes\n\n\n\n\nfamily_source_value\nSTRING\nNo\nYes\n\n\n\nstop_reason_concept_id\nINTEGER\nYes\n\n\n\n\nstop_reason_source_value\nSTRING\nNo\nYes\n\n\n\nstop_reason_source_concept_id\nINTEGER\nYes\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\n\n\n\n\nColumns Description\n\npayer_plan_period_id\nA unique identifier for each unique combination of a Person, Payer, Plan, and Period of time.\n\n\nperson_id\nThe Person covered by the Plan. The demographic details of that Person are stored in the PERSON table.\n\n\npayer_plan_period_start_date\nThe start date of the payer plan period.\n\n\npayer_plan_period_end_date\nThe end date of the payer plan period.\n\n\npayer_concept_id\nThis field represents the organization who reimburses the provider which administers care to the Person. This field refers to a standard Payer concept identifier in the Standarized Vocabularies.\n\n\npayer_source_value\nThe source code for the payer as it appears in the source data. Currently it is âpayer_ SOPT Desc | SOPT ID | Epic Payer Name| Epic Payor ID | Epic Financial Class Name | Epic Financial Class IDâ. SOPT is the payer type standard that provides a mechanism for consistent reporting of payer data to public health agencies for health care services and research\n\n\npayer_source_concept_id\nA foreign key to a payer concept that refers to the code used in the source. It is the OMOP concept id corresponding to the source code.\n\n\nplan_concept_id\nA foreign key that refers to a standard plan concept identifier that represents the health benefit plan in the Standardized Vocabularies.\n\n\nplan_source_value\nThe source code for the Personâs health benefit plan as it appears in the source data. Currently it is âEpic Plan Name| Epic Plan IDâ.\n\n\nplan_source_concept_id\nA foreign key to a plan concept that refers to the plan code used in the source data.\n\n\nsponsor_concept_id\nA foreign key that refers to a concept identifier that represents the sponsor in the Standardized Vocabularies.\n\n\nsponsor_source_value\nThe source code for the Personâs sponsor of the health plan as it appears in the source data.\n\n\nsponsor_source_concept_id\nA foreign key to a sponsor concept that refers to the sponsor code used in the source data.\n\n\nfamily_source_value\nThe source code for the Personâs family as it appears in the source data.\n\n\nstop_reason_concept_id\nA foreign key that refers to a standard termination reason that represents the reason for the termination in the Standardized Vocabularies.\n\n\nstop_reason_source_value\nThe reason for stop-coverage as it appears in the source data.\n\n\nstop_reason_source_concept_id\nA foreign key to a stop-coverage concept that refers to the code used in the source\n\n\ntrace_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "payer_plan_period"
    ]
  },
  {
    "objectID": "omop_data_dict/procedure_occurrence.html",
    "href": "omop_data_dict/procedure_occurrence.html",
    "title": "procedure_occurrence",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nprocedure_occurrence_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nprocedure_concept_id\nINTEGER\nYes\n\n\n\n\nprocedure_DATE\nDATE\nNo\nYes\nJitt\n\n\nprocedure_DATETIME\nDATETIME\nYes\nYes\nJitt\n\n\nprocedure_type_concept_id\nINTEGER\nYes\n\n\n\n\nmodifier_concept_id\nINTEGER\nYes\n\n\n\n\nquantity\nINTEGER\nNo\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_detail_id\nINTEGER\nNo\n\nOffset\n\n\nprocedure_source_value\nSTRING\nNo\n\n\n\n\nprocedure_source_concept_id\nINTEGER\nYes\n\n\n\n\nmodifier_source_value\nSTRING\nNo\n\n\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nprocedure_occurrence_id\nA system-generated unique identifier for each Procedure Occurrence.\n\n\nperson_id\nThe person_id of the person for whom the procedure is recorded.\n\n\nprocedure_concept_id\nA foreign key that refers to a standard procedure Concept identifier in the Standardized Vocabularies.\n\n\nprocedure_date\nThe date on which the Procedure was performed.\n\n\nprocedure_datetime\nThe date and time on which the Procedure was performed.\n\n\nprocedure_type_concept_id\nThis field can be used to determine the provenance of the Procedure record, as in whether the procedure was from an EHR system, insurance claim, registry, or other sources.\n\n\nmodifier_concept_id\nThe modifiers are intended to give additional information about the procedure.\n\n\nquantity\nThe quantity of procedures ordered or administered. If the quantity value is omitted, a single procedure is assumed.\n\n\nprovider_id\nThe provider in the PROVIDER table who was responsible for carrying out the procedure.\n\n\nvisit_occurrence_id\nThe visit during which the procedure occurred\n\n\nvisit_detail_id\nThe VISIT_DETAIL record during which the Procedure occurred. For example, if the Person was in the ICU at the time of the Procedure the VISIT_OCCURRENCE record would reflect the overall hospital stay and the VISIT_DETAIL record would reflect the ICU stay during the hospital visit.\n\n\nprocedure_source_value\nThe source code for the Procedure as it appears in the source data. This code is mapped to a standard procedure Concept in the Standardized Vocabularies and the original code is, stored here for reference. Procedure source codes are typically ICD-9-Proc, CPT-4, HCPCS or OPCS-4 codes.\n\n\nprocedure_source_concept_id\nThis is the concept id representing the procedure source value and may not necessarily be standard.\n\n\nmodifier_source_value\nThis field houses the verbatim value from the source data representing the modifier code for the procedure that occurred\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code responsible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "procedure_occurrence"
    ]
  },
  {
    "objectID": "omop_data_dict/relationship.html",
    "href": "omop_data_dict/relationship.html",
    "title": "relationship",
    "section": "",
    "text": "Vocabulary Tables\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nrelationship_id\nSTRING\nYes\n\n\n\n\nrelationship_name\nSTRING\nYes\n\n\n\n\nis_hierarchical\nSTRING\nYes\n\n\n\n\ndefines_ancestry\nSTRING\nYes\n\n\n\n\nreverse_relationship_id\nSTRING\nYes\n\n\n\n\nrelationship_concept_id\nINTEGER\nYes\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_row_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nrelationship_id\nThe type of relationship captured by the relationship record.\n\n\nrelationship_name\nThe text that describes the relationship type.\n\n\nis_hierarchical\nDefines whether a relationship defines concepts into classes or hierarchies. Values are 1 for hierarchical relationship or 0 if not.\n\n\ndefines_ancestry\nDefines whether a hierarchical relationship contributes to the concept_ancestor table. These are subsets of the hierarchical relationships. Valid values are 1 or 0.\n\n\nreverse_relationship_id\nThe identifier for the relationship used to define the reverse relationship between two concepts.\n\n\nrelationship_concept_id\nA foreign key that refers to an identifier in the CONCEPT table for the unique relationship concept.\n\n\nload_table_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nload_row_id (stanford construct for traceability)\nA reference to the position in the ETL code responsible for bringing in this row level data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "relationship"
    ]
  },
  {
    "objectID": "omop_data_dict/visit_occurrence.html",
    "href": "omop_data_dict/visit_occurrence.html",
    "title": "visit_occurrence",
    "section": "",
    "text": "Standard Clinical Data Table\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\n\nfield\ntype\nrequired\nphi\nphi scrubbing operation\n\n\n\n\nvisit_occurrence_id\nINTEGER\nYes\n\nOffset\n\n\nperson_id\nINTEGER\nYes\n\nSub\n\n\nvisit_concept_id\nINTEGER\nYes\n\n\n\n\nvisit_start_DATE\nDATE\nNo\nYes\nJitter\n\n\nvisit_start_DATETIME\nDATETIME\nYes\nYes\nJitter\n\n\nvisit_end_DATE\nDATE\nNo\nYes\nJitter\n\n\nvisit_end_DATETIME\nDATETIME\nYes\nYes\nJitter\n\n\nvisit_type_concept_id\nINTEGER\nYes\n\n\n\n\nprovider_id\nINTEGER\nNo\n\nOffset\n\n\ncare_site_id\nINTEGER\nNo\n\nOffset\n\n\nvisit_source_value\nSTRING\nNo\nYes\n\n\n\nvisit_source_concept_id\nINTEGER\nYes\n\n\n\n\nadmitted_from_concept_id\nINTEGER\nYes\n\n\n\n\nadmitted_from_source_value\nSTRING\nNo\n\n\n\n\ndischarge_to_concept_id\nINTEGER\nYes\n\n\n\n\ndischarge_to_source_value\nSTRING\nNo\n\n\n\n\npreceding_visit_occurrence_id\nINTEGER\nNo\n\nOffset\n\n\ntrace_id (Stanford construct for traceability)\nSTRING\nNo\nYes\nDel\n\n\nunit_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\nload_table_id (Stanford construct for traceability)\nSTRING\nNo\n\n\n\n\n\n\n\n\nColumns Description\n\nvisit_occurrence_id\nA unique identifier for each Personâs visit or encounter at a healthcare provider.\n\n\nperson_id\nA foreign key identifier to the Person for whom the visit is recorded. The demographic details of that Person are stored in the PERSON table.\n\n\nvisit_concept_id\nA foreign key that refers to a Concept identifier in the Standardized Vocabularies belonging to the âVisitâ Domain (inpatient, emergency room, etc).\n\n\nvisit_start_date\nThe start date of the visit.\n\n\nvisit_start_datetime\nThe date and time when the visit started. This defaults to 00:00:00 (midnight) if no time information is available.\n\n\nvisit_end_date\nThe end date of the visit. If this is a one-day visit the end date should match the start date.\n\n\nvisit_end_datetime\nThe date and time when the visit ended.This defaults to 00:00:00 (midnight) if no time information is available.\n\n\nvisit_type_concept_id\nUse this field to understand the provenance of the visit record, or where the record comes from.\n\n\nprovider_id\nA foreign key to the provider in the provider table who was associated with the visit.\n\n\ncare_site_id\nA foreign key to the care site in the care site table that was visited.\n\n\nvisit_source_value\nThis column contains a text string that concatenates the fields used to determine the visit_type. The following fields are concatenated in this order, with â | â separators: encounter type (enc_type_c), admission/discharge/transfer patient class (adt_pat_class_c), hospital admission type (hosp_admsn_type_c), and visit type (appt_prc_id)\n\n\nvisit_source_concept_id\nA foreign key to a Concept that repersents a distinct combination of the following three variables: ADT patient class, hospital admission type, and encounter type. One or more of these variables may be null for any given visit.\n\n\nadmitted_from_concept_id\nA foreign key to the predefined concept in the Visit Domain reflecting where the patient was admitted from.\n\n\nadmitted_from_source_value\nThe source code for where the patient was admitted from as it appears in the source data.\n\n\ndischarge_to_concept_id\nA foreign key to the predefined Concept in the Visit Domain reflecting where the patient was discharged to (discharge disposition).\n\n\ndischarge_to_source_value\nThe source code for the discharge disposition as it appears in the source data.\n\n\npreceding_visit_occurrence_id\nA foreign key to the VISIT_OCCURRENCE row of the visit immediately preceding this visit\n\n\ntrace_id (stanford construct for traceability)\nA json string with the primary keys of the table in Clarity where most of the information for a given row is sourced\n\n\nunit_id (stanford construct for traceability)\nIs a reference for the position in the ETL code resposible for bringing in this row data\n\n\nload_table_id (stanford construct for traceability)\nIs the name of the primary Clarity table in Clarity where most of the information for a given row is sourced",
    "crumbs": [
      "About",
      "Data Dictionary",
      "OMOP-CDM",
      "visit_occurrence"
    ]
  },
  {
    "objectID": "data_metrics.html",
    "href": "data_metrics.html",
    "title": "Data Metrics",
    "section": "",
    "text": "This page provides an overview of the various data metrics available in the dataset. The metrics are designed to give insights into the contents of the dataset."
  },
  {
    "objectID": "data_metrics.html#release-overview",
    "href": "data_metrics.html#release-overview",
    "title": "Data Metrics",
    "section": "Release Overview",
    "text": "Release Overview\nThis project will have multiple data releases over time. Each release will include updated and new metrics. Below is the list of available releases:\n\nFebruary 2025\nThe February 2025 release is the first release of the dataset. It includes comprehensive demographic metrics and other key data points. You can find detailed information about this release by following the link below:\n\nFebruary 2025 Metrics\n\n\n\nMay 2025\nThe May 2025 release is the second release of the dataset which includes additional data sources such as OMOP image occurrence, Philips ISPM, and Stanford cancer registry. You can find detailed information about this release by following the link below:\n\nMay 2025 Metrics\n\n\n\nAugust 2025\nThe August 2025 release is the third release of the dataset which includes additional data sources such as OMOP image occurrence, Philips ISPM, and Stanford cancer registry. You can find detailed information about this release by following the link below:\n\nAugust 2025 Metrics"
  },
  {
    "objectID": "data_metrics.html#future-releases",
    "href": "data_metrics.html#future-releases",
    "title": "Data Metrics",
    "section": "Future Releases",
    "text": "Future Releases\nFuture releases will include additional metrics and updates to the existing ones."
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html",
    "href": "feb_2025/phi_labeling_process.html",
    "title": "PHI Labeling Process",
    "section": "",
    "text": "In this report, we outline the methodology used to create a labeled dataset with annotated PHI from clinical notes. Specifically, we describe the process for sampling clinical notes and performing annotations. This process was designed to achieve the following objectives:\n\nEnsuring demographic representation across diverse patient populations\n\nMaintaining consistency in annotation across multiple annotators\n\nBalancing efficiency with quality in the annotation process\n\nManaging the resource-intensive nature of medical text annotation\n\nFigure 1 provides an overview of the labeling process.\n\n\n\n\n\n\nFigureÂ 1: Labeling Process",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html#introduction",
    "href": "feb_2025/phi_labeling_process.html#introduction",
    "title": "PHI Labeling Process",
    "section": "",
    "text": "In this report, we outline the methodology used to create a labeled dataset with annotated PHI from clinical notes. Specifically, we describe the process for sampling clinical notes and performing annotations. This process was designed to achieve the following objectives:\n\nEnsuring demographic representation across diverse patient populations\n\nMaintaining consistency in annotation across multiple annotators\n\nBalancing efficiency with quality in the annotation process\n\nManaging the resource-intensive nature of medical text annotation\n\nFigure 1 provides an overview of the labeling process.\n\n\n\n\n\n\nFigureÂ 1: Labeling Process",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html#data-sampling-methodology",
    "href": "feb_2025/phi_labeling_process.html#data-sampling-methodology",
    "title": "PHI Labeling Process",
    "section": "Data Sampling Methodology",
    "text": "Data Sampling Methodology\nThe data sampling was performed in two steps. First, we conducted a random sampling across the entire set of notes. Then, we applied diversity sampling using a set cover algorithm. The details of these procedures are outlined below.\n\nNote Characteristics Analysis\nThe sampling process incorporates textual characteristics to ensure diversity in content:\n\nNote titles are categorized to represent different types of clinical documentation.\n\nNote length distribution is analyzed using a binning approach:\n\nCalculation of the median length per note title\n\nComputation of the median of medians\n\nSelection of notes between the 25th and 75th percentiles\n\nQuantization into four distinct bins for balanced representation\n\n\n\n\nSet Cover Algorithm Implementation\nTo optimize sampling while maintaining representation across all demographic and textual characteristics, we implemented a modified set cover algorithm:\n\nInitial random sampling of 1M notes to create a computationally manageable subset\n\nApplication of a set cover algorithm to ensure representation across all defined partitions\n\nOptimization for maximum coverage with minimal redundancy",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html#annotation-guidelines-development",
    "href": "feb_2025/phi_labeling_process.html#annotation-guidelines-development",
    "title": "PHI Labeling Process",
    "section": "Annotation Guidelines Development",
    "text": "Annotation Guidelines Development\n\nGuideline Structure\nComprehensive annotation guidelines were developed through an iterative process. These guidelines include:\n\nClear definitions of annotation targets\n\nExplicit inclusion and exclusion criteria\n\nRepresentative examples\n\nDecision trees for ambiguous cases\n\nStandard operating procedures for the annotation workflow\n\nThe labeling guidelines can be found here.\n\n\nGuideline Validation\nThe guidelines underwent multiple validation cycles, including:\n\nPilot testing with experienced annotators\n\nRefinement based on inter-annotator agreement analysis\n\nIntegration of edge cases identified during initial annotation phases",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html#pre-labeling-and-annotation-distribution-process",
    "href": "feb_2025/phi_labeling_process.html#pre-labeling-and-annotation-distribution-process",
    "title": "PHI Labeling Process",
    "section": "Pre-labeling and Annotation Distribution Process",
    "text": "Pre-labeling and Annotation Distribution Process\n\nLLM Pre-Annotation Implementation\nThe pre-labeling process utilized GPT-4 via Azureâs API (version 2023-05-15), incorporating:\n\nPrompt engineering optimized using the I2B2 dataset\n\nIntegration of annotation guidelines into prompt design\n\nSystematic validation of pre-labeled outputs\n\n\n\nAnnotation Distribution\nNotes were assigned following a structured protocol:\n\nRandom assignment to ensure unbiased distribution\n\nDual annotator requirement for each note to enable quality assessment\n\nTracking system implementation to monitor annotation progress\n\nRegular checkpoints for interim quality assessments",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "feb_2025/phi_labeling_process.html#quality-control-framework",
    "href": "feb_2025/phi_labeling_process.html#quality-control-framework",
    "title": "PHI Labeling Process",
    "section": "Quality Control Framework",
    "text": "Quality Control Framework\nThe quality assessment framework employs a bilateral F1 measure approach:\n\nPrimary F1 calculation:\n\nAnnotator Aâs labels serve as the ground truth against Annotator Bâs annotations\n\nAnnotator Bâs labels serve as the ground truth against Annotator Aâs annotations\n\nThe final F1 score is computed as the arithmetic mean of both directions\n\n\n\nAdjudication Process\nAll clinical notes without 100% agreement across annotated spans undergo an adjudication process. Experienced annotators review and resolve disagreements to ensure annotation quality. Only the notes with 100% agreement or adjudicated notes are used as gold standard.",
    "crumbs": [
      "About",
      "Data Labeling",
      "February 2025",
      "PHI Labeling",
      "Labeling Process"
    ]
  },
  {
    "objectID": "may_2025/released_datasets.html",
    "href": "may_2025/released_datasets.html",
    "title": "Released Datasets",
    "section": "",
    "text": "This document provides a list of datasets as part of the May 2025 released. Each dataset is described briefly, including whether it contains Protected Health Information (PHI) or if the PHI has been scrubbed.\n\nOMOP Datasets\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_omop_phi_irb76049_may2025\nOncology OMOP-CDM v5.3.1 dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_omop_confidential_irb76049_may2025\nOncology OMOP-CDM v5.3.1 dataset with PHI Scrubbed\n\n\noncology_omop_phi_flags_irb76049_may2025\nTable with flags used to compute several metrics\n\n\n\n\n\nNeuralFrame Datasets\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_phi_irb76049_may2025\nNeuralFrame dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_neuralframe_confidential_irb76049_may2025\nNeuralFrame dataset with PHI Scrubbed\n\n\n\n\n\nPhilips ISPM Datasets\n\n\n\n\n\n\n\n\nDataset Name\nDescription\n\n\n\n\nsom-rit-phi-oncology-prod.oncology_philips_phi_irb76049_may2025\nPhilips ISPM dataset with PHI\n\n\nsom-rit-phi-oncology-prod.oncology_philips_confidential_irb76049_may2025\nPhilips ISPM dataset with PHI Scrubbed",
    "crumbs": [
      "About",
      "May 2025",
      "Released Datasets"
    ]
  },
  {
    "objectID": "data_labeling.html",
    "href": "data_labeling.html",
    "title": "Data Labeling",
    "section": "",
    "text": "This page provides an overview of our data labeling initiatives focused on extracting structured information from unstructured clinical data.",
    "crumbs": [
      "About",
      "Data Labeling"
    ]
  },
  {
    "objectID": "data_labeling.html#phi-labeling",
    "href": "data_labeling.html#phi-labeling",
    "title": "Data Labeling",
    "section": "PHI Labeling",
    "text": "PHI Labeling\nOur current focus is on labeling Protected Health Information (PHI) in clinical notes. This project is crucial for:\n\nDeveloping robust de-identification systems\nEnsuring patient privacy compliance\nCreating high-quality training data for machine learning models",
    "crumbs": [
      "About",
      "Data Labeling"
    ]
  },
  {
    "objectID": "data_labeling.html#ai-for-automatic-synoptic-reporting",
    "href": "data_labeling.html#ai-for-automatic-synoptic-reporting",
    "title": "Data Labeling",
    "section": "AI for Automatic Synoptic Reporting",
    "text": "AI for Automatic Synoptic Reporting\nOur team is using AI models to automatically extract structured information from pathology reports. Key aspects of this work include:\n\nIdentifying key data elements from College of American Pathologists (CAP) cancer protocols\nConverting unstructured free-text reports into standardized synoptic formats\nValidating model accuracy against human expert annotation\n\nThis initiative aims to improve data standardization, reduce manual extraction efforts, and enhance the completeness of cancer registry data.\n\nProject Resources\n\nFebruary 2025 Release\n\nPHI Labeling Guidelines\nPHI Labeling Report\n\n\n\nMay 2025 Release\n\nAI for Automatic Synoptic Reporting\n\nMethods and Results\n\nPHI Labeling Report",
    "crumbs": [
      "About",
      "Data Labeling"
    ]
  },
  {
    "objectID": "neuralframe_data_dict/case_diagnoses.html",
    "href": "neuralframe_data_dict/case_diagnoses.html",
    "title": "NeuralFrame Case Diagnoses",
    "section": "",
    "text": "The table onc_neuralframe_case_diagnoses contains details about the diagnoses made for each patient, including cancer types, staging, and any relevant comorbidities.\n\nTable Columns\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\nnaaccr number\n\n\n\n\naccessionnumberhosp\nSTRING\nYes\nStable Between Data Refreshes\n550\n\n\nadenoidcysticbasaloidpattern\nSTRING\n\n\n3803\n\n\nadenopathy\nSTRING\n\n\n3804\n\n\nadenopathydescription\nSTRING\n\n\n\n\n\nafppostorchiectomylabvalue\nSTRING\n\n\n3805\n\n\nafppostorchiectomylabvaluedescription\nSTRING\n\n\n\n\n\nafppostorchiectomyrange\nSTRING\n\n\n3806\n\n\nafppostorchiectomyrangedescription\nSTRING\n\n\n\n\n\nafppreorchiectomylabvalue\nSTRING\n\n\n3807\n\n\nafppreorchiectomylabvaluedescription\nSTRING\n\n\n\n\n\nafppreorchiectomyrange\nSTRING\n\n\n3808\n\n\nafppreorchiectomyrangedescription\nSTRING\n\n\n\n\n\nafppretreatmentinterpretation\nSTRING\n\n\n3809\n\n\nafppretreatmentinterpretationdescription\nSTRING\n\n\n\n\n\nafppretreatmentlabvalue\nSTRING\n\n\n3810\n\n\nafppretreatmentlabvaluedescription\nSTRING\n\n\n\n\n\najccapiversioncurrent\nSTRING\n\n\n2156\n\n\najccapiversionoriginal\nSTRING\n\n\n2157\n\n\najcccancersurvapiversioncurrent\nSTRING\n\n\n2158\n\n\najcccancersurvapiversionoriginal\nSTRING\n\n\n2159\n\n\najccid\nSTRING\n\n\n995\n\n\najcciddescription\nSTRING\n\n\n\n\n\najcctnmclinm\nSTRING\n\n\n1003\n\n\najcctnmclinmdescription\nSTRING\n\n\n\n\n\najcctnmclinn\nSTRING\n\n\n1002\n\n\najcctnmclinndescription\nSTRING\n\n\n\n\n\najcctnmclinnsuffix\nSTRING\n\n\n1034\n\n\najcctnmclinnsuffixdescription\nSTRING\n\n\n\n\n\najcctnmclinstagegroup\nSTRING\n\n\n1004\n\n\najcctnmclinstagegroupdescription\nSTRING\n\n\n\n\n\najcctnmclint\nSTRING\n\n\n1001\n\n\najcctnmclintdescription\nSTRING\n\n\n\n\n\najcctnmclintsuffix\nSTRING\n\n\n1031\n\n\najcctnmclintsuffixdescription\nSTRING\n\n\n\n\n\najcctnmpathm\nSTRING\n\n\n1013\n\n\najcctnmpathmdescription\nSTRING\n\n\n\n\n\najcctnmpathn\nSTRING\n\n\n1012\n\n\najcctnmpathndescription\nSTRING\n\n\n\n\n\najcctnmpathnsuffix\nSTRING\n\n\n1035\n\n\najcctnmpathnsuffixdescription\nSTRING\n\n\n\n\n\najcctnmpathstagegroup\nSTRING\n\n\n1014\n\n\najcctnmpathstagegroupdescription\nSTRING\n\n\n\n\n\najcctnmpatht\nSTRING\n\n\n1011\n\n\najcctnmpathtdescription\nSTRING\n\n\n\n\n\najcctnmpathtsuffix\nSTRING\n\n\n1032\n\n\najcctnmpathtsuffixdescription\nSTRING\n\n\n\n\n\najcctnmposttherapyclinm\nSTRING\n\n\n1066\n\n\najcctnmposttherapyclinmdescription\nSTRING\n\n\n\n\n\najcctnmposttherapyclinn\nSTRING\n\n\n1064\n\n\najcctnmposttherapyclinndescription\nSTRING\n\n\n\n\n\najcctnmposttherapyclinnsuffix\nSTRING\n\n\n1065\n\n\najcctnmposttherapyclinnsuffixdescription\nSTRING\n\n\n\n\n\najcctnmposttherapyclint\nSTRING\n\n\n1062\n\n\najcctnmposttherapyclintdescription\nSTRING\n\n\n\n\n\najcctnmposttherapym\nSTRING\n\n\n1023\n\n\najcctnmposttherapymdescription\nSTRING\n\n\n\n\n\najcctnmposttherapyn\nSTRING\n\n\n1022\n\n\najcctnmposttherapyndescription\nSTRING\n\n\n\n\n\najcctnmposttherapynsuffix\nSTRING\n\n\n1036\n\n\najcctnmposttherapynsuffixdescription\nSTRING\n\n\n\n\n\najcctnmposttherapystagegroup\nSTRING\n\n\n1024\n\n\najcctnmposttherapystagegroupdescription\nSTRING\n\n\n\n\n\najcctnmposttherapyt\nSTRING\n\n\n1021\n\n\najcctnmposttherapytdescription\nSTRING\n\n\n\n\n\najcctnmposttherapytsuffix\nSTRING\n\n\n1033\n\n\najcctnmposttherapytsuffixdescription\nSTRING\n\n\n\n\n\nalkrearrangement\nSTRING\n\n\n3938\n\n\nalkrearrangementdescription\nSTRING\n\n\n\n\n\nambiguousterminologydx\nSTRING\n\n\n442\n\n\nambiguousterminologydxdescription\nSTRING\n\n\n\n\n\nanemia\nSTRING\n\n\n3811\n\n\nanemiadescription\nSTRING\n\n\n\n\n\nbehaviorcodeicdo3\nSTRING\n\n\n523\n\n\nbehaviorcodeicdo3description\nSTRING\n\n\n\n\n\nbehavioricdo2\nSTRING\n\n\n430\n\n\nbehavioricdo2description\nSTRING\n\n\n\n\n\nbilirubinpretxtotallabvalue\nSTRING\n\n\n3813\n\n\nbilirubinpretxtotallabvaluedescription\nSTRING\n\n\n\n\n\nbilirubinpretxunitofmeasure\nSTRING\n\n\n3814\n\n\nbilirubinpretxunitofmeasuredescription\nSTRING\n\n\n\n\n\nboneinvasion\nSTRING\n\n\n3815\n\n\nboneinvasiondescription\nSTRING\n\n\n\n\n\nbrafmutationalanalysis\nSTRING\n\n\n3940\n\n\nbrafmutationalanalysisdescription\nSTRING\n\n\n\n\n\nbrainmolecularmarkers\nSTRING\n\n\n3816\n\n\nbrainmolecularmarkersdescription\nSTRING\n\n\n\n\n\nbreastmethodofdetection\nSTRING\n\n\n22159\n\n\nbreastmethodofdetectiondescription\nSTRING\n\n\n\n\n\nbreslowtumorthickness\nSTRING\n\n\n3817\n\n\nbreslowtumorthicknessdescription\nSTRING\n\n\n\n\n\nbsymptoms\nSTRING\n\n\n3812\n\n\nbsymptomsdescription\nSTRING\n\n\n\n\n\nca125pretreatmentinterpretation\nSTRING\n\n\n3818\n\n\nca125pretreatmentinterpretationdescription\nSTRING\n\n\n\n\n\nca199pretxlabvalue\nSTRING\n\n\n3942\n\n\nca199pretxlabvaluedescription\nSTRING\n\n\n\n\n\ncasefindingsource\nSTRING\n\n\n501\n\n\ncasefindingsourcedescription\nSTRING\n\n\n\n\n\nceapretreatmentinterpretation\nSTRING\n\n\n3819\n\n\nceapretreatmentinterpretationdescription\nSTRING\n\n\n\n\n\nceapretreatmentlabvalue\nSTRING\n\n\n3820\n\n\nceapretreatmentlabvaluedescription\nSTRING\n\n\n\n\n\nchromosome19qlossheterozygosity\nSTRING\n\n\n3802\n\n\nchromosome19qlossheterozygositydescription\nSTRING\n\n\n\n\n\nchromosome1plossheterozygosity\nSTRING\n\n\n3801\n\n\nchromosome1plossheterozygositydescription\nSTRING\n\n\n\n\n\nchromosome3status\nSTRING\n\n\n3821\n\n\nchromosome3statusdescription\nSTRING\n\n\n\n\n\nchromosome8qstatus\nSTRING\n\n\n3822\n\n\nchromosome8qstatusdescription\nSTRING\n\n\n\n\n\ncircumferentialresectionmargin\nSTRING\n\n\n3823\n\n\ncircumferentialresectionmargindescription\nSTRING\n\n\n\n\n\nclassofcase\nSTRING\n\n\n610\n\n\nclassofcasedescription\nSTRING\n\n\n\n\n\nclinicalmarginwidth\nSTRING\n\n\n3961\n\n\nclinicalmarginwidthdescription\nSTRING\n\n\n\n\n\ncocaccreditedflag\nSTRING\n\n\n2152\n\n\ncocaccreditedflagdescription\nSTRING\n\n\n\n\n\ncoccodingsyscurrent\nSTRING\n\n\n2140\n\n\ncoccodingsyscurrentdescription\nSTRING\n\n\n\n\n\ncoccodingsysoriginal\nSTRING\n\n\n2150\n\n\ncoccodingsysoriginaldescription\nSTRING\n\n\n\n\n\ncocexportflag\nSTRING\n\n\n50071\n\n\ncocexportflagdescription\nSTRING\n\n\n\n\n\ncocmeasurebreastbcsrt\nSTRING\n\n\n\n\n\ncocmeasurebreastmac\nSTRING\n\n\n\n\n\ncocmeasurecolon12rln\nSTRING\n\n\n\n\n\ncocmeasurecolonact\nSTRING\n\n\n\n\n\ncocmeasuregastricg15rln\nSTRING\n\n\n\n\n\ncocmeasurelunglct\nSTRING\n\n\n\n\n\ncocmeasurerectalrecrtct\nSTRING\n\n\n\n\n\ncodingproc\nSTRING\n\n\n70000\n\n\ncodingprocdescription\nSTRING\n\n\n\n\n\ncreatininepretreatmentlabvalue\nSTRING\n\n\n3824\n\n\ncreatininepretreatmentlabvaluedescription\nSTRING\n\n\n\n\n\ncreatininepretxunitofmeasure\nSTRING\n\n\n3825\n\n\ncreatininepretxunitofmeasuredescription\nSTRING\n\n\n\n\n\ncsextension\nSTRING\n\n\n2810\n\n\ncsextensiondescription\nSTRING\n\n\n\n\n\ncslymphnodes\nSTRING\n\n\n2830\n\n\ncslymphnodesdescription\nSTRING\n\n\n\n\n\ncslymphnodeseval\nSTRING\n\n\n2840\n\n\ncslymphnodesevaldescription\nSTRING\n\n\n\n\n\ncsmetsatdx\nSTRING\n\n\n2850\n\n\ncsmetsatdxbone\nSTRING\n\n\n2851\n\n\ncsmetsatdxbonedescription\nSTRING\n\n\n\n\n\ncsmetsatdxbrain\nSTRING\n\n\n2852\n\n\ncsmetsatdxbraindescription\nSTRING\n\n\n\n\n\ncsmetsatdxdescription\nSTRING\n\n\n\n\n\ncsmetsatdxliver\nSTRING\n\n\n2853\n\n\ncsmetsatdxliverdescription\nSTRING\n\n\n\n\n\ncsmetsatdxlung\nSTRING\n\n\n2854\n\n\ncsmetsatdxlungdescription\nSTRING\n\n\n\n\n\ncsmetseval\nSTRING\n\n\n2860\n\n\ncsmetsevaldescription\nSTRING\n\n\n\n\n\ncssitespecificfactor1\nSTRING\n\n\n2880\n\n\ncssitespecificfactor10\nSTRING\n\n\n2864\n\n\ncssitespecificfactor10description\nSTRING\n\n\n\n\n\ncssitespecificfactor11\nSTRING\n\n\n2865\n\n\ncssitespecificfactor11description\nSTRING\n\n\n\n\n\ncssitespecificfactor12\nSTRING\n\n\n2866\n\n\ncssitespecificfactor12description\nSTRING\n\n\n\n\n\ncssitespecificfactor13\nSTRING\n\n\n2867\n\n\ncssitespecificfactor13description\nSTRING\n\n\n\n\n\ncssitespecificfactor14\nSTRING\n\n\n2868\n\n\ncssitespecificfactor14description\nSTRING\n\n\n\n\n\ncssitespecificfactor15\nSTRING\n\n\n2869\n\n\ncssitespecificfactor15description\nSTRING\n\n\n\n\n\ncssitespecificfactor16\nSTRING\n\n\n2870\n\n\ncssitespecificfactor16description\nSTRING\n\n\n\n\n\ncssitespecificfactor17\nSTRING\n\n\n2871\n\n\ncssitespecificfactor17description\nSTRING\n\n\n\n\n\ncssitespecificfactor18\nSTRING\n\n\n2872\n\n\ncssitespecificfactor18description\nSTRING\n\n\n\n\n\ncssitespecificfactor19\nSTRING\n\n\n2873\n\n\ncssitespecificfactor19description\nSTRING\n\n\n\n\n\ncssitespecificfactor1description\nSTRING\n\n\n\n\n\ncssitespecificfactor2\nSTRING\n\n\n2890\n\n\ncssitespecificfactor20\nSTRING\n\n\n2874\n\n\ncssitespecificfactor20description\nSTRING\n\n\n\n\n\ncssitespecificfactor21\nSTRING\n\n\n2875\n\n\ncssitespecificfactor21description\nSTRING\n\n\n\n\n\ncssitespecificfactor22\nSTRING\n\n\n2876\n\n\ncssitespecificfactor22description\nSTRING\n\n\n\n\n\ncssitespecificfactor23\nSTRING\n\n\n2877\n\n\ncssitespecificfactor23description\nSTRING\n\n\n\n\n\ncssitespecificfactor24\nSTRING\n\n\n2878\n\n\ncssitespecificfactor24description\nSTRING\n\n\n\n\n\ncssitespecificfactor25\nSTRING\n\n\n2879\n\n\ncssitespecificfactor25description\nSTRING\n\n\n\n\n\ncssitespecificfactor2description\nSTRING\n\n\n\n\n\ncssitespecificfactor3\nSTRING\n\n\n2900\n\n\ncssitespecificfactor3description\nSTRING\n\n\n\n\n\ncssitespecificfactor4\nSTRING\n\n\n2910\n\n\ncssitespecificfactor4description\nSTRING\n\n\n\n\n\ncssitespecificfactor5\nSTRING\n\n\n2920\n\n\ncssitespecificfactor5description\nSTRING\n\n\n\n\n\ncssitespecificfactor6\nSTRING\n\n\n2930\n\n\ncssitespecificfactor6description\nSTRING\n\n\n\n\n\ncssitespecificfactor7\nSTRING\n\n\n2861\n\n\ncssitespecificfactor7description\nSTRING\n\n\n\n\n\ncssitespecificfactor8\nSTRING\n\n\n2862\n\n\ncssitespecificfactor8description\nSTRING\n\n\n\n\n\ncssitespecificfactor9\nSTRING\n\n\n2863\n\n\ncssitespecificfactor9description\nSTRING\n\n\n\n\n\ncstumorsize\nSTRING\n\n\n2800\n\n\ncstumorsizedescription\nSTRING\n\n\n\n\n\ncstumorsizeexteval\nSTRING\n\n\n2820\n\n\ncstumorsizeextevaldescription\nSTRING\n\n\n\n\n\ncsversionderived\nSTRING\n\n\n2936\n\n\ncsversionderiveddescription\nSTRING\n\n\n\n\n\ncsversioninputcurrent\nSTRING\n\n\n2937\n\n\ncsversioninputcurrentdescription\nSTRING\n\n\n\n\n\ncsversioninputoriginal\nSTRING\n\n\n2935\n\n\ncsversioninputoriginaldescription\nSTRING\n\n\n\n\n\nctrreview\nSTRING\n\n\n10028\n\n\nctrreviewdescription\nSTRING\n\n\n\n\n\ndatecaselastvalidatedcoc\nSTRING\nYes\nJitter\n\n\n\ndateconclusivedx\nSTRING\nYes\nJitter\n443\n\n\ndateconclusivedxflag\nSTRING\n\n\n448\n\n\ndateconclusivedxflagdescription\nSTRING\n\n\n\n\n\ndateofdiagnosis\nSTRING\nYes\nJitter\n390\n\n\ndateofdiagnosisflag\nSTRING\n\n\n391\n\n\ndateofmulttumors\nSTRING\nYes\nJitter\n445\n\n\ndateofmulttumorsflag\nSTRING\n\n\n439\n\n\ndateofmulttumorsflagdescription\nSTRING\n\n\n\n\n\ndateregionallndissection\nSTRING\nYes\nJitter\n682\n\n\ndateregionallndissectionflag\nSTRING\n\n\n683\n\n\ndateregionallndissectionflagdescription\nSTRING\n\n\n\n\n\ndatesentinellymphnodebiopsy\nSTRING\nYes\nJitter\n832\n\n\ndatesentinellymphnodebiopsyflag\nSTRING\n\n\n833\n\n\ndatesentinellymphnodebiopsyflagdescription\nSTRING\n\n\n\n\n\nderivedajcc6m\nSTRING\n\n\n2980\n\n\nderivedajcc6mdescript\nSTRING\n\n\n2990\n\n\nderivedajcc6mdescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc6mdescription\nSTRING\n\n\n\n\n\nderivedajcc6n\nSTRING\n\n\n2960\n\n\nderivedajcc6ndescript\nSTRING\n\n\n2970\n\n\nderivedajcc6ndescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc6ndescription\nSTRING\n\n\n\n\n\nderivedajcc6stagegrp\nSTRING\n\n\n3000\n\n\nderivedajcc6stagegrpdescription\nSTRING\n\n\n\n\n\nderivedajcc6t\nSTRING\n\n\n2940\n\n\nderivedajcc6tdescript\nSTRING\n\n\n2950\n\n\nderivedajcc6tdescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc6tdescription\nSTRING\n\n\n\n\n\nderivedajcc7m\nSTRING\n\n\n3420\n\n\nderivedajcc7mdescript\nSTRING\n\n\n3422\n\n\nderivedajcc7mdescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc7mdescription\nSTRING\n\n\n\n\n\nderivedajcc7n\nSTRING\n\n\n3410\n\n\nderivedajcc7ndescript\nSTRING\n\n\n3412\n\n\nderivedajcc7ndescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc7ndescription\nSTRING\n\n\n\n\n\nderivedajcc7stagegrp\nSTRING\n\n\n3430\n\n\nderivedajcc7stagegrpdescription\nSTRING\n\n\n\n\n\nderivedajcc7t\nSTRING\n\n\n3400\n\n\nderivedajcc7tdescript\nSTRING\n\n\n3402\n\n\nderivedajcc7tdescriptdescription\nSTRING\n\n\n\n\n\nderivedajcc7tdescription\nSTRING\n\n\n\n\n\nderivedajccflag\nSTRING\n\n\n3030\n\n\nderivedajccflagdescription\nSTRING\n\n\n\n\n\nderivedeod2018m\nSTRING\n\n\n795\n\n\nderivedeod2018mdescription\nSTRING\n\n\n\n\n\nderivedeod2018n\nSTRING\n\n\n815\n\n\nderivedeod2018ndescription\nSTRING\n\n\n\n\n\nderivedeod2018stagegroup\nSTRING\n\n\n818\n\n\nderivedeod2018t\nSTRING\n\n\n785\n\n\nderivedeod2018tdescription\nSTRING\n\n\n\n\n\nderivedeodversion\nSTRING\n\n\n\n\n\nderivedraistage\nSTRING\n\n\n3955\n\n\nderivedraistagedescription\nSTRING\n\n\n\n\n\nderivedss1977\nSTRING\n\n\n3010\n\n\nderivedss1977description\nSTRING\n\n\n\n\n\nderivedss1977flag\nSTRING\n\n\n3040\n\n\nderivedss1977flagdescription\nSTRING\n\n\n\n\n\nderivedss2000\nSTRING\n\n\n3020\n\n\nderivedss2000description\nSTRING\n\n\n\n\n\nderivedss2000flag\nSTRING\n\n\n3050\n\n\nderivedss2000flagdescription\nSTRING\n\n\n\n\n\nderivedsummarygrade2018\nSTRING\n\n\n1975\n\n\nderivedsummarystage2018\nSTRING\n\n\n762\n\n\nderivedsummarystage2018description\nSTRING\n\n\n\n\n\ndiagnosticconfirmation\nSTRING\n\n\n490\n\n\ndiagnosticconfirmationdescription\nSTRING\n\n\n\n\n\ndiscoveredbyscreening\nSTRING\n\n\n70008\n\n\ndiscoveredbyscreeningdescription\nSTRING\n\n\n\n\n\negfrmutationalanalysis\nSTRING\n\n\n3939\n\n\negfrmutationalanalysisdescription\nSTRING\n\n\n\n\n\neodextension\nSTRING\n\n\n790\n\n\neodextensiondescription\nSTRING\n\n\n\n\n\neodextensionprostpath\nSTRING\n\n\n800\n\n\neodextensionprostpathdescription\nSTRING\n\n\n\n\n\neodlymphnodeinvolv\nSTRING\n\n\n810\n\n\neodlymphnodeinvolvdescription\nSTRING\n\n\n\n\n\neodmets\nSTRING\n\n\n776\n\n\neodmetsdescription\nSTRING\n\n\n\n\n\neodprimarytumor\nSTRING\n\n\n772\n\n\neodprimarytumordescription\nSTRING\n\n\n\n\n\neodregionalnodes\nSTRING\n\n\n774\n\n\neodregionalnodesdescription\nSTRING\n\n\n\n\n\neodtumorsize\nSTRING\n\n\n780\n\n\neodtumorsizedescription\nSTRING\n\n\n\n\n\nesophagusandegjtumorepicenter\nSTRING\n\n\n3829\n\n\nesophagusandegjtumorepicenterdescription\nSTRING\n\n\n\n\n\nestrogenreceptorpercntposorrange\nSTRING\n\n\n3826\n\n\nestrogenreceptorpercntposorrangedescription\nSTRING\n\n\n\n\n\nestrogenreceptorsummary\nSTRING\n\n\n3827\n\n\nestrogenreceptorsummarydescription\nSTRING\n\n\n\n\n\nestrogenreceptortotalallredscore\nSTRING\n\n\n3828\n\n\nestrogenreceptortotalallredscoredescription\nSTRING\n\n\n\n\n\nextranodalextensionclin\nSTRING\n\n\n3830\n\n\nextranodalextensionclindescription\nSTRING\n\n\n\n\n\nextranodalextensionheadneckclin\nSTRING\n\n\n3831\n\n\nextranodalextensionheadneckclindescription\nSTRING\n\n\n\n\n\nextranodalextensionheadneckpath\nSTRING\n\n\n3832\n\n\nextranodalextensionheadneckpathdescription\nSTRING\n\n\n\n\n\nextranodalextensionpath\nSTRING\n\n\n3833\n\n\nextranodalextensionpathdescription\nSTRING\n\n\n\n\n\nextravascularmatrixpatterns\nSTRING\n\n\n3834\n\n\nextravascularmatrixpatternsdescription\nSTRING\n\n\n\n\n\nfibrosisscore\nSTRING\n\n\n3835\n\n\nfibrosisscoredescription\nSTRING\n\n\n\n\n\nfigostage\nSTRING\n\n\n3836\n\n\nfigostagedescription\nSTRING\n\n\n\n\n\nfollowupflag\nSTRING\n\n\n70009\n\n\nfollowupflagdescription\nSTRING\n\n\n\n\n\nfollowuplasttypetumor\nSTRING\n\n\n70011\n\n\nfollowuplasttypetumordescription\nSTRING\n\n\n\n\n\ngestationaltrophoblasticpxindex\nSTRING\n\n\n3837\n\n\ngleasonpatternsclinical\nSTRING\n\n\n3838\n\n\ngleasonpatternsclinicaldescription\nSTRING\n\n\n\n\n\ngleasonpatternspathological\nSTRING\n\n\n3839\n\n\ngleasonpatternspathologicaldescription\nSTRING\n\n\n\n\n\ngleasonscoreclinical\nSTRING\n\n\n3840\n\n\ngleasonscoreclinicaldescription\nSTRING\n\n\n\n\n\ngleasonscorepathological\nSTRING\n\n\n3841\n\n\ngleasonscorepathologicaldescription\nSTRING\n\n\n\n\n\ngleasontertiarypattern\nSTRING\n\n\n3842\n\n\ngleasontertiarypatterndescription\nSTRING\n\n\n\n\n\ngrade\nSTRING\n\n\n440\n\n\ngradeclinical\nSTRING\n\n\n3843\n\n\ngradeclinicaldescription\nSTRING\n\n\n\n\n\ngradedescription\nSTRING\n\n\n\n\n\ngradepathological\nSTRING\n\n\n3844\n\n\ngradepathologicaldescription\nSTRING\n\n\n\n\n\ngradepathsystem\nSTRING\n\n\n449\n\n\ngradepathsystemdescription\nSTRING\n\n\n\n\n\ngradepathvalue\nSTRING\n\n\n441\n\n\ngradepathvaluedescription\nSTRING\n\n\n\n\n\ngradeposttherapy\nSTRING\n\n\n3845\n\n\ngradeposttherapyclin\nSTRING\n\n\n1068\n\n\ngradeposttherapyclindescription\nSTRING\n\n\n\n\n\ngradeposttherapydescription\nSTRING\n\n\n\n\n\nhcgpostorchiectomylabvalue\nSTRING\n\n\n3846\n\n\nhcgpostorchiectomylabvaluedescription\nSTRING\n\n\n\n\n\nhcgpostorchiectomyrange\nSTRING\n\n\n3847\n\n\nhcgpostorchiectomyrangedescription\nSTRING\n\n\n\n\n\nhcgpreorchiectomylabvalue\nSTRING\n\n\n3848\n\n\nhcgpreorchiectomylabvaluedescription\nSTRING\n\n\n\n\n\nhcgpreorchiectomyrange\nSTRING\n\n\n3849\n\n\nhcgpreorchiectomyrangedescription\nSTRING\n\n\n\n\n\nher2ihcsummary\nSTRING\n\n\n3850\n\n\nher2ihcsummarydescription\nSTRING\n\n\n\n\n\nher2ishdualprobecopynumber\nSTRING\n\n\n3851\n\n\nher2ishdualprobecopynumberdescription\nSTRING\n\n\n\n\n\nher2ishdualproberatio\nSTRING\n\n\n3852\n\n\nher2ishdualproberatiodescription\nSTRING\n\n\n\n\n\nher2ishsingleprobecopynumber\nSTRING\n\n\n3853\n\n\nher2ishsingleprobecopynumberdescription\nSTRING\n\n\n\n\n\nher2ishsummary\nSTRING\n\n\n3854\n\n\nher2ishsummarydescription\nSTRING\n\n\n\n\n\nher2overallsummary\nSTRING\n\n\n3855\n\n\nher2overallsummarydescription\nSTRING\n\n\n\n\n\nheritabletrait\nSTRING\n\n\n3856\n\n\nheritabletraitdescription\nSTRING\n\n\n\n\n\nhighriskcytogenetics\nSTRING\n\n\n3857\n\n\nhighriskcytogeneticsdescription\nSTRING\n\n\n\n\n\nhighriskhistologicfeatures\nSTRING\n\n\n3858\n\n\nhighriskhistologicfeaturesdescription\nSTRING\n\n\n\n\n\nhistologicsubtype\nSTRING\n\n\n3960\n\n\nhistologicsubtypedescription\nSTRING\n\n\n\n\n\nhistologictypeicdo3\nSTRING\n\n\n522\n\n\nhistologictypeicdo3description\nSTRING\n\n\n\n\n\nhistologyicdo2\nSTRING\n\n\n420\n\n\nhistologyicdo2description\nSTRING\n\n\n\n\n\nhivstatus\nSTRING\n\n\n3859\n\n\nhivstatusdescription\nSTRING\n\n\n\n\n\nhospitaltumornumberccr\nSTRING\n\n\n70014\n\n\nhospitaltumornumberccrdescription\nSTRING\n\n\n\n\n\nicdo3conversionflag\nSTRING\n\n\n2116\n\n\nicdo3conversionflagdescription\nSTRING\n\n\n\n\n\ninrprothrombintime\nSTRING\n\n\n3860\n\n\ninrprothrombintimedescription\nSTRING\n\n\n\n\n\ninvasionbeyondcapsule\nSTRING\n\n\n3864\n\n\ninvasionbeyondcapsuledescription\nSTRING\n\n\n\n\n\nipsilateraladrenalglandinvolve\nSTRING\n\n\n3861\n\n\nipsilateraladrenalglandinvolvedescription\nSTRING\n\n\n\n\n\njak2\nSTRING\n\n\n3862\n\n\njak2description\nSTRING\n\n\n\n\n\nki67\nSTRING\n\n\n3863\n\n\nki67description\nSTRING\n\n\n\n\n\nkitgeneimmunohistochemistry\nSTRING\n\n\n3865\n\n\nkitgeneimmunohistochemistrydescription\nSTRING\n\n\n\n\n\nkras\nSTRING\n\n\n3866\n\n\nkrasdescription\nSTRING\n\n\n\n\n\nlaterality\nSTRING\n\n\n410\n\n\nlateralitydescription\nSTRING\n\n\n\n\n\nldhpostorchiectomyrange\nSTRING\n\n\n3867\n\n\nldhpostorchiectomyrangedescription\nSTRING\n\n\n\n\n\nldhpreorchiectomyrange\nSTRING\n\n\n3868\n\n\nldhpreorchiectomyrangedescription\nSTRING\n\n\n\n\n\nldhpretreatmentlabvalue\nSTRING\n\n\n3932\n\n\nldhpretreatmentlabvaluedescription\nSTRING\n\n\n\n\n\nldhpretreatmentlevel\nSTRING\n\n\n3869\n\n\nldhpretreatmentleveldescription\nSTRING\n\n\n\n\n\nldhupperlimitsofnormal\nSTRING\n\n\n3870\n\n\nldhupperlimitsofnormaldescription\nSTRING\n\n\n\n\n\nlnassessmethodfemoralinguinal\nSTRING\n\n\n3871\n\n\nlnassessmethodfemoralinguinaldescription\nSTRING\n\n\n\n\n\nlnassessmethodparaaortic\nSTRING\n\n\n3872\n\n\nlnassessmethodparaaorticdescription\nSTRING\n\n\n\n\n\nlnassessmethodpelvic\nSTRING\n\n\n3873\n\n\nlnassessmethodpelvicdescription\nSTRING\n\n\n\n\n\nlndistantassessmethod\nSTRING\n\n\n3874\n\n\nlndistantassessmethoddescription\nSTRING\n\n\n\n\n\nlndistantmediastinalscalene\nSTRING\n\n\n3875\n\n\nlndistantmediastinalscalenedescription\nSTRING\n\n\n\n\n\nlnheadandnecklevels1to3\nSTRING\n\n\n3876\n\n\nlnheadandnecklevels1to3description\nSTRING\n\n\n\n\n\nlnheadandnecklevels4to5\nSTRING\n\n\n3877\n\n\nlnheadandnecklevels4to5description\nSTRING\n\n\n\n\n\nlnheadandnecklevels6to7\nSTRING\n\n\n3878\n\n\nlnheadandnecklevels6to7description\nSTRING\n\n\n\n\n\nlnheadandneckother\nSTRING\n\n\n3879\n\n\nlnheadandneckotherdescription\nSTRING\n\n\n\n\n\nlnisolatedtumorcells\nSTRING\n\n\n3880\n\n\nlnisolatedtumorcellsdescription\nSTRING\n\n\n\n\n\nlnlaterality\nSTRING\n\n\n3881\n\n\nlnlateralitydescription\nSTRING\n\n\n\n\n\nlnpositiveaxillarylevel1to2\nSTRING\n\n\n3882\n\n\nlnpositiveaxillarylevel1to2description\nSTRING\n\n\n\n\n\nlnsize\nSTRING\n\n\n3883\n\n\nlnsizedescription\nSTRING\n\n\n\n\n\nlnstatusfemoralinguinal\nSTRING\n\n\n3959\n\n\nlnstatusfemoralinguinaldescription\nSTRING\n\n\n\n\n\nlnstatusfemoringuinparaaortpelv\nSTRING\n\n\n3884\n\n\nlnstatusfemoringuinparaaortpelvdescription\nSTRING\n\n\n\n\n\nlnstatusparaaortic\nSTRING\n\n\n3958\n\n\nlnstatusparaaorticdescription\nSTRING\n\n\n\n\n\nlnstatuspelvic\nSTRING\n\n\n3957\n\n\nlnstatuspelvicdescription\nSTRING\n\n\n\n\n\nlymphocytosis\nSTRING\n\n\n3885\n\n\nlymphocytosisdescription\nSTRING\n\n\n\n\n\nlymphvascularinvasion\nSTRING\n\n\n1182\n\n\nlymphvascularinvasiondescription\nSTRING\n\n\n\n\n\nmacroscopicevalofthemesorectum\nSTRING\n\n\n3950\n\n\nmacroscopicevalofthemesorectumdescription\nSTRING\n\n\n\n\n\nmajorveininvolvement\nSTRING\n\n\n3886\n\n\nmajorveininvolvementdescription\nSTRING\n\n\n\n\n\nmeasuredbasaldiameter\nSTRING\n\n\n3887\n\n\nmeasuredbasaldiameterdescription\nSTRING\n\n\n\n\n\nmeasuredthickness\nSTRING\n\n\n3888\n\n\nmeasuredthicknessdescription\nSTRING\n\n\n\n\n\nmethylationofo6mgmt\nSTRING\n\n\n3889\n\n\nmethylationofo6mgmtdescription\nSTRING\n\n\n\n\n\nmetsatdxbone\nSTRING\n\n\n1112\n\n\nmetsatdxbonedescription\nSTRING\n\n\n\n\n\nmetsatdxbrain\nSTRING\n\n\n1113\n\n\nmetsatdxbraindescription\nSTRING\n\n\n\n\n\nmetsatdxdistantln\nSTRING\n\n\n1114\n\n\nmetsatdxdistantlndescription\nSTRING\n\n\n\n\n\nmetsatdxliver\nSTRING\n\n\n1115\n\n\nmetsatdxliverdescription\nSTRING\n\n\n\n\n\nmetsatdxlung\nSTRING\n\n\n1116\n\n\nmetsatdxlungdescription\nSTRING\n\n\n\n\n\nmetsatdxother\nSTRING\n\n\n1117\n\n\nmetsatdxotherdescription\nSTRING\n\n\n\n\n\nmicrosatelliteinstability\nSTRING\n\n\n3890\n\n\nmicrosatelliteinstabilitydescription\nSTRING\n\n\n\n\n\nmicrovasculardensity\nSTRING\n\n\n3891\n\n\nmicrovasculardensitydescription\nSTRING\n\n\n\n\n\nmitoticcountuvealmelanoma\nSTRING\n\n\n3892\n\n\nmitoticcountuvealmelanomadescription\nSTRING\n\n\n\n\n\nmitoticratemelanoma\nSTRING\n\n\n3893\n\n\nmitoticratemelanomadescription\nSTRING\n\n\n\n\n\nmorphcodingsyscurrent\nSTRING\n\n\n470\n\n\nmorphcodingsyscurrentdescription\nSTRING\n\n\n\n\n\nmorphcodingsysoriginl\nSTRING\n\n\n480\n\n\nmorphcodingsysoriginldescription\nSTRING\n\n\n\n\n\nmorphtypebehavicdo2\nSTRING\n\n\n\n\n\nmorphtypebehavicdo2description\nSTRING\n\n\n\n\n\nmorphtypebehavicdo3\nSTRING\n\n\n\n\n\nmorphtypebehavicdo3description\nSTRING\n\n\n\n\n\nmultigenesignaturemethod\nSTRING\n\n\n3894\n\n\nmultigenesignaturemethoddescription\nSTRING\n\n\n\n\n\nmultigenesignatureresults\nSTRING\n\n\n3895\n\n\nmultigenesignatureresultsdescription\nSTRING\n\n\n\n\n\nmultiplicitycounter\nSTRING\n\n\n446\n\n\nmultiplicitycounterdescription\nSTRING\n\n\n\n\n\nmulttumrptasoneprim\nSTRING\n\n\n444\n\n\nmulttumrptasoneprimdescription\nSTRING\n\n\n\n\n\nnccninternationalprognosticindex\nSTRING\n\n\n3896\n\n\nnccninternationalprognosticindexdescription\nSTRING\n\n\n\n\n\nnfcaseentityid\nSTRING\nYes\nStable Between Data Refreshes\n\n\n\nnfcasestatus\nSTRING\n\n\n\n\n\nnfcasestatus\nSTRING\n\n\n\n\n\nnffacilityid\nSTRING\n\n\n50078\n\n\nnffacilityiddescription\nSTRING\n\n\n\n\n\nnfpatientsetid\nSTRING\n\n\n\n\n\nnpcrderivedajcc8tnmclinstggrp\nSTRING\n\n\n3645\n\n\nnpcrderivedajcc8tnmclinstggrpdescription\nSTRING\n\n\n\n\n\nnpcrderivedajcc8tnmpathstggrp\nSTRING\n\n\n3646\n\n\nnpcrderivedajcc8tnmpathstggrpdescription\nSTRING\n\n\n\n\n\nnpcrderivedajcc8tnmpoststggrp\nSTRING\n\n\n3647\n\n\nnpcrderivedajcc8tnmpoststggrpdescription\nSTRING\n\n\n\n\n\nnrasmutationalanalysis\nSTRING\n\n\n3941\n\n\nnrasmutationalanalysisdescription\nSTRING\n\n\n\n\n\nnumberofcoresexamined\nSTRING\n\n\n3897\n\n\nnumberofcoresexamineddescription\nSTRING\n\n\n\n\n\nnumberofcorespositive\nSTRING\n\n\n3898\n\n\nnumberofcorespositivedescription\nSTRING\n\n\n\n\n\nnumberofexaminedparaaorticnodes\nSTRING\n\n\n3899\n\n\nnumberofexaminedparaaorticnodesdescription\nSTRING\n\n\n\n\n\nnumberofexaminedpelvicnodes\nSTRING\n\n\n3900\n\n\nnumberofexaminedpelvicnodesdescription\nSTRING\n\n\n\n\n\nnumberofpositiveparaaorticnodes\nSTRING\n\n\n3901\n\n\nnumberofpositiveparaaorticnodesdescription\nSTRING\n\n\n\n\n\nnumberofpositivepelvicnodes\nSTRING\n\n\n3902\n\n\nnumberofpositivepelvicnodesdescription\nSTRING\n\n\n\n\n\noncotypedxrecurrencescoredcis\nSTRING\n\n\n3903\n\n\noncotypedxrecurrencescoredcisdescription\nSTRING\n\n\n\n\n\noncotypedxrecurrencescoreinvasiv\nSTRING\n\n\n3904\n\n\noncotypedxrecurrencescoreinvasivdescription\nSTRING\n\n\n\n\n\noncotypedxriskleveldcis\nSTRING\n\n\n3905\n\n\noncotypedxriskleveldcisdescription\nSTRING\n\n\n\n\n\noncotypedxrisklevelinvasive\nSTRING\n\n\n3906\n\n\noncotypedxrisklevelinvasivedescription\nSTRING\n\n\n\n\n\norganomegaly\nSTRING\n\n\n3907\n\n\norganomegalydescription\nSTRING\n\n\n\n\n\noverrideadmisdx\nSTRING\n\n\n70020\n\n\noverrideadmisdxdescription\nSTRING\n\n\n\n\n\noverridesitestage\nSTRING\n\n\n70022\n\n\noverridesitestagedescription\nSTRING\n\n\n\n\n\noverridesitetnmstggrp\nSTRING\n\n\n1989\n\n\noverridesitetnmstggrpdescription\nSTRING\n\n\n\n\n\noverridesstnmm\nSTRING\n\n\n1983\n\n\noverridesstnmmdescription\nSTRING\n\n\n\n\n\noverridesstnmn\nSTRING\n\n\n1982\n\n\noverridesstnmndescription\nSTRING\n\n\n\n\n\noverridetnm3\nSTRING\n\n\n1994\n\n\noverridetnm3description\nSTRING\n\n\n\n\n\noverridetnmstage\nSTRING\n\n\n1992\n\n\noverridetnmstagedescription\nSTRING\n\n\n\n\n\noverridetnmtis\nSTRING\n\n\n1993\n\n\noverridetnmtisdescription\nSTRING\n\n\n\n\n\np16\nSTRING\n\n\n3956\n\n\np16description\nSTRING\n\n\n\n\n\npathdatespeccollect1\nSTRING\nYes\nJitter\n7320\n\n\npathdatespeccollect2\nSTRING\nYes\nJitter\n7321\n\n\npathdatespeccollect3\nSTRING\nYes\nJitter\n7322\n\n\npathdatespeccollect4\nSTRING\nYes\nJitter\n7323\n\n\npathdatespeccollect5\nSTRING\nYes\nJitter\n7324\n\n\npathorderingfacno1\nSTRING\n\n\n7190\n\n\npathorderingfacno1description\nSTRING\n\n\n\n\n\npathorderingfacno2\nSTRING\n\n\n7191\n\n\npathorderingfacno2description\nSTRING\n\n\n\n\n\npathorderingfacno3\nSTRING\n\n\n7192\n\n\npathorderingfacno3description\nSTRING\n\n\n\n\n\npathorderingfacno4\nSTRING\n\n\n7193\n\n\npathorderingfacno4description\nSTRING\n\n\n\n\n\npathorderingfacno5\nSTRING\n\n\n7194\n\n\npathorderingfacno5description\nSTRING\n\n\n\n\n\npathorderphyslicno1\nSTRING\n\n\n7100\n\n\npathorderphyslicno2\nSTRING\n\n\n7101\n\n\npathorderphyslicno3\nSTRING\n\n\n7102\n\n\npathorderphyslicno4\nSTRING\n\n\n7103\n\n\npathorderphyslicno5\nSTRING\n\n\n7104\n\n\npathreportingfacid1\nSTRING\n\n\n7010\n\n\npathreportingfacid1description\nSTRING\n\n\n\n\n\npathreportingfacid2\nSTRING\n\n\n7011\n\n\npathreportingfacid2description\nSTRING\n\n\n\n\n\npathreportingfacid3\nSTRING\n\n\n7012\n\n\npathreportingfacid3description\nSTRING\n\n\n\n\n\npathreportingfacid4\nSTRING\n\n\n7013\n\n\npathreportingfacid4description\nSTRING\n\n\n\n\n\npathreportingfacid5\nSTRING\n\n\n7014\n\n\npathreportingfacid5description\nSTRING\n\n\n\n\n\npathreportnumber1\nSTRING\nYes\nStable Between Data Refreshes\n7090\n\n\npathreportnumber2\nSTRING\nYes\nStable Between Data Refreshes\n7091\n\n\npathreportnumber3\nSTRING\nYes\nStable Between Data Refreshes\n7092\n\n\npathreportnumber4\nSTRING\nYes\nStable Between Data Refreshes\n7093\n\n\npathreportnumber5\nSTRING\nYes\nStable Between Data Refreshes\n7094\n\n\npathreporttype1\nSTRING\n\n\n7480\n\n\npathreporttype1description\nSTRING\n\n\n\n\n\npathreporttype2\nSTRING\n\n\n7481\n\n\npathreporttype2description\nSTRING\n\n\n\n\n\npathreporttype3\nSTRING\n\n\n7482\n\n\npathreporttype3description\nSTRING\n\n\n\n\n\npathreporttype4\nSTRING\n\n\n7483\n\n\npathreporttype4description\nSTRING\n\n\n\n\n\npathreporttype5\nSTRING\n\n\n7484\n\n\npathreporttype5description\nSTRING\n\n\n\n\n\npediatricstage\nSTRING\n\n\n1120\n\n\npediatricstagedby\nSTRING\n\n\n1140\n\n\npediatricstagedbydescription\nSTRING\n\n\n\n\n\npediatricstagedescription\nSTRING\n\n\n\n\n\npediatricstagingsystem\nSTRING\n\n\n1130\n\n\npediatricstagingsystemdescription\nSTRING\n\n\n\n\n\npercentnecrosispostneoadjuvant\nSTRING\n\n\n3908\n\n\npercentnecrosispostneoadjuvantdescription\nSTRING\n\n\n\n\n\nperineuralinvasion\nSTRING\n\n\n3909\n\n\nperineuralinvasiondescription\nSTRING\n\n\n\n\n\nperipheralbloodinvolvement\nSTRING\n\n\n3910\n\n\nperipheralbloodinvolvementdescription\nSTRING\n\n\n\n\n\nperitonealcytology\nSTRING\n\n\n3911\n\n\nperitonealcytologydescription\nSTRING\n\n\n\n\n\nperson_id\nINTEGER\nYes\nStable Between Data Refreshes\n\n\n\npleuraleffusion\nSTRING\n\n\n3913\n\n\npleuraleffusiondescription\nSTRING\n\n\n\n\n\nprimarydiagnosis\nSTRING\n\n\n\n\n\nprimarysclerosingcholangitis\nSTRING\n\n\n3917\n\n\nprimarysclerosingcholangitisdescription\nSTRING\n\n\n\n\n\nprimarysite\nSTRING\n\n\n400\n\n\nprimarysitedescription\nSTRING\n\n\n\n\n\nprofoundimmunesuppression\nSTRING\n\n\n3918\n\n\nprofoundimmunesuppressiondescription\nSTRING\n\n\n\n\n\nprogesteronerecepprcntposorrange\nSTRING\n\n\n3914\n\n\nprogesteronerecepprcntposorrangedescription\nSTRING\n\n\n\n\n\nprogesteronerecepsummary\nSTRING\n\n\n3915\n\n\nprogesteronerecepsummarydescription\nSTRING\n\n\n\n\n\nprogesteronereceptotalallredscor\nSTRING\n\n\n3916\n\n\nprogesteronereceptotalallredscordescription\nSTRING\n\n\n\n\n\nprostatepathologicalextension\nSTRING\n\n\n3919\n\n\nprostatepathologicalextensiondescription\nSTRING\n\n\n\n\n\nprotocolparticipation\nSTRING\n\n\n1480\n\n\nprotocolparticipationdescription\nSTRING\n\n\n\n\n\npsalabvalue\nSTRING\n\n\n3920\n\n\npsalabvaluedescription\nSTRING\n\n\n\n\n\nregionalnodesexamined\nSTRING\n\n\n830\n\n\nregionalnodesexamineddescription\nSTRING\n\n\n\n\n\nregionalnodespositive\nSTRING\n\n\n820\n\n\nregionalnodespositivedescription\nSTRING\n\n\n\n\n\nresidualtumvolpostcytoreduction\nSTRING\n\n\n3921\n\n\nresidualtumvolpostcytoreductiondescription\nSTRING\n\n\n\n\n\nresponsetoneoadjuvanttherapy\nSTRING\n\n\n3922\n\n\nresponsetoneoadjuvanttherapydescription\nSTRING\n\n\n\n\n\nrxdatedxstgproc\nSTRING\nYes\nJitter\n1280\n\n\nrxdatedxstgprocflag\nSTRING\n\n\n1281\n\n\nrxdatedxstgprocflagdescription\nSTRING\n\n\n\n\n\nrxhospdxstgproc\nSTRING\n\n\n740\n\n\nrxhospdxstgprocdescription\nSTRING\n\n\n\n\n\nrxsummdxstgproc\nSTRING\n\n\n1350\n\n\nrxsummdxstgprocdescription\nSTRING\n\n\n\n\n\nsarcomatoidfeatures\nSTRING\n\n\n3925\n\n\nsarcomatoidfeaturesdescription\nSTRING\n\n\n\n\n\nscategoryclinical\nSTRING\n\n\n3923\n\n\nscategoryclinicaldescription\nSTRING\n\n\n\n\n\nscategorypathological\nSTRING\n\n\n3924\n\n\nscategorypathologicaldescription\nSTRING\n\n\n\n\n\nschema\nSTRING\n\n\n10498\n\n\nschemadiscriminator1\nSTRING\n\n\n3926\n\n\nschemadiscriminator1description\nSTRING\n\n\n\n\n\nschemadiscriminator2\nSTRING\n\n\n3927\n\n\nschemadiscriminator2description\nSTRING\n\n\n\n\n\nschemaid\nSTRING\n\n\n3800\n\n\nschemaiddescription\nSTRING\n\n\n\n\n\nschemaidversioncurrent\nSTRING\n\n\n2117\n\n\nschemaidversioncurrentdescription\nSTRING\n\n\n\n\n\nschemaidversionoriginal\nSTRING\n\n\n2118\n\n\nschemaidversionoriginaldescription\nSTRING\n\n\n\n\n\nscopelnproc1\nSTRING\n\n\n70045\n\n\nscopelnproc1description\nSTRING\n\n\n\n\n\nscopelnproc2\nSTRING\n\n\n70046\n\n\nscopelnproc2description\nSTRING\n\n\n\n\n\nscopelnproc3\nSTRING\n\n\n70047\n\n\nscopelnproc3description\nSTRING\n\n\n\n\n\nsecondarydiagnosis1\nSTRING\n\n\n3780\n\n\nsecondarydiagnosis10\nSTRING\n\n\n3798\n\n\nsecondarydiagnosis10description\nSTRING\n\n\n\n\n\nsecondarydiagnosis1description\nSTRING\n\n\n\n\n\nsecondarydiagnosis2\nSTRING\n\n\n3782\n\n\nsecondarydiagnosis2description\nSTRING\n\n\n\n\n\nsecondarydiagnosis3\nSTRING\n\n\n3784\n\n\nsecondarydiagnosis3description\nSTRING\n\n\n\n\n\nsecondarydiagnosis4\nSTRING\n\n\n3786\n\n\nsecondarydiagnosis4description\nSTRING\n\n\n\n\n\nsecondarydiagnosis5\nSTRING\n\n\n3788\n\n\nsecondarydiagnosis5description\nSTRING\n\n\n\n\n\nsecondarydiagnosis6\nSTRING\n\n\n3790\n\n\nsecondarydiagnosis6description\nSTRING\n\n\n\n\n\nsecondarydiagnosis7\nSTRING\n\n\n3792\n\n\nsecondarydiagnosis7description\nSTRING\n\n\n\n\n\nsecondarydiagnosis8\nSTRING\n\n\n3794\n\n\nsecondarydiagnosis8description\nSTRING\n\n\n\n\n\nsecondarydiagnosis9\nSTRING\n\n\n3796\n\n\nsecondarydiagnosis9description\nSTRING\n\n\n\n\n\nseercodingsyscurrent\nSTRING\n\n\n\n\n\nseercodingsysoriginal\nSTRING\n\n\n\n\n\nseersitespecificfact1\nSTRING\n\n\n3700\n\n\nseersitespecificfact1description\nSTRING\n\n\n\n\n\nseersummarystage1977\nSTRING\n\n\n760\n\n\nseersummarystage1977description\nSTRING\n\n\n\n\n\nseersummarystage2000\nSTRING\n\n\n759\n\n\nseersummarystage2000description\nSTRING\n\n\n\n\n\nsentinellymphnodesexamined\nSTRING\n\n\n834\n\n\nsentinellymphnodesexamineddescription\nSTRING\n\n\n\n\n\nsentinellymphnodespositive\nSTRING\n\n\n835\n\n\nsentinellymphnodespositivedescription\nSTRING\n\n\n\n\n\nseparatetumornodules\nSTRING\n\n\n3929\n\n\nseparatetumornodulesdescription\nSTRING\n\n\n\n\n\nsequencenumberhospital\nSTRING\n\n\n560\n\n\nsequencenumberhospitaldescription\nSTRING\n\n\n\n\n\nserumalbuminpretreatmentlevel\nSTRING\n\n\n3930\n\n\nserumalbuminpretreatmentleveldescription\nSTRING\n\n\n\n\n\nserumbeta2microglobulinpretxlvl\nSTRING\n\n\n3931\n\n\nserumbeta2microglobulinpretxlvldescription\nSTRING\n\n\n\n\n\nsitecodingsyscurrent\nSTRING\n\n\n450\n\n\nsitecodingsyscurrentdescription\nSTRING\n\n\n\n\n\nsitecodingsysoriginal\nSTRING\n\n\n460\n\n\nsitecodingsysoriginaldescription\nSTRING\n\n\n\n\n\nsiteicdo1\nSTRING\n\n\n\n\n\nstagealternate\nSTRING\n\n\n70049\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\nstanfordbileductgenetictestingperformed\nSTRING\n\n\n10023\n\n\nstanfordbileductgenetictestingperformeddescription\nSTRING\n\n\n\n\n\nstanfordbileductgenetictestingresults\nSTRING\n\n\n10024\n\n\nstanfordbileductgenetictestingresultsdescription\nSTRING\n\n\n\n\n\nstanfordbileductgenetictestingresultstext\nSTRING\nYes\nTiDE\n10025\n\n\nstanfordbileductmsi\nSTRING\n\n\n10026\n\n\nstanfordbileductmsidescription\nSTRING\n\n\n\n\n\nstanfordbileducttumormutationalburdentmb\nSTRING\n\n\n10027\n\n\nstanforddiagnosisfacility\nSTRING\n\n\n23001\n\n\nstanforddiagnosisfacilitydescription\nSTRING\n\n\n\n\n\nstanfordmelanomabraf\nSTRING\n\n\n10022\n\n\nstanfordmelanomabrafdescription\nSTRING\n\n\n\n\n\nstanfordnonreportable\nSTRING\n\n\n\n\n\nstanfordpdl1\nSTRING\n\n\n23004\n\n\nstanfordpdl1description\nSTRING\n\n\n\n\n\nstanfordsubsequent1diagnosisfacility\nSTRING\n\n\n23015\n\n\nstanfordsubsequent1diagnosisfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent2diagnosisfacility\nSTRING\n\n\n23023\n\n\nstanfordsubsequent2diagnosisfacilitydescription\nSTRING\n\n\n\n\n\nstanfordsubsequent3diagnosisfacility\nSTRING\n\n\n23031\n\n\nstanfordsubsequent3diagnosisfacilitydescription\nSTRING\n\n\n\n\n\nsummarystage2018\nSTRING\n\n\n764\n\n\nsummarystage2018description\nSTRING\n\n\n\n\n\ntextdxproclabtests\nSTRING\nYes\nTiDE\n\n\n\ntextdxprocop\nSTRING\nYes\nTiDE\n2560\n\n\ntextdxprocpe\nSTRING\nYes\nTiDE\n2520\n\n\ntextdxprocscopes\nSTRING\nYes\nTiDE\n2540\n\n\ntexthistologytitle\nSTRING\n\n\n2590\n\n\ntextplaceofdiagnosis\nSTRING\nYes\nTiDE\n2690\n\n\ntextprimarysitetitle\nSTRING\nYes\nTiDE\n2580\n\n\ntextstaging\nSTRING\nYes\nTiDE\n2600\n\n\nthrombocytopenia\nSTRING\n\n\n3933\n\n\nthrombocytopeniadescription\nSTRING\n\n\n\n\n\ntnmclindescriptor\nSTRING\n\n\n980\n\n\ntnmclindescriptordescription\nSTRING\n\n\n\n\n\ntnmclinm\nSTRING\n\n\n960\n\n\ntnmclinmdescription\nSTRING\n\n\n\n\n\ntnmclinn\nSTRING\n\n\n950\n\n\ntnmclinndescription\nSTRING\n\n\n\n\n\ntnmclinsource\nSTRING\n\n\n23006\n\n\ntnmclinsourcedescription\nSTRING\n\n\n\n\n\ntnmclinstagedby\nSTRING\n\n\n990\n\n\ntnmclinstagedbydescription\nSTRING\n\n\n\n\n\ntnmclinstagegroup\nSTRING\n\n\n970\n\n\ntnmclinstagegroupdescription\nSTRING\n\n\n\n\n\ntnmclint\nSTRING\n\n\n940\n\n\ntnmclintdescription\nSTRING\n\n\n\n\n\ntnmeditionnumber\nSTRING\n\n\n1060\n\n\ntnmeditionnumberdescription\nSTRING\n\n\n\n\n\ntnmpathdescriptor\nSTRING\n\n\n920\n\n\ntnmpathdescriptordescription\nSTRING\n\n\n\n\n\ntnmpathm\nSTRING\n\n\n900\n\n\ntnmpathmdescription\nSTRING\n\n\n\n\n\ntnmpathn\nSTRING\n\n\n890\n\n\ntnmpathndescription\nSTRING\n\n\n\n\n\ntnmpathsource\nSTRING\n\n\n23005\n\n\ntnmpathsourcedescription\nSTRING\n\n\n\n\n\ntnmpathstagedby\nSTRING\n\n\n930\n\n\ntnmpathstagedbydescription\nSTRING\n\n\n\n\n\ntnmpathstagegroup\nSTRING\n\n\n910\n\n\ntnmpathstagegroupdescription\nSTRING\n\n\n\n\n\ntnmpatht\nSTRING\n\n\n880\n\n\ntnmpathtdescription\nSTRING\n\n\n\n\n\ntumordeposits\nSTRING\n\n\n3934\n\n\ntumordepositsdescription\nSTRING\n\n\n\n\n\ntumorgrowthpattern\nSTRING\n\n\n3935\n\n\ntumorgrowthpatterndescription\nSTRING\n\n\n\n\n\ntumormarker1\nSTRING\n\n\n1150\n\n\ntumormarker1description\nSTRING\n\n\n\n\n\ntumormarker2\nSTRING\n\n\n1160\n\n\ntumormarker2description\nSTRING\n\n\n\n\n\ntumormarker3\nSTRING\n\n\n1170\n\n\ntumormarker3description\nSTRING\n\n\n\n\n\ntumorsizeclinical\nSTRING\n\n\n752\n\n\ntumorsizeclinicaldescription\nSTRING\n\n\n\n\n\ntumorsizepathologic\nSTRING\n\n\n754\n\n\ntumorsizepathologicdescription\nSTRING\n\n\n\n\n\ntumorsizesummary\nSTRING\n\n\n756\n\n\ntumorsizesummarydescription\nSTRING\n\n\n\n\n\ntypeofreportingsource\nSTRING\n\n\n500\n\n\ntypeofreportingsourcedescription\nSTRING\n\n\n\n\n\nulceration\nSTRING\n\n\n3936\n\n\nulcerationdescription\nSTRING\n\n\n\n\n\nvisceralparietalpleuralinvasion\nSTRING\n\n\n3937\n\n\nvisceralparietalpleuralinvasiondescription\nSTRING\n\n\n\n\n\nyearfirstseen\nSTRING\n\n\n620\n\n\nyearfirstseendescription\nSTRING\n\n\n\n\n\n\n\n\n\nColumns Description\n\naccessionnumberhosp\nAccession NumberâHosp :The first four numbers specify the year and the last five numbers are the numeric order in which the patient was entered into the registry database. Within a registry, all primaries for an individual must have the same accession number. The first four digits must be greater than or equal to 1944.\n\n\nadenoidcysticbasaloidpattern\nAdenoid Cystic Basaloid Pattern\n\n\nadenopathy\nAdenopathy\n\n\nadenopathydescription\nnan\n\n\nafppostorchiectomylabvalue\nAFP Post-Orchiectomy Lab Value\n\n\nafppostorchiectomylabvaluedescription\nnan\n\n\nafppostorchiectomyrange\nAFP Post-Orchiectomy Range\n\n\nafppostorchiectomyrangedescription\nnan\n\n\nafppreorchiectomylabvalue\nAFP Pre-Orchiectomy Lab Value\n\n\nafppreorchiectomylabvaluedescription\nnan\n\n\nafppreorchiectomyrange\nAFP Pre-Orchiectomy Range\n\n\nafppreorchiectomyrangedescription\nnan\n\n\nafppretreatmentinterpretation\nAFP Pretreatment Interpretation\n\n\nafppretreatmentinterpretationdescription\nnan\n\n\nafppretreatmentlabvalue\nAFP Pretreatment Lab Value\n\n\nafppretreatmentlabvaluedescription\nnan\n\n\najccapiversioncurrent\nAJCC API Version Current\n\n\najccapiversionoriginal\nAJCC API Version Original\n\n\najcccancersurvapiversioncurrent\nAJCC Cancer Surveillance DLL Version Current\n\n\najcccancersurvapiversionoriginal\nAJCC Cancer Surveillance DLL Version Original\n\n\najccid\nAJCC ID\n\n\najcciddescription\nnan\n\n\najcctnmclinm\nAJCC TNM Clin M\n\n\najcctnmclinmdescription\nnan\n\n\najcctnmclinn\nAJCC TNM Clin N\n\n\najcctnmclinndescription\nnan\n\n\najcctnmclinnsuffix\nAJCC TNM Clin N Suffix\n\n\najcctnmclinnsuffixdescription\nnan\n\n\najcctnmclinstagegroup\nAJCC TNM Clin Stage Group\n\n\najcctnmclinstagegroupdescription\nnan\n\n\najcctnmclint\nAJCC TNM Clin T\n\n\najcctnmclintdescription\nnan\n\n\najcctnmclintsuffix\nAJCC TNM Clin T Suffix\n\n\najcctnmclintsuffixdescription\nnan\n\n\najcctnmpathm\nAJCC TNM Path M\n\n\najcctnmpathmdescription\nnan\n\n\najcctnmpathn\nAJCC TNM Path N\n\n\najcctnmpathndescription\nnan\n\n\najcctnmpathnsuffix\nAJCC TNM Path N Suffix\n\n\najcctnmpathnsuffixdescription\nnan\n\n\najcctnmpathstagegroup\nAJCC TNM Path Stage Group\n\n\najcctnmpathstagegroupdescription\nnan\n\n\najcctnmpatht\nAJCC TNM Path T\n\n\najcctnmpathtdescription\nnan\n\n\najcctnmpathtsuffix\nAJCC TNM Path T Suffix\n\n\najcctnmpathtsuffixdescription\nnan\n\n\najcctnmposttherapyclinm\nAJCC TNM Post Therapy Clin (yc) M\n\n\najcctnmposttherapyclinmdescription\nnan\n\n\najcctnmposttherapyclinn\nAJCC TNM Post Therapy Clin (yc) N\n\n\najcctnmposttherapyclinndescription\nnan\n\n\najcctnmposttherapyclinnsuffix\nAJCC TNM Post Therapy Clin (yc) N Suffix\n\n\najcctnmposttherapyclinnsuffixdescription\nnan\n\n\najcctnmposttherapyclint\nAJCC TNM Post Therapy Clin (yc) T\n\n\najcctnmposttherapyclintdescription\nnan\n\n\najcctnmposttherapym\nAJCC TNM Post Therapy Path (yp) M\n\n\najcctnmposttherapymdescription\nnan\n\n\najcctnmposttherapyn\nAJCC TNM Post Therapy Path (yp) N\n\n\najcctnmposttherapyndescription\nnan\n\n\najcctnmposttherapynsuffix\nAJCC TNM Post Therapy Path (yp) N Suffix\n\n\najcctnmposttherapynsuffixdescription\nnan\n\n\najcctnmposttherapystagegroup\nAJCC TNM Post Therapy Path (yp) Stage Group\n\n\najcctnmposttherapystagegroupdescription\nnan\n\n\najcctnmposttherapyt\nAJCC TNM Post Therapy Path (yp) T\n\n\najcctnmposttherapytdescription\nnan\n\n\najcctnmposttherapytsuffix\nAJCC TNM Post Therapy Path (yp) T Suffix\n\n\najcctnmposttherapytsuffixdescription\nnan\n\n\nalkrearrangement\nALK Rearrangement\n\n\nalkrearrangementdescription\nnan\n\n\nambiguousterminologydx\nAmbiguous Terminology DX\n\n\nambiguousterminologydxdescription\nnan\n\n\nanemia\nAnemia\n\n\nanemiadescription\nnan\n\n\nbehaviorcodeicdo3\nBehavior Code ICD-O-3\n\n\nbehaviorcodeicdo3description\nnan\n\n\nbehavioricdo2\nBehavior (92-00) ICD-O-2\n\n\nbehavioricdo2description\nnan\n\n\nbilirubinpretxtotallabvalue\nBilirubin Pretreatment Total Lab Value\n\n\nbilirubinpretxtotallabvaluedescription\nnan\n\n\nbilirubinpretxunitofmeasure\nBilirubin Pretreatment Unit of Measure\n\n\nbilirubinpretxunitofmeasuredescription\nnan\n\n\nboneinvasion\nBone Invasion\n\n\nboneinvasiondescription\nnan\n\n\nbrafmutationalanalysis\nBRAF Mutational Analysis\n\n\nbrafmutationalanalysisdescription\nnan\n\n\nbrainmolecularmarkers\nBrain Molecular Markers\n\n\nbrainmolecularmarkersdescription\nnan\n\n\nbreastmethodofdetection\nBreast Method of Detection\n\n\nbreastmethodofdetectiondescription\nnan\n\n\nbreslowtumorthickness\nBreslow Tumor Thickness\n\n\nbreslowtumorthicknessdescription\nnan\n\n\nbsymptoms\nB symptoms\n\n\nbsymptomsdescription\nnan\n\n\nca125pretreatmentinterpretation\nCA-125 Pretreatment Interpretation\n\n\nca125pretreatmentinterpretationdescription\nnan\n\n\nca199pretxlabvalue\nCA 19-9 PreTX Lab Value\n\n\nca199pretxlabvaluedescription\nnan\n\n\ncasefindingsource\nCasefinding Source\n\n\ncasefindingsourcedescription\nnan\n\n\nceapretreatmentinterpretation\nCEA Pretreatment Interpretation\n\n\nceapretreatmentinterpretationdescription\nnan\n\n\nceapretreatmentlabvalue\nCEA Pretreatment Lab Value\n\n\nceapretreatmentlabvaluedescription\nnan\n\n\nchromosome19qlossheterozygosity\nChromosome 19q: Loss of Heterozygosity (LOH)\n\n\nchromosome19qlossheterozygositydescription\nnan\n\n\nchromosome1plossheterozygosity\nChromosome 1p: Loss of Heterozygosity (LOH)\n\n\nchromosome1plossheterozygositydescription\nnan\n\n\nchromosome3status\nChromosome 3 Status\n\n\nchromosome3statusdescription\nnan\n\n\nchromosome8qstatus\nChromosome 8q Status\n\n\nchromosome8qstatusdescription\nnan\n\n\ncircumferentialresectionmargin\nCircumferential Resection Margin (CRM)\n\n\ncircumferentialresectionmargindescription\nnan\n\n\nclassofcase\nClass of Case\n\n\nclassofcasedescription\nnan\n\n\nclinicalmarginwidth\nClinical Margin Width\n\n\nclinicalmarginwidthdescription\nnan\n\n\ncocaccreditedflag\nCoC Accredited Flag\n\n\ncocaccreditedflagdescription\nnan\n\n\ncoccodingsyscurrent\nCoC Coding SysâCurrent\n\n\ncoccodingsyscurrentdescription\nnan\n\n\ncoccodingsysoriginal\nCoC Coding SysâOriginal\n\n\ncoccodingsysoriginaldescription\nnan\n\n\ncocexportflag\nCoC Export Flag\n\n\ncocexportflagdescription\nnan\n\n\ncocmeasurebreastbcsrt\nnan\n\n\ncocmeasurebreastmac\nnan\n\n\ncocmeasurecolon12rln\nnan\n\n\ncocmeasurecolonact\nnan\n\n\ncocmeasuregastricg15rln\nnan\n\n\ncocmeasurelunglct\nnan\n\n\ncocmeasurerectalrecrtct\nnan\n\n\ncodingproc\nCoding Proc\n\n\ncodingprocdescription\nnan\n\n\ncreatininepretreatmentlabvalue\nCreatinine Pretreatment Lab Value\n\n\ncreatininepretreatmentlabvaluedescription\nnan\n\n\ncreatininepretxunitofmeasure\nCreatinine Pretreatment Unit of Measure\n\n\ncreatininepretxunitofmeasuredescription\nnan\n\n\ncsextension\nCS Extension\n\n\ncsextensiondescription\nnan\n\n\ncslymphnodes\nCS Lymph Nodes\n\n\ncslymphnodesdescription\nnan\n\n\ncslymphnodeseval\nCS Lymph Nodes Eval\n\n\ncslymphnodesevaldescription\nnan\n\n\ncsmetsatdx\nCS Mets at DX\n\n\ncsmetsatdxbone\nCS Mets at Dx-Bone\n\n\ncsmetsatdxbonedescription\nnan\n\n\ncsmetsatdxbrain\nCS Mets at Dx-Brain\n\n\ncsmetsatdxbraindescription\nnan\n\n\ncsmetsatdxdescription\nnan\n\n\ncsmetsatdxliver\nCS Mets at Dx-Liver\n\n\ncsmetsatdxliverdescription\nnan\n\n\ncsmetsatdxlung\nCS Mets at Dx-Lung\n\n\ncsmetsatdxlungdescription\nnan\n\n\ncsmetseval\nCS Mets Eval\n\n\ncsmetsevaldescription\nnan\n\n\ncssitespecificfactor1\nCS Site-Specific Factor 1\n\n\ncssitespecificfactor10\nCS Site-Specific Factor10\n\n\ncssitespecificfactor10description\nnan\n\n\ncssitespecificfactor11\nCS Site-Specific Factor11\n\n\ncssitespecificfactor11description\nnan\n\n\ncssitespecificfactor12\nCS Site-Specific Factor12\n\n\ncssitespecificfactor12description\nnan\n\n\ncssitespecificfactor13\nCS Site-Specific Factor13\n\n\ncssitespecificfactor13description\nnan\n\n\ncssitespecificfactor14\nCS Site-Specific Factor14\n\n\ncssitespecificfactor14description\nnan\n\n\ncssitespecificfactor15\nCS Site-Specific Factor15\n\n\ncssitespecificfactor15description\nnan\n\n\ncssitespecificfactor16\nCS Site-Specific Factor16\n\n\ncssitespecificfactor16description\nnan\n\n\ncssitespecificfactor17\nCS Site-Specific Factor17\n\n\ncssitespecificfactor17description\nnan\n\n\ncssitespecificfactor18\nCS Site-Specific Factor18\n\n\ncssitespecificfactor18description\nnan\n\n\ncssitespecificfactor19\nCS Site-Specific Factor19\n\n\ncssitespecificfactor19description\nnan\n\n\ncssitespecificfactor1description\nnan\n\n\ncssitespecificfactor2\nCS Site-Specific Factor 2\n\n\ncssitespecificfactor20\nCS Site-Specific Factor20\n\n\ncssitespecificfactor20description\nnan\n\n\ncssitespecificfactor21\nCS Site-Specific Factor21\n\n\ncssitespecificfactor21description\nnan\n\n\ncssitespecificfactor22\nCS Site-Specific Factor22\n\n\ncssitespecificfactor22description\nnan\n\n\ncssitespecificfactor23\nCS Site-Specific Factor23\n\n\ncssitespecificfactor23description\nnan\n\n\ncssitespecificfactor24\nCS Site-Specific Factor24\n\n\ncssitespecificfactor24description\nnan\n\n\ncssitespecificfactor25\nCS Site-Specific Factor25\n\n\ncssitespecificfactor25description\nnan\n\n\ncssitespecificfactor2description\nnan\n\n\ncssitespecificfactor3\nCS Site-Specific Factor 3\n\n\ncssitespecificfactor3description\nnan\n\n\ncssitespecificfactor4\nCS Site-Specific Factor 4\n\n\ncssitespecificfactor4description\nnan\n\n\ncssitespecificfactor5\nCS Site-Specific Factor 5\n\n\ncssitespecificfactor5description\nnan\n\n\ncssitespecificfactor6\nCS Site-Specific Factor 6\n\n\ncssitespecificfactor6description\nnan\n\n\ncssitespecificfactor7\nCS Site-Specific Factor 7\n\n\ncssitespecificfactor7description\nnan\n\n\ncssitespecificfactor8\nCS Site-Specific Factor 8\n\n\ncssitespecificfactor8description\nnan\n\n\ncssitespecificfactor9\nCS Site-Specific Factor 9\n\n\ncssitespecificfactor9description\nnan\n\n\ncstumorsize\nCS Tumor Size\n\n\ncstumorsizedescription\nnan\n\n\ncstumorsizeexteval\nCS Tumor Size/Ext Eval\n\n\ncstumorsizeextevaldescription\nnan\n\n\ncsversionderived\nCS Version Derived\n\n\ncsversionderiveddescription\nnan\n\n\ncsversioninputcurrent\nCS Version Input Current\n\n\ncsversioninputcurrentdescription\nnan\n\n\ncsversioninputoriginal\nCS Version Input Original\n\n\ncsversioninputoriginaldescription\nnan\n\n\nctrreview\nCTR Review\n\n\nctrreviewdescription\nnan\n\n\ndatecaselastvalidatedcoc\nnan\n\n\ndateconclusivedx\nDate Conclusive DX\n\n\ndateconclusivedxflag\nDate Conclusive DX Flag\n\n\ndateconclusivedxflagdescription\nnan\n\n\ndateofdiagnosis\nDate of Diagnosis\n\n\ndateofdiagnosisflag\nDate Of Diagnosis Flag\n\n\ndateofmulttumors\nDate of Mult Tumors\n\n\ndateofmulttumorsflag\nDate of Mult Tumors Flag\n\n\ndateofmulttumorsflagdescription\nnan\n\n\ndateregionallndissection\nDate Regional Lymph Node Dissection\n\n\ndateregionallndissectionflag\nDate Regional Lymph Node Dissection Flag\n\n\ndateregionallndissectionflagdescription\nnan\n\n\ndatesentinellymphnodebiopsy\nDate of Sentinel Lymph Node Biopsy\n\n\ndatesentinellymphnodebiopsyflag\nDate Sentinel Lymph Node Biopsy Flag\n\n\ndatesentinellymphnodebiopsyflagdescription\nnan\n\n\nderivedajcc6m\nDerived AJCC-6 M\n\n\nderivedajcc6mdescript\nDerived AJCC-6 M Descript\n\n\nderivedajcc6mdescriptdescription\nnan\n\n\nderivedajcc6mdescription\nnan\n\n\nderivedajcc6n\nDerived AJCC-6 N\n\n\nderivedajcc6ndescript\nDerived AJCC-6 N Descript\n\n\nderivedajcc6ndescriptdescription\nnan\n\n\nderivedajcc6ndescription\nnan\n\n\nderivedajcc6stagegrp\nDerived AJCC-6 Stage Grp\n\n\nderivedajcc6stagegrpdescription\nnan\n\n\nderivedajcc6t\nDerived AJCC-6 T\n\n\nderivedajcc6tdescript\nDerived AJCC-6 T Descript\n\n\nderivedajcc6tdescriptdescription\nnan\n\n\nderivedajcc6tdescription\nnan\n\n\nderivedajcc7m\nDerived AJCC-7 M\n\n\nderivedajcc7mdescript\nDerived AJCC-7 M Descript\n\n\nderivedajcc7mdescriptdescription\nnan\n\n\nderivedajcc7mdescription\nnan\n\n\nderivedajcc7n\nDerived AJCC-7 N\n\n\nderivedajcc7ndescript\nDerived AJCC-7 N Descript\n\n\nderivedajcc7ndescriptdescription\nnan\n\n\nderivedajcc7ndescription\nnan\n\n\nderivedajcc7stagegrp\nDerived AJCC-7 Stage Grp\n\n\nderivedajcc7stagegrpdescription\nnan\n\n\nderivedajcc7t\nDerived AJCC-7 T\n\n\nderivedajcc7tdescript\nDerived AJCC-7 T Descript\n\n\nderivedajcc7tdescriptdescription\nnan\n\n\nderivedajcc7tdescription\nnan\n\n\nderivedajccflag\nDerived AJCCâFlag\n\n\nderivedajccflagdescription\nnan\n\n\nderivedeod2018m\nDerived EOD 2018 M\n\n\nderivedeod2018mdescription\nnan\n\n\nderivedeod2018n\nDerived EOD 2018 N\n\n\nderivedeod2018ndescription\nnan\n\n\nderivedeod2018stagegroup\nDerived EOD 2018 Stage Group\n\n\nderivedeod2018t\nDerived EOD 2018 T\n\n\nderivedeod2018tdescription\nnan\n\n\nderivedeodversion\nnan\n\n\nderivedraistage\nDerived Rai Stage\n\n\nderivedraistagedescription\nnan\n\n\nderivedss1977\nDerived SS1977\n\n\nderivedss1977description\nnan\n\n\nderivedss1977flag\nDerived SS1977âFlag\n\n\nderivedss1977flagdescription\nnan\n\n\nderivedss2000\nDerived SS2000\n\n\nderivedss2000description\nnan\n\n\nderivedss2000flag\nDerived SS2000âFlag\n\n\nderivedss2000flagdescription\nnan\n\n\nderivedsummarygrade2018\nDerived Summary Grade 2018\n\n\nderivedsummarystage2018\nDerived Summary Stage 2018\n\n\nderivedsummarystage2018description\nnan\n\n\ndiagnosticconfirmation\nDiagnostic Confirmation\n\n\ndiagnosticconfirmationdescription\nnan\n\n\ndiscoveredbyscreening\nDiscovered by Screening\n\n\ndiscoveredbyscreeningdescription\nnan\n\n\negfrmutationalanalysis\nEGFR Mutational Analysis\n\n\negfrmutationalanalysisdescription\nnan\n\n\neodextension\nEODâExtension\n\n\neodextensiondescription\nnan\n\n\neodextensionprostpath\nEODâExtension Prost Path\n\n\neodextensionprostpathdescription\nnan\n\n\neodlymphnodeinvolv\nEODâLymph Node Involv\n\n\neodlymphnodeinvolvdescription\nnan\n\n\neodmets\nEOD Mets\n\n\neodmetsdescription\nnan\n\n\neodprimarytumor\nEOD Primary Tumor\n\n\neodprimarytumordescription\nnan\n\n\neodregionalnodes\nEOD Regional Nodes\n\n\neodregionalnodesdescription\nnan\n\n\neodtumorsize\nEODâTumor Size\n\n\neodtumorsizedescription\nnan\n\n\nesophagusandegjtumorepicenter\nEsophagus and EGJ Tumor Epicenter\n\n\nesophagusandegjtumorepicenterdescription\nnan\n\n\nestrogenreceptorpercntposorrange\nEstrogen Receptor Percent Positive or Range\n\n\nestrogenreceptorpercntposorrangedescription\nnan\n\n\nestrogenreceptorsummary\nEstrogen Receptor Summary\n\n\nestrogenreceptorsummarydescription\nnan\n\n\nestrogenreceptortotalallredscore\nEstrogen Receptor Total Allred Score\n\n\nestrogenreceptortotalallredscoredescription\nnan\n\n\nextranodalextensionclin\nExtranodal Extension Clin (non-Head and Neck)\n\n\nextranodalextensionclindescription\nnan\n\n\nextranodalextensionheadneckclin\nExtranodal Extension Head and Neck Clinical\n\n\nextranodalextensionheadneckclindescription\nnan\n\n\nextranodalextensionheadneckpath\nExtranodal Extension Head and Neck Pathological\n\n\nextranodalextensionheadneckpathdescription\nnan\n\n\nextranodalextensionpath\nExtranodal Extension Path (non-Head and Neck)\n\n\nextranodalextensionpathdescription\nnan\n\n\nextravascularmatrixpatterns\nExtravascular Matrix Patterns\n\n\nextravascularmatrixpatternsdescription\nnan\n\n\nfibrosisscore\nFibrosis Score\n\n\nfibrosisscoredescription\nnan\n\n\nfigostage\nFIGO Stage\n\n\nfigostagedescription\nnan\n\n\nfollowupflag\nFollow-up Flag\n\n\nfollowupflagdescription\nnan\n\n\nfollowuplasttypetumor\nFollow-Up Last Type Tumor\n\n\nfollowuplasttypetumordescription\nnan\n\n\ngestationaltrophoblasticpxindex\nGestational Trophoblastic Prognostic Scoring Index\n\n\ngleasonpatternsclinical\nGleason Patterns Clinical\n\n\ngleasonpatternsclinicaldescription\nnan\n\n\ngleasonpatternspathological\nGleason Patterns Pathological\n\n\ngleasonpatternspathologicaldescription\nnan\n\n\ngleasonscoreclinical\nGleason Score Clinical\n\n\ngleasonscoreclinicaldescription\nnan\n\n\ngleasonscorepathological\nGleason Score Pathological\n\n\ngleasonscorepathologicaldescription\nnan\n\n\ngleasontertiarypattern\nGleason Tertiary Pattern\n\n\ngleasontertiarypatterndescription\nnan\n\n\ngrade\nGrade\n\n\ngradeclinical\nGrade Clinical\n\n\ngradeclinicaldescription\nnan\n\n\ngradedescription\nnan\n\n\ngradepathological\nGrade Pathological\n\n\ngradepathologicaldescription\nnan\n\n\ngradepathsystem\nGrade Path System\n\n\ngradepathsystemdescription\nnan\n\n\ngradepathvalue\nGrade Path Value\n\n\ngradepathvaluedescription\nnan\n\n\ngradeposttherapy\nGrade Post Therapy Path (yp)\n\n\ngradeposttherapyclin\nGrade Post Therapy Clin (yc)\n\n\ngradeposttherapyclindescription\nnan\n\n\ngradeposttherapydescription\nnan\n\n\nhcgpostorchiectomylabvalue\nhCG Post-Orchiectomy Lab Value\n\n\nhcgpostorchiectomylabvaluedescription\nnan\n\n\nhcgpostorchiectomyrange\nhCG Post-Orchiectomy Range\n\n\nhcgpostorchiectomyrangedescription\nnan\n\n\nhcgpreorchiectomylabvalue\nhCG Pre-Orchiectomy Lab Value\n\n\nhcgpreorchiectomylabvaluedescription\nnan\n\n\nhcgpreorchiectomyrange\nhCG Pre-Orchiectomy Range\n\n\nhcgpreorchiectomyrangedescription\nnan\n\n\nher2ihcsummary\nHER2 IHC Summary\n\n\nher2ihcsummarydescription\nnan\n\n\nher2ishdualprobecopynumber\nHER2 ISH Dual Probe Copy Number\n\n\nher2ishdualprobecopynumberdescription\nnan\n\n\nher2ishdualproberatio\nHER2 ISH Dual Probe Ratio\n\n\nher2ishdualproberatiodescription\nnan\n\n\nher2ishsingleprobecopynumber\nHER2 ISH Single Probe Copy Number\n\n\nher2ishsingleprobecopynumberdescription\nnan\n\n\nher2ishsummary\nHER2 ISH Summary\n\n\nher2ishsummarydescription\nnan\n\n\nher2overallsummary\nHER2 Overall Summary\n\n\nher2overallsummarydescription\nnan\n\n\nheritabletrait\nHeritable Trait\n\n\nheritabletraitdescription\nnan\n\n\nhighriskcytogenetics\nHigh Risk Cytogenetics\n\n\nhighriskcytogeneticsdescription\nnan\n\n\nhighriskhistologicfeatures\nHigh Risk Histologic Features\n\n\nhighriskhistologicfeaturesdescription\nnan\n\n\nhistologicsubtype\nHistologic Subtype\n\n\nhistologicsubtypedescription\nnan\n\n\nhistologictypeicdo3\nHistologic Type ICD-O-3\n\n\nhistologictypeicdo3description\nnan\n\n\nhistologyicdo2\nHistology (92-00) ICD-O-2\n\n\nhistologyicdo2description\nnan\n\n\nhivstatus\nHIV Status\n\n\nhivstatusdescription\nnan\n\n\nhospitaltumornumberccr\nHospital Tumor Number CCR\n\n\nhospitaltumornumberccrdescription\nnan\n\n\nicdo3conversionflag\nICD-O-3 Conversion Flag\n\n\nicdo3conversionflagdescription\nnan\n\n\ninrprothrombintime\nInternational Normalized Ratio Prothrombin Time\n\n\ninrprothrombintimedescription\nnan\n\n\ninvasionbeyondcapsule\nInvasion Beyond Capsule\n\n\ninvasionbeyondcapsuledescription\nnan\n\n\nipsilateraladrenalglandinvolve\nIpsilateral Adrenal Gland Involvement\n\n\nipsilateraladrenalglandinvolvedescription\nnan\n\n\njak2\nJAK2:Janus Kinase 2 (JAK2, JAK 2) is a gene mutation\n\n\njak2description\nnan\n\n\nki67\nKi-67\n\n\nki67description\nnan\n\n\nkitgeneimmunohistochemistry\nKIT Gene Immunohistochemistry\n\n\nkitgeneimmunohistochemistrydescription\nnan\n\n\nkras\nKRAS\n\n\nkrasdescription\nnan\n\n\nlaterality\nLaterality\n\n\nlateralitydescription\nnan\n\n\nldhpostorchiectomyrange\nLDH Post-Orchiectomy Range\n\n\nldhpostorchiectomyrangedescription\nnan\n\n\nldhpreorchiectomyrange\nLDH Pre-Orchiectomy Range\n\n\nldhpreorchiectomyrangedescription\nnan\n\n\nldhpretreatmentlabvalue\nLDH Lab Value\n\n\nldhpretreatmentlabvaluedescription\nnan\n\n\nldhpretreatmentlevel\nLDH Level\n\n\nldhpretreatmentleveldescription\nnan\n\n\nldhupperlimitsofnormal\nLDH Upper Limits of Normal\n\n\nldhupperlimitsofnormaldescription\nnan\n\n\nlnassessmethodfemoralinguinal\nLN Assessment Method Femoral-Inguinal\n\n\nlnassessmethodfemoralinguinaldescription\nnan\n\n\nlnassessmethodparaaortic\nLN Assessment Method Para-Aortic\n\n\nlnassessmethodparaaorticdescription\nnan\n\n\nlnassessmethodpelvic\nLN Assessment Method Pelvic\n\n\nlnassessmethodpelvicdescription\nnan\n\n\nlndistantassessmethod\nLN Distant Assessment Method\n\n\nlndistantassessmethoddescription\nnan\n\n\nlndistantmediastinalscalene\nLN Distant: Mediastinal, Scalene\n\n\nlndistantmediastinalscalenedescription\nnan\n\n\nlnheadandnecklevels1to3\nLN Head and Neck Levels I-III\n\n\nlnheadandnecklevels1to3description\nnan\n\n\nlnheadandnecklevels4to5\nLN Head and Neck Levels IV-V\n\n\nlnheadandnecklevels4to5description\nnan\n\n\nlnheadandnecklevels6to7\nLN Head and Neck Levels VI-VII\n\n\nlnheadandnecklevels6to7description\nnan\n\n\nlnheadandneckother\nLN Head and Neck Other\n\n\nlnheadandneckotherdescription\nnan\n\n\nlnisolatedtumorcells\nLN Isolated Tumor Cells (ITC)\n\n\nlnisolatedtumorcellsdescription\nnan\n\n\nlnlaterality\nLN Laterality\n\n\nlnlateralitydescription\nnan\n\n\nlnpositiveaxillarylevel1to2\nLN Positive Axillary Level I-II\n\n\nlnpositiveaxillarylevel1to2description\nnan\n\n\nlnsize\nLN Size\n\n\nlnsizedescription\nnan\n\n\nlnstatusfemoralinguinal\nLN Status Femoral-Inguinal\n\n\nlnstatusfemoralinguinaldescription\nnan\n\n\nlnstatusfemoringuinparaaortpelv\nLN Status Femoral-Inguinal, Para-Aortic, Pelvic\n\n\nlnstatusfemoringuinparaaortpelvdescription\nnan\n\n\nlnstatusparaaortic\nLN Status Para-Aortic\n\n\nlnstatusparaaorticdescription\nnan\n\n\nlnstatuspelvic\nLN Status Pelvic\n\n\nlnstatuspelvicdescription\nnan\n\n\nlymphocytosis\nLymphocytosis\n\n\nlymphocytosisdescription\nnan\n\n\nlymphvascularinvasion\nLymphovascular Invasion\n\n\nlymphvascularinvasiondescription\nnan\n\n\nmacroscopicevalofthemesorectum\nMacroscopic Evaluation of Mesorectum\n\n\nmacroscopicevalofthemesorectumdescription\nnan\n\n\nmajorveininvolvement\nMajor Vein Involvement\n\n\nmajorveininvolvementdescription\nnan\n\n\nmeasuredbasaldiameter\nMeasured Basal Diameter\n\n\nmeasuredbasaldiameterdescription\nnan\n\n\nmeasuredthickness\nMeasured Thickness\n\n\nmeasuredthicknessdescription\nnan\n\n\nmethylationofo6mgmt\nMethylation of O6-Methylguanine-Methyltransferase\n\n\nmethylationofo6mgmtdescription\nnan\n\n\nmetsatdxbone\nMets at DX-Bone\n\n\nmetsatdxbonedescription\nnan\n\n\nmetsatdxbrain\nMets at DX-Brain\n\n\nmetsatdxbraindescription\nnan\n\n\nmetsatdxdistantln\nMets at Dx-Distant LN\n\n\nmetsatdxdistantlndescription\nnan\n\n\nmetsatdxliver\nMets at DX-Liver\n\n\nmetsatdxliverdescription\nnan\n\n\nmetsatdxlung\nMets at DX-Lung\n\n\nmetsatdxlungdescription\nnan\n\n\nmetsatdxother\nMets at DX-Other\n\n\nmetsatdxotherdescription\nnan\n\n\nmicrosatelliteinstability\nMicrosatellite Instability (MSI)\n\n\nmicrosatelliteinstabilitydescription\nnan\n\n\nmicrovasculardensity\nMicrovascular Density\n\n\nmicrovasculardensitydescription\nnan\n\n\nmitoticcountuvealmelanoma\nMitotic Count Uveal Melanoma\n\n\nmitoticcountuvealmelanomadescription\nnan\n\n\nmitoticratemelanoma\nMitotic Rate Melanoma\n\n\nmitoticratemelanomadescription\nnan\n\n\nmorphcodingsyscurrent\nMorph Coding SysâCurrent\n\n\nmorphcodingsyscurrentdescription\nnan\n\n\nmorphcodingsysoriginl\nMorph Coding SysâOriginl\n\n\nmorphcodingsysoriginldescription\nnan\n\n\nmorphtypebehavicdo2\nnan\n\n\nmorphtypebehavicdo2description\nnan\n\n\nmorphtypebehavicdo3\nnan\n\n\nmorphtypebehavicdo3description\nnan\n\n\nmultigenesignaturemethod\nMultigene Signature Method\n\n\nmultigenesignaturemethoddescription\nnan\n\n\nmultigenesignatureresults\nMultigene Signature Results\n\n\nmultigenesignatureresultsdescription\nnan\n\n\nmultiplicitycounter\nMultiplicity Counter\n\n\nmultiplicitycounterdescription\nnan\n\n\nmulttumrptasoneprim\nMult Tum Rpt as One Prim\n\n\nmulttumrptasoneprimdescription\nnan\n\n\nnccninternationalprognosticindex\nNCCN International Prognostic Index (IPI)\n\n\nnccninternationalprognosticindexdescription\nnan\n\n\nnfcasestatus\nnan\n\n\nnfcaseentityid\nUnique number corresponding to every new neural frame âcaseâ or event\n\n\nnfcasestatus\nnan\n\n\nnffacilityid\nNF Facility ID\n\n\nnffacilityiddescription\nnan\n\n\nnfpatientsetid\nnan\n\n\nnpcrderivedajcc8tnmclinstggrp\nNPCR Derived AJCC 8 TNM Clin Stg Grp\n\n\nnpcrderivedajcc8tnmclinstggrpdescription\nnan\n\n\nnpcrderivedajcc8tnmpathstggrp\nNPCR Derived AJCC 8 TNM Path Stg Grp\n\n\nnpcrderivedajcc8tnmpathstggrpdescription\nnan\n\n\nnpcrderivedajcc8tnmpoststggrp\nNPCR Derived AJCC 8 TNM Post Therapy Stg Grp\n\n\nnpcrderivedajcc8tnmpoststggrpdescription\nnan\n\n\nnrasmutationalanalysis\nNRAS Mutational Analysis\n\n\nnrasmutationalanalysisdescription\nnan\n\n\nnumberofcoresexamined\nNumber of Cores Examined\n\n\nnumberofcoresexamineddescription\nnan\n\n\nnumberofcorespositive\nNumber of Cores Positive\n\n\nnumberofcorespositivedescription\nnan\n\n\nnumberofexaminedparaaorticnodes\nNumber of Examined Para-Aortic Nodes\n\n\nnumberofexaminedparaaorticnodesdescription\nnan\n\n\nnumberofexaminedpelvicnodes\nNumber of Examined Pelvic Nodes\n\n\nnumberofexaminedpelvicnodesdescription\nnan\n\n\nnumberofpositiveparaaorticnodes\nNumber of Positive Para-Aortic Nodes\n\n\nnumberofpositiveparaaorticnodesdescription\nnan\n\n\nnumberofpositivepelvicnodes\nNumber of Positive Pelvic Nodes\n\n\nnumberofpositivepelvicnodesdescription\nnan\n\n\noncotypedxrecurrencescoredcis\nOncotype Dx Recurrence Score-DCIS\n\n\noncotypedxrecurrencescoredcisdescription\nnan\n\n\noncotypedxrecurrencescoreinvasiv\nOncotype Dx Recurrence Score-Invasive\n\n\noncotypedxrecurrencescoreinvasivdescription\nnan\n\n\noncotypedxriskleveldcis\nOncotype Dx Risk Level-DCIS\n\n\noncotypedxriskleveldcisdescription\nnan\n\n\noncotypedxrisklevelinvasive\nOncotype Dx Risk Level-Invasive\n\n\noncotypedxrisklevelinvasivedescription\nnan\n\n\norganomegaly\nOrganomegaly\n\n\norganomegalydescription\nnan\n\n\noverrideadmisdx\nOver-ride Admis DX\n\n\noverrideadmisdxdescription\nnan\n\n\noverridesitestage\nOver-ride Site Stage\n\n\noverridesitestagedescription\nnan\n\n\noverridesitetnmstggrp\nOver-ride Site/TNM-StgGrp\n\n\noverridesitetnmstggrpdescription\nnan\n\n\noverridesstnmm\nOver-ride SS/TNM-M\n\n\noverridesstnmmdescription\nnan\n\n\noverridesstnmn\nOver-ride SS/TNM-N\n\n\noverridesstnmndescription\nnan\n\n\noverridetnm3\nOver-ride TNM 3\n\n\noverridetnm3description\nnan\n\n\noverridetnmstage\nOver-ride TNM Stage\n\n\noverridetnmstagedescription\nnan\n\n\noverridetnmtis\nOver-ride TNM Tis\n\n\noverridetnmtisdescription\nnan\n\n\np16\np16:p16 biomarker is over-expressed (produced) in response to HPV.\n\n\np16description\nnan\n\n\npathdatespeccollect1\nPath Date Spec Collect 1\n\n\npathdatespeccollect2\nPath Date Spec Collect 2\n\n\npathdatespeccollect3\nPath Date Spec Collect 3\n\n\npathdatespeccollect4\nPath Date Spec Collect 4\n\n\npathdatespeccollect5\nPath Date Spec Collect 5\n\n\npathorderingfacno1\nPath Ordering Fac No 1\n\n\npathorderingfacno1description\nnan\n\n\npathorderingfacno2\nPath Ordering Fac No 2\n\n\npathorderingfacno2description\nnan\n\n\npathorderingfacno3\nPath Ordering Fac No 3\n\n\npathorderingfacno3description\nnan\n\n\npathorderingfacno4\nPath Ordering Fac No 4\n\n\npathorderingfacno4description\nnan\n\n\npathorderingfacno5\nPath Ordering Fac No 5\n\n\npathorderingfacno5description\nnan\n\n\npathorderphyslicno1\nPath Order Phys Lic No 1\n\n\npathorderphyslicno2\nPath Order Phys Lic No 2\n\n\npathorderphyslicno3\nPath Order Phys Lic No 3\n\n\npathorderphyslicno4\nPath Order Phys Lic No 4\n\n\npathorderphyslicno5\nPath Order Phys Lic No 5\n\n\npathreportingfacid1\nPath Reporting Fac ID 1\n\n\npathreportingfacid1description\nnan\n\n\npathreportingfacid2\nPath Reporting Fac ID 2\n\n\npathreportingfacid2description\nnan\n\n\npathreportingfacid3\nPath Reporting Fac ID 3\n\n\npathreportingfacid3description\nnan\n\n\npathreportingfacid4\nPath Reporting Fac ID 4\n\n\npathreportingfacid4description\nnan\n\n\npathreportingfacid5\nPath Reporting Fac ID 5\n\n\npathreportingfacid5description\nnan\n\n\npathreportnumber1\nPath Report Number 1\n\n\npathreportnumber2\nPath Report Number 2\n\n\npathreportnumber3\nPath Report Number 3\n\n\npathreportnumber4\nPath Report Number 4\n\n\npathreportnumber5\nPath Report Number 5\n\n\npathreporttype1\nPath Report Type 1\n\n\npathreporttype1description\nnan\n\n\npathreporttype2\nPath Report Type 2\n\n\npathreporttype2description\nnan\n\n\npathreporttype3\nPath Report Type 3\n\n\npathreporttype3description\nnan\n\n\npathreporttype4\nPath Report Type 4\n\n\npathreporttype4description\nnan\n\n\npathreporttype5\nPath Report Type 5\n\n\npathreporttype5description\nnan\n\n\npediatricstage\nPediatric Stage\n\n\npediatricstagedby\nPediatric Staged By\n\n\npediatricstagedbydescription\nnan\n\n\npediatricstagedescription\nnan\n\n\npediatricstagingsystem\nPediatric Staging System\n\n\npediatricstagingsystemdescription\nnan\n\n\npercentnecrosispostneoadjuvant\nPercent Necrosis Post Neoadjuvant\n\n\npercentnecrosispostneoadjuvantdescription\nnan\n\n\nperineuralinvasion\nPerineural Invasion\n\n\nperineuralinvasiondescription\nnan\n\n\nperipheralbloodinvolvement\nPeripheral Blood Involvement\n\n\nperipheralbloodinvolvementdescription\nnan\n\n\nperitonealcytology\nPeritoneal Cytology\n\n\nperitonealcytologydescription\nnan\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\npleuraleffusion\nPleural Effusion\n\n\npleuraleffusiondescription\nnan\n\n\nprimarydiagnosis\nnan\n\n\nprimarysclerosingcholangitis\nPrimary Sclerosing Cholangitis\n\n\nprimarysclerosingcholangitisdescription\nnan\n\n\nprimarysite\nPrimary Site\n\n\nprimarysitedescription\nnan\n\n\nprofoundimmunesuppression\nProfound Immune Suppression\n\n\nprofoundimmunesuppressiondescription\nnan\n\n\nprogesteronerecepprcntposorrange\nProgesterone Receptor Percent Positive or Range\n\n\nprogesteronerecepprcntposorrangedescription\nnan\n\n\nprogesteronerecepsummary\nProgesterone Receptor Summary\n\n\nprogesteronerecepsummarydescription\nnan\n\n\nprogesteronereceptotalallredscor\nProgesterone Receptor Total Allred Score\n\n\nprogesteronereceptotalallredscordescription\nnan\n\n\nprostatepathologicalextension\nEOD Prostate Pathologic Extension\n\n\nprostatepathologicalextensiondescription\nnan\n\n\nprotocolparticipation\nProtocol Participation\n\n\nprotocolparticipationdescription\nnan\n\n\npsalabvalue\nPSA (Prostatic Specific Antigen) Lab Value\n\n\npsalabvaluedescription\nnan\n\n\nregionalnodesexamined\nRegional Nodes Examined\n\n\nregionalnodesexamineddescription\nnan\n\n\nregionalnodespositive\nRegional Nodes Positive\n\n\nregionalnodespositivedescription\nnan\n\n\nresidualtumvolpostcytoreduction\nResidual Tumor Volume Post Cytoreduction\n\n\nresidualtumvolpostcytoreductiondescription\nnan\n\n\nresponsetoneoadjuvanttherapy\nResponse to Neoadjuvant Therapy\n\n\nresponsetoneoadjuvanttherapydescription\nnan\n\n\nrxdatedxstgproc\nRX Date DX/Stg Proc\n\n\nrxdatedxstgprocflag\nRx Date Dx/Stg Proc Flag\n\n\nrxdatedxstgprocflagdescription\nnan\n\n\nrxhospdxstgproc\nRX HospâDX/Stg Proc\n\n\nrxhospdxstgprocdescription\nnan\n\n\nrxsummdxstgproc\nRX SummâDX/Stg Proc\n\n\nrxsummdxstgprocdescription\nnan\n\n\nsarcomatoidfeatures\nSarcomatoid Features\n\n\nsarcomatoidfeaturesdescription\nnan\n\n\nscategoryclinical\nS Category Clinical\n\n\nscategoryclinicaldescription\nnan\n\n\nscategorypathological\nS Category Pathological\n\n\nscategorypathologicaldescription\nnan\n\n\nschema\nSite Specific Schema\n\n\nschemadiscriminator1\nSchema Discriminator 1\n\n\nschemadiscriminator1description\nnan\n\n\nschemadiscriminator2\nSchema Discriminator 2\n\n\nschemadiscriminator2description\nnan\n\n\nschemaid\nSchema ID\n\n\nschemaiddescription\nnan\n\n\nschemaidversioncurrent\nSchema ID Version Current\n\n\nschemaidversioncurrentdescription\nnan\n\n\nschemaidversionoriginal\nSchema ID Version Original\n\n\nschemaidversionoriginaldescription\nnan\n\n\nscopelnproc1\nScope LN Proc 1\n\n\nscopelnproc1description\nnan\n\n\nscopelnproc2\nScope LN Proc 2\n\n\nscopelnproc2description\nnan\n\n\nscopelnproc3\nScope LN Proc 3\n\n\nscopelnproc3description\nnan\n\n\nsecondarydiagnosis1\nSecondary Diagnosis 1\n\n\nsecondarydiagnosis10\nSecondary Diagnosis 10\n\n\nsecondarydiagnosis10description\nnan\n\n\nsecondarydiagnosis1description\nnan\n\n\nsecondarydiagnosis2\nSecondary Diagnosis 2\n\n\nsecondarydiagnosis2description\nnan\n\n\nsecondarydiagnosis3\nSecondary Diagnosis 3\n\n\nsecondarydiagnosis3description\nnan\n\n\nsecondarydiagnosis4\nSecondary Diagnosis 4\n\n\nsecondarydiagnosis4description\nnan\n\n\nsecondarydiagnosis5\nSecondary Diagnosis 5\n\n\nsecondarydiagnosis5description\nnan\n\n\nsecondarydiagnosis6\nSecondary Diagnosis 6\n\n\nsecondarydiagnosis6description\nnan\n\n\nsecondarydiagnosis7\nSecondary Diagnosis 7\n\n\nsecondarydiagnosis7description\nnan\n\n\nsecondarydiagnosis8\nSecondary Diagnosis 8\n\n\nsecondarydiagnosis8description\nnan\n\n\nsecondarydiagnosis9\nSecondary Diagnosis 9\n\n\nsecondarydiagnosis9description\nnan\n\n\nseercodingsyscurrent\nnan\n\n\nseercodingsysoriginal\nnan\n\n\nseersitespecificfact1\nSEER Site-Specific Fact 1\n\n\nseersitespecificfact1description\nnan\n\n\nseersummarystage1977\nSEER Summary Stage 1977\n\n\nseersummarystage1977description\nnan\n\n\nseersummarystage2000\nSEER Summary Stage 2000\n\n\nseersummarystage2000description\nnan\n\n\nsentinellymphnodesexamined\nSentinel Lymph Nodes Examined\n\n\nsentinellymphnodesexamineddescription\nnan\n\n\nsentinellymphnodespositive\nSentinel Lymph Nodes Positive\n\n\nsentinellymphnodespositivedescription\nnan\n\n\nseparatetumornodules\nSeparate Tumor Nodules\n\n\nseparatetumornodulesdescription\nnan\n\n\nsequencenumberhospital\nSequence NumberâHospital\n\n\nsequencenumberhospitaldescription\nnan\n\n\nserumalbuminpretreatmentlevel\nSerum Albumin Pretreatment Level\n\n\nserumalbuminpretreatmentleveldescription\nnan\n\n\nserumbeta2microglobulinpretxlvl\nSerum Beta-2 Microglobulin Pretreatment Level\n\n\nserumbeta2microglobulinpretxlvldescription\nnan\n\n\nsitecodingsyscurrent\nSite Coding SysâCurrent\n\n\nsitecodingsyscurrentdescription\nnan\n\n\nsitecodingsysoriginal\nSite Coding SysâOriginal\n\n\nsitecodingsysoriginaldescription\nnan\n\n\nsiteicdo1\nnan\n\n\nstagealternate\nStage Alternate\n\n\nstanford_patient_uid\nInternal Stanford tracking ID for Neural frame (this is the patientâs MRN | DOB)\n\n\nstanfordbileductgenetictestingperformed\nStanford Bile Duct Genetic Testing Performed\n\n\nstanfordbileductgenetictestingperformeddescription\nnan\n\n\nstanfordbileductgenetictestingresults\nStanford Bile Duct Genetic Testing Results\n\n\nstanfordbileductgenetictestingresultsdescription\nnan\n\n\nstanfordbileductgenetictestingresultstext\nStanford Bile Duct Genetic Testing Results Text\n\n\nstanfordbileductmsi\nStanford Bile Duct MSI\n\n\nstanfordbileductmsidescription\nnan\n\n\nstanfordbileducttumormutationalburdentmb\nStanford Bile Duct Tumor Mutational Burden (TMB)\n\n\nstanforddiagnosisfacility\nStanford Diagnosis Facility\n\n\nstanforddiagnosisfacilitydescription\nnan\n\n\nstanfordmelanomabraf\nStanford Melanoma BRAF\n\n\nstanfordmelanomabrafdescription\nnan\n\n\nstanfordnonreportable\nnan\n\n\nstanfordpdl1\nStanford PdL1 (Lung)\n\n\nstanfordpdl1description\nnan\n\n\nstanfordsubsequent1diagnosisfacility\nStanford Subsequent 1 Diagnosis Facility\n\n\nstanfordsubsequent1diagnosisfacilitydescription\nnan\n\n\nstanfordsubsequent2diagnosisfacility\nStanford Subsequent 2 Diagnosis Facility\n\n\nstanfordsubsequent2diagnosisfacilitydescription\nnan\n\n\nstanfordsubsequent3diagnosisfacility\nStanford Subsequent 3 Diagnosis Facility\n\n\nstanfordsubsequent3diagnosisfacilitydescription\nnan\n\n\nsummarystage2018\nSummary Stage 2018\n\n\nsummarystage2018description\nnan\n\n\ntextdxproclabtests\nTextâDX ProcâLab Tests\n\n\ntextdxprocop\nTextâDX ProcâOp\n\n\ntextdxprocpe\nTextâDX ProcâPE\n\n\ntextdxprocscopes\nTextâDX ProcâScopes\n\n\ntexthistologytitle\nTextâHistology Title\n\n\ntextplaceofdiagnosis\nTextâPlace of Diagnosis\n\n\ntextprimarysitetitle\nTextâPrimary Site Title\n\n\ntextstaging\nTextâStaging\n\n\nthrombocytopenia\nThrombocytopenia\n\n\nthrombocytopeniadescription\nnan\n\n\ntnmclindescriptor\nTNM Clin Descriptor\n\n\ntnmclindescriptordescription\nnan\n\n\ntnmclinm\nTNM Clin M\n\n\ntnmclinmdescription\nnan\n\n\ntnmclinn\nTNM Clin N\n\n\ntnmclinndescription\nnan\n\n\ntnmclinsource\nTNM Clin Source\n\n\ntnmclinsourcedescription\nnan\n\n\ntnmclinstagedby\nTNM Clin Staged By\n\n\ntnmclinstagedbydescription\nnan\n\n\ntnmclinstagegroup\nTNM Clin Stage Group\n\n\ntnmclinstagegroupdescription\nnan\n\n\ntnmclint\nTNM Clin T\n\n\ntnmclintdescription\nnan\n\n\ntnmeditionnumber\nTNM Edition Number\n\n\ntnmeditionnumberdescription\nnan\n\n\ntnmpathdescriptor\nTNM Path Descriptor\n\n\ntnmpathdescriptordescription\nnan\n\n\ntnmpathm\nTNM Path M\n\n\ntnmpathmdescription\nnan\n\n\ntnmpathn\nTNM Path N\n\n\ntnmpathndescription\nnan\n\n\ntnmpathsource\nTNM Path Source\n\n\ntnmpathsourcedescription\nnan\n\n\ntnmpathstagedby\nTNM Path Staged By\n\n\ntnmpathstagedbydescription\nnan\n\n\ntnmpathstagegroup\nTNM Path Stage Group\n\n\ntnmpathstagegroupdescription\nnan\n\n\ntnmpatht\nTNM Path T\n\n\ntnmpathtdescription\nnan\n\n\ntumordeposits\nTumor Deposits\n\n\ntumordepositsdescription\nnan\n\n\ntumorgrowthpattern\nTumor Growth Pattern\n\n\ntumorgrowthpatterndescription\nnan\n\n\ntumormarker1\nTumor Marker 1\n\n\ntumormarker1description\nnan\n\n\ntumormarker2\nTumor Marker 2\n\n\ntumormarker2description\nnan\n\n\ntumormarker3\nTumor Marker 3\n\n\ntumormarker3description\nnan\n\n\ntumorsizeclinical\nTumor Size Clinical\n\n\ntumorsizeclinicaldescription\nnan\n\n\ntumorsizepathologic\nTumor Size Pathologic\n\n\ntumorsizepathologicdescription\nnan\n\n\ntumorsizesummary\nTumor Size Summary\n\n\ntumorsizesummarydescription\nnan\n\n\ntypeofreportingsource\nType of Reporting Source\n\n\ntypeofreportingsourcedescription\nnan\n\n\nulceration\nUlceration\n\n\nulcerationdescription\nnan\n\n\nvisceralparietalpleuralinvasion\nVisceral and Parietal Pleural Invasion\n\n\nvisceralparietalpleuralinvasiondescription\nnan\n\n\nyearfirstseen\nYear First Seen\n\n\nyearfirstseendescription\nnan\n\n\nstanford_patient_uid\nInternal Stanford tracking ID for Neural frame",
    "crumbs": [
      "About",
      "Data Dictionary",
      "NeuralFrame",
      "NeuralFrame Case Diagnoses"
    ]
  },
  {
    "objectID": "neuralframe_data_dict/case_outcomes.html",
    "href": "neuralframe_data_dict/case_outcomes.html",
    "title": "NeuralFrame Case Outcomes",
    "section": "",
    "text": "The table onc_neuralframe_case_outcomes includes information related to patient outcomes, such as survival rates, disease progression, and overall health status.\n\nTable Columns\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\nnaaccr number\n\n\n\n\nautopsy\nSTRING\n\n\n1930\n\n\nautopsydescription\nSTRING\n\n\n\n\n\ncancerstatus\nSTRING\n\n\n1770\n\n\ncancerstatusdescription\nSTRING\n\n\n\n\n\ncauseofdeath\nSTRING\n\n\n1910\n\n\ncauseofdeathdescription\nSTRING\n\n\n\n\n\ndate1stcrsrxcoc\nSTRING\nYes\nJitter\n1270\n\n\ndate1stcrsrxcocflag\nSTRING\n\n\n1271\n\n\ndate1stcrsrxcocflagdescription\nSTRING\n\n\n\n\n\ndateabstracted\nSTRING\nYes\nJitter\n12003\n\n\ndatecasecompleted\nSTRING\nYes\nJitter\n2090\n\n\ndatecasecompletedcoc\nSTRING\nYes\nJitter\n2092\n\n\ndatecasefirstcompleted\nSTRING\nYes\nJitter\n12001\n\n\ndatecaseinitiated\nSTRING\nYes\nJitter\n2085\n\n\ndatecaselastchanged\nSTRING\nYes\nJitter\n2100\n\n\ndatecaselastvalidated\nSTRING\nYes\nJitter\n12000\n\n\ndatecasereportexported\nSTRING\nYes\nJitter\n2110\n\n\ndatecasereportexportedcoc\nSTRING\nYes\nJitter\n50074\n\n\ndatecasereportfirstexported\nSTRING\nYes\nJitter\n12010\n\n\ndatecasereportfirstexportedcoc\nSTRING\nYes\nJitter\n50081\n\n\ndatefirstpositivebx\nSTRING\nYes\nJitter\n10070\n\n\ndateinitialrxseer\nSTRING\nYes\nJitter\n1260\n\n\ndateinitialrxseerflag\nSTRING\n\n\n1261\n\n\ndateinitialrxseerflagdescription\nSTRING\n\n\n\n\n\ndatekaciintegratedcasefindingadded\nSTRING\nYes\nJitter\n43210\n\n\ndatekaciintegratedfollowupupdated\nSTRING\nYes\nJitter\n22325\n\n\ndatenorxdecision\nSTRING\nYes\nJitter\n10072\n\n\ndateof1stcontact\nSTRING\nYes\nJitter\n580\n\n\ndateof1stcontactflag\nSTRING\n\n\n581\n\n\ndateof1stcontactflagdescription\nSTRING\n\n\n\n\n\ndateofinptadm\nSTRING\nYes\nJitter\n590\n\n\ndateofinptadmflag\nSTRING\n\n\n591\n\n\ndateofinptadmflagdescription\nSTRING\n\n\n\n\n\ndateofinptdisch\nSTRING\nYes\nJitter\n600\n\n\ndateofinptdischflag\nSTRING\n\n\n601\n\n\ndateofinptdischflagdescription\nSTRING\n\n\n\n\n\ndateoflastcancerstatus\nSTRING\nYes\nJitter\n1772\n\n\ndateoflastcancerstatusflag\nSTRING\n\n\n1773\n\n\ndateoflastcancerstatusflagdescription\nSTRING\n\n\n\n\n\ndateoflastcontact\nSTRING\nYes\nJitter\n1750\n\n\ndateoflastcontactflag\nSTRING\n\n\n1751\n\n\ndateoflastcontactflagdescription\nSTRING\n\n\n\n\n\neventcoursenumber\nSTRING\n\n\n100002\n\n\neventcoursenumberdescription\nSTRING\n\n\n\n\n\nfollowingregistry\nSTRING\n\n\n\n\n\nfollowupcontactcountry\nSTRING\n\n\n\n\n\nfollowupflag\nSTRING\n\n\n70009\n\n\nfollowupflagdescription\nSTRING\n\n\n\n\n\nfollowupoutcomestext\nSTRING\nYes\nTiDE\n12121\n\n\nfollowupsource\nSTRING\n\n\n1790\n\n\nfollowupsourcedescription\nSTRING\n\n\n\n\n\nicdrevisionnumber\nSTRING\n\n\n1920\n\n\nicdrevisionnumberdescription\nSTRING\n\n\n\n\n\ninpatientstatus\nSTRING\n\n\n605\n\n\ninpatientstatusdescription\nSTRING\n\n\n\n\n\ninstitutionreferredfrom\nSTRING\n\n\n2410\n\n\ninstitutionreferredfromdescription\nSTRING\n\n\n\n\n\ninstitutionreferredto\nSTRING\n\n\n2420\n\n\ninstitutionreferredtodescription\nSTRING\n\n\n\n\n\nlastfollowuphospital\nSTRING\n\n\n2430\n\n\nlpchrefractoryleukemia\nSTRING\n\n\n10031\n\n\nlpchrefractoryleukemiadescription\nSTRING\n\n\n\n\n\nncdbcovid19tximpact\nSTRING\n\n\n3946\n\n\nncdbcovid19tximpactdescription\nSTRING\n\n\n\n\n\nncdbsarscov2pos\nSTRING\n\n\n3944\n\n\nncdbsarscov2posdate\nSTRING\nYes\nJitter\n3945\n\n\nncdbsarscov2posdescription\nSTRING\n\n\n\n\n\nncdbsarscov2test\nSTRING\n\n\n3943\n\n\nncdbsarscov2testdescription\nSTRING\n\n\n\n\n\nnextfollowupsource\nSTRING\n\n\n1800\n\n\nnextfollowupsourcedescription\nSTRING\n\n\n\n\n\nnfcaseentityid\nSTRING\nYes\nStable Between Data Refreshes\n\n\n\nnfcasestatus\nSTRING\n\n\n\n\n\nnffacilityid\nSTRING\n\n\n50078\n\n\nnffacilityiddescription\nSTRING\n\n\n\n\n\nperson_id\nINTEGER\nYes\nStable Between Data Refreshes\n\n\n\nplaceofdeath\nSTRING\nYes\nDel\n\n\n\nplaceofdeathcountry\nSTRING\n\n\n1944\n\n\nplaceofdeathcountrydescription\nSTRING\n\n\n\n\n\nplaceofdeathstate\nSTRING\n\n\n1942\n\n\nplaceofdeathstatedescription\nSTRING\n\n\n\n\n\nqualityofsurvival\nSTRING\n\n\n\n\n\nrecurrencedate1st\nSTRING\nYes\nJitter\n1860\n\n\nrecurrencedate1stflag\nSTRING\n\n\n1861\n\n\nrecurrencedate1stflagdescription\nSTRING\n\n\n\n\n\nrecurrencetype1st\nSTRING\n\n\n1880\n\n\nrecurrencetype1stdescription\nSTRING\n\n\n\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\n\nvitalstatus\nSTRING\n\n\n1760\n\n\nvitalstatusdescription\nSTRING\n\n\n\n\n\nvitalstatusrecode\nSTRING\n\n\n1762\n\n\nvitalstatusrecodedescription\nSTRING\n\n\n\n\n\n\n\n\n\nColumns Description\n\nstanford_patient_uid\nInternal Stanford tracking ID for Neural frame\n\n\nnfcaseentityid\nUnique number corresponding to every new neural frame âcaseâ or event\n\n\nnfcasestatus\nnan\n\n\nnffacilityid\nNF Facility ID\n\n\nnffacilityiddescription\nnan\n\n\ndate1stcrsrxcoc\nDate 1st Crs RX CoC\n\n\ndate1stcrsrxcocflag\nDate 1St Crs Rx Coc Flag\n\n\ndate1stcrsrxcocflagdescription\nnan\n\n\nautopsy\nAutopsy\n\n\nautopsydescription\nnan\n\n\ncancerstatus\nCancer Status\n\n\ncancerstatusdescription\nnan\n\n\ncauseofdeath\nCause of Death\n\n\ncauseofdeathdescription\nnan\n\n\ndateabstracted\nDate Abstracted\n\n\ndatecasecompleted\nDate Case Completed\n\n\ndatecasecompletedcoc\nDate Case CompletedâCoC\n\n\ndatecasefirstcompleted\nDate Case First Completed\n\n\ndatecaseinitiated\nDate Case Initiated\n\n\ndatecaselastchanged\nDate Case Last Changed\n\n\ndatecaselastvalidated\nDate Case Last Validated\n\n\ndatecasereportexported\nDate Case Report Exported\n\n\ndatecasereportexportedcoc\nDate Case Report Exported CoC\n\n\ndatecasereportfirstexported\nDate Case Report First Exported State\n\n\ndatecasereportfirstexportedcoc\nDate Case Report First Exported CoC\n\n\ndatefirstpositivebx\nDate First Positive Bx\n\n\ndateinitialrxseer\nDate Initial RX SEER\n\n\ndateinitialrxseerflag\nDate Initial Rx Seer Flag\n\n\ndateinitialrxseerflagdescription\nnan\n\n\ndatekaciintegratedcasefindingadded\nDate KACI Integrated Casefinding Added\n\n\ndatekaciintegratedfollowupupdated\nDate KACI Integrated Follow-Up Updated\n\n\ndatenorxdecision\nDate No Rx Decision\n\n\ndateof1stcontact\nDate of 1st Contact\n\n\ndateof1stcontactflag\nDate Of 1St Contact Flag\n\n\ndateof1stcontactflagdescription\nnan\n\n\ndateofinptadm\nDate of Inpt Adm\n\n\ndateofinptadmflag\nDate of Inpatient Admission Flag\n\n\ndateofinptadmflagdescription\nnan\n\n\ndateofinptdisch\nDate of Inpt Disch\n\n\ndateofinptdischflag\nDate of Inpatient Discharge Flag\n\n\ndateofinptdischflagdescription\nnan\n\n\ndateoflastcancerstatus\nDate of Last Cancer (tumor) Status\n\n\ndateoflastcancerstatusflag\nDate Of Last Cancer (Tumor) Status Flag\n\n\ndateoflastcancerstatusflagdescription\nnan\n\n\ndateoflastcontact\nDate of Last Contact\n\n\ndateoflastcontactflag\nDate Of Last Contact Flag\n\n\ndateoflastcontactflagdescription\nnan\n\n\neventcoursenumber\nEvent Course\n\n\neventcoursenumberdescription\nnan\n\n\nfollowupflag\nFollow-up Flag\n\n\nfollowupflagdescription\nnan\n\n\nfollowupsource\nFollow-Up Source\n\n\nfollowupsourcedescription\nnan\n\n\nfollowupoutcomestext\nText-Automatic Followup/Outcomes Only\n\n\nicdrevisionnumber\nICD Revision Number\n\n\nicdrevisionnumberdescription\nnan\n\n\nlpchrefractoryleukemia\nLPCH Refractory Leukemia\n\n\nlpchrefractoryleukemiadescription\nnan\n\n\nncdbcovid19tximpact\nNCDBâCOVID19âTx Impact\n\n\nncdbcovid19tximpactdescription\nnan\n\n\nncdbsarscov2pos\nNCDBâSARSCoV2âPos\n\n\nncdbsarscov2posdate\nNCDBâSARSCoV2âPos Date\n\n\nncdbsarscov2posdescription\nnan\n\n\nncdbsarscov2test\nNCDBâSARSCoV2âTest\n\n\nncdbsarscov2testdescription\nnan\n\n\nnextfollowupsource\nNext Follow-Up Source\n\n\nnextfollowupsourcedescription\nnan\n\n\nplaceofdeathcountry\nPlace of DeathâCountry\n\n\nplaceofdeathcountrydescription\nnan\n\n\nplaceofdeathstate\nPlace of DeathâState\n\n\nplaceofdeathstatedescription\nnan\n\n\nrecurrencedate1st\nRecurrence Dateâ1st\n\n\nrecurrencedate1stflag\nRecurrence Dateâ1St Flag\n\n\nrecurrencedate1stflagdescription\nnan\n\n\nrecurrencetype1st\nRecurrence Typeâ1st\n\n\nrecurrencetype1stdescription\nnan\n\n\nvitalstatus\nVital Status\n\n\nvitalstatusdescription\nnan\n\n\nvitalstatusrecode\nVital Status Recode\n\n\nvitalstatusrecodedescription\nnan\n\n\nfollowingregistry\nnan\n\n\nfollowupcontactcountry\nnan\n\n\ninpatientstatus\nInpatient Status\n\n\ninpatientstatusdescription\nnan\n\n\ninstitutionreferredfrom\nInstitution Referred From\n\n\ninstitutionreferredfromdescription\nnan\n\n\ninstitutionreferredto\nInstitution Referred To\n\n\ninstitutionreferredtodescription\nnan\n\n\nlastfollowuphospital\nLast Follow-Up Hospital\n\n\nplaceofdeath\nPlace of Death\n\n\nqualityofsurvival\nnan\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset",
    "crumbs": [
      "About",
      "Data Dictionary",
      "NeuralFrame",
      "NeuralFrame Case Outcomes"
    ]
  },
  {
    "objectID": "philips_ispm_data_dict/aberrations.html",
    "href": "philips_ispm_data_dict/aberrations.html",
    "title": "Philips ISPM Aberration",
    "section": "",
    "text": "The table onc_philips_mtb_aberrations contains genomic testing information from the Philips IntelliSpace Precision Medicine (ISPM) genomics database at Stanford. The fields in this table are related to genomic testing details about each sample, as well as the specimen accession number which can be used to link to the Philips ISPM Orders table.\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\n\n\n\n\naberration_class\nSTRING\n\n\n\n\naberration_type\nSTRING\n\n\n\n\naccession_number\nSTRING\nYes\nHash\n\n\nchrom\nSTRING\n\n\n\n\nhgnc_gene\nSTRING\n\n\n\n\nid\nSTRING\nYes\nStable Between Data Refreshes\n\n\nis_selected_aberration_flag\nINT64\n\n\n\n\nperson_id\nINT64\nYes\nStable Between Data Refreshes\n\n\nstanford_aa_change\nSTRING\n\n\n\n\nstanford_break_1\nSTRING\n\n\n\n\nstanford_break_2\nSTRING\n\n\n\n\nstanford_gene\nSTRING\n\n\n\n\nstanford_hgvs_coding\nSTRING\n\n\n\n\nstanford_hgvs_genomic\nSTRING\n\n\n\n\nstanford_hgvs_protein\nSTRING\n\n\n\n\nstanford_interpretation\nSTRING\nYes\nTiDE\n\n\nstanford_minimum_copies\nSTRING\n\n\n\n\nstanford_pathogenicity\nSTRING\n\n\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\nstanford_region_1\nSTRING\n\n\n\n\nstanford_transcript\nSTRING\n\n\n\n\nstanford_vaf\nSTRING\n\n\n\n\nstanford_variant\nSTRING\n\n\n\n\n\n\n\n\nColumns Description\n\naberration_class\nAberration class (No description available)\n\n\naberration_type\nAberration type (No description available)\n\n\naccession_number\nIdentifier for the specimen. This field can be used to link to the pat_diag_orders table. Note that there can be multiple records with the same accession number.\n\n\nchrom\nThe chromosome number that the gene impacted by the aberration is located on (No description available)\n\n\nhgnc_gene\nThe HUGO Gene Nomenclature Committee (HGNC)-approved name for the gene impacted by the aberration (No description available)\n\n\nid\nPrimary Key for aberrations table (No description available)\n\n\nis_selected_aberration_flag\nFlag indicating if the aberration record is a âselected aberrationâ (id is in the selected_aberrations staging table).\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\nstanford_aa_change\nAmino acid (AA) change as reported in the Stanford STAMP results report. First letter indicates the amino acid impacted, indicated by its one-letter code, then a series of numbers which indicate the position of the amino acid within the protein sequence, then a string abbreviation which denotes the type of mutation (example - G646fs is a frameshift mutation occurring at the amino acid Glycine, position 646 within the protein sequence for the protein encoded by the impacted ASXL1 gene). (No description available)\n\n\nstanford_break_1\nNo description available. This field is not well-populated.\n\n\nstanford_break_2\nNo description available. This field is not well-populated.\n\n\nstanford_gene\nGene impacted by the aberration, as reported in the Stanford STAMP results report. (No description available)\n\n\nstanford_hgvs_coding\nStandardized HGVS nomenclature representation for the variants in the coding DNA sequence of a gene, as reported in the Stanford STAMP results report (No description available)\n\n\nstanford_hgvs_genomic\nStandardized HGVS nomenclature representation for the variants in the genomic sequence of a chromosome, as reported in the Stanford STAMP results report (No description available)\n\n\nstanford_hgvs_protein\nStandardized HGVS nomenclature representation for the variants in the protein sequence, as reported in the Stanford STAMP results report (No description available)\n\n\nstanford_interpretation\nText field containing interpretation of the aberration found, as reported in the Stanford STAMP results report (No description available)\n\n\nstanford_minimum_copies\nNo description available. This field is not well-populated.\n\n\nstanford_pathogenicity\nPathogenicity level of the aberration (No description available)\n\n\nstanford_patient_uid\nInternal Stanford tracking ID (this is the patientâs MRN | DOB)\n\n\nstanford_region_1\nNo description available. This field is not well-populated.\n\n\nstanford_transcript\nNo description available.\n\n\nstanford_vaf\nVariant allele frequency (VAF), as reported in the Stanford STAMP results report (No description available)\n\n\nstanford_variant\nFull variant the aberration causes, as reported in the Stanford STAMP results report (No description available)",
    "crumbs": [
      "About",
      "Data Dictionary",
      "Philips ISPM",
      "Philips ISPM Aberration"
    ]
  },
  {
    "objectID": "philips_ispm_data_dict/specimen_data.html",
    "href": "philips_ispm_data_dict/specimen_data.html",
    "title": "Philips ISPM Specimen",
    "section": "",
    "text": "The table onc_philips_mtb_specimen_data includes specimen-related information from the Philips IntelliSpace Precision Medicine (ISPM) genomics database at Stanford. The fields in this table are related to specimen details, including accession numbers and collection information.\n\nTable Columns\n\n\n\n\n\n\n\n\n\n\ncolumn name\ntype\nphi\nphi-scrubbing operation\n\n\n\n\naccession_number\nSTRING\nYes\nHash\n\n\ncollection_collected_datetime\nSTRING\n\nJitter\n\n\ncreated\nDATETIME\nYes\nJitter\n\n\nisprimary\nSTRING\n\n\n\n\nperson_id\n\nYes\nStable Between Data Refreshes\n\n\nsampleid\nSTRING\nYes\nNullified\n\n\nsampletype\nSTRING\n\n\n\n\nspecimen_identifier\nSTRING\n\nNullified\n\n\nstanford_patient_uid\nSTRING\nYes\nDel\n\n\ntumorpercentage\nSTRING\n\n\n\n\n\n\n\n\nColumns Description\n\naccession_number\nIdentifier for the specimen. This field can be used to link to the pat_diag_orders table. Note that there can be multiple records with the same accession number.\n\n\ncollection_collected_datetime\nDatetime for specimen collection. Entirely null field.\n\n\ncreated\nTimestamp of specimen creation. The combination of created and accession_number is the Primary Key for specimen_data table\n\n\nisprimary\nThis is a field indicating if the specimen is from the primary tumor site.\n\n\nperson_id\nPerson_id as corresponds to the OMOP dataset\n\n\nsampleid\nFree-text field containing a mix of information, such as testing sites and/or accession numbers etc. Nullify for now but we will explore further in the future\n\n\nsampletype\nNo description available\n\n\nspecimen_identifier\nEntirely null field\n\n\nstanford_patient_uid\nInternal Stanford tracking ID (this is the patientâs MRN | DOB)\n\n\ntumorpercentage\nRefers to percentage of tumor cells compared to whole sample present in the sample selected, for performing next-generation sequencing (NGS) test.",
    "crumbs": [
      "About",
      "Data Dictionary",
      "Philips ISPM",
      "Philips ISPM Specimen"
    ]
  },
  {
    "objectID": "dicom_data_dict/dicom_data_dictionary.html",
    "href": "dicom_data_dict/dicom_data_dictionary.html",
    "title": "DICOM Data Dictionary",
    "section": "",
    "text": "DICOM_Tag_Number\nDICOM_Tag_Name\nDICOM_Tag_Description\n\n\n\n\n(0010,0020)\nPatientID\nPatient ID\n\n\n(0008,0050)\nAccessionNumber\nAccession Number\n\n\n(0010,0010)\nPatientName\nPatient's Name\n\n\n(0008,103E)\nSeriesDescription\nSeries Description\n\n\n(0008,1030)\nStudyDescription\nStudy Description\n\n\n(0018,1030)\nProtocolName\nProtocol Name\n\n\n(0008,0005)\nSpecificCharacterSet\nSpecific Character Set\n\n\n(0008,0008)\nImageType\nImage Type\n\n\n(0008,0016)\nSOPClassUID\nSOP Class UID\n\n\n(0008,0060)\nModality\nModality\n\n\n(0008,0070)\nManufacturer\nManufacturer\n\n\n(0008,1090)\nManufacturerModelName\nManufacturer's Model Name\n\n\n(0008,2111)\nDerivationDescription\nDerivation Description\n\n\n(0002,0003)\nMediaStorageSOPInstanceUID\nMedia Storage SOP Instance UID\n\n\n(0008,0018)\nSOPInstanceUID\nSOP Instance UID\n\n\n(0008,1140)\nReferencedImageSequence\nReferenced Image Sequence\n\n\n(0008,1155)\nReferencedSOPInstanceUID\nReferenced SOP Instance UID\n\n\n(0008,3010)\nIrradiationEventUID\nIrradiation Event UID\n\n\n(0020,000D)\nStudyInstanceUID\nStudy Instance UID\n\n\n(0020,000E)\nSeriesInstanceUID\nSeries Instance UID\n\n\n(0020,0052)\nFrameOfReferenceUID\nFrame of Reference UID\n\n\n(0020,0200)\nSynchronizationFrameOfReferenceUID\nSynchronization Frame of Reference UID\n\n\n(0028,1199)\nPaletteColorLookupTableUID\nPalette Color Lookup Table UID\n\n\n(0028,1214)\nLargePaletteColorLookupTableUID\nLarge Palette Color Lookup Table UID\n\n\n(0040,A124)\nUID\nUID\n\n\n(0070,1101)\nPresentationDisplayCollectionUID\nPresentation Display Collection UID\n\n\n(0070,1102)\nPresentationSequenceCollectionUID\nPresentation Sequence Collection UID\n\n\n(0088,0140)\nStorageMediaFileSetUID\nStorage Media File-set UID\n\n\n(3006,0024)\nReferencedFrameOfReferenceUID\nReferenced Frame of Reference UID\n\n\n(3006,00C2)\nRelatedFrameOfReferenceUID\nRelated Frame of Reference UID\n\n\n(0018,0010)\nContrastBolusAgent\nContrast/Bolus Agent\n\n\n(0018,0015)\nBodyPartExamined\nBody Part Examined\n\n\n(0018,0020)\nScanningSequence\nScanning Sequence\n\n\n(0018,0021)\nSequenceVariant\nSequence Variant\n\n\n(0018,0022)\nScanOptions\nScan Options\n\n\n(0018,0023)\nMRAcquisitionType\nMR Acquisition Type\n\n\n(0018,0050)\nSliceThickness\nSlice Thickness\n\n\n(0018,0088)\nSpacingBetweenSlices\nSpacing Between Slices\n\n\n(0018,0090)\nDataCollectionDiameter\nData Collection Diameter\n\n\n(0018,1000)\nDeviceSerialNumber\nDevice Serial Number\n\n\n(0018,1020)\nSoftwareVersions\nSoftware Versions\n\n\n(0018,1164)\nImagerPixelSpacing\nImager Pixel Spacing\n\n\n(0020,0011)\nSeriesNumber\nSeries Number\n\n\n(0020,0012)\nAcquisitionNumber\nAcquisition Number\n\n\n(0020,0013)\nInstanceNumber\nInstance Number\n\n\n(0020,1002)\nImagesInAcquisition\nImages in Acquisition\n\n\n(0020,0032)\nImagePositionPatient\nImage Position (Patient)\n\n\n(0020,0037)\nImageOrientationPatient\nImage Orientation (Patient)\n\n\n(0020,0060)\nLaterality\nLaterality\n\n\n(0020,1040)\nPositionReferenceIndicator\nPosition Reference Indicator\n\n\n(0020,1041)\nSliceLocation\nSlice Location\n\n\n(0028,0030)\nPixelSpacing\nPixel Spacing\n\n\n(0028,0002)\nSamplesPerPixel\nSamples per Pixel\n\n\n(0028,0004)\nPhotometricInterpretation\nPhotometric Interpretation\n\n\n(0028,0006)\nPlanarConfiguration\nPlanar Configuration\n\n\n(0028,0008)\nNumberOfFrames\nNumber of Frames\n\n\n(0028,0009)\nFrameIncrementPointer\nFrame Increment Pointer\n\n\n(0028,000A)\nFrameDimensionPointer\nFrame Dimension Pointer\n\n\n(0028,0010)\nRows\nRows\n\n\n(0028,0011)\nColumns\nColumns\n\n\n(0028,0012)\nPlanes\nPlanes\n\n\n(0028,0034)\nPixelAspectRatio\nPixel Aspect Ratio\n\n\n(0028,0100)\nBitsAllocated\nBits Allocated\n\n\n(0028,0101)\nBitsStored\nBits Stored\n\n\n(0028,0102)\nHighBit\nHigh Bit\n\n\n(0028,0103)\nPixelRepresentation\nPixel Representation\n\n\n(0028,0106)\nSmallestImagePixelValue\nSmallest Image Pixel Value\n\n\n(0028,0107)\nLargestImagePixelValue\nLargest Image Pixel Value\n\n\n(0028,0120)\nPixelPaddingValue\nPixel Padding Value\n\n\n(0028,0121)\nPixelPaddingRangeLimit\nPixel Padding Range Limit\n\n\n(0028,0200)\nImageLocation\nImage Location\n\n\n(0028,0300)\nQualityControlImage\nQuality Control Image\n\n\n(0028,1090)\nRecommendedViewingMode\nRecommended Viewing Mode\n\n\n(0028,9001)\nDataPointRows\nData Point Rows\n\n\n(0028,9002)\nDataPointColumns\nData Point Columns\n\n\n(0028,9108)\nDataRepresentation\nData Representation\n\n\n(0028,1050)\nWindowCenter\nWindow Center\n\n\n(0028,1051)\nWindowWidth\nWindow Width\n\n\n(0028,1052)\nRescaleIntercept\nRescale Intercept\n\n\n(0028,1053)\nRescaleSlope\nRescale Slope\n\n\n(0028,1054)\nRescaleType\nRescale Type\n\n\n(0028,1055)\nWindowCenterWidthExplanation\nWindow Center & Width Explanation\n\n\n(0028,1056)\nVOILUTFunction\nVOI LUT Function\n\n\n(0028,1101)\nRedPaletteColorLookupTableDescriptor\nRed Palette Color Lookup Table Descriptor\n\n\n(0028,1102)\nGreenPaletteColorLookupTableDescriptor\nGreen Palette Color Lookup Table Descriptor\n\n\n(0028,1103)\nBluePaletteColorLookupTableDescriptor\nBlue Palette Color Lookup Table Descriptor\n\n\n(0028,1201)\nRedPaletteColorLookupTableData\nRed Palette Color Lookup Table Data\n\n\n(0028,1202)\nGreenPaletteColorLookupTableData\nGreen Palette Color Lookup Table Data\n\n\n(0028,1203)\nBluePaletteColorLookupTableData\nBlue Palette Color Lookup Table Data\n\n\n(0028,2000)\nICCProfile\nICC Profile\n\n\n(0028,2110)\nLossyImageCompression\nLossy Image Compression\n\n\n(0028,2112)\nLossyImageCompressionRatio\nLossy Image Compression Ratio\n\n\n(0028,2114)\nLossyImageCompressionMethod\nLossy Image Compression Method\n\n\n(0062,0002)\nSegmentSequence\nSegment Sequence\n\n\n(0018,0080)\nRepetitionTime\nRepetition Time\n\n\n(0018,0081)\nEchoTime\nEcho Time\n\n\n(0018,0082)\nInversionTime\nInversion Time\n\n\n(0018,0083)\nNumberOfAverages\nNumber of Averages\n\n\n(0018,0084)\nImagingFrequency\nImaging Frequency\n\n\n(0018,0085)\nImagedNucleus\nImaged Nucleus\n\n\n(0018,0086)\nEchoNumbers\nEcho Number(s)\n\n\n(0018,0087)\nMagneticFieldStrength\nMagnetic Field Strength\n\n\n(0018,0091)\nEchoTrainLength\nEcho Train Length\n\n\n(0018,0095)\nPixelBandwidth\nPixel Bandwidth\n\n\n(0018,1060)\nTriggerTime\nTrigger Time\n\n\n(0018,1100)\nReconstructionDiameter\nReconstruction Diameter\n\n\n(0018,9005)\nPulseSequenceName\nPulse Sequence Name\n\n\n(0018,9087)\nDiffusionBValue\nDiffusion b-value\n\n\n(0018,1074)\nRadionuclideTotalDose\nRadionuclide Total Dose\n\n\n(0018,1075)\nRadionuclideHalfLife\nRadionuclide Half Life\n\n\n(0018,1088)\nHeartRate\nHeart Rate\n\n\n(0018,1201)\nTimeOfLastCalibration\nTime of Last Calibration\n\n\n(0018,9732)\nPETFrameAcquisitionSequence\nPET Frame Acquisition Sequence\n\n\n(0018,9733)\nPETDetectorMotionDetailsSequence\nPET Detector Motion Details Sequence\n\n\n(0018,9736)\nPETFrameCorrectionFactorsSequence\nPET Frame Correction Factors Sequence\n\n\n(0018,9738)\nAttenuationCorrectionSource\nAttenuation Correction Source\n\n\n(0018,9810)\nZeroVelocityPixelValue\nZero Velocity Pixel Value\n\n\n(0054,0202)\nTypeOfDetectorMotion\nType of Detector Motion\n\n\n(0054,0300)\nRadionuclideCodeSequence\nRadionuclide Code Sequence\n\n\n(0054,1000)\nSeriesType\nSeries Type\n\n\n(0054,1001)\nUnits\nUnits\n\n\n(0054,1006)\nSUVType\nSUV Type\n\n\n(0054,1102)\nDecayCorrection\nDecay Correction\n\n\n(0054,1300)\nFrameReferenceTime\nFrame Reference Time\n\n\n(0054,1323)\nScatterFractionFactor\nScatter Fraction Factor\n\n\n(0018,0060)\nKVP\nKVP\n\n\n(0018,1110)\nDistanceSourceToDetector\nDistance Source to Detector\n\n\n(0018,1111)\nDistanceSourceToPatient\nDistance Source to Patient\n\n\n(0018,1120)\nGantryDetectorTilt\nGantry/Detector Tilt\n\n\n(0018,1130)\nTableHeight\nTable Height\n\n\n(0018,1140)\nRotationDirection\nRotation Direction\n\n\n(0018,1151)\nXRayTubeCurrent\nX-Ray Tube Current\n\n\n(0018,1152)\nExposure\nExposure\n\n\n(0018,1160)\nFilterType\nFilter Type\n\n\n(0018,1170)\nGeneratorPower\nGenerator Power\n\n\n(0018,1190)\nFocalSpots\nFocal Spot(s)\n\n\n(0018,1210)\nConvolutionKernel\nConvolution Kernel\n\n\n(0018,7050)\nFilterMaterial\nFilter Material\n\n\n(0018,1114)\nEstimatedRadiographicMagnificationFactor\nEstimated Radiographic Magnification Factor\n\n\n(0018,1153)\nExposureInuAs\nExposure in uAs\n\n\n(0018,1155)\nRadiationSetting\nRadiation Setting\n\n\n(0018,1500)\nPositionerMotion\nPositioner Motion\n\n\n(0018,1510)\nPositionerPrimaryAngle\nPositioner Primary Angle\n\n\n(0018,1511)\nPositionerSecondaryAngle\nPositioner Secondary Angle\n\n\n(0018,1600)\nShutterShape\nShutter Shape\n\n\n(0018,1620)\nVerticesOfThePolygonalShutter\nVertices of the Polygonal Shutter\n\n\n(0018,1622)\nShutterPresentationValue\nShutter Presentation Value\n\n\n(0018,1624)\nShutterPresentationColorCIELabValue\nShutter Presentation Color CIELab Value\n\n\n(0018,1250)\nReceiveCoilName\nReceive Coil Name\n\n\n(0018,9417)\nFrameAcquisitionSequence\nFrame Acquisition Sequence\n\n\n(0018,9434)\nExposureControlSensingRegionsSequence\nExposure Control Sensing Regions Sequence\n\n\n(0018,9435)\nExposureControlSensingRegionShape\nExposure Control Sensing Region Shape\n\n\n(0018,9436)\nExposureControlSensingRegionLeftVerticalEdge\nExposure Control Sensing Region Left Vertical Edge\n\n\n(0018,9438)\nExposureControlSensingRegionUpperHorizontalEdge\nExposure Control Sensing Region Upper Horizontal Edge\n\n\n(0018,9070)\nCardiacRRIntervalSpecified\nCardiac R-R Interval Specified\n\n\n(0018,9073)\nAcquisitionDuration\nAcquisition Duration\n\n\n(0018,9075)\nDiffusionDirectionality\nDiffusion Directionality\n\n\n(0018,9076)\nDiffusionGradientDirectionSequence\nDiffusion Gradient Direction Sequence\n\n\n(0018,9077)\nParallelAcquisition\nParallel Acquisition\n\n\n(0022,0001)\nLightPathFilterPassThroughWavelength\nLight Path Filter Pass-Through Wavelength\n\n\n(0022,0002)\nLightPathFilterPassBand\nLight Path Filter Pass Band\n\n\n(0022,0003)\nImagePathFilterPassThroughWavelength\nImage Path Filter Pass-Through Wavelength\n\n\n(0022,0005)\nPatientEyeMovementCommanded\nPatient Eye Movement Commanded\n\n\n(0022,0006)\nPatientEyeMovementCommandCodeSequence\nPatient Eye Movement Command Code Sequence\n\n\n(0022,0007)\nSphericalLensPower\nSpherical Lens Power\n\n\n(0022,0008)\nCylinderLensPower\nCylinder Lens Power\n\n\n(0022,0009)\nCylinderAxis\nCylinder Axis\n\n\n(0022,1007)\nOphthalmicAxialMeasurementsRightEyeSequence\nOphthalmic Axial Measurements Right Eye Sequence\n\n\n(0022,1019)\nOphthalmicAxialLength\nOphthalmic Axial Length\n\n\n(0022,1050)\nOphthalmicAxialLengthMeasurementsSequence\nOphthalmic Axial Length Measurements Sequence\n\n\n(0018,0070)\nCountsAccumulated\nCounts Accumulated\n\n\n(0018,0071)\nAcquisitionTerminationCondition\nAcquisition Termination Condition\n\n\n(0018,0073)\nAcquisitionStartCondition\nAcquisition Start Condition\n\n\n(0018,0075)\nAcquisitionTerminationConditionData\nAcquisition Termination Condition Data\n\n\n(0018,1040)\nContrastBolusRoute\nContrast/Bolus Route\n\n\n(0018,1041)\nContrastBolusVolume\nContrast/Bolus Volume\n\n\n(0018,1242)\nActualFrameDuration\nActual Frame Duration\n\n\n(0018,1243)\nCountRate\nCount Rate\n\n\n(0018,1300)\nScanVelocity\nScan Velocity\n\n\n(0018,1301)\nWholeBodyTechnique\nWhole Body Technique\n\n\n(0018,1302)\nScanLength\nScan Length\n\n\n(0018,1310)\nAcquisitionMatrix\nAcquisition Matrix\n\n\n(0018,1312)\nInPlanePhaseEncodingDirection\nIn-plane Phase Encoding Direction\n\n\n(0018,1314)\nFlipAngle\nFlip Angle\n\n\n(0018,1320)\nB1rms\nB1rms\n\n\n(0018,1700)\nCollimatorShape\nCollimator Shape\n\n\n(0018,1702)\nCollimatorLeftVerticalEdge\nCollimator Left Vertical Edge\n\n\n(0018,1704)\nCollimatorRightVerticalEdge\nCollimator Right Vertical Edge\n\n\n(0018,1710)\nCenterOfCircularCollimator\nCenter of Circular Collimator\n\n\n(0018,1720)\nVerticesOfThePolygonalCollimator\nVertices of the Polygonal Collimator\n\n\n(0018,6020)\nReferencePixelX0\nReference Pixel X0\n\n\n(0018,6040)\nTMLinePositionX1Retired\nTM-Line Position X1 (Retired)\n\n\n(0054,0011)\nNumberOfEnergyWindows\nNumber of Energy Windows\n\n\n(0054,0022)\nDetectorInformationSequence\nDetector Information Sequence\n\n\n(0054,0050)\nRotationVector\nRotation Vector\n\n\n(0054,0051)\nNumberOfRotations\nNumber of Rotations\n\n\n(0054,0060)\nRRIntervalVector\nR-R Interval Vector\n\n\n(0054,0061)\nNumberOfRRIntervals\nNumber of R-R Intervals\n\n\n(0054,0070)\nTimeSlotVector\nTime Slot Vector\n\n\n(0054,0080)\nSliceVector\nSlice Vector\n\n\n(0054,0090)\nAngularViewVector\nAngular View Vector\n\n\n(0054,0100)\nTimeSliceVector\nTime Slice Vector\n\n\n(0054,1330)\nImageIndex\nImage Index\n\n\n(0018,0026)\nInterventionDrugInformationSequence\nIntervention Drug Information Sequence\n\n\n(0018,0031)\nRadiopharmaceutical\nRadiopharmaceutical\n\n\n(0018,0032)\nEnergyWindowCenterline\nEnergy Window Centerline\n\n\n(0018,0040)\nCineRate\nCine Rate\n\n\n(0018,9737)\nRadiopharmaceuticalUsageSequence\nRadiopharmaceutical Usage Sequence\n\n\n(0018,9749)\nPETReconstructionSequence\nPET Reconstruction Sequence\n\n\n(0018,9751)\nPETFrameTypeSequence\nPET Frame Type Sequence\n\n\n(0054,0016)\nRadiopharmaceuticalInformationSequence\nRadiopharmaceutical Information Sequence\n\n\n(0054,1400)\nCountsIncluded\nCounts Included\n\n\n(0054,1401)\nDeadTimeCorrectionFlag\nDead Time Correction Flag\n\n\n(0018,1166)\nGrid\nGrid\n\n\n(0018,1191)\nAnodeTargetMaterial\nAnode Target Material\n\n\n(0018,1405)\nRelativeXRayExposure\nRelative X-Ray Exposure\n\n\n(0018,1508)\nPositionerType\nPositioner Type\n\n\n(0018,1530)\nDetectorPrimaryAngle\nDetector Primary Angle\n\n\n(0018,1531)\nDetectorSecondaryAngle\nDetector Secondary Angle\n\n\n(0018,6000)\nSensitivity\nSensitivity\n\n\n(0018,7060)\nExposureControlMode\nExposure Control Mode\n\n\n(0018,7062)\nExposureControlModeDescription\nExposure Control Mode Description\n\n\n(0018,9538)\nPerProjectionAcquisitionSequence\nPer Projection Acquisition Sequence\n\n\n(0040,0318)\nOrganExposed\nOrgan Exposed\n\n\n(0040,8302)\nEntranceDoseInmGy\nEntrance Dose in mGy\n\n\n(0018,1147)\nFieldOfViewShape\nField of View Shape\n\n\n(0018,1149)\nFieldOfViewDimensions\nField of View Dimension(s)\n\n\n(0018,1180)\nCollimatorGridName\nCollimator/grid Name\n\n\n(0018,1400)\nAcquisitionDeviceProcessingDescription\nAcquisition Device Processing Description\n\n\n(0018,1401)\nAcquisitionDeviceProcessingCode\nAcquisition Device Processing Code\n\n\n(0018,1450)\nColumnAngulation\nColumn Angulation\n\n\n(0018,1470)\nTomoAngle\nTomo Angle\n\n\n(0018,7000)\nDetectorConditionsNominalFlag\nDetector Conditions Nominal Flag\n\n\n(0018,7030)\nFieldOfViewOrigin\nField of View Origin\n\n\n(0018,7032)\nFieldOfViewRotation\nField of View Rotation\n\n\n(0018,7034)\nFieldOfViewHorizontalFlip\nField of View Horizontal Flip\n\n\n(0018,7040)\nGridAbsorbingMaterial\nGrid Absorbing Material\n\n\n(0018,7041)\nGridSpacingMaterial\nGrid Spacing Material\n\n\n(0018,7042)\nGridThickness\nGrid Thickness\n\n\n(0018,7044)\nGridPitch\nGrid Pitch\n\n\n(0018,7046)\nGridAspectRatio\nGrid Aspect Ratio\n\n\n(0018,7052)\nFilterThicknessMinimum\nFilter Thickness Minimum\n\n\n(0018,7054)\nFilterThicknessMaximum\nFilter Thickness Maximum\n\n\n(0020,9116)\nPlaneOrientationSequence\nPlane Orientation Sequence\n\n\n(0028,0A02)\nPixelSpacingCalibrationType\nPixel Spacing Calibration Type\n\n\n(0028,0A04)\nPixelSpacingCalibrationDescription\nPixel Spacing Calibration Description\n\n\n(0008,9092)\nReferencedImageEvidenceSequence\nReferenced Image Evidence Sequence\n\n\n(0018,9371)\nXRayDetectorID\nX-Ray Detector ID\n\n\n(0018,9461)\nFieldOfViewDimensionsInFloat\nField of View Dimension(s) in Float\n\n\n(0018,9462)\nIsocenterReferenceSystemSequence\nIsocenter Reference System Sequence\n\n\n(0018,9476)\nXRayGeometrySequence\nX-Ray Geometry Sequence\n\n\n(0018,9477)\nIrradiationEventIdentificationSequence\nIrradiation Event Identification Sequence\n\n\n(0018,9504)\nXRay3DFrameTypeSequence\nX-Ray 3D Frame Type Sequence\n\n\n(0018,9506)\nContributingSourcesSequence\nContributing Sources Sequence\n\n\n(0018,9507)\nXRay3DAcquisitionSequence\nX-Ray 3D Acquisition Sequence\n\n\n(0018,9508)\nPrimaryPositionerScanArc\nPrimary Positioner Scan Arc\n\n\n(0018,9528)\nAlgorithmDescription\nAlgorithm Description\n\n\n(0018,9530)\nXRay3DReconstructionSequence\nX-Ray 3D Reconstruction Sequence\n\n\n(0018,9531)\nReconstructionDescription\nReconstruction Description\n\n\n(0018,1050)\nSpatialResolution\nSpatial Resolution\n\n\n(0018,1063)\nFrameTime\nFrame Time\n\n\n(0018,1065)\nFrameTimeVector\nFrame Time Vector\n\n\n(0018,1066)\nFrameDelay\nFrame Delay\n\n\n(0018,106E)\nTriggerSamplePosition\nTrigger Sample Position\n\n\n(0018,1090)\nCardiacNumberOfImages\nCardiac Number of Images\n\n\n(0018,2001)\nPageNumberVector\nPage Number Vector\n\n\n(0018,5010)\nTransducerData\nTransducer Data\n\n\n(0018,5012)\nFocusDepth\nFocus Depth\n\n\n(0018,5020)\nProcessingFunction\nProcessing Function\n\n\n(0018,5021)\nPostprocessingFunction\nPostprocessing Function\n\n\n(0018,5022)\nMechanicalIndex\nMechanical Index\n\n\n(0018,5024)\nBoneThermalIndex\nBone Thermal Index\n\n\n(0018,5026)\nCranialThermalIndex\nCranial Thermal Index\n\n\n(0018,5027)\nSoftTissueThermalIndex\nSoft Tissue Thermal Index\n\n\n(0018,5028)\nSoftTissueFocusThermalIndex\nSoft Tissue-focus Thermal Index\n\n\n(0018,5029)\nSoftTissueSurfaceThermalIndex\nSoft Tissue-surface Thermal Index\n\n\n(0018,5030)\nDynamicRange\nDynamic Range\n\n\n(0018,5040)\nTotalGain\nTotal Gain\n\n\n(0018,5050)\nDepthOfScanField\nDepth of Scan Field\n\n\n(0018,6011)\nSequenceOfUltrasoundRegions\nSequence of Ultrasound Regions\n\n\n(0018,6031)\nTransducerType\nTransducer Type\n\n\n(0018,6032)\nPulseRepetitionFrequency\nPulse Repetition Frequency\n\n\n(0018,7001)\nDetectorTemperature\nDetector Temperature\n\n\n(0018,7004)\nDetectorType\nDetector Type\n\n\n(0018,7020)\nDetectorElementPhysicalSize\nDetector Element Physical Size\n\n\n(0018,7022)\nDetectorElementSpacing\nDetector Element Spacing\n\n\n(0028,6010)\nRepresentativeFrameNumber\nRepresentative Frame Number\n\n\n(7FE0,0010)\nPixelData\nPixel Data",
    "crumbs": [
      "About",
      "Data Dictionary",
      "DICOM"
    ]
  },
  {
    "objectID": "aug_2025/metrics_clinical.html",
    "href": "aug_2025/metrics_clinical.html",
    "title": "Oncology Cohort",
    "section": "",
    "text": "Release Version: August 2025 (IRB76049)"
  },
  {
    "objectID": "aug_2025/metrics_clinical.html#patient-distribution-across-data-sources",
    "href": "aug_2025/metrics_clinical.html#patient-distribution-across-data-sources",
    "title": "Oncology Cohort",
    "section": "Patient Distribution Across Data Sources",
    "text": "Patient Distribution Across Data Sources"
  },
  {
    "objectID": "aug_2025/cap_forms_methods.html",
    "href": "aug_2025/cap_forms_methods.html",
    "title": "AI for Automatic Synoptic Reporting",
    "section": "",
    "text": "CAP (College of American Pathologists) forms are standardized cancer reporting protocols that have revolutionized pathology practice by replacing inconsistent narrative reports with structured, synoptic formats containing essential diagnostic and prognostic information. Developed over 35 years ago to address significant variability in cancer reporting, these evidence-based protocols ensure complete, uniform documentation of malignant tumors across all healthcare institutions, directly improving patient outcomes and clinical decision-making.\nLung resection CAP forms are particularly critical in thoracic oncology, providing standardized reporting templates for primary lung cancers that include essential elements such as tumor size, histologic type and grade, surgical margins, lymph node status, and staging classifications. These lung-specific protocols have demonstrated measurable clinical impact, with studies showing that synoptic reporting achieves 88.4% completeness compared to only 2.6% for traditional descriptive reports, leading to more accurate staging, better treatment planning, and improved survival rates.\nBy establishing consistent terminology and data capture requirements, CAP lung resection forms enhance communication between pathologists and oncologists, ensure regulatory compliance with Commission on Cancer standards, and provide the structured data foundation necessary for personalized cancer care, targeted therapy selection, and multidisciplinary treatment coordination. The widespread adoption of these standardized protocols, supported by electronic integration into laboratory information systems, has positioned pathologists as key members of the lung cancer care team while enabling seamless data exchange for cancer registries, research, and quality improvement initiatives.\nAt Stanford, CAP forms were implemented within Epic using SmartForms. SmartForms is an Epic product that allows the capture of semi-structured information within the EHR that can later be used to generate free-form reports. In this case, the structured information from the CAP forms is captured on SmartForms, which later generate the synoptic reporting section within the pathology report. As a consequence, for relevant cases, the pathology report will contain this section.\nFor this task, we aim to use AI to populate the CAP forms automatically by using all the other elements from the pathology report. We formulated this as a question-answering problem, where the context for each question is the entire pathology report, the question is the particular CAP form element, and the answer is the value/selection to be populated.\nFor this initial experiment, we collected a dataset with 390 patients and 390 lung resection forms. The forms were reported between November 2022 and April 2025. The table below summarizes the demographics for this dataset.\nAttaching package: 'table1'\n\n\nThe following objects are masked from 'package:base':\n\n    units, units&lt;-\n\n\n\n\n\n\n\n\n\n\n\n\n\nFEMALE\n(N=237)\nMALE\n(N=153)\nOverall\n(N=390)\n\n\n\n\nAge\n\n\n\n\n\n18-44\n6 (2.5%)\n10 (6.5%)\n16 (4.1%)\n\n\n45-59\n47 (19.8%)\n18 (11.8%)\n65 (16.7%)\n\n\n60-69\n72 (30.4%)\n42 (27.5%)\n114 (29.2%)\n\n\n70-79\n87 (36.7%)\n60 (39.2%)\n147 (37.7%)\n\n\n80+\n25 (10.5%)\n23 (15.0%)\n48 (12.3%)\n\n\nRace\n\n\n\n\n\nAmerican Indian or Alaska Native\n2 (0.8%)\n1 (0.7%)\n3 (0.8%)\n\n\nAsian\n74 (31.2%)\n49 (32.0%)\n123 (31.5%)\n\n\nBlack or African American\n4 (1.7%)\n2 (1.3%)\n6 (1.5%)\n\n\nNative Hawaiian or Other Pacific Islander\n2 (0.8%)\n2 (1.3%)\n4 (1.0%)\n\n\nUnknown\n19 (8.0%)\n21 (13.7%)\n40 (10.3%)\n\n\nWhite\n136 (57.4%)\n78 (51.0%)\n214 (54.9%)\n\n\nEthnicity\n\n\n\n\n\nHispanic or Latino\n20 (8.4%)\n10 (6.5%)\n30 (7.7%)\n\n\nNot Hispanic or Latino\n210 (88.6%)\n141 (92.2%)\n351 (90.0%)\n\n\nUnknown\n7 (3.0%)\n2 (1.3%)\n9 (2.3%)"
  },
  {
    "objectID": "aug_2025/cap_forms_methods.html#methods-and-results",
    "href": "aug_2025/cap_forms_methods.html#methods-and-results",
    "title": "AI for Automatic Synoptic Reporting",
    "section": "Methods and Results",
    "text": "Methods and Results\nFor this experiment, we used several state-of-the-art LLMs to assess their capabilities to extract the information required for lung resection CAP forms. As mentioned before, we formulated the problem as a question-answering problem. Each LLM was tested in a zero-shot setting, where no actual examples were given. Each LLM was asked to answer a single question using the entire pathology report (excluding the synoptic report) and instructions that contained the most recent lung resection CAP forms instructions. We asked the LLMs to provide the answers using JSON to facilitate the parsing of the actual answers.\nTo automatically evaluate the output, we used the traditional BERT score, which evaluates the semantic similarity between the generated answer and the reference answer. The results of this evaluation are shown in the figure below.\n\n\n\n\n\n\nHere, we can see that Claude 3.5 is slightly better than Llama 4. However, the distribution for most LLMs is certainly wide, showing lack of consistency across all questions. To investigate this further, a heatmap was constructed and is shown in the figure below. Here, we can clearly see the variability across different questions and how GPT-4 consistently underperforms for this particular task. The questions itself and the descriptions of each question can be found below the graph.\n\n\n\n\n\n\n\nADDITIONAL FINDINGS - Documents other pathologic findings in the specimen beyond the primary tumor, such as atypical adenomatous hyperplasia, granulomatous inflammation, or emphysema.\n\nCLOSEST MARGIN(S) TO INVASIVE CARCINOMA - Identifies which specific surgical margin (bronchial, vascular, parenchymal, or chest wall) is nearest to the invasive tumor.\n\nDISTANCE FROM INVASIVE CARCINOMA TO CLOSEST MARGIN - Measures in centimeters how far the invasive tumor extends from the nearest surgical margin.\n\nHISTOLOGIC GRADE - Assesses the degree of tumor differentiation using grading schemes specific to tumor type (G1-well differentiated to G4-undifferentiated).\n\nLYMPH NODE(S) FROM PRIOR PROCEDURES - Documents whether lymph nodes from previous surgical procedures are included in the current specimen.\n\nLYMPHOVASCULAR INVASION - Reports the presence of tumor cells within lymphatic vessels, arteries, or veins.\n\nMARGIN STATUS FOR INVASIVE CARCINOMA - Determines whether invasive tumor is present at any surgical margin or if all margins are negative.\n\nMARGIN STATUS FOR NON-INVASIVE TUMOR - Assesses whether carcinoma in situ or lepidic components are present at surgical margins.\n\nNODAL SITE(S) EXAMINED - Documents which specific lymph node stations according to the IASLC map were sampled and examined.\n\nNODAL SITE(S) WITH TUMOR - Identifies which specific lymph node stations contain metastatic tumor.\n\nNUMBER OF LYMPH NODES EXAMINED - Provides the total count of lymph nodes examined in the specimen.\n\nNUMBER OF LYMPH NODES WITH TUMOR - Reports the count of lymph nodes containing metastatic tumor.\n\nPROCEDURE - Specifies the type of surgical resection performed (wedge resection, lobectomy, pneumonectomy, etc.).\n\nREGIONAL LYMPH NODE STATUS - Provides overall assessment of whether regional lymph nodes contain tumor or are negative.\n\nSPECIMEN LATERALITY - Indicates whether the lung specimen is from the right or left side.\n\nSPREAD THROUGH AIR SPACES (STAS) - Documents the presence of tumor cells extending beyond the main tumor into surrounding air spaces as micropapillary clusters, solid nests, or single cells.\n\nTNM DESCRIPTORS - Assigns pathologic TNM staging categories (pT, pN, pM) based on tumor size, nodal involvement, and distant metastasis.\n\nTOTAL TUMOR SIZE (SIZE OF ENTIRE TUMOR) - Measures the greatest dimension of the entire tumor including both invasive and non-invasive components.\n\nTUMOR FOCALITY - Determines whether there is a single tumor focus, multiple separate nodules, or multifocal disease.\n\nTUMOR SITE - Identifies the specific anatomic location of the tumor within the lung (upper lobe, lower lobe, bronchus, etc.).\n\nVISCERAL PLEURA INVASION - Assesses whether tumor penetrates beyond the elastic layer of the visceral pleura or extends to the pleural surface.\n\nFurther investigation is required to evaluate and characterize the failure modes of each of the LLMs. Additionally, the baseline performance indicates that fine-tuning an open-source model like Llama 4 may yield better results."
  },
  {
    "objectID": "may_2025/phi_labeling_report.html",
    "href": "may_2025/phi_labeling_report.html",
    "title": "PHI Labeling Metrics",
    "section": "",
    "text": "In this section, we present an analysis of the population characteristics and note attributes for the labeled sample used in our study. We compare these characteristics with the broader STARR-OMOP population to provide context and highlight any significant differences. The analysis includes age distribution, note length distribution and and note types. For PHI (Protected Health Information) distribution it is only shown on the labeled sample.\n\nAge Distribution\nBelow a histogram of the distribution of ages of the population represented in the labeled notes. For comparison the characteristics of the entire STARR-OMOP population are shown as well. The Age of the patient is calculated as at the moment of the extraction and not at the moment the note was written.\n\nLabeled SampleSTARR-OMOP\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDemographic Groups\nIn this section, we present a detailed analysis of the demographic characteristics of the labeled sample used in our study. We compare these characteristics with the broader STARR-OMOP population to provide context and highlight any significant differences. The analysis includes age distribution, sex, race, and ethnicity. This comparison helps to understand the representativeness of the labeled sample and identify teh characteristics of the biased sample.\n\nAgeSexRaceEthnicity\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAge Group\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\n0-17\n169\n12.12\n24,709,539\n10.82\n\n\n18-44\n361\n25.90\n51,841,502\n22.70\n\n\n45-64\n343\n24.61\n53,873,202\n23.59\n\n\n65+\n521\n37.37\n97,932,528\n42.89\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSex\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nFEMALE\n719\n51.58\n128,810,665\n56.41\n\n\nMALE\n666\n47.78\n99,506,081\n43.57\n\n\nNo matching concept\n9\n0.65\nNA\nNA\n\n\nUnknown\nNA\nNA\n40,025\n0.02\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRace\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nAmerican Indian or Alaska Native\n72\n5.16\n985,689\n0.43\n\n\nAsian\n222\n15.93\n40,808,962\n17.87\n\n\nBlack or African American\n177\n12.70\n11,182,306\n4.90\n\n\nNative Hawaiian or Other Pacific Islander\n111\n7.96\n2,854,092\n1.25\n\n\nUnknown\n422\n30.27\n51,605,777\n22.60\n\n\nWhite\n390\n27.98\n120,919,945\n52.95\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEthnicity\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn1\n%\nn1\n%\n\n\n\n\nHispanic or Latino\n408\n29.27\n39,152,701\n17.15\n\n\nNot Hispanic or Latino\n764\n54.81\n173,951,827\n76.18\n\n\nUnknown\n222\n15.93\n15,252,243\n6.68\n\n\n\n1 Note: 'n' represents the number of notes, not the number of patients.\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote Length Distribution\nBelow the note length distribution for the clinical notes sampled for the labeling task. For comparison the distribution of the lengths for STARR-OMOP is shown. The note length distribution is shown in characters.\n\nLabeled SampleComparison with STARR-OMOP\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRange\n\nSTARR-OMOP\n\n\nLabeled Sample\n\n\n\nn\n%\nn\n%\n\n\n\n\n0 - 500\n96,583,879\n42.30\n146\n10.47\n\n\n500 - 2500\n71,191,327\n31.18\n1,240\n88.95\n\n\n2500 - 10000\n49,905,133\n21.85\n8\n0.57\n\n\n10000 - 50000\n10,631,213\n4.66\nNA\nNA\n\n\n50000 - 1e+05\n41,626\n0.02\nNA\nNA\n\n\n1e+05 - 1150000\n3,593\n0.00\nNA\nNA\n\n\n\n\n\n\n\n\n\n\n\n\nPHI Distribution\nIn this section, we present an analysis of the distribution of PHI entities within the labeled sample. The analysis includes the frequency of different PHI entities and their distribution across documents. This helps to understand the prevalence of various PHI types in the dataset and provides insights into the labeling process. The analysis is divided into two parts: the total count of each PHI entity type and the distribution of PHI entities per document. It is important to clarify that DOCTOR and HOSPITAL are not classified as PHI in the Safe-Harbor definition. However, being able to identify and obfuscate such information may be important for potential data sharing use cases.\n\nOverallPer Document\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote Types\nIn this section, we present an analysis of the different types of clinical notes included in the labeled sample used in our study. We compare these note types with the broader STARR-OMOP population to provide context and highlight any significant differences. This comparison helps to understand the representativeness of the labeled sample and identify the differences in the bias sample in the types of notes included. The analysis includes the distribution of note types and their frequencies in both the labeled sample and the STARR-OMOP population. In the distribution below there are several types that contain radiology and pathology reports. Among those are the notes labeled as procedures. Those are a combination of clinical results that are a result of procedures.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDistribution of Note Types in the Dataset\n\n\nNote Type\n\nLabeled Sample\n\n\nSTARR-OMOP\n\n\n\nn\n%\nn\n%\n\n\n\n\nletter\n45\n3.23\n6,889,804\n3.02\n\n\nimaging\n36\n2.58\n27,170,511\n11.90\n\n\nprocedures\n36\n2.58\n2,542,658\n1.11\n\n\nprogress notes\n34\n2.44\n54,086,167\n23.68\n\n\nclinic support note\n32\n2.30\n3,041,493\n1.33\n\n\npatient instructions\n32\n2.30\n9,786,849\n4.29\n\n\ndischarge instructions\n31\n2.22\n1,983,103\n0.87\n\n\ntelephone encounter\n31\n2.22\n38,675,938\n16.94\n\n\nnursing note\n29\n2.08\n1,605,802\n0.70\n\n\nconsults\n27\n1.94\n3,313,915\n1.45\n\n\ncare plan note\n26\n1.87\n4,139,518\n1.81\n\n\nh&p\n26\n1.87\n1,787,536\n0.78\n\n\npathology\n26\n1.87\n1,812,971\n0.79\n\n\nrtf letter\n26\n1.87\n3,549,891\n1.55\n\n\nanesthesia procedure notes\n25\n1.79\n762,798\n0.33\n\n\nunmapped external results\n24\n1.72\n900,521\n0.39\n\n\nanesthesia postprocedure evaluation\n23\n1.65\n915,373\n0.40\n\n\ncare plan\n23\n1.65\n145,491\n0.06\n\n\necg\n23\n1.65\n527,231\n0.23\n\n\npathology and cytology\n23\n1.65\n395,258\n0.17\n\n\nprocedure note\n23\n1.65\n241,589\n0.11\n\n\nassessment & plan note\n22\n1.58\n2,240,039\n0.98\n\n\nlab\n21\n1.51\n24,825,380\n10.87\n\n\nrn transfer note\n20\n1.43\n238,578\n0.10\n\n\nsign out note\n19\n1.36\n2,080,313\n0.91\n\n\nunmapped external note\n19\n1.36\n277,058\n0.12\n\n\npr charge\n18\n1.29\n617,387\n0.27\n\n\noperative note\n17\n1.22\n521,214\n0.23\n\n\noperative report\n17\n1.22\n969,031\n0.42\n\n\nconsult follow-up\n16\n1.15\n1,159,388\n0.51\n\n\ndocumentation clarification\n16\n1.15\n179,822\n0.08\n\n\nmicrobiology\n16\n1.15\n812,474\n0.36\n\n\ned provider notes\n15\n1.08\n1,862,895\n0.82\n\n\ned temp/rap patient\n15\n1.08\n142,004\n0.06\n\n\nmicrobiology culture\n15\n1.08\n1,097,747\n0.48\n\n\nlab panel\n14\n1.00\n118,246\n0.05\n\n\npoint of care testing\n14\n1.00\n368,205\n0.16\n\n\ntransplant summary\n14\n1.00\n1,282,579\n0.56\n\n\nancillary\n13\n0.93\n1,176,069\n0.52\n\n\ngroup note\n13\n0.93\n66,342\n0.03\n\n\ninterval h&p note\n13\n0.93\n200,704\n0.09\n\n\nadvance care planning\n12\n0.86\n97,282\n0.04\n\n\ned notes\n12\n0.86\n6,496,913\n2.85\n\n\nip letter\n12\n0.86\n301,987\n0.13\n\n\nrehab daily note\n12\n0.86\n516,657\n0.23\n\n\nnursing referral\n11\n0.79\n205,098\n0.09\n\n\nphysical therapy\n11\n0.79\n184,380\n0.08\n\n\nanesthesia preprocedure evaluation\n10\n0.72\n1,148,683\n0.50\n\n\ner notes\n10\n0.72\n43,442\n0.02\n\n\nh&p interval\n10\n0.72\n244,086\n0.11\n\n\nnsg picc refer\n10\n0.72\n127,275\n0.06\n\n\nperfusion event\n10\n0.72\n13,641\n0.01\n\n\npft\n10\n0.72\n172,001\n0.08\n\n\nconsult\n9\n0.65\n533,155\n0.23\n\n\nimaging non-reportable\n9\n0.65\n1,584,644\n0.69\n\n\nneurology\n9\n0.65\n112,384\n0.05\n\n\nnursing\n9\n0.65\n19,401\n0.01\n\n\nrehab\n9\n0.65\n657,127\n0.29\n\n\naccountable care division cm note\n8\n0.57\n143,998\n0.06\n\n\ndischarge summary\n8\n0.57\n1,040,761\n0.46\n\n\nh&p (view-only)\n8\n0.57\n171,763\n0.08\n\n\nhiv lab non-restricted\n8\n0.57\n25,412\n0.01\n\n\noutpatient letter\n8\n0.57\n307,086\n0.13\n\n\nwound care\n8\n0.57\n46,420\n0.02\n\n\ncode blue/rapid response team note\n7\n0.50\n8,238\n0.00\n\n\nhealth plan operations cm note\n7\n0.50\n37,015\n0.02\n\n\nimmediate post op note\n7\n0.50\n83,068\n0.04\n\n\nlactation note\n7\n0.50\n274,944\n0.12\n\n\npharmacy medication review\n7\n0.50\n50,057\n0.02\n\n\nvascular ultrasound\n7\n0.50\n78,447\n0.03\n\n\nanesthesia post-op follow-up note\n6\n0.43\n50,193\n0.02\n\n\ncardiac services\n6\n0.43\n40,949\n0.02\n\n\necho\n6\n0.43\n642,794\n0.28\n\n\npsych\n6\n0.43\n386,747\n0.17\n\n\nsignificant event\n6\n0.43\n8,713\n0.00\n\n\nslp\n6\n0.43\n82,010\n0.04\n\n\ndermatology\n5\n0.36\n5,511\n0.00\n\n\ngi\n5\n0.36\n317,911\n0.14\n\n\nhospice\n5\n0.36\n4,221\n0.00\n\n\nob\n5\n0.36\n41,869\n0.02\n\n\nanesthesia post-op\n4\n0.29\n88,070\n0.04\n\n\nblood bank\n4\n0.29\n21,218\n0.01\n\n\ndischarge instr - other orders\n4\n0.29\n37,133\n0.02\n\n\nhospital course\n4\n0.29\n18,606\n0.01\n\n\nmanual entry echo\n4\n0.29\n11,058\n0.00\n\n\nmiscellaneous\n4\n0.29\n6,922\n0.00\n\n\noccupational therapy\n4\n0.29\n193,917\n0.08\n\n\nor surgeon\n4\n0.29\n14,425\n0.01\n\n\npatient care conference\n4\n0.29\n25,671\n0.01\n\n\nplan of care\n4\n0.29\n646,309\n0.28\n\n\nanesthesia followup note\n3\n0.22\n48,523\n0.02\n\n\nbh treatment plan\n3\n0.22\n7,561\n0.00\n\n\ncare conference\n3\n0.22\n29,554\n0.01\n\n\ncath angio\n3\n0.22\n42,514\n0.02\n\n\nclinical letter\n3\n0.22\n357,922\n0.16\n\n\ncommittee review\n3\n0.22\n21,630\n0.01\n\n\nconsult follow up\n3\n0.22\n103,375\n0.05\n\n\nechocardiography\n3\n0.22\n287,578\n0.13\n\n\nhome health plan of care\n3\n0.22\n674\n0.00\n\n\nir procedure notes\n3\n0.22\n13,264\n0.01\n\n\nl&d delivery note\n3\n0.22\n62,042\n0.03\n\n\nrespiratory care\n3\n0.22\n10,302\n0.00\n\n\nresult encounter note\n3\n0.22\n37,539\n0.02\n\n\nsubjective & objective\n3\n0.22\n120,904\n0.05\n\n\ntransfer center follow up clinical screen\n3\n0.22\n9,203\n0.00\n\n\ntransfer center initial clinical screen\n3\n0.22\n20,031\n0.01\n\n\nacp (advance care planning)\n2\n0.14\n752\n0.00\n\n\ncardiac angio\n2\n0.14\n6,686\n0.00\n\n\ncase communication\n2\n0.14\n8,315\n0.00\n\n\ndischarge instr - brief hospital\n2\n0.14\n76,477\n0.03\n\n\ned triage notes\n2\n0.14\n13,480\n0.01\n\n\nelectrophysiology\n2\n0.14\n26,980\n0.01\n\n\nevent note\n2\n0.14\n3,478\n0.00\n\n\nhiv lab restricted\n2\n0.14\n162,940\n0.07\n\n\nlab only\n2\n0.14\n1,341\n0.00\n\n\nlab only - beaker\n2\n0.14\n45,177\n0.02\n\n\nltc provider review\n2\n0.14\n2,003\n0.00\n\n\nmanual entry imaging\n2\n0.14\n7,752\n0.00\n\n\nradiation oncology treatment summary\n2\n0.14\n25,144\n0.01\n\n\nreference labs\n2\n0.14\n503,157\n0.22\n\n\nspeech language pathology\n2\n0.14\n36,237\n0.02\n\n\ntransfer of care summary\n2\n0.14\n21,769\n0.01\n\n\nvisit note\n2\n0.14\n12,203\n0.01\n\n\naddendum note\n1\n0.07\n2,098,264\n0.92\n\n\nanesthesia pre-op\n1\n0.07\n4,118\n0.00\n\n\ncardiac monitors\n1\n0.07\n732\n0.00\n\n\ncode documentation\n1\n0.07\n1,069\n0.00\n\n\ndisch intstr - brief hosp trans\n1\n0.07\n41,461\n0.02\n\n\ndischarge instr - activity\n1\n0.07\n15,477\n0.01\n\n\ndischarge instr - appointments\n1\n0.07\n38,729\n0.02\n\n\ndischarge instr - diet\n1\n0.07\n14,731\n0.01\n\n\ndischarge instr - radiology\n1\n0.07\n291\n0.00\n\n\nent\n1\n0.07\n1,473\n0.00\n\n\ninterim summary\n1\n0.07\n22,826\n0.01\n\n\nmanual entry lab\n1\n0.07\n31,434\n0.01\n\n\nmedication review\n1\n0.07\n20,691\n0.01\n\n\nmock-up query\n1\n0.07\n2,147\n0.00\n\n\nmulti-disciplinary team discussion\n1\n0.07\n19\n0.00\n\n\nnutrition services\n1\n0.07\n179,213\n0.08\n\n\nor postop\n1\n0.07\n4,351\n0.00\n\n\not\n1\n0.07\n16,264\n0.01\n\n\npre-procedure assessment\n1\n0.07\n3,159\n0.00\n\n\npre-procedure instructions\n1\n0.07\n1,953\n0.00\n\n\nrehab evaluation\n1\n0.07\n86,611\n0.04\n\n\nresearch note\n1\n0.07\n4,243\n0.00\n\n\ntelephone encounter follow up\n1\n0.07\n45,473\n0.02",
    "crumbs": [
      "About",
      "Data Labeling",
      "May 2025",
      "PHI labeling",
      "Labeling Report"
    ]
  },
  {
    "objectID": "aug_2025/tumor_board.html",
    "href": "aug_2025/tumor_board.html",
    "title": "Tumor Board",
    "section": "",
    "text": "Summary:\nAs of May 2025, Tumor Board encounters are defined using the EPIC patient encounter data tables. Specifically, Thoracic Tumor Board patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers in addition to having a Tumor Board encounter.\nNote: Thoracic Tumor Board definition will be narrowed further due to observations from cross-comparison between encounter data in Epic Hyperspace versus Epic Clarity.\nAs of May 2025, From 13,598 patients with thoracic cancer, 2,662 also had a Tumor Board encounter.\n\n\nSummary of Patient Population\nThe demographic categories examined include Age, Sex, Race, and Ethnicity.\n\n\n\n\n\n\n\n\nThoracic Tumor Board\n\n\nCharacteristic\n\nCount (N)\nPercentage (%)\n\n\n\n\nTotal\nTotal number of pts\n2,662\n100\n\n\nAge\n0-17\n2\n0\n\n\nAge\n18-44\n92\n3\n\n\nAge\n45-64\n627\n24\n\n\nAge\n65+\n1,941\n73\n\n\nSex\nMale\n1,222\n46\n\n\nSex\nFemale\n1,439\n54\n\n\nSex\nUnknown\n1\n0\n\n\nRace\nAmerican Indian-Alaska Native\n8\n0\n\n\nRace\nAsian\n834\n31\n\n\nRace\nNative Hawaii\n26\n1\n\n\nRace\nBlack\n71\n3\n\n\nRace\nWhite\n1,420\n53\n\n\nRace\nOther-Unknown\n303\n11\n\n\nEthnicity\nHispanic Latino\n193\n7\n\n\nEthnicity\nNOT Hispanic Latino\n2,407\n90\n\n\nEthnicity\nOther-Missing\n62\n2\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Case Status\nThe Stanford Cancer Registry keeps track of every cancer case at Stanford and uses theÂ case status variableÂ to monitor each caseâs progress. The major categories are:Â Completed, Not Reportable,Â andÂ Incomplete.\n\nNot ReportableÂ cases refer to cases that are not reportable to the state per cancer registry rules, or those that have already been abstracted.\nIncompleteÂ cases are reportable and have been abstracted, but are marked as incomplete due to pending treatment information or unresolved edit errors. These edits can arise for a variety of reasons, such as version changes by the state registry or code updates by standard-setting agencies.\nCompletedÂ cases are reportable, have been fully abstracted, and have passed all edit checks. These cases are transmitted to the state.\n\nPlease note that theÂ IncompleteÂ case status is eventually updated to eitherÂ CompletedÂ orÂ Not Reportable.\nThe distribution of case status for Thoracic Tumor Board encounter patients are listed below:\n\n\n\n\n\n\n\n\n\n\n\nCase Status\nNumber of Patients\n\n\n\n\nComplete\n2,228\n\n\nIncomplete\n130\n\n\nNot Reportable\n304\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nImage Occurrence\nAs of May 2025, 2,659 with thoracic tumor board encounter had image occurrence procedures.\n\nAnatomic SitesModality Types\n\n\n\n\n\n\n\n\n\n\nNote: The following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report, REG: Registration, KO: Key Object Selection, PR: Presentation State"
  },
  {
    "objectID": "aug_2025/tumor_board_updated.html",
    "href": "aug_2025/tumor_board_updated.html",
    "title": "Tumor Board",
    "section": "",
    "text": "Tumor Board encounters are defined using the OMOP visit_occurrence table, where the source value for the visit contains the phrase âtumor boardâ. Specifically, Thoracic Tumor Board patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers in addition to having a Tumor Board encounter.\nNote: Thoracic Tumor Board definition will be narrowed further due to observations from cross-comparison between encounter data in Epic Hyperspace versus Epic Clarity.\nAs of August 2025, From 13,880 patients with thoracic cancer, 2,748 also had a Tumor Board encounter."
  },
  {
    "objectID": "aug_2025/tumor_board_updated.html#tumor-board-encounter",
    "href": "aug_2025/tumor_board_updated.html#tumor-board-encounter",
    "title": "Tumor Board",
    "section": "Tumor Board Encounter",
    "text": "Tumor Board Encounter"
  },
  {
    "objectID": "aug_2025/tumor_board_updated.html#data-sources-across-tumor-board",
    "href": "aug_2025/tumor_board_updated.html#data-sources-across-tumor-board",
    "title": "Tumor Board",
    "section": "Data Sources Across Tumor Board",
    "text": "Data Sources Across Tumor Board\n\n\n\n\n\n\n\n\nData Sources Across Tumor Board\n\n\nData Sources\nCount (N)\nPercentage (%)\n\n\n\n\nTumor Board Patients\n25,897\n100\n\n\nTumor Board Patients with Registry Data\n22,386\n86\n\n\nTumor Board Patients with Imaging and Registry Data\n21,766\n84\n\n\nTumor Board Patients with Imaging and Genomic Data\n3,855\n15\n\n\nTumor Board Patients with Thoracic Cancer\n2,748\n11\n\n\n\n\n\n\n\n\n\n\n\n\n\nSummary of Patient Population\nThe demographic categories examined include Age, Sex, Race, and Ethnicity.\n\n\n\n\n\n\n\n\nThoracic Tumor Board\n\n\nCharacteristic\n\nCount (N)\nPercentage (%)\n\n\n\n\nTotal\nTotal number of pts\n2,748\n100\n\n\nAge\n0-17\n2\n0\n\n\nAge\n18-44\n95\n3\n\n\nAge\n45-64\n637\n23\n\n\nAge\n65+\n2,014\n73\n\n\nSex\nMale\n1,253\n46\n\n\nSex\nFemale\n1,494\n54\n\n\nSex\nUnknown\n1\n0\n\n\nRace\nAmerican Indian-Alaska Native\n8\n0\n\n\nRace\nAsian\n858\n31\n\n\nRace\nNative Hawaii\n26\n1\n\n\nRace\nBlack\n75\n3\n\n\nRace\nWhite\n1,465\n53\n\n\nRace\nOther-Unknown\n316\n11\n\n\nEthnicity\nHispanic Latino\n201\n7\n\n\nEthnicity\nNOT Hispanic Latino\n2,485\n90\n\n\nEthnicity\nOther-Missing\n62\n2\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNeural Frame Case Status\nThe Stanford Cancer Registry keeps track of every cancer case at Stanford and uses theÂ case status variableÂ to monitor each caseâs progress. The major categories are:Â Completed, Not Reportable,Â andÂ Incomplete.\n\nNot ReportableÂ cases refer to cases that are not reportable to the state per cancer registry rules, or those that have already been abstracted.\nIncompleteÂ cases are reportable and have been abstracted, but are marked as incomplete due to pending treatment information or unresolved edit errors. These edits can arise for a variety of reasons, such as version changes by the state registry or code updates by standard-setting agencies.\nCompletedÂ cases are reportable, have been fully abstracted, and have passed all edit checks. These cases are transmitted to the state.\n\nPlease note that theÂ IncompleteÂ case status is eventually updated to eitherÂ CompletedÂ orÂ Not Reportable.\nThe distribution of case status for Thoracic Tumor Board encounter patients are listed below:\n\n\n\n\n\n\n\n\n\n\n\nCase Status\nNumber of Patients\n\n\n\n\nComplete\n2,289\n\n\nNot Reportable\n309\n\n\nIncomplete\n150\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nImage Occurrence\nAs of August 2025, out of 2,748 thoracic tumor board patients,\n2,715 (98.8%) also had image occurrence procedures.\nNote: The following analysis is presented for series occurrences above 500.\n\nAnatomic SitesModality Types\n\n\n\n\n\n\n\n\n\n\nThe following modality source values without image pixel were excluded from the analysis:\nSR: Structured Report, REG: Registration, KO: Key Object Selection, PR: Presentation State"
  },
  {
    "objectID": "may_2025/philips_metrics.html",
    "href": "may_2025/philips_metrics.html",
    "title": "Philips ISPM",
    "section": "",
    "text": "Philips IntelliSpace Precision Medicine (ISPM) includes genomics database at Stanford. This data is geared towards identifying genetic mutations that can be targeted for precision medicine, with the goal of improving therapeutic outcomes through personalized treatment strategies. As of May 2025, 15,541 STAMP tests were ordered for 10,972 patients.\n\n\n\n\n\n\n\n\n\n\n\nTest Types\nN_Case\nMin_Date\nMax_Date\n\n\n\n\nStanford Stamp Test\n15,369\n2018-03\n2025-03\n\n\nFoundation One Ckb Test\n172\n2016-10\n2025-03\n\n\n\nTotal number of ordered tests: 15,541"
  },
  {
    "objectID": "may_2025/philips_metrics.html#aberration-metrics",
    "href": "may_2025/philips_metrics.html#aberration-metrics",
    "title": "Philips ISPM",
    "section": "Aberration Metrics:",
    "text": "Aberration Metrics:\nThe aberration table provides a structured overview of genetic changes, categorizing them into specific types and broader classes. Each entry in the table includes the following key components:\n\nAberration Types: An aberration type describes a specific change to DNA. These are specific alterations in DNA that can affect gene function and contribute to various diseases. Each type represents a distinct change, such as missense variant, deletions, duplications, or point mutations.\nChromosomes: This field indicates the chromosomal location of the gene associated with the aberration. For example if a gene is located on chromosome 17, it will be presented as âchr17â.\nHGNC Gene and Detected Mutations: The HGNC (HUGO Gene Nomenclature Committee) provides standardized names for human genes. Detected mutations refer to specific changes found in these genes that may be important for specific therapies, such as gene therapy or personalized medicine.\n\n\nAll Cancer TypesThoracic Cancer\n\n\nThe following analysis displays the genes distribution of positive aberration above 200 cases.\n\nBarplotHeatmap\n\n\nHGNC Gene Distribution:\n\n\n\n\n\n\n\nSummary Table of HGNC Gene Distribution\n\n\n\n\n\n\n\n\n\nGenes Distribution by Chromosomes\n\n\n\n\n\n\n\n\n\n\nDistribution of Genes by Aberration Type\n\n\n\n\n\n\n\n\n\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers.\nFrom 13,598 unique thoracic patients, 2,161 patients were included in Philips ISPM database with 2,135 aberration cases.\n\nDistribution of Gene Types by Pathogenicity\n\n\n\n\n\n\n\n\nKRAS Mutations\nThe KRAS gene is a critical component in cell signaling pathways that regulate cell growth and division, and mutations in this gene are frequently associated with various cancers including thoracic cancers. Among patients with thoracic cancer with mutations in the KRAS gene, the most common amino acid alterations occurring are listed as follow:"
  },
  {
    "objectID": "may_2025/philips_metrics.html#summary-table-of-hgnc-gene-distribution",
    "href": "may_2025/philips_metrics.html#summary-table-of-hgnc-gene-distribution",
    "title": "Philips ISPM",
    "section": "Summary Table of HGNC Gene Distribution",
    "text": "Summary Table of HGNC Gene Distribution"
  },
  {
    "objectID": "may_2025/philips_metrics.html#distribution-of-genes-by-aberration-type",
    "href": "may_2025/philips_metrics.html#distribution-of-genes-by-aberration-type",
    "title": "Philips ISPM",
    "section": "Distribution of Genes by Aberration Type",
    "text": "Distribution of Genes by Aberration Type"
  },
  {
    "objectID": "may_2025/philips_metrics.html#distribution-of-gene-types-by-pathogenicity",
    "href": "may_2025/philips_metrics.html#distribution-of-gene-types-by-pathogenicity",
    "title": "Philips ISPM",
    "section": "Distribution of Gene Types by Pathogenicity",
    "text": "Distribution of Gene Types by Pathogenicity"
  },
  {
    "objectID": "may_2025/philips_metrics.html#kras-mutations",
    "href": "may_2025/philips_metrics.html#kras-mutations",
    "title": "Philips ISPM",
    "section": "KRAS Mutations",
    "text": "KRAS Mutations\nThe KRAS gene is a critical component in cell signaling pathways that regulate cell growth and division, and mutations in this gene are frequently associated with various cancers including thoracic cancers. Among patients with thoracic cancer with mutations in the KRAS gene, the most common amino acid alterations occurring are listed as follow:"
  },
  {
    "objectID": "aug_2025/philips_metrics.html",
    "href": "aug_2025/philips_metrics.html",
    "title": "Philips ISPM",
    "section": "",
    "text": "Philips IntelliSpace Precision Medicine (ISPM) includes genomics database at Stanford. This data is geared towards identifying genetic mutations that can be targeted for precision medicine, with the goal of improving therapeutic outcomes through personalized treatment strategies. As of August 2025, 20,090 STAMP tests were ordered for 14,106 patients.\n\n\n\n\n\n\n\n\n\n\n\nTest Types\nN_Case\nMin_Date\nMax_Date\n\n\n\n\nFoundation One Ckb Test\n3,437\n2001-07\n2025-07\n\n\nStanford Stamp Test\n16,653\n2018-03\n2025-07\n\n\n\nTotal number of ordered tests: 20,090\n\n\n\n\n\n\n\n\nNote: Additional FoundationOne (F1) test data was backfilled between the May release and the Philips export dated from 07/13/25 to 08/05/25, which was used for the August release. More data is expected in future releases"
  },
  {
    "objectID": "aug_2025/philips_metrics.html#aberration-metrics",
    "href": "aug_2025/philips_metrics.html#aberration-metrics",
    "title": "Philips ISPM",
    "section": "Aberration Metrics:",
    "text": "Aberration Metrics:\nThe aberration table provides a structured overview of genetic changes, categorizing them into specific types and broader classes. Each entry in the table includes the following key components:\n\nAberration Types: An aberration type describes a specific change to DNA. These are specific alterations in DNA that can affect gene function and contribute to various diseases. Each type represents a distinct change, such as missense variant, deletions, duplications, or point mutations.\nChromosomes: This field indicates the chromosomal location of the gene associated with the aberration. For example if a gene is located on chromosome 17, it will be presented as âchr17â.\nHGNC Gene and Detected Mutations: The HGNC (HUGO Gene Nomenclature Committee) provides standardized names for human genes. Detected mutations refer to specific changes found in these genes that may be important for specific therapies, such as gene therapy or personalized medicine.\n\n\nAll Cancer TypesThoracic Cancer\n\n\nThe following analysis displays the genes distribution of positive aberration above 200 cases.\n\nBarplotHeatmap\n\n\nHGNC Gene Distribution:\n\n\n\n\n\n\n\nSummary Table of HGNC Gene Distribution\n\n\n\n\n\n\n\n\n\nGenes Distribution by Chromosomes\n\n\n\n\n\n\n\n\n\n\nDistribution of Genes by Aberration Type\n\n\n\n\n\n\n\n\n\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancers.\nFrom 13,880 unique thoracic patients, 2,390 patients were included in Philips ISPM database with 2,362 aberration cases.\n\nDistribution of Gene Types by Pathogenicity\n\n\n\n\n\n\n\n\nKRAS Mutations\nThe KRAS gene is a critical component in cell signaling pathways that regulate cell growth and division, and mutations in this gene are frequently associated with various cancers including thoracic cancers. Among patients with thoracic cancer with mutations in the KRAS gene, the most common amino acid alterations occurring are listed as follow:"
  },
  {
    "objectID": "aug_2025/philips_metrics.html#summary-table-of-hgnc-gene-distribution",
    "href": "aug_2025/philips_metrics.html#summary-table-of-hgnc-gene-distribution",
    "title": "Philips ISPM",
    "section": "Summary Table of HGNC Gene Distribution",
    "text": "Summary Table of HGNC Gene Distribution"
  },
  {
    "objectID": "aug_2025/philips_metrics.html#distribution-of-genes-by-aberration-type",
    "href": "aug_2025/philips_metrics.html#distribution-of-genes-by-aberration-type",
    "title": "Philips ISPM",
    "section": "Distribution of Genes by Aberration Type",
    "text": "Distribution of Genes by Aberration Type"
  },
  {
    "objectID": "aug_2025/philips_metrics.html#distribution-of-gene-types-by-pathogenicity",
    "href": "aug_2025/philips_metrics.html#distribution-of-gene-types-by-pathogenicity",
    "title": "Philips ISPM",
    "section": "Distribution of Gene Types by Pathogenicity",
    "text": "Distribution of Gene Types by Pathogenicity"
  },
  {
    "objectID": "aug_2025/philips_metrics.html#kras-mutations",
    "href": "aug_2025/philips_metrics.html#kras-mutations",
    "title": "Philips ISPM",
    "section": "KRAS Mutations",
    "text": "KRAS Mutations\nThe KRAS gene is a critical component in cell signaling pathways that regulate cell growth and division, and mutations in this gene are frequently associated with various cancers including thoracic cancers. Among patients with thoracic cancer with mutations in the KRAS gene, the most common amino acid alterations occurring are listed as follow:"
  },
  {
    "objectID": "aug_2025/neural_frame.html",
    "href": "aug_2025/neural_frame.html",
    "title": "Neural Frame Metrics",
    "section": "",
    "text": "The Stanford Cancer Registry data is integrated with the California Cancer Registry and updated monthly, encompassing approximately 800 variables related to various cancer. As of January 2022, the KACIÂ® application from NeuralFrame was approved for abstracting and transmitting diagnosed cases, with Stanford adopting it in 2023. Neural Frame connects to EPIC to extract relevant data, including pathology notes.\nWithin Neural Frame, Class of Case (CoC) divides cases into two groups: cancer cases are categorized as Analytic (reportable with complete data) or Non-analytic (not reportable by law, with complete data only from 2022 onward).\n\nAnalytic: Analytic cases include patients with initial diagnoses and full or partial treatments at Stanford. Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the programâs primary responsibility in managing the cancer. Analytic cases are grouped according to the location of diagnosis and treatment.\nNon-analytic: Non-analytic cases include recurrences, consults only, and in-transit patients. Non-analytic cases (codes 30-49 and 99) can be abstracted by the facility to fulfill central registry requirements or upon request from the facilityâs cancer program. The grouping of non-analytic cases is based on the reason for their classification, whether they received care at the facility or were abstracted for other reasons."
  },
  {
    "objectID": "aug_2025/neural_frame.html#thoracic-cancer-cohort",
    "href": "aug_2025/neural_frame.html#thoracic-cancer-cohort",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Cohort",
    "text": "Thoracic Cancer Cohort\nThoracic cancer patients are identified based on their primary site descriptions in the Neural Frame diagnoses data, which include diagnoses of lung, bronchus, or thymus cancer. The thoracic cancer cohort includes patients diagnosed with primary malignancies located in the thoracic cavity, as defined by the International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) primary site codes. Specifically, the cohort is defined by the following ICD-O-3 topography codes:\n\nC34.0 â Main bronchus\nC34.1 â Upper lobe, lung\nC34.2 â Middle lobe, lung\nC34.3 â Lower lobe, lung\nC34.8 â Overlapping lesion of lung\nC34.9 â Lung, not otherwise specified (NOS)\nC37.9 â Thymus"
  },
  {
    "objectID": "aug_2025/neural_frame.html#multiple-primary",
    "href": "aug_2025/neural_frame.html#multiple-primary",
    "title": "Neural Frame Metrics",
    "section": "Multiple Primary",
    "text": "Multiple Primary\nWithin the thoracic cancer cohort, a subset of patients presents with multiple primary thoracic malignancies. This designation refers to the presence of two or more histologically distinct malignant tumors arising independently within the thoracic cavity, rather than as metastases from a single primary site. These neoplasms may occur synchronously, identified concurrently or within a short time interval, or metachronously, developing at distinct time points."
  },
  {
    "objectID": "aug_2025/neural_frame.html#thoracic-cancer-metrics",
    "href": "aug_2025/neural_frame.html#thoracic-cancer-metrics",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Metrics",
    "text": "Thoracic Cancer Metrics\nThis visualization summarizes the characteristics of thoracic cancer cases by:\n\nCases, Diagnoses, Staging\nTreatment\nSocial History\nFollow up Outcome\n\n\nCases & DiagnosesTreatmentFollow-up OutcomeSocial History\n\n\n\nStanford Cancer Registry Case Status\nThe Stanford Cancer Registry tracks all cancer cases diagnosed or treated at Stanford. Each case is assigned a case status to reflect its reporting stage. The primary categories include:\n\nCompleted: Reportable cases that have been fully abstracted and passed all edit checks. These cases are transmitted to the state registry.\nNot Reportable: Cases that do not meet state reporting requirements or have already been abstracted and submitted.\nIncomplete/Suspense: Reportable cases that have been abstracted but cannot yet be transmitted due to missing treatment information or unresolved edit errors. These may result from version changes, coding updates, or other registry requirements.\n\nThe case status ensures accurate tracking and timely reporting of cancer data to meet regulatory and research standards.\nAs of August 2025, there are 13,880 unique thoracic cancer patients with 78% completed cases.\n\n\n\n\n\n\n\n\n\n\n\nPatient Summary by Diagnosis Year\nThe following distribution summarizes the number of diagnosed thoracic patients over time.\n\n\n\n\n\n\n\n\nHistology Distribution & ICDO3 Codes\nThoracic cancer encompasses a diverse group of histologic subtypes, with Non-Small Cell Lung Cancer (NSCLC) representing the majority of cases and Small Cell Lung Cancer (SCLC).\nThoracic cancer is categorized into detailed histologic groups using ICD-O-3 codes and then further grouped into four overarching categories for simplified analysis. The main histology groups include:\n\nNon-Small Cell Lung Carcinoma (NSCLC): This group encompasses the majority of lung cancer and includes subtypes such as:\n\nAdenocarcinoma (8140â8147)\nSquamous Cell Carcinoma (8070â8080)\nLarge Cell Carcinoma (8010â8015)\nNon-Small Cell Carcinoma NOS (8046)\n\nSmall Cell Lung Carcinoma (SCLC): Represented by ICD-O-3 codes 8041â8045, this group is characterized by more aggressive, rapidly progressing tumors.\nOther Specified Histologies: These include a range of less common thoracic cancer such as:\n\nCarcinoid Tumors (8240â8249)\nSarcoma (8800â8806)\nMesothelioma (9050â9053)\nAcinar Cell Carcinoma (8550â8551)\nBronchiolo-alveolar Carcinoma (8250â8257)\nNeoplasms (8000â8005)\nPapillary Adenocarcinoma (8260â8265)\nPapillary Carcinoma (8050â8052)\n\nOther/Unspecified Histologies: Any histology not falling into the categories above.\n\n\n\nThoracic Cancer Histology Distribution\nFrom 10,826 thoracic patients with completed cases, the majority 7,602 were diagnosed with Non-Small Cell Lung Carcinoma (NSCLC).\n\n\n\n\n\n\n\n\n\n\n\n\nHistology\nN(%) of Patients\n\n\n\n\nNSCLC\n7,602 (70.2%)\n\n\nOther Specified\n1,891 (17.5%)\n\n\nOther Unspecified\n1,138 (10.5%)\n\n\nSCLC\n561 (5.2%)\n\n\n\nNote: Patients could have multiple histologies\n\n\n\n\n\n\n\n\n\n\n\nHistology Type Summary\n\nBar PlotICDO3 Table\n\n\nThe following horizontal bar chart presents the hierarchical distribution of thoracic cancer cases, showing both major categories (NSCLC, SCLC, Other Specified, and Other Unspecified) and their corresponding histological subtypes.\n\nClick legend items to show/hide specific main categories\nHover over bars to see detailed information\nDouble-click legend items to isolate a single category o to restore all categories\n\n\nDistribution of Thoracic Cancer Cases by Histology Types\n\n\n\n\n\n\n\n\nTable Summary of Histology Groups\n\n\n\n\n\n\n\n\n\nAll the ICDO3 code and histology subgrouping are listed in the following table:\n\n\n\n\n\n\n\n\n\n\n\nCancer Staging\nCancer staging is categorized as:\n\nStage 0: Carcinoma in situ (neoplastic cells confined to the epithelium without invasion) with no evidence of invasion beyond the basement membrane.\nOccult: A malignancy is confirmed by cytology or metastatic presentation without a known primary, meaning that the primary tumor is not clinically or radiologically identifiable.\nStage I: A localized tumor confined to the organ of origin, with no regional lymph node involvement or distant metastasis.\nStage II: A tumor of larger size or with limited regional extension that may involve adjacent structures or limited regional lymph nodes.\nStage III: Locally advanced disease characterized by involvement of regional lymph nodes and/or extension to nearby tissues.\nStage IV: Distant metastatic disease where the tumor has spread to distant organs or non-regional lymph nodes.\n\n\n\nSummary of Staging of Thoracic Cancer Patients\nThe following table summarizes the staging status of thoracic patients with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nStaging Status\nPatient Count\nPercentage (%)\n\n\n\n\nStage IV: Distant metastatic disease\n4,416\n41\n\n\nStage I: Localized tumor confined to the organ of origin\n2,859\n26\n\n\nStage III: Locally advanced disease\n1,832\n17\n\n\nUnknown\n1,034\n10\n\n\nStage II: Larger tumor size or limited regional extension\n790\n7\n\n\nOccult: Malignancy confirmed by cytology or metastatic presentation without known primary\n49\n0\n\n\nStage 0: Carcinoma in situ\n39\n0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe following table summarizes the distribution of thoracic cancer treatment types including chemotherapy, radiation therapy, and surgery across the patient cohort with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nTreatment\nPatient Count\nPercentage\n\n\n\n\nChemotherapy\n5,336\n49\n\n\nSurgery\n4,717\n44\n\n\nRadiation Therapy\n4,311\n40\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe following table summarizes the distribution of thoracic cancer recurrence status with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nRecurrence Type Category\nPatient Count\n\n\n\n\nNever been disease-free\n6,346\n\n\nDisease-free after treatment and has not had a recurrence\n4,229\n\n\nDistant recurrence\n436\n\n\nIt is unknown whether the disease has recurred or if the patient was ever disease-free.\n304\n\n\nLocal recurrence\n248\n\n\nDisease has recurred, but the type of recurrence is unknown.\n190\n\n\nRegional recurrence\n97\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFrom 13,880 unique thoracic cancer patients, the majority didnât have any records of smoking status and alcohol use in Neural Frame.\n\nSmoking Status (Neural Frame)\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nNot Available\n13,707\n\n\nNever used\n110\n\n\nPrevious use\n79\n\n\nCigarette smoker, current\n31\n\n\nUnknown\n3\n\n\n\nNote: sum of sungroups exceeds the denominator due to multiple responses by patients\n\n\n\n\n\n\n\n\n\n\nSmoking Status (OMOP)\nThe information regarding the most recent smoking status of patients with thoracic cancer was generated by querying the OMOP database. For patients diagnosed with lung, bronchus, or thymus cancer, relevant patient records were linked to their smoking status in OMOP observation table by filtering out the smoking concept ID (43054909), which included multiple entries over time. By ranking these entries by date, the analysis focused on retrieving only the most recent smoking status for each patient as follow.\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nFormer\n6,219\n\n\nNever\n4,425\n\n\nEvery Day\n685\n\n\nNever Assessed\n313\n\n\nSome Days\n120\n\n\nUnknown\n29\n\n\nPassive Smoke Exposure - Never Smoker\n29\n\n\nLight Smoker\n18\n\n\nHeavy Smoker\n12\n\n\nSmoker, Current Status Unknown\n8\n\n\n\nNote: 2,022 patients didn't have smoking concept ID in the observation table\n\n\n\n\n\n\n\n\n\n\nAlcohol Use (Neural Frame)\n\n\n\n\n\n\n\n\n\n\n\nDescription\nPatient Count\n\n\n\n\nNot Available\n13,795\n\n\nNo history of alcohol use\n72\n\n\nCurrent use of alcohol\n35\n\n\nPast history of alcohol use, does not currently use\n10\n\n\nAlcohol usage unknown\n3\n\n\n\nNote: sum of sungroups exceeds the denominator due to multiple responses by patients"
  },
  {
    "objectID": "aug_2025/neural_frame.html#stanford-cancer-registry-case-status",
    "href": "aug_2025/neural_frame.html#stanford-cancer-registry-case-status",
    "title": "Neural Frame Metrics",
    "section": "Stanford Cancer Registry Case Status",
    "text": "Stanford Cancer Registry Case Status\nThe Stanford Cancer Registry tracks all cancer cases diagnosed or treated at Stanford. Each case is assigned a case status to reflect its reporting stage. The primary categories include:\n\nCompleted: Reportable cases that have been fully abstracted and passed all edit checks. These cases are transmitted to the state registry.\nNot Reportable: Cases that do not meet state reporting requirements or have already been abstracted and submitted.\nIncomplete/Suspense: Reportable cases that have been abstracted but cannot yet be transmitted due to missing treatment information or unresolved edit errors. These may result from version changes, coding updates, or other registry requirements.\n\nThe case status ensures accurate tracking and timely reporting of cancer data to meet regulatory and research standards.\nAs of August 2025, there are 13,880 unique thoracic cancer patients with 78% completed cases."
  },
  {
    "objectID": "aug_2025/neural_frame.html#patient-summary-by-diagnosis-year",
    "href": "aug_2025/neural_frame.html#patient-summary-by-diagnosis-year",
    "title": "Neural Frame Metrics",
    "section": "Patient Summary by Diagnosis Year",
    "text": "Patient Summary by Diagnosis Year\nThe following distribution summarizes the number of diagnosed thoracic patients over time."
  },
  {
    "objectID": "aug_2025/neural_frame.html#histology-distribution-icdo3-codes",
    "href": "aug_2025/neural_frame.html#histology-distribution-icdo3-codes",
    "title": "Neural Frame Metrics",
    "section": "Histology Distribution & ICDO3 Codes",
    "text": "Histology Distribution & ICDO3 Codes\nThoracic cancer encompasses a diverse group of histologic subtypes, with Non-Small Cell Lung Cancer (NSCLC) representing the majority of cases and Small Cell Lung Cancer (SCLC).\nThoracic cancer is categorized into detailed histologic groups using ICD-O-3 codes and then further grouped into four overarching categories for simplified analysis. The main histology groups include:\n\nNon-Small Cell Lung Carcinoma (NSCLC): This group encompasses the majority of lung cancer and includes subtypes such as:\n\nAdenocarcinoma (8140â8147)\nSquamous Cell Carcinoma (8070â8080)\nLarge Cell Carcinoma (8010â8015)\nNon-Small Cell Carcinoma NOS (8046)\n\nSmall Cell Lung Carcinoma (SCLC): Represented by ICD-O-3 codes 8041â8045, this group is characterized by more aggressive, rapidly progressing tumors.\nOther Specified Histologies: These include a range of less common thoracic cancer such as:\n\nCarcinoid Tumors (8240â8249)\nSarcoma (8800â8806)\nMesothelioma (9050â9053)\nAcinar Cell Carcinoma (8550â8551)\nBronchiolo-alveolar Carcinoma (8250â8257)\nNeoplasms (8000â8005)\nPapillary Adenocarcinoma (8260â8265)\nPapillary Carcinoma (8050â8052)\n\nOther/Unspecified Histologies: Any histology not falling into the categories above."
  },
  {
    "objectID": "aug_2025/neural_frame.html#thoracic-cancer-histology-distribution",
    "href": "aug_2025/neural_frame.html#thoracic-cancer-histology-distribution",
    "title": "Neural Frame Metrics",
    "section": "Thoracic Cancer Histology Distribution",
    "text": "Thoracic Cancer Histology Distribution\nFrom 10,826 thoracic patients with completed cases, the majority 7,602 were diagnosed with Non-Small Cell Lung Carcinoma (NSCLC).\n\n\n\n\n\n\n\n\n\n\n\n\nHistology\nN(%) of Patients\n\n\n\n\nNSCLC\n7,602 (70.2%)\n\n\nOther Specified\n1,891 (17.5%)\n\n\nOther Unspecified\n1,138 (10.5%)\n\n\nSCLC\n561 (5.2%)\n\n\n\nNote: Patients could have multiple histologies"
  },
  {
    "objectID": "aug_2025/neural_frame.html#histology-type-summary",
    "href": "aug_2025/neural_frame.html#histology-type-summary",
    "title": "Neural Frame Metrics",
    "section": "Histology Type Summary",
    "text": "Histology Type Summary\n\nBar PlotICDO3 Table\n\n\nThe following horizontal bar chart presents the hierarchical distribution of thoracic cancer cases, showing both major categories (NSCLC, SCLC, Other Specified, and Other Unspecified) and their corresponding histological subtypes.\n\nClick legend items to show/hide specific main categories\nHover over bars to see detailed information\nDouble-click legend items to isolate a single category o to restore all categories\n\n\nDistribution of Thoracic Cancer Cases by Histology Types\n\n\n\n\n\n\n\n\nTable Summary of Histology Groups\n\n\n\n\n\n\n\n\n\nAll the ICDO3 code and histology subgrouping are listed in the following table:"
  },
  {
    "objectID": "aug_2025/neural_frame.html#distribution-of-thoracic-cancer-cases-by-histology-types",
    "href": "aug_2025/neural_frame.html#distribution-of-thoracic-cancer-cases-by-histology-types",
    "title": "Neural Frame Metrics",
    "section": "Distribution of Thoracic Cancer Cases by Histology Types",
    "text": "Distribution of Thoracic Cancer Cases by Histology Types"
  },
  {
    "objectID": "aug_2025/neural_frame.html#table-summary-of-histology-groups",
    "href": "aug_2025/neural_frame.html#table-summary-of-histology-groups",
    "title": "Neural Frame Metrics",
    "section": "Table Summary of Histology Groups",
    "text": "Table Summary of Histology Groups"
  },
  {
    "objectID": "aug_2025/neural_frame.html#cancer-staging",
    "href": "aug_2025/neural_frame.html#cancer-staging",
    "title": "Neural Frame Metrics",
    "section": "Cancer Staging",
    "text": "Cancer Staging\nCancer staging is categorized as:\n\nStage 0: Carcinoma in situ (neoplastic cells confined to the epithelium without invasion) with no evidence of invasion beyond the basement membrane.\nOccult: A malignancy is confirmed by cytology or metastatic presentation without a known primary, meaning that the primary tumor is not clinically or radiologically identifiable.\nStage I: A localized tumor confined to the organ of origin, with no regional lymph node involvement or distant metastasis.\nStage II: A tumor of larger size or with limited regional extension that may involve adjacent structures or limited regional lymph nodes.\nStage III: Locally advanced disease characterized by involvement of regional lymph nodes and/or extension to nearby tissues.\nStage IV: Distant metastatic disease where the tumor has spread to distant organs or non-regional lymph nodes."
  },
  {
    "objectID": "aug_2025/neural_frame.html#summary-of-staging-of-thoracic-cancer-patients",
    "href": "aug_2025/neural_frame.html#summary-of-staging-of-thoracic-cancer-patients",
    "title": "Neural Frame Metrics",
    "section": "Summary of Staging of Thoracic Cancer Patients",
    "text": "Summary of Staging of Thoracic Cancer Patients\nThe following table summarizes the staging status of thoracic patients with completed cases.\n\n\n\n\n\n\n\n\n\n\n\nStaging Status\nPatient Count\nPercentage (%)\n\n\n\n\nStage IV: Distant metastatic disease\n4,416\n41\n\n\nStage I: Localized tumor confined to the organ of origin\n2,859\n26\n\n\nStage III: Locally advanced disease\n1,832\n17\n\n\nUnknown\n1,034\n10\n\n\nStage II: Larger tumor size or limited regional extension\n790\n7\n\n\nOccult: Malignancy confirmed by cytology or metastatic presentation without known primary\n49\n0\n\n\nStage 0: Carcinoma in situ\n39\n0"
  }
]